
<html lang="en"     class="pb-page"  data-request-id="586fac05-6073-41b5-8693-2b441c2acf01"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;issue:issue:10.1021/jmcmar.2011.54.issue-19;pageGroup:string:Publication Pages;subPage:string:Full Text;article:article:10.1021/jm200285z"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="N-(2-{3-[3,5-Bis(trifluoromethyl)phenyl]ureido}ethyl)-glycyrrhetinamide (6b): A Novel Anticancer Glycyrrhetinic Acid Derivative that Targets the Proteasome and Displays Anti-Kinase Activity" /></meta><meta name="dc.Creator" content="Benjamin  Lallemand" /></meta><meta name="dc.Creator" content="Fabien  Chaix" /></meta><meta name="dc.Creator" content="Marina  Bury" /></meta><meta name="dc.Creator" content="Céline  Bruyère" /></meta><meta name="dc.Creator" content="Jean  Ghostin" /></meta><meta name="dc.Creator" content="Jean-Paul  Becker" /></meta><meta name="dc.Creator" content="Cédric  Delporte" /></meta><meta name="dc.Creator" content="Michel  Gelbcke" /></meta><meta name="dc.Creator" content="Véronique  Mathieu" /></meta><meta name="dc.Creator" content="Jacques  Dubois" /></meta><meta name="dc.Creator" content="Martine  Prévost" /></meta><meta name="dc.Creator" content="Ivan  Jabin" /></meta><meta name="dc.Creator" content="Robert  Kiss" /></meta><meta name="dc.Description" content="18-β-Glycyrrhetinic acid (GA; 1) and many of its derivatives are cytotoxic in cancer cells. The current study aims to characterize the anticancer effects of 17 novel 1 derivatives. On the basis of ..." /></meta><meta name="Description" content="18-β-Glycyrrhetinic acid (GA; 1) and many of its derivatives are cytotoxic in cancer cells. The current study aims to characterize the anticancer effects of 17 novel 1 derivatives. On the basis of ..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="September 2, 2011" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm200285z" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2011 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm200285z" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm200285z" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm200285z" /></link>
        
    
    

<title>N-(2-{3-[3,5-Bis(trifluoromethyl)phenyl]ureido}ethyl)-glycyrrhetinamide (6b): A Novel Anticancer Glycyrrhetinic Acid Derivative that Targets the Proteasome and Displays Anti-Kinase Activity | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm200285z" /></meta><meta property="og:title" content="N-(2-{3-[3,5-Bis(trifluoromethyl)phenyl]ureido}ethyl)-glycyrrhetinamide (6b): A Novel Anticancer Glycyrrhetinic Acid Derivative that Targets the Proteasome and Displays Anti-Kinase Activity" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-19/jm200285z/production/images/large/jm-2011-00285z_0006.jpeg" /></meta><meta property="og:description" content="18-β-Glycyrrhetinic acid (GA; 1) and many of its derivatives are cytotoxic in cancer cells. The current study aims to characterize the anticancer effects of 17 novel 1 derivatives. On the basis of these studies, N-(2-{3-[3,5-bis(trifluoromethyl)phenyl]ureido}ethyl)-glycyrrhetinamide (6b) appeared to be the most potent compound, with IC50in vitro growth inhibitory concentrations in single-digit micromolarity in a panel of 8 cancer cell lines. Compound 6b is cytostatic and displays similar efficiency in apoptosis-sensitive versus apoptosis-resistant cancer cell lines through, at least partly, the inhibition of the activity of a cluster of a dozen kinases that are implicated in cancer cell proliferation and in the control of the actin cytoskeleton organization. Compound 6b also inhibits the activity of the 3 proteolytic units of the proteasome. Compound 6b thus represents an interesting hit from which future compounds could be derived to improve chemotherapeutic regimens that aim to combat cancers associated with poor prognoses." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm200285z"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm200285z">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm200285z&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm200285z&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm200285z&amp;href=/doi/10.1021/jm200285z" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2011</span><span class="cit-fg-volume">, 54</span><span class="cit-fg-issue">, 19</span><span class="cit-fg-pageRange">, 6501-6513</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/54/19" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm200114f" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm200312v" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title"><i>N</i>-(2-{3-[3,5-Bis(trifluoromethyl)phenyl]ureido}ethyl)-glycyrrhetinamide (<b>6b</b>): A Novel Anticancer Glycyrrhetinic Acid Derivative that Targets the Proteasome and Displays Anti-Kinase Activity</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Benjamin++Lallemand">Benjamin Lallemand</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Fabien++Chaix">Fabien Chaix</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Marina++Bury">Marina Bury</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=C%C3%A9line++Bruy%C3%A8re">Céline Bruyère</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jean++Ghostin">Jean Ghostin</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jean-Paul++Becker">Jean-Paul Becker</a></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=C%C3%A9dric++Delporte">Cédric Delporte</a></span><span class="author-xref-symbol author-aff-symbol"><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Michel++Gelbcke">Michel Gelbcke</a></span><span class="author-xref-symbol author-aff-symbol"><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=V%C3%A9ronique++Mathieu">Véronique Mathieu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jacques++Dubois">Jacques Dubois</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Martine++Pr%C3%A9vost">Martine Prévost</a></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ivan++Jabin">Ivan Jabin</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Robert++Kiss">Robert Kiss</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-text"><sup>†</sup>Laboratoire de Chimie Bioanalytique, Toxicologie et Chimie Physique Appliquée, <sup>‡</sup>Laboratoire de Toxicologie, and <sup>#</sup>Laboratoire de Chimie Pharmaceutique Organique, Faculté de Pharmacie, Université Libre de Bruxelles (ULB), and <sup>§</sup>Laboratoire de Chimie Organique and <sup>⊥</sup>Laboratoire de Structure et Fonction des Membranes Biologiques, Faculté des Sciences, ULB, Brussels, Belgium</span></div><div class="corresp-info">Tel.: +32 477 62 20 83; E-mail: <a href="/cdn-cgi/l/email-protection#9eecf5f7ededdeebf2fcb0fffdb0fcfb"><span class="__cf_email__" data-cfemail="0b79606278784b7e6769256a6825696e">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm200285z&amp;href=/doi/10.1021%2Fjm200285z" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2011</span></span><span class="cit-volume">, 54</span><span class="cit-issue">, 19</span><span class="cit-pageRange">, 6501–6513</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">September 2, 2011</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>11 March 2011</li><li><span class="item_label"><b>Published</b> online</span>2 September 2011</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 13 October 2011</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm200285z" title="DOI URL">https://doi.org/10.1021/jm200285z</a></div><div class="article_header-article-copyright"><strong>Copyright © 2011 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D6501%26pageCount%3D13%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DBenjamin%2BLallemand%252C%2BFabien%2BChaix%252C%2BMarina%2BBury%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D54%26issueNum%3D19%26contentID%3Djm200285z%26title%3DN-%25282-%257B3-%255B3%252C5-Bis%2528trifluoromethyl%2529phenyl%255Dureido%257Dethyl%2529-glycyrrhetinamide%2B%25286b%2529%253A%2BA%2BNovel%2BAnticancer%2BGlycyrrhetinic%2BAcid%2BDerivative%2Bthat%2BTargets%2Bthe%2BProteasome%2Band%2BDisplays%2BAnti-Kinase%2BActivity%26numPages%3D13%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D6513%26publicationDate%3DOctober%2B2011">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm200285z"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1736</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">30</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm200285z" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;N-(2-{3-[3,5-Bis(trifluoromethyl)phenyl]ureido}ethyl)-glycyrrhetinamide (6b): A Novel Anticancer Glycyrrhetinic Acid Derivative that Targets the Proteasome and Displays Anti-Kinase Activity&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Benjamin&quot;,&quot;last_name&quot;:&quot;Lallemand&quot;},{&quot;first_name&quot;:&quot;Fabien&quot;,&quot;last_name&quot;:&quot;Chaix&quot;},{&quot;first_name&quot;:&quot;Marina&quot;,&quot;last_name&quot;:&quot;Bury&quot;},{&quot;first_name&quot;:&quot;Céline&quot;,&quot;last_name&quot;:&quot;Bruyère&quot;},{&quot;first_name&quot;:&quot;Jean&quot;,&quot;last_name&quot;:&quot;Ghostin&quot;},{&quot;first_name&quot;:&quot;Jean-Paul&quot;,&quot;last_name&quot;:&quot;Becker&quot;},{&quot;first_name&quot;:&quot;Cédric&quot;,&quot;last_name&quot;:&quot;Delporte&quot;},{&quot;first_name&quot;:&quot;Michel&quot;,&quot;last_name&quot;:&quot;Gelbcke&quot;},{&quot;first_name&quot;:&quot;Véronique&quot;,&quot;last_name&quot;:&quot;Mathieu&quot;},{&quot;first_name&quot;:&quot;Jacques&quot;,&quot;last_name&quot;:&quot;Dubois&quot;},{&quot;first_name&quot;:&quot;Martine&quot;,&quot;last_name&quot;:&quot;Prévost&quot;},{&quot;first_name&quot;:&quot;Ivan&quot;,&quot;last_name&quot;:&quot;Jabin&quot;},{&quot;first_name&quot;:&quot;Robert&quot;,&quot;last_name&quot;:&quot;Kiss&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2011&quot;,&quot;month&quot;:&quot;09&quot;,&quot;day&quot;:&quot;02&quot;,&quot;issue&quot;:&quot;19&quot;,&quot;volume&quot;:&quot;54&quot;,&quot;pages&quot;:&quot;6501-6513&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm200285z&quot;},&quot;abstract&quot;:&quot;18-β-Glycyrrhetinic acid (GA; 1) and many of its derivatives are cytotoxic in cancer cells. The current study aims to characterize the anticancer effects of 17 novel 1 derivatives. On the basis of these studies, N-(2-{3-[3,5-bis(trifluoromethyl)phenyl]ureido}ethyl)-glycyrrhetinamide (6b) appeared to be the most potent compound, with IC50in vitro growth inhibitory concentrations in single-digit micromolarity in a panel of 8 cancer cell lines. Compound 6b is cytostatic and displays similar efficiency in apoptosis-sensitive versus apoptosis-resistant cancer cell lines through, at least partly, the inhibition of the activity of a cluster of a dozen kinases that are implicated in cancer cell proliferation and in the control of the actin cytoskeleton organization. Compound 6b also inhibits the activity of the 3 proteolytic units of the proteasome. Compound 6b thus represents an interesting hit from which future compounds could be derived to improve chemotherapeutic regimens that aim to combat cancers associated wit&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm200285z&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm200285z" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm200285z&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm200285z" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm200285z&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm200285z" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm200285z&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm200285z&amp;href=/doi/10.1021/jm200285z" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm200285z" /></input><a href="/doi/pdf/10.1021/jm200285z" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (4 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm200285z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm200285z%26sid%3Dliteratum%253Aachs%26pmid%3D21888390%26genre%3Darticle%26aulast%3DLallemand%26date%3D2011%26atitle%3DN-%25282-%257B3-%255B3%252C5-Bis%2528trifluoromethyl%2529phenyl%255Dureido%257Dethyl%2529-glycyrrhetinamide%2B%25286b%2529%253A%2BA%2BNovel%2BAnticancer%2BGlycyrrhetinic%2BAcid%2BDerivative%2Bthat%2BTargets%2Bthe%2BProteasome%2Band%2BDisplays%2BAnti-Kinase%2BActivity%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D54%26issue%3D19%26spage%3D6501%26epage%3D6513%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292258" title="Cancer">Cancer</a>,</li><li><a href="/action/doSearch?ConceptID=291788" title="Reaction products">Reaction products</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=291149" title="Apoptosis">Apoptosis</a>,</li><li><a href="/action/doSearch?ConceptID=290896" title="Cells">Cells</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/54/19" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-19/jmcmar.2011.54.issue-19/production/jmcmar.2011.54.issue-19.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-19/jm200285z/production/images/medium/jm-2011-00285z_0006.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-19/jm200285z/production/images/large/jm-2011-00285z_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200285z&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">18-β-Glycyrrhetinic acid (GA; <b>1</b>) and many of its derivatives are cytotoxic in cancer cells. The current study aims to characterize the anticancer effects of 17 novel <b>1</b> derivatives. On the basis of these studies, <i>N</i>-(2-{3-[3,5-bis(trifluoromethyl)phenyl]ureido}ethyl)-glycyrrhetinamide (<b>6b</b>) appeared to be the most potent compound, with IC<sub>50</sub><i>in vitro</i> growth inhibitory concentrations in single-digit micromolarity in a panel of 8 cancer cell lines. Compound <b>6b</b> is cytostatic and displays similar efficiency in apoptosis-sensitive versus apoptosis-resistant cancer cell lines through, at least partly, the inhibition of the activity of a cluster of a dozen kinases that are implicated in cancer cell proliferation and in the control of the actin cytoskeleton organization. Compound <b>6b</b> also inhibits the activity of the 3 proteolytic units of the proteasome. Compound <b>6b</b> thus represents an interesting hit from which future compounds could be derived to improve chemotherapeutic regimens that aim to combat cancers associated with poor prognoses.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_57877" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_57877" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">18-β-Glycyrrhetinic acid (GA; <b>1</b>) is the main constituent of <i>Glycyrrhiza glabra</i>, which has long been used as an antitussive, anti-inflammatory, antiulcer, antiallergic, immunotropic, and hypolipidemic agent.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> The <i>in vitro</i> growth inhibiting activity of <b>1</b> was reported three decades ago in mouse<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> and human<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> cancer cell lines, and the <b>1</b>-induced <i>in vivo</i> activity has also been reported in various experimental cancer models.<a onclick="showRef(event, 'ref4 ref5 ref6'); return false;" href="javascript:void(0);" class="ref ref4 ref5 ref6">(4-6)</a><b>1</b> displays both cytostatic<a onclick="showRef(event, 'ref5 ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref5 ref7 ref8">(5, 7, 8)</a> and cytotoxic<a onclick="showRef(event, 'ref7 ref9'); return false;" href="javascript:void(0);" class="ref ref7 ref9">(7, 9)</a> effects in cancer cells, depending on the concentrations, the cell line, and durations of treatment. Cytostatic effects are mediated through the arrest of cancer cells into the G1 phase of the cell cycle as it was shown for <b>1</b> and related compounds including ursolic acid and 18 β-erythrotriol at 20–25 μM range concentrations.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a></div><div class="NLM_p">The <b>1</b>-induced cytotoxic effects in cancer cells occur at higher doses and relate to pro-apoptotic stimuli.<a onclick="showRef(event, 'ref4 ref7 ref9 ref10 ref11'); return false;" href="javascript:void(0);" class="ref ref4 ref7 ref9 ref10 ref11">(4, 7, 9-11)</a> Indeed, <b>1</b> at micromolar concentrations, when added to rat liver mitochondria, induces swelling, loss of membrane potential, pyridine nucleotide oxidation, and release of cytochrome <i>c</i> and apoptosis inducing factor.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> Salvi et al.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> argue that altogether these data indicate that <b>1</b> is an inducer of mitochondrial permeability transition that triggers the pro-apoptotic pathway. Lee et al.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> report that <b>1</b> potentiates the apoptotic effects of trichostatin A, a histone deacetylase inhibitor, in ovarian cancer cells by increasing the activation of the caspase-8-dependent pathway as well as the activation of the mitochondria-mediated cell death.</div><div class="NLM_p">Schwarz and Csuk<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> have claimed that improving the antitumor activity of <b>1</b> without affecting its pro-apoptotic effects is expected to be a major challenge of the derivatization of <b>1</b>. However, the aim of the current study was to obtain cytostatic and noncytotoxic (pro-apoptotic) <b>1</b> derivatives because many cancers develop acquired chemoresistance during chronic treatment with cytotoxic drugs in the form of the multidrug resistance (MDR) phenotype.<a onclick="showRef(event, 'ref13 ref14'); return false;" href="javascript:void(0);" class="ref ref13 ref14">(13, 14)</a> In addition, various cancer types display intrinsic resistance to pro-apoptotic stimuli, and thus to conventional chemotherapy and radiotherapy. One solution to apoptosis resistance and to the MDR phenotype entails supplementing cytotoxic therapeutic regimens with cytostatic agents.</div><div class="NLM_p">We have based our <b>1</b>-related derivatization strategy on the fact that <b>1</b> and several <b>1</b> derivatives are already known to target various kinases<a onclick="showRef(event, 'ref15 ref16 ref17 ref18 ref19'); return false;" href="javascript:void(0);" class="ref ref15 ref16 ref17 ref18 ref19">(15-19)</a> or to act as proteasome inhibitors.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a><b>1</b> and its derivatives can also target peroxysome proliferator-activated receptors (PPARs),<a onclick="showRef(event, 'ref15 ref21 ref22 ref23 ref24'); return false;" href="javascript:void(0);" class="ref ref15 ref21 ref22 ref23 ref24">(15, 21-24)</a> which control the expression of networks of genes that encode proteins involved in all aspects of lipid metabolism.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> In addition, PPARs are tumor growth modifiers that act via the regulation of cancer cell apoptosis, proliferation, and differentiation and also through their action on the tumor cell environment, angiogenesis, inflammation, and immune cell functions.<a onclick="showRef(event, 'ref25 ref26'); return false;" href="javascript:void(0);" class="ref ref25 ref26">(25, 26)</a></div><div class="NLM_p">The current study characterizes the <i>in vitro</i> anticancer activity of 17 novel <b>1</b> derivatives and 3 <b>1</b> derivatives that have already been described in the literature, namely, compounds <b>2</b>,<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a><b>8</b>,<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> and <b>9</b><a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> (see Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a> and Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a> for the chemical structures). The IC<sub>50</sub><i>in vitro</i> growth inhibitory concentration of each compound has been determined in 8 cancer cell lines, leading to a structure–activity relationship. The influences of the most interesting compounds have then been analyzed at the levels of proteasome activity inhibition, supported by a molecular docking analysis. The PPAR-γ activation and the inhibition of several kinases have also been evaluated. Lastly, the pro-apoptotic effects of <b>1</b> and <b>6b</b> have been characterized in two cancer cell lines.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-19/jm200285z/production/images/medium/jm-2011-00285z_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-19/jm200285z/production/images/large/jm-2011-00285z_0008.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Chemical structure of GA (<b>1</b>) illustrating the R1 and R2 sites on which modifications were carried out (see Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-19/jm200285z/production/images/large/jm-2011-00285z_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200285z&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Characterization of the <i>in Vitro</i> Growth Inhibitory Activity of 17 Novel and 3 (<b>2</b>, <b>8</b>, <b>9</b>) Already Known GA (<b>1</b>) Derivatives versus <b>1</b> in a Panel of 8 Cancer Cell Lines</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-19/jm200285z/production/images/medium/jm-2011-00285z_0004.gif" alt="" id="fx1" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>Table a</sup><p class="last">P indicates purity.</p></div><div class="footnote" id="t1fn2"><sup>Table b</sup><p class="last">The stability of the products was measured with HPLC analysis following incubation in MEM cell culture medium at 37 °C over 7 days. Results are expressed as the % of the incubated compound recovered.</p></div><div class="footnote" id="t1fn3"><sup>Table c</sup><p class="last">The IC<sub>50</sub><i>in vitro</i> growth inhibitory concentrations were determined using the MTT colorimetric assay. The cell lines include the following: human U373 (ECACC code 89081403), T98G (ATCC code CRL1690), and Hs683 (ATCC code HTB-138) glioblastoma, the A549 (DSMZ code ACC107) NSCLC, the MCF-7 (DSMZ code ACC115) breast cancer, and the PC-3 (DSMZ code ACC465) prostate cancer and SKMEL-28 (ATCC code HTB-72) melanoma. One mouse cell line, i.e., the B16F10 melanoma model (ATCC code CRL-6475) was also analyzed.</p></div><div class="footnote" id="t1fn4"><sup>Table d</sup><p class="last">Six data points were available for each concentration tested and nine concentrations (from 0.01 to 100 μM, with semilog increases) were available for each cell line.</p></div></div><div></div></div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_32115" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_32115" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">To increase the anticancer activity of <b>1</b> and to obtain potent cytostatic compounds, various families of derivatives have been synthesized through chemical modifications at the carboxylic acid group (see R1 in Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a> and Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>).</div><div class="NLM_p">First, monoamides (<b>3a</b>–<b>f</b>) were synthesized through peptidic coupling reactions between <b>1</b> and various primary amines (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>). These reactions were conducted in the presence of <i>N,N</i>′-dicyclohexylcarbodiimide (DCC) and hydroxybenzotriazole (HOB<i>t</i>) and produced the desired derivatives in approximately 60–80% yields after flash chromatography (FC) purification (see the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>). The keto derivative <b>3e</b> was prepared by the oxidation of <b>3d</b>. In addition to these monoamides, we were also interested in the grafting of a primary amino group to have ready access to different families of compounds. Thus, the peptidic coupling reaction was also applied to the monoprotected ethylenediamine,<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> leading to a 64% yield of the amido derivative <b>5</b>. A subsequent deprotection of the amino group under acidic conditions produced the versatile intermediate <b>2</b><a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> in 97% yield. Reaction of <b>2</b> either with acyl chlorides, isocyanates, or thioisocyanates led to diamido (<b>4a</b>–<b>e</b>), ureido (<b>6a</b>–<b>c</b>), and thioureido (<b>7a</b>,<b>b</b>) derivatives, respectively, in good yields after FC purification.</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-19/jm200285z/production/images/medium/jm-2011-00285z_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-19/jm200285z/production/images/large/jm-2011-00285z_0005.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. <sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-19/jm200285z/production/images/large/jm-2011-00285z_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200285z&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 1°. DCC, HOBt, DIPEA, DMF, RT, 30 min; 2°. R<sub>1</sub>NH<sub>2</sub>, RT, overnight; (b) 1°. DCC, HOBt, DIPEA, DMF, RT, 30 min; 2°. H<sub>2</sub>N(CH<sub>2</sub>)<sub>2</sub>NHBoc, RT, overnight, 64%; (c) TFA, DCM, 0 °C, 3 h, 97%; (d) DMAP, RCOCl, DCM; (e) THF, RNCO, RT, 20 h; (f) THF, RNCS, RT, 20 h; (g) Jones reagent, acetone, 0 °C, 45 min, 98%.</p></p></figure><div class="NLM_p last">Finally, the reference compounds, <b>8</b><a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> and <b>9</b>,<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> were synthesized according to procedures described in the literature (see the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>).</div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i5">Results</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_23626" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_23626" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6"> Determination of the IC<sub>50</sub><i>in Vitro</i> Growth Inhibitory Concentration</h3><div class="NLM_p">The IC<sub>50</sub><i>in vitro</i> growth inhibitory concentrations of all of the synthesized compounds were determined with a MTT colorimetric assay<a onclick="showRef(event, 'ref30 ref31 ref32 ref33'); return false;" href="javascript:void(0);" class="ref ref30 ref31 ref32 ref33">(30-33)</a> in a panel of seven human and one mouse cancer cell lines after three days of culturing the cancer cells with the respective drugs (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>).</div><div class="NLM_p last">The histological origin of each cancer cell line in this study is detailed in the legend of Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>, and of these eight cancer cell lines, the human U373<a onclick="showRef(event, 'ref33 ref34'); return false;" href="javascript:void(0);" class="ref ref33 ref34">(33, 34)</a> and T98G<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> GBM, the A549 NSCLC,<a onclick="showRef(event, 'ref35 ref36'); return false;" href="javascript:void(0);" class="ref ref35 ref36">(35, 36)</a> and the SKMEL-28<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> cell lines were previously demonstrated to show various levels of resistance to distinct pro-apoptotic stimuli. Similarly, the sensitivity to apoptosis was reported for the human Hs683 oligodendroglioma,<a onclick="showRef(event, 'ref33 ref34'); return false;" href="javascript:void(0);" class="ref ref33 ref34">(33, 34)</a> the MCF-7 breast,<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> the PC-3 prostate<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> cell lines, and for the mouse B16F10<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> melanoma cell line. Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a> shows that all compounds under study display similar growth inhibitory activity whether the cancer cell lines are sensitive or rather resistant to pro-apoptotic stimuli. It must nevertheless be emphasized that most <b>1</b>-related monoamides, i.e., <b>3a</b>, <b>3b</b>, <b>3d</b>, <b>3e</b>, and <b>3f</b>, seem to be less efficient in apoptosis-resistant (U373, T98G, A549, SKMEL-28) than in apoptosis-sensitive cell lines (Hs683, MCF-7, PC-3, B16F10) (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). However, these differences did not reach statistical levels of significance, because <i>n</i> = 4 in each group only, and because heterogeneous responses were observed between the cancer cell lines with respect to a given compound (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>).</div></div><div id="sec3_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> Compound <b>1</b> is Cytotoxic, while Compound <b>6b</b> Is Cytostatic</h3><div class="NLM_p">Flow cytometry analyses revealed that <b>1</b> at its IC<sub>50</sub><i>in vitro</i> growth inhibitory concentrations (see Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>) induced slight pro-apoptotic effects in U373 GBM cells, but marked ones in A549 ones (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>A) as expected from data published in the literature.<a onclick="showRef(event, 'ref7 ref9'); return false;" href="javascript:void(0);" class="ref ref7 ref9">(7, 9)</a><b>1</b> did not induce cytostatic effects in U373 GBM and A549 NSCLC cells as revealed by the absence of accumulation of cancer cells in the G1 phase of the cell cycle (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>B), a feature expected to occur when <b>1</b> displays cytostatic effects.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> Compound <b>6b</b> appeared cytostatic according to the fact that it did not induce apoptosis in U373 GBM and A549 NSCLC cells (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>A). However, this cytostatic effects did not relate to the accumulation of cancer cells in the G1 phase (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>B), a feature that prompted us to analyze <b>6b</b>-induced effects on the kinome and on the proteasome as detailed below.</div><figure id="fig2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-19/jm200285z/production/images/medium/jm-2011-00285z_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-19/jm200285z/production/images/large/jm-2011-00285z_0001.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. (A) Determination of the percentages of A549 NSCLC and U373 GBM cells undergoing apoptosis during 48 and 72 h of treatment with 80 (U373 cells) and 100 (A549 cells) μM for compound <b>1</b> and 10 μM (for both cell lines) for compound <b>6b</b>. Negative (Ct<sup>–</sup>) and positive (Ct<sup>+</sup>) controls available in the kit were used along with 1 μM narciclasine-treated human PC-3 prostate cancer cells as controls for this experiment. (B) Growth rate determination (i.e., the determination of the % of cells in the G1 phase of the cell cycle) for the U373 GBM and A549 NSCLC cells treated as in (C). Each experimental condition was performed in triplicate, and the data are presented as the mean ± SD values.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-19/jm200285z/production/images/large/jm-2011-00285z_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200285z&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> Characterizing <b>6b</b>-Induced Effects on a Panel of 333 Kinases</h3><div class="NLM_p">Compound <b>6b</b> was assayed at 1 μM in a panel of 333 kinases (see the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>). <b>6b</b> displayed <i>in vitro</i> growth inhibitory concentrations that range between 4 and 12 μM among the 8 cancer cell lines analyzed in the current study (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). Therefore, 1 μM represents between 8% and 25% of these <i>in vitro</i> growth inhibitory concentrations. In this very low concentration range, <b>6b</b> inhibited the activity of the 12 kinases listed in Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a> by ≥50%. Among these kinases, 4 already are inhibitors that have been studied in clinical trials, whereas no inhibitors are being examined in clinical trials for the remaining 8 kinases.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Identification of the Kinases Targeted by Compound <b>6b</b> at a Concentration of 1 μM<a class="ref internalNav" href="#tbl2-fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">kinases</th><th class="colsep0 rowsep0" align="center">name or family</th><th class="colsep0 rowsep0" align="center" char=".">% of <b>6b</b>-induced inhibition at 1 μM</th><th class="colsep0 rowsep0" align="center">major cancer types in which the kinase displays significant roles in cell biology</th><th class="colsep0 rowsep0" align="center">compounds currently in clinical trials targeting this kinase versus cancer types</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>ALK</b></td><td class="colsep0 rowsep0" align="left">Anaplastic lymphoma kinases</td><td class="colsep0 rowsep0" align="char" char=".">69</td><td class="colsep0 rowsep0" align="left">Anaplastic large cell lymphoma, inflammatory myofibroblastic tumors, nonsmall cell lung cancer, and neuroblastoma</td><td class="colsep0 rowsep0" align="left">Crizotinib, an oral ALK inhibitor, was demonstrated to provide dramatic clinical benefit with little toxicity in patients with advanced NSCLC</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>BMX</b></td><td class="colsep0 rowsep0" align="left">B-tyrosine kinases family</td><td class="colsep0 rowsep0" align="char" char=".">52</td><td class="colsep0 rowsep0" align="left">Androgen-independent prostate cancers. Also implicated in the chemoresistance of small-cell-lung cancers, play a role in cell growth and differentiation</td><td class="colsep0 rowsep0" align="left">None</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>PAK2</b></td><td class="colsep0 rowsep0" align="left">p-21 associated kinases family</td><td class="colsep0 rowsep0" align="char" char=".">51</td><td class="colsep0 rowsep0" align="left">Ovarian cancers, regule the actin cytoskeleton during cell motility and invasion</td><td class="colsep0 rowsep0" align="left">None</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>EPHB1</b></td><td class="colsep0 rowsep0" align="left">Eph receptor tyrosine kinases</td><td class="colsep0 rowsep0" align="char" char=".">64</td><td class="colsep0 rowsep0" align="left">Ovarian cancers; colon cancers, play a role in the cell adhesion and migration</td><td class="colsep0 rowsep0" align="left">None</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>EPHB4</b></td><td class="colsep0 rowsep0" align="left">Eph receptor tyrosine kinases</td><td class="colsep0 rowsep0" align="char" char=".">64</td><td class="colsep0 rowsep0" align="left">Ovarian cancers; colon cancers; gastric cancers; prostate cancers, module integrin-mediated adhesion</td><td class="colsep0 rowsep0" align="left">None</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>RET</b></td><td class="colsep0 rowsep0" align="left">R tyrosine kinases family</td><td class="colsep0 rowsep0" align="char" char=".">48</td><td class="colsep0 rowsep0" align="left">Thyroid cancers; Multiple endocrine neoplasia type 2 (MEN 2), play a role in the cell adhesion and migration</td><td class="colsep0 rowsep0" align="left">None</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>ZAP70</b></td><td class="colsep0 rowsep0" align="left">Zeta-chain (TCR) associated protein kinases</td><td class="colsep0 rowsep0" align="char" char=".">67</td><td class="colsep0 rowsep0" align="left">Chronic lymphocytic leukemia (CLL), play a role in cell migration</td><td class="colsep0 rowsep0" align="left">None</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>FGF-R2</b></td><td class="colsep0 rowsep0" align="left">Fibroblast growth factor receptor type 2</td><td class="colsep0 rowsep0" align="char" char=".">67</td><td class="colsep0 rowsep0" align="left">Breast cancers; gastric cancers; endometrial cancers; prostate cancers, play a role in the cell proliferation</td><td class="colsep0 rowsep0" align="left">AZD2171 - Ki23057 - PD173074 - SU5402</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>FES</b></td><td class="colsep0 rowsep0" align="left">Fes tyrosine kinases</td><td class="colsep0 rowsep0" align="char" char=".">59</td><td class="colsep0 rowsep0" align="left">Not yet clearly defined</td><td class="colsep0 rowsep0" align="left">None</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>FYN</b></td><td class="colsep0 rowsep0" align="left">Src kinase family</td><td class="colsep0 rowsep0" align="char" char=".">72</td><td class="colsep0 rowsep0" align="left">Prostate cancers, play a role in the cell proliferation, morphogenesis and motility</td><td class="colsep0 rowsep0" align="left">Dasatinib, an orally available small-molecule multikinase inhibitor</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>IGF-R1</b></td><td class="colsep0 rowsep0" align="left">Insulin-like growth factor type 1</td><td class="colsep0 rowsep0" align="char" char=".">64</td><td class="colsep0 rowsep0" align="left">Breast cancers; colon cancers; head and neck cancers</td><td class="colsep0 rowsep0" align="left">Dalotuzumab</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>MATK</b></td><td class="colsep0 rowsep0" align="left">Megakaryocyte-associated tyrosine kinases</td><td class="colsep0 rowsep0" align="char" char=".">50</td><td class="colsep0 rowsep0" align="left">Not yet clearly defined</td><td class="colsep0 rowsep0" align="left">None</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl2-fn1"><div class="footnote" id="tbl2-fn1"><sup>a</sup><p class="last">The panel of 333 kinases that have been investigated are provided in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>.</p></div></div></div><div class="NLM_p last">Most, if not all, of these kinases (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>), including ALK,<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> BMX,<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> EPHB1 and EPHB4,<a onclick="showRef(event, 'ref41 ref42'); return false;" href="javascript:void(0);" class="ref ref41 ref42">(41, 42)</a> Fes and Fyn,<a onclick="showRef(event, 'ref43 ref44'); return false;" href="javascript:void(0);" class="ref ref43 ref44">(43, 44)</a> FGF-R2,<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> IGFR1,<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> RET,<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> ZAP70,<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> and PAK2,<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> play somewhat important roles in cancer cell proliferation, adhesion, motility and invasion, and thus in cancer cell migration and cancer metastatic processes.</div></div><div id="sec3_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> Several Compounds under Study Target the Proteasome</h3><div class="NLM_p">On the basis of the fact that <b>1</b> derivatives can target the proteasome, we biochemically analyzed the effects of six <b>1</b> derivatives in addition to compounds <b>1</b>, <b>2</b>, <b>8</b>, and <b>9</b> on the three proteasome catalytic units, including the trypsin-like, the caspase-like, and the chymotrypsin-like units. Each compound was tested at its mean MTT colorimetric assay-related IC<sub>50</sub> concentrations calculated on the eight cancer cell lines (see Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). The proteasome inhibitor MG-132<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> was analyzed at a concentration of 0.5 μM.</div><div class="NLM_p">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>A shows that 60 μM <b>2</b> inhibited the three proteasome catalytic units with an efficiency that was similar to that of the 0.5 μM MG-132. Compound <b>6b</b> (7 μM) also inhibited the three catalytic units of the proteasome, but at a much lower concentration than <b>2</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>A). While the remaining compounds, <b>1</b> (90 μM), <b>3a</b> (60 μM), <b>3b</b> (70 μM), <b>3e</b> (80 μM), <b>3f</b> (50 μM), <b>7a</b> (25 μM), <b>8</b> (3 μM), and <b>9</b> (30 μM), inhibited the activity of the trypsin-like catalytic unit, they also activated the caspase-like and the chymotrypsin-like catalytic units (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>A).</div><figure id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-19/jm200285z/production/images/medium/jm-2011-00285z_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-19/jm200285z/production/images/large/jm-2011-00285z_0002.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. (A) Determination of the effects of the 10 compounds in this study on the proteolytic activity of the proteasome in human U373 GBM cells treated with each compound at their IC<sub>50</sub><i>in vitro</i> growth inhibitory concentrations, which are detailed in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>. MG-132 (0.5 μM) was used as a reference compound. The data are presented as mean ± SD values calculated in triplicate for each experimental condition. The <i>Y</i>-axis is on a logarithmic scale. (B) Ribbon representation of the 20S proteasome crystallographic structure bound to the fellutamide B ligand in the three pairs of binding sites (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3D29">3D29</a>): chymotrypsin-like sites (CT-L), trypsin-like sites (T-L), caspase-like sites (C-L). Fellutamide B is depicted as balls. (C,D) Comparison of the predicted best affinity binding modes of compounds <b>6b</b> (C) and <b>3e</b> (D) in the chymotrypsin-like site of the 3D29 crystal structure. The ligands are depicted as sticks and the protein is represented by its molecular surface. The S3 specificity pocket is indicated.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-19/jm200285z/production/images/large/jm-2011-00285z_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200285z&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In order to get a deeper insight into the molecular basis of the proteasome recognition by the different compounds, we performed molecular docking experiments at each of the caspase-like (C-L; Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>B), trypsin-like (T-L; Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>B), or chymotrypsin-like (CT-L; Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>B) sites of proteolytic functions. Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>B illustrates these three doublets of proteolytic sites in a crystal structure complexed to fellutamide B<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3D29">3D29</a>). The structure of the proteasome has also been determined with bortezomib, the sole antiproteasome marketed compound to date, bound at all six sites. We did not use bortezomib for our docking analyses because it contains a boron atom that is not supported in the default force field used and optimized for the <i>Glide</i> software that was employed in this study.</div><div class="NLM_p">To assess the reliability of our docking procedure, the crystallographic ligand, fellutamide B, was docked in the three different pairs of binding sites of the yeast proteasome after removal of all water molecules and ligands. The docked poses were compared with the positions of the crystal ligand by computing the root-mean-square deviation (rmsd), which measures the distance between the poses. A rmsd value for the backbone atoms was found to range between 0.6 and 2.0 Å for all sites, indicating a high similarity between the docked and the experimental positions of the crystallographic ligand.</div><div class="NLM_p">Compound <b>6b</b>, the molecule exhibiting the best affinity, was docked in the three different catalytic sites. A detailed analysis identified in all three sites two types of binding modes. In one of these two modes, the 3,5-bis(trifluoromethyl)phenyl moiety accommodates the S1 specificity pocket<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> and the diamide group forms several hydrogen bonds. This mode appears to present similarities to the mode of binding of several known peptide inhibitors,<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> which mimic the proteasome susbstrate backbone. The second mode which is more largely represented in the chymotrypsin and caspase-like sites depicts the 3,5-bis(trifluoromethyl)phenyl moiety bound in the S3 specificity pocket. This mode agrees with the inhibition potency, at the chymotrypsin-like site and to a lesser extent at the caspase-like site, of proteasome inhibitors containing 3,5-bis(trifluoromethyl)phenyl at the S3 position.<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> To attempt to discriminate between these two binding modes, we performed docking of <b>6b</b> in a series of proteasome crystal structures in complex with different inhibitors, most of them bound to the chymotrypsin-like site (PDB codes <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3NZJ">3NZJ</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3MG8">3MG8</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3MG4">3MG4</a>, and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3GPJ">3GPJ</a>). Overall, the most common docked pose portrayed the 3,5-bis(trifluoromethyl)phenyl moiety of <b>6b</b> in the S3 specificity pocket. Docking experiments including protein flexibility (induced-fit protocol from Schrodinger Inc.) in the form of flexible side chain residues selected in the vicinity of the S1 specificity pocket corroborate this binding mode.</div><div class="NLM_p last">A unique feature of <b>6b</b> is to inhibit with a similar potency the three catalytic units, whereas our other GA derivatives exhibit a large discrepancy in their activity toward the different sites. We thus carried out the docking of <b>3e</b> in the chymotrypsin-like and the trypsin-like binding sites which feature the largest potency difference. In the chymotrypsin-like site, <b>3e</b> occupies none of the specificity pockets in contrast to <b>6b</b> (see Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>C and D). In the trypsin-like site, however, the best binding poses of <b>3e</b> show that its aromatic moiety visits the S1 specificity pocket, as for compound <b>6b</b>. Interestingly, a significantly higher potency was measured at the chymotrypsine-like site for a noncovalent inhibitor featuring a 3,4,5-trimethoxybenzylamine at the S3 position relative to the derivative containing only one methoxy.<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a></div></div><div id="sec3_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> Several Compounds in this Study Were Found to Inhibit PPAR-γ</h3><div class="NLM_p">On the basis of the fact that <b>1</b> derivatives can target PPAR-γ, we also biochemically analyzed PPAR-γ inhibition versus the activation induced by the 10 compounds described above for the proteasome inhibition analyses. The compounds were studied at the same concentrations as those reported above for the proteasome inhibition analyses. Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a> shows that <b>1</b>, <b>2</b>, and <b>6b</b> did not significantly (<i>p</i> > 0.05; Kruskal–Wallis with Dunn’s procedure) modify PPAR-γ activity as compared to the control, whereas the remaining seven <b>1</b> derivatives inhibited PPAR-γ activity (<i>p</i> > 0.05; Kruskal–Wallis with Dunn’s procedure, except for <b>3f</b><i>p</i> < 0.05) (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>B).</div><figure id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-19/jm200285z/production/images/medium/jm-2011-00285z_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-19/jm200285z/production/images/large/jm-2011-00285z_0003.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Determination of activating versus inhibiting effects of the 10 compounds in this study (the same as those used for proteasome-related studies; see Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>A) on PPAR-γ. Each compound has been analyzed at its IC<sub>50</sub> in vitro growth inhibitory concentration in the human U373 GBM cell line (see Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a> and its legend) treated for 6 h with the compound. The data are presented as mean ± SD values calculated in triplicate for each experimental condition. Determination of the effects of the 10 compounds after 6 h of treatment of human U373 GBM cells.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-19/jm200285z/production/images/large/jm-2011-00285z_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200285z&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i12">Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_32747" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_32747" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Cancer remains a devastating disease, and the number of cancer-related deaths is still increasing. More than 90% of cancer patients die from tumor metastases, which are intrinsically resistant to apoptosis;<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a> therefore, these tumors are unresponsive to a large majority of currently available anticancer drugs, which generally work through apoptosis induction.<a onclick="showRef(event, 'ref57 ref58'); return false;" href="javascript:void(0);" class="ref ref57 ref58">(57, 58)</a> Before metastasizing, many cancer types also display intrinsic resistance to proapoptotic stimuli; these include head and neck cancers,<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a> non-small-cell lung cancer (NSCLC),<a onclick="showRef(event, 'ref35 ref60'); return false;" href="javascript:void(0);" class="ref ref35 ref60">(35, 60)</a> melanoma,<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a> pancreatic cancer,<a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a> esophageal cancer,<a onclick="showRef(event, 'ref63 ref64'); return false;" href="javascript:void(0);" class="ref ref63 ref64">(63, 64)</a> and gliomas.<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a> As emphasized by Landis-Piwowar et al.,<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a> drug resistance limits the effectiveness of treatment options and is a major challenge faced by current cancer research. As detailed below, an additive effect has been observed in cancer cells treated with bortezomib in combination with traditional chemotherapeutics, and in some cases, drug resistance has been overcome.<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a> In the same manner, one of the kinases targeted by <b>6b</b>, i.e., BMX,<a onclick="showRef(event, 'ref67'); return false;" href="javascript:void(0);" class="ref ref67">(67)</a> is implicated in cancer drug resistance. Thus, <b>6b</b>, apart its intrinsic anticancer activity that makes it able to overcome resistance to pro-apoptotic stimuli, could also overcome cancer drug resistance if administered with conventional chemotherapeutics.</div><div class="NLM_p">The IC<sub>50</sub><i>in vitro</i> growth inhibitory concentrations of all newly synthesized compounds are lower than that of <b>1</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>), clearly showing the importance of the amido subunit to increase anticancer activity, at least <i>in vitro</i>. According to the fact that the oxidation of the hydroxy group on the C-3 position decreases the <i>in vitro</i> anticancer activity (<b>3d</b> vs <b>3e</b>), this position was not further modified in the frame of the current study. The results reveal that most <b>1</b>-related monoamides could display weaker growth inhibitory activity in apoptosis-resistant cancer cell lines (i.e., >100 μM) compared to apoptosis-sensitive cancer cell lines (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). Therefore, monoamide <b>1</b> derivatives (<b>3a</b>–<b>f</b>) do not seem to be appropriate drugs to combat those cancer types associated with poor prognoses because they are able to resist pro-apoptotic stimuli. In comparison with monoamido (<b>3</b>) and diamido (<b>4</b>) groups, the ureido (<b>6</b>) and thioureido (<b>7</b>) ones lead to a better <i>in vitro</i> anticancer activity. Finally, the addition of electron-withdrawing groups on the aromatic part of the ureido moieties (<b>6a</b> vs <b>6b</b>) seems to reinforce this <i>in vitro</i> anticancer activity as revealed by the MTT colorimetric assay.</div><div class="NLM_p">As discussed below, <b>6b</b> emerges as a hit from the current <b>1</b> derivatives. At first glance, one could estimate that <b>6b</b> would be difficult to be further developed due to its high molecular weight and poor hydrosolubility. However, preliminary data we obtained already indicate that <b>6b</b> can be formulated as specific microemulsions for oral and i.v. administrations, a project that is currently ongoing in our laboratory.</div><div class="NLM_p">Together, these data led us to focus less on the monoamide (<b>3a</b>–<b>f</b>) and diamido-<b>1</b> (<b>4a</b>–<b>e</b>) derivatives and more on the remaining compounds in this study. We thus decided to pay particular attention to <b>6b</b>, which appeared to be the most potent compound from the current series in terms of <i>in vitro</i> growth inhibitory activity in a panel of four apoptosis-resistant and four apoptosis-sensitive cancer cells lines (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). In addition, <b>6b</b> also appeared to be an actual cytostatic compound as revealed by flow cytometry analyses (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>).</div><div class="NLM_p">We then analyzed <b>6b</b>’s ability to inhibit proteasome activity because <b>1</b> and certain of its derivatives have already been shown to act as proteasome inhibitors.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> Proteasomes are large, multicatalytic proteinase complexes located in the cytosol and in the nucleus of eukaryotic cells.<a onclick="showRef(event, 'ref68 ref69'); return false;" href="javascript:void(0);" class="ref ref68 ref69">(68, 69)</a> The ubiquitin–proteasome system is responsible for the degradation of most intracellular proteins and therefore plays an essential regulatory role in critical cellular processes, including cell cycle progression, proliferation, differentiation, angiogenesis, and apoptosis.<a onclick="showRef(event, 'ref68 ref69 ref70'); return false;" href="javascript:void(0);" class="ref ref68 ref69 ref70">(68-70)</a> Human cancer cells possess elevated levels of proteasome activity and are more sensitive to proteasome inhibitors than normal cells.<a onclick="showRef(event, 'ref68'); return false;" href="javascript:void(0);" class="ref ref68">(68)</a> Proteasome inhibition bypasses, at least partly, the resistance of cancer cells to apoptosis because it activates macroautophagy, a compensatory protein degradation system,<a onclick="showRef(event, 'ref71'); return false;" href="javascript:void(0);" class="ref ref71">(71)</a> and other pro-survival signaling pathways.<a onclick="showRef(event, 'ref72'); return false;" href="javascript:void(0);" class="ref ref72">(72)</a> Inhibition of these autoprotective responses sensitizes cancer cells to the antiproliferative effects of proteasome inhibitors.<a onclick="showRef(event, 'ref72'); return false;" href="javascript:void(0);" class="ref ref72">(72)</a> The proteasome inhibitor bortezomib (PS-341) was the first clinically available proteasome inhibitor and was approved by the FDA in 2003 for the treatment of multiple myeloma.<a onclick="showRef(event, 'ref73'); return false;" href="javascript:void(0);" class="ref ref73">(73)</a> However, despite clinical benefits, bortezomib causes various types of toxicities including peripheral neuropathy<a onclick="showRef(event, 'ref74'); return false;" href="javascript:void(0);" class="ref ref74">(74)</a> and thrombocytopenia.<a onclick="showRef(event, 'ref75'); return false;" href="javascript:void(0);" class="ref ref75">(75)</a></div><div class="NLM_p">The current study reveals that <b>1</b> inhibits the trypsine-like catalytic activity of the proteasome by ∼50% while it activates the chymotrypsin-like catalytic activity. It also appears to be without any apparent effects on the caspase-like catalytic activity when tested at its IC<sub>50</sub><i>in vitro</i> growth inhibitory concentration (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>A). The already known compound <b>2</b>,<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> i.e., <i>N</i>-(2-aminoethyl)-glycyrrhetinamide, behaved as a proteasome inhibitor, probably because of its amine function, which is well-known to have potent activity on cell viability (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). In addition, its IC<sub>50</sub> growth inhibitory concentrations in the eight cancer cell lines under study was similar to the one displayed by <b>1</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). The novel GA derivative <b>6b</b> (<i>N</i>-(2-{3-[3,5-bis(trifluoromethyl)phenyl]ureido}ethyl)-glycyrrhetinamide) was also able to inhibit the three catalytic units of the proteasome (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>A). At first glance, <b>6b</b> appears to be less potent than <b>2</b> in its inhibitory activity toward the proteasome (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>A). However, it should be noted that compound <b>6b</b> has been tested at a concentration of 7 μM (i.e., its IC<sub>50</sub><i>in vitro</i> growth inhibitory concentration; Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>), whereas compound <b>2</b> has been tested at 60 μM (also its IC<sub>50</sub><i>in vitro</i> growth inhibitory concentration; Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). Compound <b>6b</b> could therefore be considered as a novel GA derivative that acts both as a proteasome inhibitor and as a kinase inhibitor, as detailed below. It must be noticed that, apart from <b>2</b> and <b>6b</b>, the remaining compounds under study for which their effects on the proteasome have been analyzed display activating rather than inhibiting effects on the proteasome.</div><div class="NLM_p">Before analyzing the antikinase profile of <b>6b</b>, we investigated its effects on PPARs because <b>1</b> and several of its derivatives can also target PPARs.<a onclick="showRef(event, 'ref21 ref22 ref23 ref24'); return false;" href="javascript:void(0);" class="ref ref21 ref22 ref23 ref24">(21-24)</a> PPAR agonists, particularly thiazolidinedione derivatives, are promising therapeutic agents because they exert both a direct anticancer and a broad spectrum of antistromal, antiangiogenic, and immuno-modulating activities.<a onclick="showRef(event, 'ref25 ref76'); return false;" href="javascript:void(0);" class="ref ref25 ref76">(25, 76)</a> However, the great majority of reports from the literature clearly indicate that PPAR-targeting anticancer agents must display overall agonistic and not antagonistic activity for PPAR-γ.<a onclick="showRef(event, 'ref77 ref78 ref79 ref80'); return false;" href="javascript:void(0);" class="ref ref77 ref78 ref79 ref80">(77-80)</a> Chintharlapalli et al.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> and Jutooru et al.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> demonstrated PPAR-γ activation with <b>1</b> derivatives in colon and pancreatic cancer cells, respectively. Thus, we wanted to confirm that <b>6b</b> does not antagonize PPAR-γ activity before further deciphering the mechanisms of action through which it displays its cytostatic activity in cancer cells. The data illustrated in Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>B confirm that <b>6b</b> (and also <b>2</b>) did not antagonize PPAR-γ activity, whereas the remaining compounds, including the reference compounds <b>8</b><a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> and <b>9</b>,<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> antagonized PPAR-γ activity when assayed at their IC<sub>50</sub><i>in vitro</i> growth inhibitory concentration (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>).</div><div class="NLM_p">Together, these data thus highlight the fact that <b>6b</b>, which is a novel GA (<b>1</b>) derivative, displays marked <i>in vitro</i> activity both in apoptosis-resistant and apoptosis-sensitive cancer cells and that this cytostatic activity is partly mediated through the inhibition of the three catalytic units of the proteasome. As previously indicated in the Introduction, <b>1</b> and/or several <b>1</b> derivatives are also known to target various kinases, including the following: phosphatidylinositol-3-kinase (PI3–K) and p42 and p38 mitogen-activated protein kinase (MAPK),<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> src,<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> protein kinase C (PKC),<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> VEGF receptor 2 (VEGFR2), mTOR kinase, ribosomal S6 kinase (S6K),<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> and the PI3K/Akt/GSK3β pathway.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> Kinase inhibitors are the largest class of new anticancer drugs,<a onclick="showRef(event, 'ref81'); return false;" href="javascript:void(0);" class="ref ref81">(81)</a> and approximately 150 kinase inhibitors have been subjected to recent clinical testing, with ∼45 kinases listed as primary targets.<a onclick="showRef(event, 'ref82'); return false;" href="javascript:void(0);" class="ref ref82">(82)</a> However, it is already apparent that most cancers can avoid the inhibition of any single kinase.<a onclick="showRef(event, 'ref81'); return false;" href="javascript:void(0);" class="ref ref81">(81)</a> It becomes, in fact, increasingly obvious that it is mandatory to inhibit multiple kinases,<a onclick="showRef(event, 'ref81'); return false;" href="javascript:void(0);" class="ref ref81">(81)</a> and partial inhibition of a small number of kinases appears to be a more promising strategy.<a onclick="showRef(event, 'ref83'); return false;" href="javascript:void(0);" class="ref ref83">(83)</a> The data from the present study reveal that <b>6b</b> inhibits the activity of a dozen kinases, and most if not all of them are implicated in cancer cell proliferation and migration (see Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). It thus seems that the cytostatic activity of <b>6b</b> relates, at least partly, to the targeting of this cluster of kinases, a feature that was observed at 1 μM, which is a concentration ranging between 8% and 25% of the IC<sub>50</sub><i>in vitro</i> growth inhibitory concentrations determined in a panel of eight distinct cancer cell lines. These <b>6b</b>-mediated effects on kinases that are implicated in cancer cell proliferation and migration (with the implication of the actin cytoskeleton that also exerts major roles in cytokinesis, and thus in cell proliferation) can explain, at least partly, the <b>6b</b>-induced cytostatic effects.</div><div class="NLM_p last">In conclusion, the present study provides a novel <b>1</b> derivative, <b>6b</b>, which displays cytostatic and not cytotoxic effects in cancer cells. These cytostatic effects occur, at least partly, through the targeting of a limited number of 12 kinases that are implicated in cancer cell proliferation and migration and through antiproteasome activity, including the three catalytic units of the proteasome, while <b>6b</b> does not inhibit PPAR-γ activity in cancer cells. In contrast, <b>1</b> is less efficient than <b>6b</b> in inhibiting proteasome activity and it is cytotoxic, at least partly through the activation of pro-apoptotic processes. Compound <b>1</b>, i.e., glycyrrhetinic acid, displays <i>in vitro</i> growth inhibitory activity in various cancer cells with an efficiency that is about ten times weaker than that displayed by <b>6b</b>. We are currently developing specifically formulated forms of <b>6b</b> to proceed with <i>in vivo</i> experiments aimed at investigating the anticancer activity of <b>6b</b> as a single agent or in association with conventional cytotoxic chemotherapeutics.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i13">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_22403" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_22403" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Chemistry</h3><div id="sec5_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i15" class="anchor-spacer"></div><h4 class="article-section__title" id="_i15"> General Methods</h4><div class="NLM_p last">Before their use, the solvents were distilled and dried using standard methods, i.e., THF and ether from Na/benzophenone, and CH<sub>2</sub>Cl<sub>2</sub> from P<sub>2</sub>O<sub>5</sub>. The <sup>1</sup>H NMR and <sup>13</sup>C NMR spectra were recorded on a Bruker Avance 300 spectrometer in CDCl<sub>3</sub> using the residual isotopic solvent CHCl<sub>3</sub> and CH<sub>3</sub>OH, respectively, as references for δ<sub>H</sub> = 7.26 ppm, δ<sub>C</sub> = 77.16 ppm, δ<sub>H</sub> = 3.31 ppm, δ<sub>C</sub> = 49.00 ppm. The following abbreviations are used for spin multiplicity: s, singlet; d, doublet; t, triplet; q, quadruplet, qt, quintuplet; m, multiplet; br, broad. <sup>1</sup>H NMR and <sup>13</sup>C NMR spectra were assigned by comparison with NMR spectra of oleanane compounds previously described in the literature.<a onclick="showRef(event, 'ref84 ref85'); return false;" href="javascript:void(0);" class="ref ref84 ref85">(84, 85)</a> Routine thin-layer chromatography (TLC) was performed on silica gel plates (Silica gel GF254 from VWR), and visualization was performed using UV. Flash column chromatography was carried out using silica gel at moderate pressure (spherical particle size 60–200 μm from MP Biomedicals). HPLC analyses were performed with an Agilent 1100 series HPLC system (Agilent, Diegem, Belgium). The chromatographic system was an RX-C8 (5 μm) (4.6 mm × 250 mm) (Agilent, Diegem, Belgium) using the same mobile phase for all compounds: MeOH–water 90:10 (0.1% TFA) 20 min. The detection system was an Agilent Diode Array Detector G1315B (monitoring wavelength given for each compound) (Agilent, Diegem, Belgium). The purity given was measured by this HPLC method at 249 nm. However, we are aware that this method does not take into account the cocrystallized solvents that could be detected with NMR. High-resolution mass spectra (positive mode) were recorded by direct infusion in a 6520 series electrospray ion source (ESI)–quadrupole time-of-flight (Q-TOF) mass spectrometer (Agilent, Palo Alto, CA, USA). The error between the observed mass and the calculated mass is expressed in ppm. Below 3 ppm, the compounds were considered to have the predicted formula. The infrared spectra were recorded as KBr pellets on a Perkin-Elmer 1750 FT-spectrophotometer (Perkin-Elmer, Waltham, MA, USA) and the wavelengths are expressed in cm<sup>–1</sup>. The monoprotected ethylenediamine, i.e., H<sub>2</sub>NCH<sub>2</sub>CH<sub>2</sub>NHBoc, was synthesized according to procedures previously described in the literature.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> The purity of each synthesized compound was verified by means of <sup>1</sup>H NMR, HRMS, and HPLC-UV analyses and reached a level >95% (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>).</div></div><div id="sec5_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i16" class="anchor-spacer"></div><h4 class="article-section__title" id="_i16"> Procedure for the Synthesis of <i>N</i>-(2-Aminoethyl)-glycyrrhetinamide (<b>2</b>)</h4><div class="NLM_p last">Compound <b>5</b> (450 mg, 0.735 mmol) was dissolved in DCM (9 mL) at 0 °C under stirring. Trifluoroacetic acid (1 mL, 13 mmol) was added, and the reaction was stirred at 0 °C for 3 h. The reaction mixture was evaporated below 50 °C and then poured into dry sodium bicarbonate and ice, extracted with dichloromethane, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated to produce the corresponding amine in quantitative yield.</div></div><div id="sec5_1_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i17" class="anchor-spacer"></div><h4 class="article-section__title" id="_i17"> General Procedure for 18 β-Glycyrrhetinamides (<b>3</b>, <b>5</b>)</h4><div class="NLM_p last">18-β-Glycyrrhetinic acid (200 mg, 0.43 mmol) was dissolved in DMF (10 mL) at room temperature under stirring. <i>N,N</i>′-Dicyclohexylcarbodiimide (175.3 mg, 0.85 mmol), 1-hydroxy-1<i>H</i>-benzotriazole (86.1 mg, 0.64 mmol), and diisopropylethylamine (444 μL, 2.55 mmol) were added successively to the reaction mixture. After 30 min, the solution was cooled at 0 °C, and the primary amine was added dropwise. The reaction mixture was brought to room temperature and then was stirred overnight. The reaction mixture was concentrated under vacuum and water was added. After dichloromethane extraction, the organic layer was dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under vacuum. <i>N,N</i>′-Dicyclourea was eliminated by trituration in acetonitrile. The organic layer was evaporated under vacuum. The crude product was then chromatographed on silica (cyclohexane; ethyl acetate).</div></div><div id="sec5_1_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i18" class="anchor-spacer"></div><h4 class="article-section__title" id="_i18"> Procedure for the Synthesis of <b>3e</b> from <b>3d</b></h4><div class="NLM_p last">Compound <b>3d</b> (200 mg, 0.331 mmol) was dissolved in acetone (20 mL) at 0 °C under stirring. Jones reagent (150 μL) was added dropwise until the reaction mixture became orange. After 45 min, methanol was added until the solution turned dark green. The reaction was poured into a mixture of ice and water (20 mL), and then acetone and methanol were removed under reduced pressure. The aqueous residue was extracted three times with 10 mL DCM. The combined organic extracts were washed first with water (10 mL) and then with brine (10 mL) and dried over Na<sub>2</sub>SO<sub>4</sub>. The solvent was evaporated under vacuum, leading to a solid that corresponds to compound <b>3e</b> (98% yield).</div></div><div id="sec5_1_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i19" class="anchor-spacer"></div><h4 class="article-section__title" id="_i19"> General Procedure for 18 β-Glycyrrhetindiamides (<b>4</b>)</h4><div class="NLM_p last">Compound <b>2</b> (100.8 mg, 0.20 mmol) was dissolved in 4 mL of anhydrous DCM. <i>N,N</i>′-Dimethylaminopyridine (48.7 mg, 0.40 mmol) was then added to this solution. After cooling at 0 °C, the acyl chloride (0.20 mmol) was added dropwise to the reaction mixture, which was then stirred at room temperature for 12 h. The mixture was concentrated under vacuum. The residual solid was dissolved in 20 mL of DCM and the organic layer was washed twice with 20 mL of 1 M HCl. The aqueous layer was then extracted twice with 10 mL of DCM. The combined organic layers were washed twice with 20 mL of 1 M NaOH, and the aqueous layers were extracted twice with 10 mL of DCM. The combined organic layers were dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure. The crude product was then chromatographed on silica (DCM; methanol).</div></div><div id="sec5_1_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i20" class="anchor-spacer"></div><h4 class="article-section__title" id="_i20"> General Procedure for (Thio)Ureido-glycyrrhetinamides (<b>6</b>, <b>7</b>)</h4><div class="NLM_p last">Compound <b>2</b> (90.9 mg, 0.18 mmol) was dissolved in 4 mL of anhydrous THF. The desired isocyanate or thioisocyanate (0.18 mmol) was added. The reaction mixture was stirred at room temperature for 20 h and was concentrated under vacuum. The residual solid was then chromatographed on silica (DCM; methanol), with the exception of compounds <b>6b</b> and <b>7b</b>, which were purified through trituration in Et<sub>2</sub>O.</div></div><div id="sec5_1_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21"> <i>N</i>-(2-{3-[3,5-Bis(trifluoromethyl)phenyl]ureido}ethyl)-glycyrrhetinamide (<b>6b</b>)</h4><div class="NLM_p last">Yield: 36%. Rf = 0.30 (DCM; MeOH 95:5). RP-HPLC: purity = 99%, <i>t</i><sub><i>R</i></sub> = 8.40 min <sup>1</sup>H NMR characteristic protons (HSQC, 300 MHz, CD<sub>3</sub>OD): δ (ppm) = 8.02 (s, 2H, Ar–H35, H39), 7.42 (s, 1H, Ar-H37), 5.61 (s, 1H, CH-12), 3.62–3.22 (m, 4H, NHCH<sub>2</sub>CH<sub>2</sub>NH), 3.15 (dd, 1H, <i>J</i> = 7.0 Hz, 5.1 Hz, CH-3), 2.66 (dt, 1H, <i>J</i> = 13.0 Hz, 3.0 Hz, CH-1), 2.37 (s, 1H, CH-9), 1.38 (s, 3H, Me-H27), 1.10 (s, 3H, Me-H29), 1.05 (s, 3H, Me-H25), 0.98 (s, 3H, Me-H23), 0.94 (s, 3H, Me-H26), 0.78 (s, 3H, Me-H24), 0.74 (s, 3H, Me-H28). <sup>13</sup>C NMR (HSQC, 75 MHz, CD<sub>3</sub>OD): δ (ppm) = 202.4 (C11), 179.4 (C30), 172.6 (C13), 157.6 (C33), 143.4 (C34), 133.0 (q, <i>J</i> = 33.0 Hz, C36/C38), 128.9 (C12), 124.8 (q, <i>J</i> = 270.1 Hz, CF<sub>3</sub>), 118.8 (q, <i>J</i> = 3.0 Hz, C35/C39), 115.3 (q, <i>J</i> = 7.0 Hz, C37), 79.4 (C3), 63.1 (C9), 56.2 (C5), 49.3 (C18), 46.6 (C14), 44.9 (C20), 44.5 (C8), 42.6 (C19), 41.1 (C31/C32*), 40.6 (C31/C32*), 40.3 (C1), 40.2 (C4), 38.7 (C22), 38.3 (C10), 33.7 (C7), 32.9 (C17), 31.9 (C21), 29.6 (C29), 29.1 (C28), 28.7(C23), 27.8 (C2), 27.6 (C15/C16*), 27.4 (C15/C16*), 23.7 (C27), 19.1 (C26), 18.6 (C6), 16.8 (C25), 16.3 (C24). IR (KBr): ν (cm<sup>–1</sup>): 3360 (OH), 2932 (CH aliphatic), 1643 (C═O), 1544, 1467, 1386. Mp: 201 °C. HRMS (ESI-QTOF) calcd for (<b>6b</b>) C<sub>41</sub>H<sub>55</sub>F<sub>6</sub>N<sub>3</sub>O<sub>4</sub> (M+H<sup>+</sup>) 768.4170, obsd 768.4167, error: 0.29 ppm.</div></div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> Pharmacology</h3><div id="sec5_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> Determination of <i>in Vitro</i> Anticancer Activity</h4><div class="NLM_p">The histological types and origin of the eight cancer cell lines are detailed in the legend of Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>. The cells were cultured in RPMI (Invitrogen, Merelbeke, Belgium) media supplemented with 10% heat inactivated fetal calf serum (Invitrogen). All culture media were supplemented with 4 mM glutamine, 100 μg/mL gentamicin, and penicillin–streptomycin (200 U/mL and 200 μg/mL) (Invitrogen).</div><div class="NLM_p last">The overall growth level of human cancer cell lines was determined using a colorimetric MTT (3-[4,5-dimethylthiazol-2yl-diphenyl tetrazolium bromide, Sigma, Belgium) assay as detailed previously.<a onclick="showRef(event, 'ref30 ref31 ref32 ref33'); return false;" href="javascript:void(0);" class="ref ref30 ref31 ref32 ref33">(30-33)</a> Each experimental condition was performed in six replicates.</div></div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> Molecular Docking</h3><div class="NLM_p">Docking was conducted using the <i>Glide</i> program (version 4.5),<a onclick="showRef(event, 'ref86'); return false;" href="javascript:void(0);" class="ref ref86">(86)</a> which positions the 3D structure of flexible ligands in the 3D structure of rigid or partially flexible receptors.</div><div class="NLM_p last">Docking experiments were performed on the X-ray crystallographic structure of the 20S proteasome from <i>Saccharomyces cerevisae</i> (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3D29">3D29</a>).<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> The 20S proteasome is highly conserved from yeast to human.<a onclick="showRef(event, 'ref87'); return false;" href="javascript:void(0);" class="ref ref87">(87)</a> The protein structures were prepared using the Protein Preparation Wizard in the Schrödinger software graphical user interface Maestro. Glide XP docking protocol and scoring function were used to dock in the rigid receptors and to score the poses of the different ligands. The default settings of <i>Glide</i> version 4.5 were used for the remaining parameters. For each docking run, the binding zone was defined as a cube of length 40 Å. This cube was centered on the former positions of the removed ligand cocrystallized with the protein in each proteolytic site. The initial 3D structures of the ligands were generated with the <i>CORINA</i> program.<a onclick="showRef(event, 'ref88'); return false;" href="javascript:void(0);" class="ref ref88">(88)</a></div></div><div id="sec5_3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> Biochemical Analyses Aimed at Characterizing Anti-Proteasome Activity</h3><div class="NLM_p">The substrates used for performing this assay were Suc-LLVY-Glo<sup></sup>, Z-LRR-Glo,<sup></sup> and Z-nLPnLD-Glo for the chymotrypsin-like, trypsin-like, and caspase-like assay, respectively. U373 GBM cells were incubated at a concentration of 5000 cells/mL for 48 h in three different 96-microwell plates (one plate for each catalytic site). U373 GBM cells were then treated with each compound at their IC<sub>50</sub><i>in vitro</i> growth inhibitory concentration (see Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>) for two days. Cells were then washed with PBS (Invitrogen, Merelbeke, Belgium) before adding digitonin at 0.025% to rapidly and selectively permeate the cytoplasmic membranes.<a onclick="showRef(event, 'ref89'); return false;" href="javascript:void(0);" class="ref ref89">(89)</a> Proteasome-Glo reagent (Promega Corporation, USA), specific for a catalytic site, was added in each well sample. Because the light of the aminoluciferine released was proportional to the rate of proteasome cleavage of the substrate, after 10 min of dark incubation, the bioluminescence of each well was measured with an ActiveGlo LR-100 luminometer (DSLabs, USA). Each experiment was conducted in triplicate. These cells’ bioluminescence assay was normalized by a concomitant cell viability assay (using the MTT colorimetric assay as detailed before) performed using strictly identical conditions.</div><div id="sec5_3_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> PPAR-γ Activity Assay</h4><div class="NLM_p last">U373 glioblastoma cells were treated with each compound at their IC<sub>50</sub><i>in vitro</i> growth inhibitory concentration (see Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a> and its legend) for 6 h. After these incubations, cells were collected and nuclear extracts were purified according to the manufacturer’s instructions (Cayman Chemical; Complete Transcription Factor Assay Kit). In brief, cells were detached with trypsin and centrifuged at 300 g for 5 min. The pellets were resuspended in an ice-cold PBS/Phosphatase inhibitor solution for 5 min. This step was repeated once. Extracts were resuspended in ice-cold hypotonic buffer and incubated for 15 min. To break the cytoplasmic membrane, cells were treated with Nonidet p-40 (Sigma-Aldrich, Bornem, Belgium). The extracts were centrifuged and the cytoplasmic fraction was saved for other applications. The pellet was resuspended in an extraction buffer containing protease inhibitor and incubated with gentle rocking for 30 min on ice. Extracts were centrifuged at 14 000 <i>g</i> for 10 min at 4 °C. The supernatant contained the nuclear fraction. Nuclear extracts were loaded in 96 well plates and incubated overnight at 4 °C. The primary antibody (from the PPAR-γ; Complete Transcription Factor Assay Kit) was added and incubated for one hour at room temperature. The wells were washed 5 times and a goat antirabbit HRP conjugated secondary antibody was added and incubated for one hour at room temperature. The wells were washed 5 times. Developing solution was added for 45 min and absorbance was measured at 450 nm with a spectrophotometer (Biorad model 680XR, Biorad, Nazareth, Belgium).</div></div><div id="sec5_3_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> Flow Cytometry Determination of Apoptosis and Cell Cycle Kinetics</h4><div class="NLM_p last">Analyses of apoptosis and cell cycle kinetics were performed with the APO AF detection kit (BD Pharmingen, Erembodegem-Aalst, Belgium) according to the manufacturer’s instructions and based on a procedure we previously described.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> The cancer cells were treated for 48 or 72 h with their respective IC<sub>50</sub><i>in vitro</i> growth inhibitory concentrations, 10 μM for U373 and A549 cancer cells (<b>6b</b>), and 80 and 100 μM for U373 and A549 cancer cells (<b>1</b>). TUNEL labeling of U373 GBM and A549 NSCLC cells was performed for 1 h at 37 °C followed by propidium iodide (PI) staining (5 μg/mL) in the presence of RNase. Stained cells were analyzed on a CellLab Quanta SC flow cytometer (Beckman Coulter; Analis, Suarlee, Belgium).</div></div><div id="sec5_3_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> Kinase Activity Determination</h4><div class="NLM_p last">We originally prepared ProQinase (Freiburg, Germany) with <b>6b</b> as a stock solution in 100% DMSO, and aliquots were further diluted with water in 96 well microliter plates immediately before use. For each kinase assay, 5 μL from a 2 × 10<sup>5</sup> M/10% DMSO compound solution were transferred into the assay plates. The final volume of the assay was 50 μL. The final assay concentration of <b>6b</b> was 1 μM. A radiometric protein kinase assay (<sup>33</sup>PanQinase Activity Assay) was used to measure the kinase activity of the 333 protein kinases under study, as detailed previously.<a onclick="showRef(event, 'ref90'); return false;" href="javascript:void(0);" class="ref ref90">(90)</a></div></div><div id="sec5_3_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> Statistical Analyses</h4><div class="NLM_p last">Data obtained from independent groups were compared by the nonparametric Kruskal–Wallis (Dunn’s procedure), Mann–Whitney U, or Spearman Rank Correlation tests. The statistical analysis was performed using <i>Statistica</i> software (Statsoft, Tulsa, OK).</div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i30"><a href="/doi/suppl/10.1021/jm200285z">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_78535" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_78535" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The characterization data for all compounds that have been synthesized and biologically evaluated in this study (HPLC, <sup>1</sup>H NMR, <sup>13</sup>C NMR, mass spectra, etc.) and the detailed biological and biochemical protocols.This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm200285z/suppl_file/jm200285z_si_001.pdf">jm200285z_si_001.pdf (413.0 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm200285z" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_45808" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_45808" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Robert Kiss</span> - <span class="hlFld-Affiliation affiliation">†Laboratoire de Chimie Bioanalytique, Toxicologie et Chimie Physique Appliquée, ‡Laboratoire de Toxicologie, and #Laboratoire de Chimie Pharmaceutique Organique, Faculté de Pharmacie, Université Libre de Bruxelles (ULB), and §Laboratoire de Chimie Organique and ⊥Laboratoire de Structure et Fonction des Membranes Biologiques, Faculté des Sciences, ULB, Brussels, Belgium</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#11637a78626251647d733f70723f7374"><span class="__cf_email__" data-cfemail="3b49505248487b4e5759155a5815595e">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Benjamin Lallemand</span> - <span class="hlFld-Affiliation affiliation">†Laboratoire de Chimie Bioanalytique, Toxicologie et Chimie Physique Appliquée, ‡Laboratoire de Toxicologie, and #Laboratoire de Chimie Pharmaceutique Organique, Faculté de Pharmacie, Université Libre de Bruxelles (ULB), and §Laboratoire de Chimie Organique and ⊥Laboratoire de Structure et Fonction des Membranes Biologiques, Faculté des Sciences, ULB, Brussels, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Fabien Chaix</span> - <span class="hlFld-Affiliation affiliation">†Laboratoire de Chimie Bioanalytique, Toxicologie et Chimie Physique Appliquée, ‡Laboratoire de Toxicologie, and #Laboratoire de Chimie Pharmaceutique Organique, Faculté de Pharmacie, Université Libre de Bruxelles (ULB), and §Laboratoire de Chimie Organique and ⊥Laboratoire de Structure et Fonction des Membranes Biologiques, Faculté des Sciences, ULB, Brussels, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Marina Bury</span> - <span class="hlFld-Affiliation affiliation">†Laboratoire de Chimie Bioanalytique, Toxicologie et Chimie Physique Appliquée, ‡Laboratoire de Toxicologie, and #Laboratoire de Chimie Pharmaceutique Organique, Faculté de Pharmacie, Université Libre de Bruxelles (ULB), and §Laboratoire de Chimie Organique and ⊥Laboratoire de Structure et Fonction des Membranes Biologiques, Faculté des Sciences, ULB, Brussels, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Céline Bruyère</span> - <span class="hlFld-Affiliation affiliation">†Laboratoire de Chimie Bioanalytique, Toxicologie et Chimie Physique Appliquée, ‡Laboratoire de Toxicologie, and #Laboratoire de Chimie Pharmaceutique Organique, Faculté de Pharmacie, Université Libre de Bruxelles (ULB), and §Laboratoire de Chimie Organique and ⊥Laboratoire de Structure et Fonction des Membranes Biologiques, Faculté des Sciences, ULB, Brussels, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jean Ghostin</span> - <span class="hlFld-Affiliation affiliation">†Laboratoire de Chimie Bioanalytique, Toxicologie et Chimie Physique Appliquée, ‡Laboratoire de Toxicologie, and #Laboratoire de Chimie Pharmaceutique Organique, Faculté de Pharmacie, Université Libre de Bruxelles (ULB), and §Laboratoire de Chimie Organique and ⊥Laboratoire de Structure et Fonction des Membranes Biologiques, Faculté des Sciences, ULB, Brussels, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jean-Paul Becker</span> - <span class="hlFld-Affiliation affiliation">†Laboratoire de Chimie Bioanalytique, Toxicologie et Chimie Physique Appliquée, ‡Laboratoire de Toxicologie, and #Laboratoire de Chimie Pharmaceutique Organique, Faculté de Pharmacie, Université Libre de Bruxelles (ULB), and §Laboratoire de Chimie Organique and ⊥Laboratoire de Structure et Fonction des Membranes Biologiques, Faculté des Sciences, ULB, Brussels, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Cédric Delporte</span> - <span class="hlFld-Affiliation affiliation">†Laboratoire de Chimie Bioanalytique, Toxicologie et Chimie Physique Appliquée, ‡Laboratoire de Toxicologie, and #Laboratoire de Chimie Pharmaceutique Organique, Faculté de Pharmacie, Université Libre de Bruxelles (ULB), and §Laboratoire de Chimie Organique and ⊥Laboratoire de Structure et Fonction des Membranes Biologiques, Faculté des Sciences, ULB, Brussels, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michel Gelbcke</span> - <span class="hlFld-Affiliation affiliation">†Laboratoire de Chimie Bioanalytique, Toxicologie et Chimie Physique Appliquée, ‡Laboratoire de Toxicologie, and #Laboratoire de Chimie Pharmaceutique Organique, Faculté de Pharmacie, Université Libre de Bruxelles (ULB), and §Laboratoire de Chimie Organique and ⊥Laboratoire de Structure et Fonction des Membranes Biologiques, Faculté des Sciences, ULB, Brussels, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Véronique Mathieu</span> - <span class="hlFld-Affiliation affiliation">†Laboratoire de Chimie Bioanalytique, Toxicologie et Chimie Physique Appliquée, ‡Laboratoire de Toxicologie, and #Laboratoire de Chimie Pharmaceutique Organique, Faculté de Pharmacie, Université Libre de Bruxelles (ULB), and §Laboratoire de Chimie Organique and ⊥Laboratoire de Structure et Fonction des Membranes Biologiques, Faculté des Sciences, ULB, Brussels, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jacques Dubois</span> - <span class="hlFld-Affiliation affiliation">†Laboratoire de Chimie Bioanalytique, Toxicologie et Chimie Physique Appliquée, ‡Laboratoire de Toxicologie, and #Laboratoire de Chimie Pharmaceutique Organique, Faculté de Pharmacie, Université Libre de Bruxelles (ULB), and §Laboratoire de Chimie Organique and ⊥Laboratoire de Structure et Fonction des Membranes Biologiques, Faculté des Sciences, ULB, Brussels, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Martine Prévost</span> - <span class="hlFld-Affiliation affiliation">†Laboratoire de Chimie Bioanalytique, Toxicologie et Chimie Physique Appliquée, ‡Laboratoire de Toxicologie, and #Laboratoire de Chimie Pharmaceutique Organique, Faculté de Pharmacie, Université Libre de Bruxelles (ULB), and §Laboratoire de Chimie Organique and ⊥Laboratoire de Structure et Fonction des Membranes Biologiques, Faculté des Sciences, ULB, Brussels, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ivan Jabin</span> - <span class="hlFld-Affiliation affiliation">†Laboratoire de Chimie Bioanalytique, Toxicologie et Chimie Physique Appliquée, ‡Laboratoire de Toxicologie, and #Laboratoire de Chimie Pharmaceutique Organique, Faculté de Pharmacie, Université Libre de Bruxelles (ULB), and §Laboratoire de Chimie Organique and ⊥Laboratoire de Structure et Fonction des Membranes Biologiques, Faculté des Sciences, ULB, Brussels, Belgium</span></div></li></ul></li><li></li><li></li><li></li></ul></div><div class="ack"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i31">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_01317" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_01317" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Q-TOF was acquired thanks to grants from the Fonds National de la Recherche Scientifique (FRS-FNRS) no 34553.08 and from the Université Libre de Bruxelles (ULB-FER2007). Marina Bury is the holder of a grant FRIA from the FNRS and Cédric Delporte is a PhD student from the FNRS. Robert Kiss is a director of research with the FNRS. Jean-Paul Becker is a postdoctoral fellow supported by the F.R.S.-FNRS. Martine Prévost is ‘Maître de Recherche’ at the FNRS. We thank Prof. M. Luhmer and Dr. R. D’Orazio from CIREM (ULB) for NMR spectra recording, Dr. P. Van Antwerpen for the HRMS analysis from Analytical Platform of the Pharmacy Faculty (ULB), and V. Megalizzi for the setting up of the proteasome test.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i32" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i32"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i33" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i33"> Abbreviations</h2><tr><td class="NLM_term">ATCC</td><td class="NLM_def"><p class="first last">American Type Culture Collection</p></td></tr><tr><td class="NLM_term">DSMZ</td><td class="NLM_def"><p class="first last">Deutsche Sammlung von Mikroorganismen and Zellkulturen</p></td></tr><tr><td class="NLM_term">ECACC</td><td class="NLM_def"><p class="first last">European Collection of Cell Culture</p></td></tr><tr><td class="NLM_term">GA</td><td class="NLM_def"><p class="first last">Glycyrrhetinic acid</p></td></tr><tr><td class="NLM_term">GBM</td><td class="NLM_def"><p class="first last">Glioblastoma</p></td></tr><tr><td class="NLM_term">MTT</td><td class="NLM_def"><p class="first last">3-(4,5)-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide</p></td></tr><tr><td class="NLM_term">NSCLC</td><td class="NLM_def"><p class="first last">Non-small-cell lung carcinoma</p></td></tr><tr><td class="NLM_term">PPARs</td><td class="NLM_def"><p class="first last">Peroxysome proliferator-activated receptors</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i34">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_05460" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_05460" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 90 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Obolentseva, G. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Litvinenko, V. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ammosov, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Popova, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sampiev, A. M.</span><span> </span><span class="NLM_article-title">Pharmacological and therapeutic properties of licorice preparations</span> <span class="citation_source-journal">Pharm. Chem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">427</span><span class="NLM_x">–</span> <span class="NLM_lpage">434</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm200285z&amp;key=10.1007%2FBF02510095" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm200285z&amp;key=1%3ACAS%3A528%3ADC%252BD3cXitlaiurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=1999&pages=427-434&author=G.+V.+Obolentsevaauthor=V.+I.+Litvinenkoauthor=A.+S.+Ammosovauthor=T.+P.+Popovaauthor=A.+M.+Sampiev&title=Pharmacological+and+therapeutic+properties+of+licorice+preparations"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological and therapeutic properties of licorice preparations</span></div><div class="casAuthors">Obolentseva, G. V.; Litvinenko, V. I.; Ammosov, A. S.; Popova, T. P.; Sampiev, A. M.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmaceutical Chemistry Journal (Translation of Khimiko-Farmatsevticheskii Zhurnal)</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">427-434</span>CODEN:
                <span class="NLM_cas:coden">PCJOAU</span>;
        ISSN:<span class="NLM_cas:issn">0091-150X</span>.
    
            (<span class="NLM_cas:orgname">Consultants Bureau</span>)
        </div><div class="casAbstract">A review with 233 refs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqdYml3W0b_7Vg90H21EOLACvtfcHk0liSpJp6TF002w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXitlaiurk%253D&md5=7c25467d53fe60468cb26a24c9310b2d</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1007%2FBF02510095&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF02510095%26sid%3Dliteratum%253Aachs%26aulast%3DObolentseva%26aufirst%3DG.%2BV.%26aulast%3DLitvinenko%26aufirst%3DV.%2BI.%26aulast%3DAmmosov%26aufirst%3DA.%2BS.%26aulast%3DPopova%26aufirst%3DT.%2BP.%26aulast%3DSampiev%26aufirst%3DA.%2BM.%26atitle%3DPharmacological%2520and%2520therapeutic%2520properties%2520of%2520licorice%2520preparations%26jtitle%3DPharm.%2520Chem.%2520J.%26date%3D1999%26volume%3D33%26spage%3D427%26epage%3D434" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Abe, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohya, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamoto, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shibuya, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arichi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Odashima, S.</span><span> </span><span class="NLM_article-title">Effects of glycyrrhizin and glycyrrhetinic acid on growth and melanogenesis in cultured B16 melanoma cells</span> <span class="citation_source-journal">Eur. J. Cancer Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1987</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">1549</span><span class="NLM_x">–</span> <span class="NLM_lpage">1555</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm200285z&amp;key=10.1016%2F0277-5379%2887%2990099-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm200285z&amp;key=3678319" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm200285z&amp;key=1%3ACAS%3A528%3ADyaL1cXivFw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=1987&pages=1549-1555&author=H.+Abeauthor=N.+Ohyaauthor=K.+F.+Yamamotoauthor=T.+Shibuyaauthor=S.+Arichiauthor=S.+Odashima&title=Effects+of+glycyrrhizin+and+glycyrrhetinic+acid+on+growth+and+melanogenesis+in+cultured+B16+melanoma+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of glycyrrhizin and glycyrrhetinic acid on growth and melanogenesis in cultured B16 melanoma cells</span></div><div class="casAuthors">Abe, Hiroko; Ohya, Nobuo; Yamamoto, Kohzaburo Fujikawa; Shibuya, Tomonori; Arichi, Shigeru; Odashima, Shizuo</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Cancer & Clinical Oncology</span>
        (<span class="NLM_cas:date">1987</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1549-55</span>CODEN:
                <span class="NLM_cas:coden">EJCODS</span>;
        ISSN:<span class="NLM_cas:issn">0277-5379</span>.
    </div><div class="casAbstract">The effects of glycyrrhizin (I) and its aglycon, glycyrrhetinic acid (II), on the growth and differentiation of mouse melanoma (B16) cells in culture were studied.  II inhibited the growth of B16 melanoma cells, caused morphol. alterations and stimulated melanogenesis.  I also resulted in the same changes but only when the concn. was 20 times more than that needed for II.  When II was removed after 84 h of treatment, the growth rate recovered slightly, but the doubling time was about twice that of the control.  Cytofluorometric anal. showed that the growth inhibition of II is the result of inhibition of the transfer from G1 to S phase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpVCR6Z17EnGLVg90H21EOLACvtfcHk0lgS3lkA2ondHg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1cXivFw%253D&md5=cc74670d01b03337319c8d1a38a05571</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2F0277-5379%2887%2990099-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0277-5379%252887%252990099-X%26sid%3Dliteratum%253Aachs%26aulast%3DAbe%26aufirst%3DH.%26aulast%3DOhya%26aufirst%3DN.%26aulast%3DYamamoto%26aufirst%3DK.%2BF.%26aulast%3DShibuya%26aufirst%3DT.%26aulast%3DArichi%26aufirst%3DS.%26aulast%3DOdashima%26aufirst%3DS.%26atitle%3DEffects%2520of%2520glycyrrhizin%2520and%2520glycyrrhetinic%2520acid%2520on%2520growth%2520and%2520melanogenesis%2520in%2520cultured%2520B16%2520melanoma%2520cells%26jtitle%3DEur.%2520J.%2520Cancer%2520Clin.%2520Oncol.%26date%3D1987%26volume%3D23%26spage%3D1549%26epage%3D1555" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Okamoto, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshida, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mizusaki, S.</span><span> </span><span class="NLM_article-title">Inhibition of 12-O-tetradecanoylphorbol-13-acetate-induced induction in Epstein-Barr virus early antigen in Raji cells</span> <span class="citation_source-journal">Cancer Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1983</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">47</span><span class="NLM_x">–</span> <span class="NLM_lpage">53</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm200285z&amp;key=10.1016%2F0304-3835%2883%2990134-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm200285z&amp;key=6850568" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm200285z&amp;key=1%3ACAS%3A528%3ADyaL3sXktVWlsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=1983&pages=47-53&author=H.+Okamotoauthor=D.+Yoshidaauthor=S.+Mizusaki&title=Inhibition+of+12-O-tetradecanoylphorbol-13-acetate-induced+induction+in+Epstein-Barr+virus+early+antigen+in+Raji+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of 12-O-tetradecanoylphorbol-13-acetate-induced induction in Epstein-Barr virus early antigen in Raji cells</span></div><div class="casAuthors">Okamoto, Hitoshi; Yoshida, Daisuke; Mizusaki, Shigenobu</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (Shannon, Ireland)</span>
        (<span class="NLM_cas:date">1983</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">47-53</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    </div><div class="casAbstract">Retinol  [68-26-8], 5 flavonoids, 3 steroids, and 7 sweetening agents were studied for their effects on TPA (I)  [16561-29-8]-induced early antigen (EA) of Epstein-Barr virus (EBV) in Raji cells.  Concomitant treatment of Raji cells with TPA and retinol inhibited EA induction.  Among flavonoids, quercetin  [117-39-5] resulted in effective inhibition of EA induction by TPA and α-naphthoflavone  [604-59-1] showed a weakly inhibitory effect.  None of the other flavonoids such as rutin  [153-18-4], catechin  [154-23-4] and β-naphthoflavone  [6051-87-2] affected the induction of EBV-EA by TPA.  β-Estradiol  [50-28-2] obviously inhibited EBV-EA induction by TPA, but hydrocortisone  [50-23-7] did not show any inhibitory effect.  Glycyrrhetinic acid, steviol, phyllodulcin and perrillartine also strongly inhibited EBV-EA induction.  Glycyrrhizin  [1405-86-3] and stevioside  [57817-89-7], glycosides of glycyrrhetinic acid  [471-53-4] and steviol  [471-80-7], did not inhibit the induction of EBV-EA by TPA.  Some of these inhibitors may be effective in inhibiting the in vivo tumor promotion by TPA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMhn98hrIvc7Vg90H21EOLACvtfcHk0lgS3lkA2ondHg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3sXktVWlsrY%253D&md5=6edaa2eb895927ef70549c0aaf189f74</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2F0304-3835%2883%2990134-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0304-3835%252883%252990134-9%26sid%3Dliteratum%253Aachs%26aulast%3DOkamoto%26aufirst%3DH.%26aulast%3DYoshida%26aufirst%3DD.%26aulast%3DMizusaki%26aufirst%3DS.%26atitle%3DInhibition%2520of%252012-O-tetradecanoylphorbol-13-acetate-induced%2520induction%2520in%2520Epstein-Barr%2520virus%2520early%2520antigen%2520in%2520Raji%2520cells%26jtitle%3DCancer%2520Lett.%26date%3D1983%26volume%3D19%26spage%3D47%26epage%3D53" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Hibasami, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwase, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshioka, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takahashi, H.</span><span> </span><span class="NLM_article-title">Glycyrrhetic acid (a metabolic substance and aglycon of glycyrrhizin) induces apoptosis in human hepatoma, promyelotic leukemia and stomach cancer cells</span> <span class="citation_source-journal">Int. J. Mol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">215</span><span class="NLM_x">–</span> <span class="NLM_lpage">219</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm200285z&amp;key=16391818" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm200285z&amp;key=1%3ACAS%3A528%3ADC%252BD28XhsVems74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2006&pages=215-219&author=H.+Hibasamiauthor=H.+Iwaseauthor=K.+Yoshiokaauthor=H.+Takahashi&title=Glycyrrhetic+acid+%28a+metabolic+substance+and+aglycon+of+glycyrrhizin%29+induces+apoptosis+in+human+hepatoma%2C+promyelotic+leukemia+and+stomach+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Glycyrrhetic acid (a metabolic substance and aglycon of glycyrrhizin) induces apoptosis in human hepatoma, promyelotic leukemia and stomach cancer cells</span></div><div class="casAuthors">Hibasami, Hiroshige; Iwase, Hirosi; Yoshioka, Kazumi; Takahashi, Hidehisa</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Molecular Medicine</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">215-219</span>CODEN:
                <span class="NLM_cas:coden">IJMMFG</span>;
        ISSN:<span class="NLM_cas:issn">1107-3756</span>.
    
            (<span class="NLM_cas:orgname">International Journal of Molecular Medicine</span>)
        </div><div class="casAbstract">We have investigated the effect of glycyrrhetic acid (GR) which is metabolic substance of glycyrrhizin, on DNA of human hepatoma (HLE), promyelotic leukemia (HL-60) and stomach cancer (KATO III) cells.  GR displayed apoptotic effects against HLE, HL-60 and KATO III cells.  The fragmentation of DNA by GR to oligonucleosomal-sized fragments, a characteristic of apoptosis, was dose- and time-dependent in these cell lines.  These findings suggest that growth inhibition of these cell lines by GR result from the induction of apoptosis by the compd.  Inhibitors of caspases did not suppress the DNA fragmentation caused by GR.  N-acetyl-L-cysteine, an antioxidant drug, weakly inhibited the DNA fragmentation caused by GR suggesting that active oxidants work partly as an apoptosis-inducing transfer substance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpm5LSdAeap-LVg90H21EOLACvtfcHk0lgS3lkA2ondHg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhsVems74%253D&md5=dc50bcb99f77068ea8765fa4352a754f</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHibasami%26aufirst%3DH.%26aulast%3DIwase%26aufirst%3DH.%26aulast%3DYoshioka%26aufirst%3DK.%26aulast%3DTakahashi%26aufirst%3DH.%26atitle%3DGlycyrrhetic%2520acid%2520%2528a%2520metabolic%2520substance%2520and%2520aglycon%2520of%2520glycyrrhizin%2529%2520induces%2520apoptosis%2520in%2520human%2520hepatoma%252C%2520promyelotic%2520leukemia%2520and%2520stomach%2520cancer%2520cells%26jtitle%3DInt.%2520J.%2520Mol.%2520Med.%26date%3D2006%26volume%3D17%26spage%3D215%26epage%3D219" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Isbrucker, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burdock, G. A.</span><span> </span><span class="NLM_article-title">Risk and safety assessment on the consumption of licorice root (Glycyrrhiza sp.), its extract and powder as a food ingredient, with emphasis on the pharmacology and toxicology of glycyrrhizin</span> <span class="citation_source-journal">Regul. Toxicol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">167</span><span class="NLM_x">–</span> <span class="NLM_lpage">192</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm200285z&amp;key=10.1016%2Fj.yrtph.2006.06.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm200285z&amp;key=16884839" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm200285z&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1Shu7nO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2006&pages=167-192&author=R.+A.+Isbruckerauthor=G.+A.+Burdock&title=Risk+and+safety+assessment+on+the+consumption+of+licorice+root+%28Glycyrrhiza+sp.%29%2C+its+extract+and+powder+as+a+food+ingredient%2C+with+emphasis+on+the+pharmacology+and+toxicology+of+glycyrrhizin"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Risk and safety assessment on the consumption of licorice root (Glycyrrhiza sp.), its extract and powder as a food ingredient, with emphasis on the pharmacology and toxicology of glycyrrhizin</span></div><div class="casAuthors">Isbrucker, R. A.; Burdock, G. A.</div><div class="citationInfo"><span class="NLM_cas:title">Regulatory Toxicology and Pharmacology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">167-192</span>CODEN:
                <span class="NLM_cas:coden">RTOPDW</span>;
        ISSN:<span class="NLM_cas:issn">0273-2300</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Licorice (or 'liquorice') is a plant of ancient origin and steeped in history.  Licorice exts. and its principal component, glycyrrhizin, have extensive use in foods, tobacco and in both traditional and herbal medicine.  As a result, there is a high level of use of licorice and glycyrrhizin in the US with an estd. consumption of 0.027-3.6 mg glycyrrhizin/kg/day.  Both products have been approved for use in foods by most national and supranational regulatory agencies.  Biochem. studies indicate that glycyrrhizinates inhibit 11β-hydroxysteroid dehydrogenase, the enzyme responsible for inactivating cortisol.  As a result, the continuous, high level exposure to glycyrrhizin compds. can produce hypermineralocorticoid-like effects in both animals and humans.  These effects are reversible upon withdrawal of licorice or glycyrrhizin.  Other in vivo and clin. studies have reported beneficial effects of both licorice and glycyrrhizin consumption including anti-ulcer, anti-viral, and hepatoprotective responses.  Various genotoxic studies have indicated that glycyrrhizin is neither teratogenic nor mutagenic, and may possess anti-genotoxic properties under certain conditions.  The pharmacokinetics of glycyrrhizin have been described and show that its bioavailability is reduced when consumed as licorice; this has hampered attempts to establish clear dose-effect levels in animals and humans.  Based on the in vivo and clin. evidence, we propose an acceptable daily intake of 0.015-0.229 mg glycyrrhizin/kg body wt./day.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqjZnEsEDY27LVg90H21EOLACvtfcHk0ljWIob27ArKIQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1Shu7nO&md5=2327dc6295670decb4904d60b393c3b2</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.yrtph.2006.06.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.yrtph.2006.06.002%26sid%3Dliteratum%253Aachs%26aulast%3DIsbrucker%26aufirst%3DR.%2BA.%26aulast%3DBurdock%26aufirst%3DG.%2BA.%26atitle%3DRisk%2520and%2520safety%2520assessment%2520on%2520the%2520consumption%2520of%2520licorice%2520root%2520%2528Glycyrrhiza%2520sp.%2529%252C%2520its%2520extract%2520and%2520powder%2520as%2520a%2520food%2520ingredient%252C%2520with%2520emphasis%2520on%2520the%2520pharmacology%2520and%2520toxicology%2520of%2520glycyrrhizin%26jtitle%3DRegul.%2520Toxicol.%2520Pharmacol.%26date%3D2006%26volume%3D46%26spage%3D167%26epage%3D192" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Zhang, M.-Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yin, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shrubsole, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kon, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pozzi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, R. C.</span><span> </span><span class="NLM_article-title">Inhibition of 11beta-hydroxysteroid dehydrogenase type II selectively blocks the tumor COX-2 pathway and suppresses colon carcinogenesis in mice and humans</span> <span class="citation_source-journal">J. Clin. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">119</span><span class="NLM_x">, </span> <span class="NLM_fpage">876</span><span class="NLM_x">–</span> <span class="NLM_lpage">885</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=119&publication_year=2009&pages=876-885&author=M.-Z.+Zhangauthor=J.+Xuauthor=B.+Yaoauthor=H.+Yinauthor=Q.+Caiauthor=M.+J.+Shrubsoleauthor=X.+Chenauthor=V.+Konauthor=W.+Zhengauthor=A.+Pozziauthor=R.+C.+Harris&title=Inhibition+of+11beta-hydroxysteroid+dehydrogenase+type+II+selectively+blocks+the+tumor+COX-2+pathway+and+suppresses+colon+carcinogenesis+in+mice+and+humans"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DM.-Z.%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DYao%26aufirst%3DB.%26aulast%3DYin%26aufirst%3DH.%26aulast%3DCai%26aufirst%3DQ.%26aulast%3DShrubsole%26aufirst%3DM.%2BJ.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DKon%26aufirst%3DV.%26aulast%3DZheng%26aufirst%3DW.%26aulast%3DPozzi%26aufirst%3DA.%26aulast%3DHarris%26aufirst%3DR.%2BC.%26atitle%3DInhibition%2520of%252011beta-hydroxysteroid%2520dehydrogenase%2520type%2520II%2520selectively%2520blocks%2520the%2520tumor%2520COX-2%2520pathway%2520and%2520suppresses%2520colon%2520carcinogenesis%2520in%2520mice%2520and%2520humans%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2009%26volume%3D119%26spage%3D876%26epage%3D885" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Satomi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishino, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shibata, S.</span><span> </span><span class="NLM_article-title">Glycyrrhetinic acid and related compounds induce G1 arrest and apoptosis in human hepatocellular carcinoma HepG2</span> <span class="citation_source-journal">Anticancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">4043</span><span class="NLM_x">–</span> <span class="NLM_lpage">4047</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm200285z&amp;key=16309197" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm200285z&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht12it7zE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2005&pages=4043-4047&author=Y.+Satomiauthor=H.+Nishinoauthor=S.+Shibata&title=Glycyrrhetinic+acid+and+related+compounds+induce+G1+arrest+and+apoptosis+in+human+hepatocellular+carcinoma+HepG2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Glycyrrhetinic acid and related compounds induce G1 arrest and apoptosis in human hepatocellular carcinoma HepG2</span></div><div class="casAuthors">Satomi, Yoshiko; Nishino, Hoyoku; Shibata, Shoji</div><div class="citationInfo"><span class="NLM_cas:title">Anticancer Research</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">6B</span>),
    <span class="NLM_cas:pages">4043-4047</span>CODEN:
                <span class="NLM_cas:coden">ANTRD4</span>;
        ISSN:<span class="NLM_cas:issn">0250-7005</span>.
    
            (<span class="NLM_cas:orgname">International Institute of Anticancer Research</span>)
        </div><div class="casAbstract">Glycyrrhetinic acid (GA) and its related compds. are known to have anti-inflammatory activity and also to inhibit liver carcinogenesis and tumor growth.  GA and related compds. inhibited cell proliferation of the human hepatoma cell line, HepG2.  Among five compds. tested, ursolic acid and 18β-olean-12-ene-3β, 23, 28-triol (18β-erythrotriol) were comparatively effective, where the 50% ID was 20 μM and 25 μM, resp.  Flow-cytometric anal. showed that GA and the related compds. arrested the cell cycle in the G1-phase; in addn., GA-related compds. induced apoptosis at high dose.  Western blot anal. indicated that the induction of apoptosis by GA and ursolic acid was accompanied with an activation of caspase-8 and a redn. in the anti-apoptotic proteins, Bcl-2 and Bcl-xL, although the pro-apoptotic proteins, Box and Bak, remained unaffected.  These results suggest that GA and its related compds. may be potent agents in liver cancer treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqweWdvqUmqKLVg90H21EOLACvtfcHk0ljWIob27ArKIQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht12it7zE&md5=f094cb71d69c29db07311c71ac052675</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSatomi%26aufirst%3DY.%26aulast%3DNishino%26aufirst%3DH.%26aulast%3DShibata%26aufirst%3DS.%26atitle%3DGlycyrrhetinic%2520acid%2520and%2520related%2520compounds%2520induce%2520G1%2520arrest%2520and%2520apoptosis%2520in%2520human%2520hepatocellular%2520carcinoma%2520HepG2%26jtitle%3DAnticancer%2520Res.%26date%3D2005%26volume%3D25%26spage%3D4043%26epage%3D4047" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Hawthorne, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallagher, S.</span><span> </span><span class="NLM_article-title">Effects of glycyrrhetinic acid and liquorice extract on cell proliferation and prostate-specific antigen secretion in LNCaP prostate cancer cells</span> <span class="citation_source-journal">J. Pharm. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">661</span><span class="NLM_x">–</span> <span class="NLM_lpage">666</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm200285z&amp;key=10.1211%2Fjpp.60.5.0013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm200285z&amp;key=18416944" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm200285z&amp;key=1%3ACAS%3A528%3ADC%252BD1cXltlemt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2008&pages=661-666&author=S.+Hawthorneauthor=S.+Gallagher&title=Effects+of+glycyrrhetinic+acid+and+liquorice+extract+on+cell+proliferation+and+prostate-specific+antigen+secretion+in+LNCaP+prostate+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of glycyrrhetinic acid and liquorice extract on cell proliferation and prostate-specific antigen secretion in LNCaP prostate cancer cells</span></div><div class="casAuthors">Hawthorne, Susan; Gallagher, Sandra</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacy and Pharmacology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">661-666</span>CODEN:
                <span class="NLM_cas:coden">JPPMAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3573</span>.
    
            (<span class="NLM_cas:orgname">Pharmaceutical Press</span>)
        </div><div class="casAbstract">Glycyrrhetinic acid (GA) is the active metabolite of glycyrrhizic acid, one of the components of liquorice ext.  It has been shown to possess anti-inflammatory activity and to inhibit hepatic tumor growth.  In this preliminary study, we have shown that GA could significantly reduce the rate of proliferation of LNCaP androgen dependent prostate cancer cells, whereas it had no effect on proliferation of PC3 and DU145 androgen-independent prostate cancer cells.  Addnl., GA could significantly reduce the prodn. of prostate-specific antigen by LNCaP cells maintained in-vitro.  This study provides a sound platform for further investigation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGql68cUY2StxbVg90H21EOLACvtfcHk0ljWIob27ArKIQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXltlemt78%253D&md5=c5273eca1b0923d075201b4ad8c61166</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1211%2Fjpp.60.5.0013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1211%252Fjpp.60.5.0013%26sid%3Dliteratum%253Aachs%26aulast%3DHawthorne%26aufirst%3DS.%26aulast%3DGallagher%26aufirst%3DS.%26atitle%3DEffects%2520of%2520glycyrrhetinic%2520acid%2520and%2520liquorice%2520extract%2520on%2520cell%2520proliferation%2520and%2520prostate-specific%2520antigen%2520secretion%2520in%2520LNCaP%2520prostate%2520cancer%2520cells%26jtitle%3DJ.%2520Pharm.%2520Pharmacol.%26date%3D2008%26volume%3D60%26spage%3D661%26epage%3D666" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Lee, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, Y. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jang, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Myung, S. C.</span><span> </span><span class="NLM_article-title">18beta-glycyrrhetinic acid potentiates apoptotic effect of trichostatin A on human epithelial ovarian carcinoma cell lines</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">649</span><span class="NLM_x">, </span> <span class="NLM_fpage">354</span><span class="NLM_x">–</span> <span class="NLM_lpage">361</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm200285z&amp;key=10.1016%2Fj.ejphar.2010.09.047" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm200285z&amp;key=20868669" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm200285z&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlKktbvN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=649&publication_year=2010&pages=354-361&author=C.+S.+Leeauthor=J.+C.+Yangauthor=Y.+J.+Kimauthor=E.+R.+Jangauthor=W.+Kimauthor=S.+C.+Myung&title=18beta-glycyrrhetinic+acid+potentiates+apoptotic+effect+of+trichostatin+A+on+human+epithelial+ovarian+carcinoma+cell+lines"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">18β-Glycyrrhetinic acid potentiates apoptotic effect of trichostatin A on human epithelial ovarian carcinoma cell lines</span></div><div class="casAuthors">Lee, Chung Soo; Yang, Jae Chon; Kim, Yun Jeong; Jang, Eun-Ra; Kim, Wonyong; Myung, Soon Chul</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">649</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">354-361</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The licorice-derived compds. glycyrrhizin and 18β-glycyrrhetinic acid have been shown to induce apoptosis in various cancer cells.  However, the effect of these licorice compds. on the apoptotic effect of histone deacetylase inhibitors in epithelial ovarian carcinoma cells has not been detd.  We assessed the effect of 18β-glycyrrhetinic acid on trichostatin A-induced apoptosis in the human epithelial carcinoma cell lines OVCAR-3 and SK-OV-3.  Trichostatin A induced nuclear damage, decreased Bid and Bcl-2 protein levels, increased in Bax levels, induced cytochrome c release, activated caspase-8, -9 and -3, and increased tumor suppressor p53 levels.  18β-Glycyrrhetinic acid potentiated the trichostatin A-induced apoptosis-related protein activation and cell death.  Unlike 18β-glycyrrhetinic acid, up to 25 μM of the pro-compd. glycyrrhizin did not induce cell death and did not affect trichostatin A-induced apoptosis.  The results suggest that 18β-glycyrrhetinic acid may potentiate the apoptotic effects of trichostatin A against ovarian carcinoma cell lines by increasing the activation of the caspase-8-dependent pathway as well as the activation of the mitochondria-mediated cell death pathway, leading to activation of caspases.  18β-Glycyrrhetinic acid may enhance the therapeutic effect of trichostatin A against epithelial ovarian adenocarcinoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr6Aljw6v9VHLVg90H21EOLACvtfcHk0lh8-xHl7jKr0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlKktbvN&md5=80d249cac36f2502e9f25c7cd1a05bbd</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2010.09.047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2010.09.047%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DC.%2BS.%26aulast%3DYang%26aufirst%3DJ.%2BC.%26aulast%3DKim%26aufirst%3DY.%2BJ.%26aulast%3DJang%26aufirst%3DE.%2BR.%26aulast%3DKim%26aufirst%3DW.%26aulast%3DMyung%26aufirst%3DS.%2BC.%26atitle%3D18beta-glycyrrhetinic%2520acid%2520potentiates%2520apoptotic%2520effect%2520of%2520trichostatin%2520A%2520on%2520human%2520epithelial%2520ovarian%2520carcinoma%2520cell%2520lines%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2010%26volume%3D649%26spage%3D354%26epage%3D361" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Salvi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fiore, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Armanini, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toninello, A.</span><span> </span><span class="NLM_article-title">Glycyrrhetinic acid-induced permeability transition in rat liver mitochondria</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">2375</span><span class="NLM_x">–</span> <span class="NLM_lpage">2379</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2003&pages=2375-2379&author=M.+Salviauthor=C.+Fioreauthor=D.+Armaniniauthor=A.+Toninello&title=Glycyrrhetinic+acid-induced+permeability+transition+in+rat+liver+mitochondria"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSalvi%26aufirst%3DM.%26aulast%3DFiore%26aufirst%3DC.%26aulast%3DArmanini%26aufirst%3DD.%26aulast%3DToninello%26aufirst%3DA.%26atitle%3DGlycyrrhetinic%2520acid-induced%2520permeability%2520transition%2520in%2520rat%2520liver%2520mitochondria%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2003%26volume%3D66%26spage%3D2375%26epage%3D2379" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Lee, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, Y. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, S. J.</span><span> </span><span class="NLM_article-title">18beta-Glycyrrhetinic acid induces apoptotic cell death in SiHa cells and exhibits a synergistic effect against antibiotic anti-cancer drug toxicity</span> <span class="citation_source-journal">Life Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">83</span><span class="NLM_x">, </span> <span class="NLM_fpage">481</span><span class="NLM_x">–</span> <span class="NLM_lpage">489</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=2008&pages=481-489&author=C.+S.+Leeauthor=Y.+J.+Kimauthor=M.+S.+Leeauthor=E.+S.+Hanauthor=S.+J.+Lee&title=18beta-Glycyrrhetinic+acid+induces+apoptotic+cell+death+in+SiHa+cells+and+exhibits+a+synergistic+effect+against+antibiotic+anti-cancer+drug+toxicity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DC.%2BS.%26aulast%3DKim%26aufirst%3DY.%2BJ.%26aulast%3DLee%26aufirst%3DM.%2BS.%26aulast%3DHan%26aufirst%3DE.%2BS.%26aulast%3DLee%26aufirst%3DS.%2BJ.%26atitle%3D18beta-Glycyrrhetinic%2520acid%2520induces%2520apoptotic%2520cell%2520death%2520in%2520SiHa%2520cells%2520and%2520exhibits%2520a%2520synergistic%2520effect%2520against%2520antibiotic%2520anti-cancer%2520drug%2520toxicity%26jtitle%3DLife%2520Sci.%26date%3D2008%26volume%3D83%26spage%3D481%26epage%3D489" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Schwarz, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Csuk, R.</span><span> </span><span class="NLM_article-title">Synthesis and antitumour activity of glycyrrhetinic acid derivatives</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">7458</span><span class="NLM_x">–</span> <span class="NLM_lpage">7474</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2010&pages=7458-7474&author=S.+Schwarzauthor=R.+Csuk&title=Synthesis+and+antitumour+activity+of+glycyrrhetinic+acid+derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSchwarz%26aufirst%3DS.%26aulast%3DCsuk%26aufirst%3DR.%26atitle%3DSynthesis%2520and%2520antitumour%2520activity%2520of%2520glycyrrhetinic%2520acid%2520derivatives%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2010%26volume%3D18%26spage%3D7458%26epage%3D7474" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Anuchapreeda, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leechanachai, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ambudkar, S. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Limtrakul, P. N.</span><span> </span><span class="NLM_article-title">Modulation of P-glycoprotein expression and function by curcumin in multidrug-resistant human KB cells</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">573</span><span class="NLM_x">–</span> <span class="NLM_lpage">582</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm200285z&amp;key=10.1016%2FS0006-2952%2802%2901224-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm200285z&amp;key=12167476" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm200285z&amp;key=1%3ACAS%3A528%3ADC%252BD38XmtVWls7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2002&pages=573-582&author=S.+Anuchapreedaauthor=P.+Leechanachaiauthor=M.+M.+Smithauthor=S.+V.+Ambudkarauthor=P.+N.+Limtrakul&title=Modulation+of+P-glycoprotein+expression+and+function+by+curcumin+in+multidrug-resistant+human+KB+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Modulation of P-glycoprotein expression and function by curcumin in multidrug-resistant human KB cells</span></div><div class="casAuthors">Anuchapreeda, Songyot; Leechanachai, Pranee; Smith, Melissa M.; Ambudkar, Suresh V.; Limtrakul, Porn-ngarm</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">573-582</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">Multidrug resistance (MDR) is a phenomenon that is often assocd. with decreased intracellular drug accumulation in the tumor cells of a patient, resulting from enhanced drug efflux.  It is often related to the overexpression of P-glycoprotein (Pgp) on the surface of tumor cells, thereby reducing drug cytotoxicity.  In this study, curcumin was tested for its potential ability to modulate the expression and function of Pgp in the multidrug-resistant human cervical carcinoma cell line KB-V1.  Western blot anal. and reverse transcription-polymerase chain reaction (RT-PCR) showed that treatment with 1, 5, and 10 μM curcumin for up to 72 h was able to significantly lower Pgp expression in KB-V1 cells.  Curcumin (1-10 μM) decreased Pgp expression in a concn.-dependent manner and was also found to have the same effect on MDR1 mRNA levels.  The effect of curcumin on Pgp function was demonstrated by rhodamine 123 (Rh123) accumulation and efflux in Pgp-expressing KB-V1 cells.  Curcumin increased Rh123 accumulation in a concn.-dependent manner (1-55 μM) and inhibited the efflux of Rh123 from these cells, but did not affect the efflux of Rh123 from the wild-type drug-sensitive KB-3-1 cells.  Treatment of drug-resistant KB-V1 cells with curcumin increased their sensitivity to vinblastine, which was consistent with an increased intracellular accumulation of Rh123.  In addn., curcumin inhibited verapamil-stimulated ATPase activity and the photoaffinity labeling of Pgp with the prazosin analog [125I]iodoarylazidoprazosin in a concn.-dependent manner, demonstrating that curcumin interacts directly with the transporter.  Thus, curcumin seems to be able to modulate the in vitro expression and function of Pgp in multidrug-resistant human KB-V1 cells.  In summary, this study describes the duel modulation of MDR1 expression and Pgp function by the phytochem. curcumin, which may be an attractive new agent for the chemosensitization of cancer cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqISvxyjK1_XrVg90H21EOLACvtfcHk0lgWZyNKl3BDqw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XmtVWls7g%253D&md5=38eee74912cd894d85ebc666bb38b967</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2FS0006-2952%2802%2901224-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0006-2952%252802%252901224-8%26sid%3Dliteratum%253Aachs%26aulast%3DAnuchapreeda%26aufirst%3DS.%26aulast%3DLeechanachai%26aufirst%3DP.%26aulast%3DSmith%26aufirst%3DM.%2BM.%26aulast%3DAmbudkar%26aufirst%3DS.%2BV.%26aulast%3DLimtrakul%26aufirst%3DP.%2BN.%26atitle%3DModulation%2520of%2520P-glycoprotein%2520expression%2520and%2520function%2520by%2520curcumin%2520in%2520multidrug-resistant%2520human%2520KB%2520cells%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2002%26volume%3D64%26spage%3D573%26epage%3D582" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Mayur, Y. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peters, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prasad, V. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lemo, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sathish, N. K.</span><span> </span><span class="NLM_article-title">Design of new drug molecules to be used in reversing multidrug resistance in cancer cells</span> <span class="citation_source-journal">Curr. Cancer Drug Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">298</span><span class="NLM_x">–</span> <span class="NLM_lpage">306</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm200285z&amp;key=10.2174%2F156800909788166619" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm200285z&amp;key=19442050" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm200285z&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmslansL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2009&pages=298-306&author=Y.+C.+Mayurauthor=G.+J.+Petersauthor=V.+V.+Prasadauthor=C.+Lemoauthor=N.+K.+Sathish&title=Design+of+new+drug+molecules+to+be+used+in+reversing+multidrug+resistance+in+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Design of new drug molecules to be used in reversing multidrug resistance in cancer cells</span></div><div class="casAuthors">Mayur, Y. C.; Peters, G. J.; Prasad, V. V. S. Rajendra; Lemos, C.; Sathish, N. K.</div><div class="citationInfo"><span class="NLM_cas:title">Current Cancer Drug Targets</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">298-306</span>CODEN:
                <span class="NLM_cas:coden">CCDTB9</span>;
        ISSN:<span class="NLM_cas:issn">1568-0096</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Over the past two decades, a no. of chem. entities have been investigated in the continuing quest to reverse P-glycoprotein (P-gp) mediated multidrug resistance (MDR) in cancer cells and some have undergone clin. trials, but currently none are in clin. use.  Unfortunately, most of these agents suffer clin. from their intrinsic toxicity or from undesired effects on the pharmacokinetics of the accompanying anti-cancer drugs.  An acridonecarboxamide (GF120918), Imidazo acridone (C1311) and timethylene acridone deriv. 1,3-bis(9-oxoacridin-10-yl)-propane (PBA) have already been shown to be among the group of compds. known to modify P-gp mediated MDR in cancer.  In the recent past it has been identified that various N10-substituted acridones can reverse the multidrug resistance (MDR) in cancer by selectively inhibiting the multidrug resistance assocd. protein (MRP) and calmodulin dependent cAMP phosphodiesterase.  This article envisages the various drugs being developed for treating MDR in cancer cells and esp. the acridone derivs. which are being developed by the author.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZfok-7B596LVg90H21EOLACvtfcHk0lgWZyNKl3BDqw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmslansL0%253D&md5=2403c3c2eac28dca5ebb7a6944a7d5a1</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.2174%2F156800909788166619&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156800909788166619%26sid%3Dliteratum%253Aachs%26aulast%3DMayur%26aufirst%3DY.%2BC.%26aulast%3DPeters%26aufirst%3DG.%2BJ.%26aulast%3DPrasad%26aufirst%3DV.%2BV.%26aulast%3DLemo%26aufirst%3DC.%26aulast%3DSathish%26aufirst%3DN.%2BK.%26atitle%3DDesign%2520of%2520new%2520drug%2520molecules%2520to%2520be%2520used%2520in%2520reversing%2520multidrug%2520resistance%2520in%2520cancer%2520cells%26jtitle%3DCurr.%2520Cancer%2520Drug%2520Targets%26date%3D2009%26volume%3D9%26spage%3D298%26epage%3D306" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Jutooru, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chadalapaka, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chintharlapalli, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Papineni, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Safe, S.</span><span> </span><span class="NLM_article-title">Induction of apoptosis and nonsteroidal anti-inflammatory drug-activated gene 1 in pancreatic cancer cells by a glycyrrhetinic acid derivative</span> <span class="citation_source-journal">Mol. Carcinog.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">692</span><span class="NLM_x">–</span> <span class="NLM_lpage">702</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm200285z&amp;key=10.1002%2Fmc.20518" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm200285z&amp;key=19125423" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm200285z&amp;key=1%3ACAS%3A528%3ADC%252BD1MXpt1Wlsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2009&pages=692-702&author=I.+Jutooruauthor=G.+Chadalapakaauthor=S.+Chintharlapalliauthor=S.+Papineniauthor=S.+Safe&title=Induction+of+apoptosis+and+nonsteroidal+anti-inflammatory+drug-activated+gene+1+in+pancreatic+cancer+cells+by+a+glycyrrhetinic+acid+derivative"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Induction of apoptosis and nonsteroidal anti-inflammatory drug-activated gene 1 in pancreatic cancer cells by a glycyrrhetinic acid derivative</span></div><div class="casAuthors">Jutooru, Indira; Chadalapaka, Gayathri; Chintharlapalli, Sudhakar; Papineni, Sabitha; Safe, Stephen</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Carcinogenesis</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">692-702</span>CODEN:
                <span class="NLM_cas:coden">MOCAE8</span>;
        ISSN:<span class="NLM_cas:issn">0899-1987</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Me 2-cyano-3,11-dioxo-18β-olean-1,12-dien-30-oate (CDODA-Me) is a synthetic triterpenoid derived from glycyrrhetinic acid, a bioactive phytochem. in licorice, CDODA-Me inhibits growth of Panc1 and Panc28 pancreatic cancer cell lines and activates peroxisome proliferator-activated receptor γ (PPARγ)-dependent transactivation in these cells.  CDODA-Me also induced p21 and p27 protein expression and down regulates cyclin D1; however, these responses were receptor-independent.  CDODA-Me induced apoptosis in Panc1 and Panc28 cells, and this was accompanied by receptor-independent induction of the proapoptotic proteins early growth response-1 (Egr-1), nonsteroidal anti-inflammatory drug-activated gene-1 (NAG-1), and activating transcription factor-3 (ATF3).  Induction of NAG-1 and Egr-1 by CDODA-Me was dependent on activation of phosphatidylinositol-3-kinase (PI3-K) and/or p42 and p38 mitogen-activated protein kinase (MAPK) pathways but there were differences between Panc28 and Panc1 cells.  Induction of NAG-1 in Panc28 cells was p38-MAPK- and PI3-K-dependent but Egr-1-independent, whereas induction in Panc1 cells was assocd. with activation of p38-MAPK, PI3-K, and p42-MAPK and was only partially Egr-1-dependent.  This is the first report of the induction of the proapoptotic protein NAG-1 in pancreatic cancer cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhzVZfoBgDl7Vg90H21EOLACvtfcHk0lgWZyNKl3BDqw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXpt1Wlsbs%253D&md5=7cea4c3a96a1108f892675231a0053b8</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1002%2Fmc.20518&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmc.20518%26sid%3Dliteratum%253Aachs%26aulast%3DJutooru%26aufirst%3DI.%26aulast%3DChadalapaka%26aufirst%3DG.%26aulast%3DChintharlapalli%26aufirst%3DS.%26aulast%3DPapineni%26aufirst%3DS.%26aulast%3DSafe%26aufirst%3DS.%26atitle%3DInduction%2520of%2520apoptosis%2520and%2520nonsteroidal%2520anti-inflammatory%2520drug-activated%2520gene%25201%2520in%2520pancreatic%2520cancer%2520cells%2520by%2520a%2520glycyrrhetinic%2520acid%2520derivative%26jtitle%3DMol.%2520Carcinog.%26date%3D2009%26volume%3D48%26spage%3D692%26epage%3D702" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Chung, T. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, Y. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J. C.</span><span> </span><span class="NLM_article-title">18beta-glycyrrhetinic acid promotes src interaction with connexin43 in rat cardiomyocytes</span> <span class="citation_source-journal">J. Cell Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">100</span><span class="NLM_x">, </span> <span class="NLM_fpage">653</span><span class="NLM_x">–</span> <span class="NLM_lpage">664</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2007&pages=653-664&author=T.+H.+Chungauthor=S.+M.+Wangauthor=Y.+C.+Changauthor=Y.+L.+Chenauthor=J.+C.+Wu&title=18beta-glycyrrhetinic+acid+promotes+src+interaction+with+connexin43+in+rat+cardiomyocytes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChung%26aufirst%3DT.%2BH.%26aulast%3DWang%26aufirst%3DS.%2BM.%26aulast%3DChang%26aufirst%3DY.%2BC.%26aulast%3DChen%26aufirst%3DY.%2BL.%26aulast%3DWu%26aufirst%3DJ.%2BC.%26atitle%3D18beta-glycyrrhetinic%2520acid%2520promotes%2520src%2520interaction%2520with%2520connexin43%2520in%2520rat%2520cardiomyocytes%26jtitle%3DJ.%2520Cell%2520Biochem.%26date%3D2007%26volume%3D100%26spage%3D653%26epage%3D664" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Kawakami, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ikarashi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kase, Y.</span><span> </span><span class="NLM_article-title">Glycyrrhizin and its metabolite 18beta-glycyrhetinic acid in glycyrrhiza, a constituent herb of yokukansan, ameliorate thiamine deficiency-induced dysfunction of glutamate transport in cultured rat cortical astrocytes</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">626</span><span class="NLM_x">, </span> <span class="NLM_fpage">154</span><span class="NLM_x">–</span> <span class="NLM_lpage">158</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm200285z&amp;key=10.1016%2Fj.ejphar.2009.09.046" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm200285z&amp;key=19818347" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm200285z&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsV2mtLrK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=626&publication_year=2010&pages=154-158&author=Z.+Kawakamiauthor=Y.+Ikarashiauthor=Y.+Kase&title=Glycyrrhizin+and+its+metabolite+18beta-glycyrhetinic+acid+in+glycyrrhiza%2C+a+constituent+herb+of+yokukansan%2C+ameliorate+thiamine+deficiency-induced+dysfunction+of+glutamate+transport+in+cultured+rat+cortical+astrocytes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Glycyrrhizin and its metabolite 18β-glycyrrhetinic acid in glycyrrhiza, a constituent herb of yokukansan, ameliorate thiamine deficiency-induced dysfunction of glutamate transport in cultured rat cortical astrocytes</span></div><div class="casAuthors">Kawakami, Zenji; Ikarashi, Yasushi; Kase, Yoshio</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">626</span>
        (<span class="NLM_cas:issue">2-3</span>),
    <span class="NLM_cas:pages">154-158</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Effects of yokukansan, a traditional Japanese medicine, on thiamin deficiency (TD)-induced decrease of glutamate uptake were examd. in cultured rat cortical astrocytes.  Yokukansan (100-500 μg/mL) ameliorated the TD-induced decrease in glutamate uptake by astrocytes, implying that yokukansan may contain active herbs and compds. possessing this effect.  Among the seven constituent herbs of yokukansan, significant effects were found for glycyrrhiza.  Furthermore, glycyrrhizin and its metabolite 18β-glycyrrhetinic acid (10-7-10-4 M), among the eight components of glycyrrhiza, ameliorated the TD-induced decrease of glutamate uptake in astrocytes in a concn.-dependent manner.  These substances inhibited protein kinase C (PKC) activity under the in vitro conditions.  These lines of evidence suggest that glycyrrhizin, a main component of glycyrrhiza, and its metabolite 18β-glycyrrhetinic acid are likely responsible for amelioration of dysfunction of glutamate transport in astrocytes.  The inhibition of the PKC activity might be related to the pharmacol. efficacy of these substances.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrtH42Ko_m777Vg90H21EOLACvtfcHk0licP1eiV6rwuA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsV2mtLrK&md5=aec534c27c07d2acc0690348747b96bf</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2009.09.046&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2009.09.046%26sid%3Dliteratum%253Aachs%26aulast%3DKawakami%26aufirst%3DZ.%26aulast%3DIkarashi%26aufirst%3DY.%26aulast%3DKase%26aufirst%3DY.%26atitle%3DGlycyrrhizin%2520and%2520its%2520metabolite%252018beta-glycyrhetinic%2520acid%2520in%2520glycyrrhiza%252C%2520a%2520constituent%2520herb%2520of%2520yokukansan%252C%2520ameliorate%2520thiamine%2520deficiency-induced%2520dysfunction%2520of%2520glutamate%2520transport%2520in%2520cultured%2520rat%2520cortical%2520astrocytes%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2010%26volume%3D626%26spage%3D154%26epage%3D158" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Pang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Safe, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, M.</span><span> </span><span class="NLM_article-title">Methyl 2-cyano-3,11-dioxo-18-olean-1,12-dien-30-oate (CDODA-Me), a derivative of glycyrrhetinic acid, functions as a potent angiogenesis inhibitor</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">335</span><span class="NLM_x">, </span> <span class="NLM_fpage">172</span><span class="NLM_x">–</span> <span class="NLM_lpage">179</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm200285z&amp;key=10.1124%2Fjpet.110.171066" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm200285z&amp;key=20631299" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm200285z&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht1GisrrL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=335&publication_year=2010&pages=172-179&author=X.+Pangauthor=L.+Zhangauthor=Y.+Wuauthor=L.+Linauthor=J.+Liauthor=W.+Quauthor=S.+Safeauthor=M.+Liu&title=Methyl+2-cyano-3%2C11-dioxo-18-olean-1%2C12-dien-30-oate+%28CDODA-Me%29%2C+a+derivative+of+glycyrrhetinic+acid%2C+functions+as+a+potent+angiogenesis+inhibitor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Methyl 2-cyano-3,11-dioxo-18-olean-1,12-dien-30-oate (CDODA-Me), a derivative of glycyrrhetinic acid, functions as a potent angiogenesis inhibitor</span></div><div class="casAuthors">Pang, Xiufeng; Zhang, Li; Wu, Yougen; Lin, Lei; Li, Jingjie; Qu, Weijing; Safe, Stephen; Liu, Mingyao</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">335</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">172-179</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Me 2-cyano-3,11-dioxo-18-olean-1,12-dien-30-oate (CDODA-Me), a triterpenoid acid derived synthetically from glycyrrhetinic acid, has been characterized as a peroxisome proliferator-activated receptor γ agonist with a broad range of receptor-dependent and -independent anticancer activities.  Although CDODA-Me decreases the expression of some angiogenic genes in cancer cells, the direct effects of this compd. on angiogenesis have not been defined.  In this study, we have extensively investigated the activities of CDODA-Me in multiple angiogenesis assays.  Our results showed that this agent inhibited vascular endothelial growth factor (VEGF)-induced proliferation, migration, invasion, and lamellipodium and capillary-like structure formation of human umbilical endothelial cells (HUVECs) in a concn.-dependent manner.  Moreover, CDODA-Me abrogated VEGF-induced sprouting of microvessels from rat aortic rings ex vivo and inhibited the generation of new vasculature in the Matrigel plugs in vivo, where CDODA-Me significantly decreased the no. of infiltrating von Willebrand factor-pos. endothelial cells.  To understand the mol. basis of this antiangiogenic activity, we examd. the signaling pathways in CDODA-Me-treated HUVECs.  Our results showed that CDODA-Me significantly suppressed the activation of VEGF receptor 2 (VEGFR2) and interfered with the mammalian target of rapamycin (mTOR) signaling, including mTOR kinase and its downstream ribosomal S6 kinase (S6K), but had little effect on the activities of extracellular signal-regulated protein kinase and AKT.  Taken together, CDODA-Me blocks several key steps of angiogenesis by inhibiting VEGF/VEGFR2 and mTOR/S6K signaling pathways, making the compd. a promising agent for the treatment of cancer and angiogenesis-related pathologies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQ0xXkgJvMW7Vg90H21EOLACvtfcHk0licP1eiV6rwuA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht1GisrrL&md5=b767a2e223baaadee95c91943300c3ac</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1124%2Fjpet.110.171066&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.110.171066%26sid%3Dliteratum%253Aachs%26aulast%3DPang%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DLin%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DQu%26aufirst%3DW.%26aulast%3DSafe%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DM.%26atitle%3DMethyl%25202-cyano-3%252C11-dioxo-18-olean-1%252C12-dien-30-oate%2520%2528CDODA-Me%2529%252C%2520a%2520derivative%2520of%2520glycyrrhetinic%2520acid%252C%2520functions%2520as%2520a%2520potent%2520angiogenesis%2520inhibitor%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2010%26volume%3D335%26spage%3D172%26epage%3D179" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Kao, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shyu, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yen, G. C.</span><span> </span><span class="NLM_article-title">Glycyrrhizic acid and 18beta-glycyrrhetinic acid inhibit inflammation via PI3K/Akt/GSK3beta signaling and glucocorticoid receptor activation</span> <span class="citation_source-journal">J. Agric. Food Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">8623</span><span class="NLM_x">–</span> <span class="NLM_lpage">8629</span></span><div class="citationLinks">[<a href="/doi/10.1021/jf101841r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2010&pages=8623-8629&author=T.+Kaoauthor=M.+H.+Shyuauthor=G.+C.+Yen&title=Glycyrrhizic+acid+and+18beta-glycyrrhetinic+acid+inhibit+inflammation+via+PI3K%2FAkt%2FGSK3beta+signaling+and+glucocorticoid+receptor+activation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fjf101841r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjf101841r%26sid%3Dliteratum%253Aachs%26aulast%3DKao%26aufirst%3DT.%26aulast%3DShyu%26aufirst%3DM.%2BH.%26aulast%3DYen%26aufirst%3DG.%2BC.%26atitle%3DGlycyrrhizic%2520acid%2520and%252018beta-glycyrrhetinic%2520acid%2520inhibit%2520inflammation%2520via%2520PI3K%252FAkt%252FGSK3beta%2520signaling%2520and%2520glucocorticoid%2520receptor%2520activation%26jtitle%3DJ.%2520Agric.%2520Food%2520Chem.%26date%3D2010%26volume%3D58%26spage%3D8623%26epage%3D8629" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Huang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qian, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, C. H.</span><span> </span><span class="NLM_article-title">Synthesis and proteasome inhibition of glycyrrhetinic acid derivatives</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">6696</span><span class="NLM_x">–</span> <span class="NLM_lpage">6701</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2008&pages=6696-6701&author=L.+Huangauthor=D.+Yuauthor=P.+Hoauthor=K.+Qianauthor=K.+H.+Leeauthor=C.+H.+Chen&title=Synthesis+and+proteasome+inhibition+of+glycyrrhetinic+acid+derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DL.%26aulast%3DYu%26aufirst%3DD.%26aulast%3DHo%26aufirst%3DP.%26aulast%3DQian%26aufirst%3DK.%26aulast%3DLee%26aufirst%3DK.%2BH.%26aulast%3DChen%26aufirst%3DC.%2BH.%26atitle%3DSynthesis%2520and%2520proteasome%2520inhibition%2520of%2520glycyrrhetinic%2520acid%2520derivatives%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2008%26volume%3D16%26spage%3D6696%26epage%3D6701" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Chintharlapalli, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Papineni, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jutooru, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McAlees, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Safe, S.</span><span> </span><span class="NLM_article-title">Structure-dependent activity of glycyrrhetinic acid derivatives as peroxisome proliferator-activated receptor gamma agonists in colon cancer cells</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">1588</span><span class="NLM_x">–</span> <span class="NLM_lpage">1598</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm200285z&amp;key=10.1158%2F1535-7163.MCT-07-0022" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Fjm200285z&amp;key=17513608" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm200285z&amp;key=1%3ACAS%3A528%3ADC%252BD2sXotFaltLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=1588-1598&author=S.+Chintharlapalliauthor=S.+Papineniauthor=I.+Jutooruauthor=A.+McAleesauthor=S.+Safe&title=Structure-dependent+activity+of+glycyrrhetinic+acid+derivatives+as+peroxisome+proliferator-activated+receptor+gamma+agonists+in+colon+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-dependent activity of glycyrrhetinic acid derivatives as peroxisome proliferator-activated receptor γ agonists in colon cancer cells</span></div><div class="casAuthors">Chintharlapalli, Sudhakar; Papineni, Sabitha; Jutooru, Indira; McAlees, Alan; Safe, Stephen</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1588-1598</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Glycyrrhizin, a pentacyclic triterpene glycoside, is the major phytochem. in licorice.  This compd. and its hydrolysis product glycyrrhetinic acid have been assocd. with the multiple therapeutic properties of licorice exts.  We have investigated the effects of 2-cyano substituted analogs of glycyrrhetinic acid on their cytotoxicities and activity as selective peroxisome proliferator-activated receptor γ (PPARγ) agonists.  Me 2-cyano-3,11-dioxo-18β-olean-1,12-dien-30-oate (β-CDODA-Me) and Me 2-cyano-3,11-dioxo-18α-olean-1,12-dien-30-oate (α-CDODA-Me) were more cytotoxic to colon cancer cells than their descyano analogs and introduction of the 2-cyano group into the pentacyclic ring system was necessary for the PPARγ agonist activity of α-CDODA-Me and β-CDODA-Me isomers.  However, in mammalian two-hybrid assays, both compds. differentially induced interactions of PPARγ with coactivators, suggesting that these isomers, which differ only in the stereochem. at C18 which affects conformation of the E-ring, are selective receptor modulators.  This selectivity in colon cancer cells was shown for the induction of two proapoptotic proteins, namely caveolin-1 and the tumor-suppressor gene Kruppel-like factor-4 (KLF-4).  β-CDODA-Me but not α-CDODA-Me induced caveolin-1 in SW480 colon cancer cells, whereas caveolin-1 was induced by both compds. in HT-29 and HCT-15 colon cancer cells.  The CDODA-Me isomers induced KLF-4 mRNA levels in HT-29 and SW480 cells but had minimal effects on KLF-4 expression in HCT-15 cells.  These induced responses were inhibited by cotreatment with a PPARγ antagonist.  This shows for the first time that PPARγ agonists derived from glycyrrhetinic acid induced cell-dependent caveolin-1 and KLF-4 expression through receptor-dependent pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvJmHLJ_RNV7Vg90H21EOLACvtfcHk0lhJUogq7AEBlQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXotFaltLc%253D&md5=aa8edc5fb5085357b784555ed17088ed</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-07-0022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-07-0022%26sid%3Dliteratum%253Aachs%26aulast%3DChintharlapalli%26aufirst%3DS.%26aulast%3DPapineni%26aufirst%3DS.%26aulast%3DJutooru%26aufirst%3DI.%26aulast%3DMcAlees%26aufirst%3DA.%26aulast%3DSafe%26aufirst%3DS.%26atitle%3DStructure-dependent%2520activity%2520of%2520glycyrrhetinic%2520acid%2520derivatives%2520as%2520peroxisome%2520proliferator-activated%2520receptor%2520gamma%2520agonists%2520in%2520colon%2520cancer%2520cells%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2007%26volume%3D6%26spage%3D1588%26epage%3D1598" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Chintharlapalli, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Papineni, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Konopleva, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andreef, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samudio, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Safe, S.</span><span> </span><span class="NLM_article-title">2-cyano-3,12-dioxoolean-1,9-dien-28-oic acid and related compounds inhibit growth of colon cancer cells through peroxisome proliferator-activated receptor gamma-dependent and -independent pathways</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">119</span><span class="NLM_x">–</span> <span class="NLM_lpage">128</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2005&pages=119-128&author=S.+Chintharlapalliauthor=S.+Papineniauthor=M.+Konoplevaauthor=M.+Andreefauthor=I.+Samudioauthor=S.+Safe&title=2-cyano-3%2C12-dioxoolean-1%2C9-dien-28-oic+acid+and+related+compounds+inhibit+growth+of+colon+cancer+cells+through+peroxisome+proliferator-activated+receptor+gamma-dependent+and+-independent+pathways"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChintharlapalli%26aufirst%3DS.%26aulast%3DPapineni%26aufirst%3DS.%26aulast%3DKonopleva%26aufirst%3DM.%26aulast%3DAndreef%26aufirst%3DM.%26aulast%3DSamudio%26aufirst%3DI.%26aulast%3DSafe%26aufirst%3DS.%26atitle%3D2-cyano-3%252C12-dioxoolean-1%252C9-dien-28-oic%2520acid%2520and%2520related%2520compounds%2520inhibit%2520growth%2520of%2520colon%2520cancer%2520cells%2520through%2520peroxisome%2520proliferator-activated%2520receptor%2520gamma-dependent%2520and%2520-independent%2520pathways%26jtitle%3DMol.%2520Pharmacol.%26date%3D2005%26volume%3D68%26spage%3D119%26epage%3D128" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Papineni, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chintharlapalli, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Safe, S.</span><span> </span><span class="NLM_article-title">Methyl 2-cyano-3,11-dioxo-18beta -olean-1,12-dien-30-oate is a peroxisome proliferator-activated receptor-gamma agonist that induces receptor-independent apoptosis in LNCaP prostate cancer cells</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">73</span><span class="NLM_x">, </span> <span class="NLM_fpage">553</span><span class="NLM_x">–</span> <span class="NLM_lpage">565</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2008&pages=553-565&author=S.+Papineniauthor=S.+Chintharlapalliauthor=S.+Safe&title=Methyl+2-cyano-3%2C11-dioxo-18beta+-olean-1%2C12-dien-30-oate+is+a+peroxisome+proliferator-activated+receptor-gamma+agonist+that+induces+receptor-independent+apoptosis+in+LNCaP+prostate+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPapineni%26aufirst%3DS.%26aulast%3DChintharlapalli%26aufirst%3DS.%26aulast%3DSafe%26aufirst%3DS.%26atitle%3DMethyl%25202-cyano-3%252C11-dioxo-18beta%2520-olean-1%252C12-dien-30-oate%2520is%2520a%2520peroxisome%2520proliferator-activated%2520receptor-gamma%2520agonist%2520that%2520induces%2520receptor-independent%2520apoptosis%2520in%2520LNCaP%2520prostate%2520cancer%2520cells%26jtitle%3DMol.%2520Pharmacol.%26date%3D2008%26volume%3D73%26spage%3D553%26epage%3D565" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Chadalapaka, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jutooru, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McAlees, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stefanac, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Safe, S.</span><span> </span><span class="NLM_article-title">Structure-dependent inhibition of bladder and pancreatic cancer cell growth by 2-substituted glycyrrhetinic and ursolic acid derivatives</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">2633</span><span class="NLM_x">–</span> <span class="NLM_lpage">2639</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Fjm200285z&amp;key=10.1016%2Fj.bmcl.2008.03.031" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Fjm200285z&amp;key=18359628" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Fjm200285z&amp;key=1%3ACAS%3A528%3ADC%252BD1cXks1akt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=2633-2639&author=G.+Chadalapakaauthor=I.+Jutooruauthor=A.+McAleesauthor=T.+Stefanacauthor=S.+Safe&title=Structure-dependent+inhibition+of+bladder+and+pancreatic+cancer+cell+growth+by+2-substituted+glycyrrhetinic+and+ursolic+acid+derivatives"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-dependent inhibition of bladder and pancreatic cancer cell growth by 2-substituted glycyrrhetinic and ursolic acid derivatives</span></div><div class="casAuthors">Chadalapaka, Gayathri; Jutooru, Indira; McAlees, Alan; Stefanac, Tom; Safe, Stephen</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2633-2639</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Derivs. of oleanolic acid, ursolic acid and glycyrrhetinic acid substituted with electron-withdrawing groups at the 2-position in the A-ring which also contains a 1-en-3-one structure are potent inhibitors of cancer cell growth.  In this study, the authors have compared the effects of several 2-substituted analogs of triterpenoid acid Me esters derived from ursolic and glycyrrhetinic acid on proliferation of KU7 and 253JB-V bladder and Panc-1 and Panc-28 pancreatic cancer cells.  The results show that the 2-cyano and 2-trifluoromethyl derivs. were the most active compds.  The glycyrrhetinic acid derivs. with the rearranged C-ring contg. the 9(11)-en-12-one structure were generally more active than the corresponding 12-en-11-one isomers.  However, differences in growth inhibitory IC50 values were highly variable and dependent on the 2-substituent (CN vs. CF3) and cancer cell context.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmwh5uCbF087Vg90H21EOLACvtfcHk0lhJUogq7AEBlQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXks1akt7k%253D&md5=771ec0944a2ae699d7448d46d27db90b</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2008.03.031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2008.03.031%26sid%3Dliteratum%253Aachs%26aulast%3DChadalapaka%26aufirst%3DG.%26aulast%3DJutooru%26aufirst%3DI.%26aulast%3DMcAlees%26aufirst%3DA.%26aulast%3DStefanac%26aufirst%3DT.%26aulast%3DSafe%26aufirst%3DS.%26atitle%3DStructure-dependent%2520inhibition%2520of%2520bladder%2520and%2520pancreatic%2520cancer%2520cell%2520growth%2520by%25202-substituted%2520glycyrrhetinic%2520and%2520ursolic%2520acid%2520derivatives%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D2633%26epage%3D2639" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Michalik, L.; Wahli, W.</span><span> </span><span class="NLM_article-title">PPARs mediate lipid signaling in inflammation and cancer</span>.  <span class="citation_source-journal">PPAR Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span>ID 134059, doi:<span class="refDoi"> DOI: 10.1155/2008/134059</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Fjm200285z&amp;key=10.1155%2F2008%2F134059" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Fjm200285z&amp;key=19125181" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=L.+Michalik&author=W.+Wahli&title=PPARs+mediate+lipid+signaling+in+inflammation+and+cancer&doi=10.1155%2F2008%2F134059"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1155%2F2008%2F134059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2008%252F134059%26sid%3Dliteratum%253Aachs%26aulast%3DMichalik%26aufirst%3DL.%26atitle%3DPPARs%2520mediate%2520lipid%2520signaling%2520in%2520inflammation%2520and%2520cancer%26jtitle%3DPPAR%2520Res.%26date%3D2008%26doi%3D10.1155%2F2008%2F134059" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Bundscherer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reichle, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hafner, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vogt, T.</span><span> </span><span class="NLM_article-title">Targeting the tumor stroma with peroxisome proliferator activated receptor (PPAR) agonists</span> <span class="citation_source-journal">Anticancer Agents Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">816</span><span class="NLM_x">–</span> <span class="NLM_lpage">821</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Fjm200285z&amp;key=10.2174%2F187152009789056912" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Fjm200285z&amp;key=19594413" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Fjm200285z&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtVWnt7vJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2009&pages=816-821&author=A.+Bundschererauthor=A.+Reichleauthor=C.+Hafnerauthor=S.+Meyerauthor=T.+Vogt&title=Targeting+the+tumor+stroma+with+peroxisome+proliferator+activated+receptor+%28PPAR%29+agonists"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the tumor stroma with peroxisome proliferator activated receptor (PPAR) agonists</span></div><div class="casAuthors">Bundscherer, Annika; Reichle, Albrecht; Hafner, Christian; Meyer, Stefanie; Vogt, Thomas</div><div class="citationInfo"><span class="NLM_cas:title">Anti-Cancer Agents in Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">816-821</span>CODEN:
                <span class="NLM_cas:coden">AAMCE4</span>;
        ISSN:<span class="NLM_cas:issn">1871-5206</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Tumor cells depend on and are able to modulate the tumor stroma establishing a permissive and supportive environment of their own.  Targeting the tumor stroma has evolved as a novel concept that has attracted attention of cancer researchers aiming at the treatment of metastatic cancer.  The novel paradigm is that modulating the stroma will possibly not cure the cancer, but will make it a manageable disease for long periods of time by prohibiting the cancer from growing beyond a certain mass.  Accordingly, in the last years, a multitude of stroma-targeting agents were developed comprising either classic small mol. drugs (e.g. sorafenib, an inhibitor of multiple tyrosine kinases) or recombinant antibodies (e.g. anti-VEGF) for targeting of tumor angiogenesis.  Apart from these specifically targeted drugs, some well established drugs, primarily designed for non-oncol. diseases, have revealed antitumor activity on the basis of nuclear receptor modulation unfolding pleiotropic biol. effects including stroma modulation.  Peroxisome Proliferator Activated Receptor (PPAR) agonists, particularly thiazolidinedione derivs. such as pioglitazone and ciglitazone, are promising examples as they exert both a direct antitumoral and a broad spectrum of anti-stromal, antiangiogenic and immuno-modulating activities.  This review will focus on the stroma-mediated anticancer activities of PPAR agonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpgmcPYNkI_97Vg90H21EOLACvtfcHk0ljgBfdVQLqu1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVWnt7vJ&md5=6f0d53556a4459df9785d05992ad55ab</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.2174%2F187152009789056912&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F187152009789056912%26sid%3Dliteratum%253Aachs%26aulast%3DBundscherer%26aufirst%3DA.%26aulast%3DReichle%26aufirst%3DA.%26aulast%3DHafner%26aufirst%3DC.%26aulast%3DMeyer%26aufirst%3DS.%26aulast%3DVogt%26aufirst%3DT.%26atitle%3DTargeting%2520the%2520tumor%2520stroma%2520with%2520peroxisome%2520proliferator%2520activated%2520receptor%2520%2528PPAR%2529%2520agonists%26jtitle%3DAnticancer%2520Agents%2520Med.%2520Chem.%26date%3D2009%26volume%3D9%26spage%3D816%26epage%3D821" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">He, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dong, Y. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, L.</span><span> </span><span class="NLM_article-title">Preparation and properties of a novel thermo-responsive poly(N-isopropylacrylamide) hydrogel containing glycyrrhetinic acid</span> <span class="citation_source-journal">J. Mater. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">4078</span><span class="NLM_x">–</span> <span class="NLM_lpage">4086</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Fjm200285z&amp;key=10.1007%2Fs10853-009-3588-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm200285z&amp;key=1%3ACAS%3A528%3ADC%252BD1MXms1alurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2009&pages=4078-4086&author=X.+Heauthor=S.+Yuauthor=Y.+Y.+Dongauthor=F.+Yanauthor=L.+Chen&title=Preparation+and+properties+of+a+novel+thermo-responsive+poly%28N-isopropylacrylamide%29+hydrogel+containing+glycyrrhetinic+acid"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Preparation and properties of a novel thermo-responsive poly(N-isopropylacrylamide) hydrogel containing glycyrrhetinic acid</span></div><div class="casAuthors">He, Xiaoling; Yu, Shen; Dong, You Yu; Yan, Fanyong; Chen, Li</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Materials Science</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">4078-4086</span>CODEN:
                <span class="NLM_cas:coden">JMTSAS</span>;
        ISSN:<span class="NLM_cas:issn">0022-2461</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A novel thermo-responsive poly(N-isopropylacrylamide) (PNIPAAm) hydrogel contg. glycyrrhetinic acid(GA) was synthesized by free radical copolymn.  The structure of the product was confirmed by FT-IR and 1H-NMR spectra.  The temp. responsibility and swelling properties of the copolymd. hydrogel were investigated by differential scanning calorimetry (DSC) and gravimetric methods.  The results indicated that GA-incorporated hydrogel was still temp. responsive and the swelling ratio decreased with the increasing of temp.  The lower crit. soln. temp. (LCST) of GA-incorporated hydrogel and poly(N-isopropylacrylamide) hydrogel was 30.00 °C and 31.21 °C, resp., in distd. water.  However, these two values were shifted to 28.22 °C and 29.16 °C in cell culture media.  The novel hydrogel also exhibited reversible temp. responsibility.  Deswelling kinetics indicated that the copolymd. hydrogel deswelled more rapidly than poly(N-isopropylacrylamide) hydrogel.  Since GA has specific binding capacity to asialoglycoprotein receptors on the membrane of hepatocyte, this novel hydrogel with GA could be expected as good candidate for hepatic cell culture.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDGUyALHOzXLVg90H21EOLACvtfcHk0ljgBfdVQLqu1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXms1alurk%253D&md5=a446cc48144f20254d88ae39a0a02892</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1007%2Fs10853-009-3588-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10853-009-3588-3%26sid%3Dliteratum%253Aachs%26aulast%3DHe%26aufirst%3DX.%26aulast%3DYu%26aufirst%3DS.%26aulast%3DDong%26aufirst%3DY.%2BY.%26aulast%3DYan%26aufirst%3DF.%26aulast%3DChen%26aufirst%3DL.%26atitle%3DPreparation%2520and%2520properties%2520of%2520a%2520novel%2520thermo-responsive%2520poly%2528N-isopropylacrylamide%2529%2520hydrogel%2520containing%2520glycyrrhetinic%2520acid%26jtitle%3DJ.%2520Mater.%2520Sci.%26date%3D2009%26volume%3D44%26spage%3D4078%26epage%3D4086" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Tatsuzaki, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taniguchi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bastow, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakagawa-Goto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morris-Natschke, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Itokawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baba, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, K.-H.</span><span> </span><span class="NLM_article-title">Anti-tumor agents: Novel glycyrrhetinic acid-dehydrozingerone conjugates as cytotoxic agents</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">6193</span><span class="NLM_x">–</span> <span class="NLM_lpage">6199</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2007&pages=6193-6199&author=J.+Tatsuzakiauthor=M.+Taniguchiauthor=K.+F.+Bastowauthor=K.+Nakagawa-Gotoauthor=S.+L.+Morris-Natschkeauthor=H.+Itokawaauthor=K.+Babaauthor=K.-H.+Lee&title=Anti-tumor+agents%3A+Novel+glycyrrhetinic+acid-dehydrozingerone+conjugates+as+cytotoxic+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTatsuzaki%26aufirst%3DJ.%26aulast%3DTaniguchi%26aufirst%3DM.%26aulast%3DBastow%26aufirst%3DK.%2BF.%26aulast%3DNakagawa-Goto%26aufirst%3DK.%26aulast%3DMorris-Natschke%26aufirst%3DS.%2BL.%26aulast%3DItokawa%26aufirst%3DH.%26aulast%3DBaba%26aufirst%3DK.%26aulast%3DLee%26aufirst%3DK.-H.%26atitle%3DAnti-tumor%2520agents%253A%2520Novel%2520glycyrrhetinic%2520acid-dehydrozingerone%2520conjugates%2520as%2520cytotoxic%2520agents%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2007%26volume%3D15%26spage%3D6193%26epage%3D6199" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Fukuoka, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kida, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakajima, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsumagari, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watanabe, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inaba, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mori, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsumura, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakano, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takeshita, K.</span><span> </span><span class="NLM_article-title">Thermo-responsive extraction of cadmium(II) ion with TPEN-NIPA gel. Effect of the number of polymerizable double bond toward gel formation and the extracting behavior</span> <span class="citation_source-journal">Tetrahedron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">1721</span><span class="NLM_x">–</span> <span class="NLM_lpage">1727</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=1721-1727&author=S.+Fukuokaauthor=T.+Kidaauthor=Y.+Nakajimaauthor=T.+Tsumagariauthor=W.+Watanabeauthor=Y.+Inabaauthor=A.+Moriauthor=T.+Matsumuraauthor=Y.+Nakanoauthor=K.+Takeshita&title=Thermo-responsive+extraction+of+cadmium%28II%29+ion+with+TPEN-NIPA+gel.+Effect+of+the+number+of+polymerizable+double+bond+toward+gel+formation+and+the+extracting+behavior"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFukuoka%26aufirst%3DS.%26aulast%3DKida%26aufirst%3DT.%26aulast%3DNakajima%26aufirst%3DY.%26aulast%3DTsumagari%26aufirst%3DT.%26aulast%3DWatanabe%26aufirst%3DW.%26aulast%3DInaba%26aufirst%3DY.%26aulast%3DMori%26aufirst%3DA.%26aulast%3DMatsumura%26aufirst%3DT.%26aulast%3DNakano%26aufirst%3DY.%26aulast%3DTakeshita%26aufirst%3DK.%26atitle%3DThermo-responsive%2520extraction%2520of%2520cadmium%2528II%2529%2520ion%2520with%2520TPEN-NIPA%2520gel.%2520Effect%2520of%2520the%2520number%2520of%2520polymerizable%2520double%2520bond%2520toward%2520gel%2520formation%2520and%2520the%2520extracting%2520behavior%26jtitle%3DTetrahedron%26date%3D2010%26volume%3D66%26spage%3D1721%26epage%3D1727" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Joseph, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Darro, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Béliard, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lesur, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collignon, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Decaestecker, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frydman, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guillaumet, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiss, R.</span><span> </span><span class="NLM_article-title">3-aryl-2-quinolone derivatives: synthesis and characterization of <i>in vitro</i> and <i>in vivo</i> anti-tumor effects with emphasis on a new therapeutical target connected with cell migration</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">2543</span><span class="NLM_x">–</span> <span class="NLM_lpage">2555</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm010978m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=2543-2555&author=B.+Josephauthor=F.+Darroauthor=A.+B%C3%A9liardauthor=B.+Lesurauthor=F.+Collignonauthor=C.+Decaesteckerauthor=A.+Frydmanauthor=G.+Guillaumetauthor=R.+Kiss&title=3-aryl-2-quinolone+derivatives%3A+synthesis+and+characterization+of+in+vitro+and+in+vivo+anti-tumor+effects+with+emphasis+on+a+new+therapeutical+target+connected+with+cell+migration"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fjm010978m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm010978m%26sid%3Dliteratum%253Aachs%26aulast%3DJoseph%26aufirst%3DB.%26aulast%3DDarro%26aufirst%3DF.%26aulast%3DB%25C3%25A9liard%26aufirst%3DA.%26aulast%3DLesur%26aufirst%3DB.%26aulast%3DCollignon%26aufirst%3DF.%26aulast%3DDecaestecker%26aufirst%3DC.%26aulast%3DFrydman%26aufirst%3DA.%26aulast%3DGuillaumet%26aufirst%3DG.%26aulast%3DKiss%26aufirst%3DR.%26atitle%3D3-aryl-2-quinolone%2520derivatives%253A%2520synthesis%2520and%2520characterization%2520of%2520in%2520vitro%2520and%2520in%2520vivo%2520anti-tumor%2520effects%2520with%2520emphasis%2520on%2520a%2520new%2520therapeutical%2520target%2520connected%2520with%2520cell%2520migration%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26spage%3D2543%26epage%3D2555" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Ozap-Yaman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Hoog, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amadei, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pitié, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gamez, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dewelle, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mijatovic, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meunier, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiss, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reedijk, J.</span><span> </span><span class="NLM_article-title">Platined copper (3-clip-phen) complexes as effective DNA-cleaving and cytotoxic agents</span> <span class="citation_source-journal">Chem.—Eur. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">3418</span><span class="NLM_x">–</span> <span class="NLM_lpage">3426</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Fjm200285z&amp;key=10.1002%2Fchem.200702021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Fjm200285z&amp;key=18293353" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2008&pages=3418-3426&author=S.+Ozap-Yamanauthor=P.+de+Hoogauthor=G.+Amadeiauthor=M.+Piti%C3%A9author=P.+Gamezauthor=J.+Dewelleauthor=T.+Mijatovicauthor=B.+Meunierauthor=R.+Kissauthor=J.+Reedijk&title=Platined+copper+%283-clip-phen%29+complexes+as+effective+DNA-cleaving+and+cytotoxic+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1002%2Fchem.200702021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fchem.200702021%26sid%3Dliteratum%253Aachs%26aulast%3DOzap-Yaman%26aufirst%3DS.%26aulast%3Dde%2BHoog%26aufirst%3DP.%26aulast%3DAmadei%26aufirst%3DG.%26aulast%3DPiti%25C3%25A9%26aufirst%3DM.%26aulast%3DGamez%26aufirst%3DP.%26aulast%3DDewelle%26aufirst%3DJ.%26aulast%3DMijatovic%26aufirst%3DT.%26aulast%3DMeunier%26aufirst%3DB.%26aulast%3DKiss%26aufirst%3DR.%26aulast%3DReedijk%26aufirst%3DJ.%26atitle%3DPlatined%2520copper%2520%25283-clip-phen%2529%2520complexes%2520as%2520effective%2520DNA-cleaving%2520and%2520cytotoxic%2520agents%26jtitle%3DChem.%25E2%2580%2594Eur.%2520J.%26date%3D2008%26volume%3D14%26spage%3D3418%26epage%3D3426" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Lamoral-Theys, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andolfi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Goietsenoven, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cimmino, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Calvé, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wauthoz, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mégalizzi, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gras, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruyère, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dubois, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathieu, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kornienko, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiss, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evidente, A.</span><span> </span><span class="NLM_article-title">Lycorine, the main phenanthridine Amaryllidaceae alkaloid, exhibits significant antitumor activity in cancer cells that display resistance to proapoptotic stimuli: An investigation of structure-activity relationship and mechanistic insight</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">6244</span><span class="NLM_x">–</span> <span class="NLM_lpage">6256</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm901031h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=6244-6256&author=D.+Lamoral-Theysauthor=A.+Andolfiauthor=G.+Van+Goietsenovenauthor=A.+Cimminoauthor=B.+Le+Calv%C3%A9author=N.+Wauthozauthor=V.+M%C3%A9galizziauthor=T.+Grasauthor=C.+Bruy%C3%A8reauthor=J.+Duboisauthor=V.+Mathieuauthor=A.+Kornienkoauthor=R.+Kissauthor=A.+Evidente&title=Lycorine%2C+the+main+phenanthridine+Amaryllidaceae+alkaloid%2C+exhibits+significant+antitumor+activity+in+cancer+cells+that+display+resistance+to+proapoptotic+stimuli%3A+An+investigation+of+structure-activity+relationship+and+mechanistic+insight"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fjm901031h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901031h%26sid%3Dliteratum%253Aachs%26aulast%3DLamoral-Theys%26aufirst%3DD.%26aulast%3DAndolfi%26aufirst%3DA.%26aulast%3DVan%2BGoietsenoven%26aufirst%3DG.%26aulast%3DCimmino%26aufirst%3DA.%26aulast%3DLe%2BCalv%25C3%25A9%26aufirst%3DB.%26aulast%3DWauthoz%26aufirst%3DN.%26aulast%3DM%25C3%25A9galizzi%26aufirst%3DV.%26aulast%3DGras%26aufirst%3DT.%26aulast%3DBruy%25C3%25A8re%26aufirst%3DC.%26aulast%3DDubois%26aufirst%3DJ.%26aulast%3DMathieu%26aufirst%3DV.%26aulast%3DKornienko%26aufirst%3DA.%26aulast%3DKiss%26aufirst%3DR.%26aulast%3DEvidente%26aufirst%3DA.%26atitle%3DLycorine%252C%2520the%2520main%2520phenanthridine%2520Amaryllidaceae%2520alkaloid%252C%2520exhibits%2520significant%2520antitumor%2520activity%2520in%2520cancer%2520cells%2520that%2520display%2520resistance%2520to%2520proapoptotic%2520stimuli%253A%2520An%2520investigation%2520of%2520structure-activity%2520relationship%2520and%2520mechanistic%2520insight%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D6244%26epage%3D6256" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Ingrassia, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lefranc, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dewelle, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pottier, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathieu, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spiegl-Kreinecker, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sauvage, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">El Yazidi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dehoux, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berger, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Quaquebeke, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiss, R.</span><span> </span><span class="NLM_article-title">Structure-activity relationship analysis of novel derivatives of narciclasine (an Amaryllidaceae isocarbostyril derivative) as potential anticancer agents</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">1100</span><span class="NLM_x">–</span> <span class="NLM_lpage">1114</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm8013585" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=1100-1114&author=L.+Ingrassiaauthor=F.+Lefrancauthor=J.+Dewelleauthor=L.+Pottierauthor=V.+Mathieuauthor=S.+Spiegl-Kreineckerauthor=S.+Sauvageauthor=M.+El+Yazidiauthor=M.+Dehouxauthor=W.+Bergerauthor=E.+Van+Quaquebekeauthor=R.+Kiss&title=Structure-activity+relationship+analysis+of+novel+derivatives+of+narciclasine+%28an+Amaryllidaceae+isocarbostyril+derivative%29+as+potential+anticancer+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fjm8013585&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm8013585%26sid%3Dliteratum%253Aachs%26aulast%3DIngrassia%26aufirst%3DL.%26aulast%3DLefranc%26aufirst%3DF.%26aulast%3DDewelle%26aufirst%3DJ.%26aulast%3DPottier%26aufirst%3DL.%26aulast%3DMathieu%26aufirst%3DV.%26aulast%3DSpiegl-Kreinecker%26aufirst%3DS.%26aulast%3DSauvage%26aufirst%3DS.%26aulast%3DEl%2BYazidi%26aufirst%3DM.%26aulast%3DDehoux%26aufirst%3DM.%26aulast%3DBerger%26aufirst%3DW.%26aulast%3DVan%2BQuaquebeke%26aufirst%3DE.%26aulast%3DKiss%26aufirst%3DR.%26atitle%3DStructure-activity%2520relationship%2520analysis%2520of%2520novel%2520derivatives%2520of%2520narciclasine%2520%2528an%2520Amaryllidaceae%2520isocarbostyril%2520derivative%2529%2520as%2520potential%2520anticancer%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D1100%26epage%3D1114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Branle, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lefranc, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Camby, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeuken, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geurts-Moespot, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sprenger, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sweep, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiss, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salmon, I.</span><span> </span><span class="NLM_article-title">Evaluation of the efficiency of chemotherapy in <i>in vivo</i> orthotopic models of human glioma cells with and without 1p19q deletions and in C6 rat orthotopic allografts serving for the evaluation of surgery combined with chemotherapy</span> <span class="citation_source-journal">Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">95</span><span class="NLM_x">, </span> <span class="NLM_fpage">641</span><span class="NLM_x">–</span> <span class="NLM_lpage">655</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=2002&pages=641-655&author=F.+Branleauthor=F.+Lefrancauthor=I.+Cambyauthor=J.+Jeukenauthor=A.+Geurts-Moespotauthor=S.+Sprengerauthor=F.+Sweepauthor=R.+Kissauthor=I.+Salmon&title=Evaluation+of+the+efficiency+of+chemotherapy+in+in+vivo+orthotopic+models+of+human+glioma+cells+with+and+without+1p19q+deletions+and+in+C6+rat+orthotopic+allografts+serving+for+the+evaluation+of+surgery+combined+with+chemotherapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBranle%26aufirst%3DF.%26aulast%3DLefranc%26aufirst%3DF.%26aulast%3DCamby%26aufirst%3DI.%26aulast%3DJeuken%26aufirst%3DJ.%26aulast%3DGeurts-Moespot%26aufirst%3DA.%26aulast%3DSprenger%26aufirst%3DS.%26aulast%3DSweep%26aufirst%3DF.%26aulast%3DKiss%26aufirst%3DR.%26aulast%3DSalmon%26aufirst%3DI.%26atitle%3DEvaluation%2520of%2520the%2520efficiency%2520of%2520chemotherapy%2520in%2520in%2520vivo%2520orthotopic%2520models%2520of%2520human%2520glioma%2520cells%2520with%2520and%2520without%25201p19q%2520deletions%2520and%2520in%2520C6%2520rat%2520orthotopic%2520allografts%2520serving%2520for%2520the%2520evaluation%2520of%2520surgery%2520combined%2520with%2520chemotherapy%26jtitle%3DCancer%26date%3D2002%26volume%3D95%26spage%3D641%26epage%3D655" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Mathieu, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Remmelink, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Haene, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Penant, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaussin, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Ginckel, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Darro, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiss, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salmon, I.</span><span> </span><span class="NLM_article-title">Development of a chemoresistant orthotopic human nonsmall cell lung carcinoma model in nude mice</span> <span class="citation_source-journal">Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">101</span><span class="NLM_x">, </span> <span class="NLM_fpage">1908</span><span class="NLM_x">–</span> <span class="NLM_lpage">1918</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2004&pages=1908-1918&author=A.+Mathieuauthor=M.+Remmelinkauthor=N.+D%E2%80%99Haeneauthor=S.+Penantauthor=J.+F.+Gaussinauthor=R.+Van+Ginckelauthor=F.+Darroauthor=R.+Kissauthor=I.+Salmon&title=Development+of+a+chemoresistant+orthotopic+human+nonsmall+cell+lung+carcinoma+model+in+nude+mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMathieu%26aufirst%3DA.%26aulast%3DRemmelink%26aufirst%3DM.%26aulast%3DD%25E2%2580%2599Haene%26aufirst%3DN.%26aulast%3DPenant%26aufirst%3DS.%26aulast%3DGaussin%26aufirst%3DJ.%2BF.%26aulast%3DVan%2BGinckel%26aufirst%3DR.%26aulast%3DDarro%26aufirst%3DF.%26aulast%3DKiss%26aufirst%3DR.%26aulast%3DSalmon%26aufirst%3DI.%26atitle%3DDevelopment%2520of%2520a%2520chemoresistant%2520orthotopic%2520human%2520nonsmall%2520cell%2520lung%2520carcinoma%2520model%2520in%2520nude%2520mice%26jtitle%3DCancer%26date%3D2004%26volume%3D101%26spage%3D1908%26epage%3D1918" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Mijatovic, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathieu, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaussin, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Nève, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ribaucour, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Quaquebeke, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dumont, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Darro, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiss, R.</span><span> </span><span class="NLM_article-title">Cardenolide-induced lysosomal membrane permeabilization demonstrates therapeutic benefits in experimental human non-small cell lung cancers</span> <span class="citation_source-journal">Neoplasia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">402</span><span class="NLM_x">–</span> <span class="NLM_lpage">412</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2006&pages=402-412&author=T.+Mijatovicauthor=V.+Mathieuauthor=J.+F.+Gaussinauthor=N.+De+N%C3%A8veauthor=F.+Ribaucourauthor=E.+Van+Quaquebekeauthor=P.+Dumontauthor=F.+Darroauthor=R.+Kiss&title=Cardenolide-induced+lysosomal+membrane+permeabilization+demonstrates+therapeutic+benefits+in+experimental+human+non-small+cell+lung+cancers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMijatovic%26aufirst%3DT.%26aulast%3DMathieu%26aufirst%3DV.%26aulast%3DGaussin%26aufirst%3DJ.%2BF.%26aulast%3DDe%2BN%25C3%25A8ve%26aufirst%3DN.%26aulast%3DRibaucour%26aufirst%3DF.%26aulast%3DVan%2BQuaquebeke%26aufirst%3DE.%26aulast%3DDumont%26aufirst%3DP.%26aulast%3DDarro%26aufirst%3DF.%26aulast%3DKiss%26aufirst%3DR.%26atitle%3DCardenolide-induced%2520lysosomal%2520membrane%2520permeabilization%2520demonstrates%2520therapeutic%2520benefits%2520in%2520experimental%2520human%2520non-small%2520cell%2520lung%2520cancers%26jtitle%3DNeoplasia%26date%3D2006%26volume%3D5%26spage%3D402%26epage%3D412" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Mathieu, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pirker, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin de Lassalle, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vernier, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mijatovic, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Neve, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaussin, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dehoux, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lefranc, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berger, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiss, R.</span><span> </span><span class="NLM_article-title">The sodium pump alpha-1 subunit: a disease progression-related target for metastatic melanoma treatment</span> <span class="citation_source-journal">J. Cell Mol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">3960</span><span class="NLM_x">–</span> <span class="NLM_lpage">3972</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Fjm200285z&amp;key=10.1111%2Fj.1582-4934.2009.00708.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Fjm200285z&amp;key=19243476" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Fjm200285z&amp;key=1%3ACAS%3A280%3ADC%252BC3c7kvFChsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2009&pages=3960-3972&author=V.+Mathieuauthor=C.+Pirkerauthor=E.+Martin+de+Lassalleauthor=M.+Vernierauthor=T.+Mijatovicauthor=N.+De+Neveauthor=J.+F.+Gaussinauthor=M.+Dehouxauthor=F.+Lefrancauthor=W.+Bergerauthor=R.+Kiss&title=The+sodium+pump+alpha-1+subunit%3A+a+disease+progression-related+target+for+metastatic+melanoma+treatment"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">The sodium pump alpha1 sub-unit: a disease progression-related target for metastatic melanoma treatment</span></div><div class="casAuthors">Mathieu Veronique; Pirker Christine; Martin de Lassalle Elisabeth; Vernier Mathieu; Mijatovic Tatjana; DeNeve Nancy; Gaussin Jean-Francois; Dehoux Mischael; Lefranc Florence; Berger Walter; Kiss Robert</div><div class="citationInfo"><span class="NLM_cas:title">Journal of cellular and molecular medicine</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">9B</span>),
    <span class="NLM_cas:pages">3960-72</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Melanomas remain associated with dismal prognosis because they are naturally resistant to apoptosis and they markedly metastasize.  Up-regulated expression of sodium pump alpha sub-units has previously been demonstrated when comparing metastatic to non-metastatic melanomas.  Our previous data revealed that impairing sodium pump alpha1 activity by means of selective ligands, that are cardiotonic steroids, markedly impairs cell migration and kills apoptosis-resistant cancer cells.  The objective of this study was to determine the expression levels of sodium pump alpha sub-units in melanoma clinical samples and cell lines and also to characterize the role of alpha1 sub-units in melanoma cell biology.  Quantitative RT-PCR, Western blotting and immunohistochemistry were used to determine the expression levels of sodium pump alpha sub-units.  In vitro cytotoxicity of various cardenolides and of an anti-alpha1 siRNA was evaluated by means of MTT assay, quantitative videomicroscopy and through apoptosis assays.  The in vivo activity of a novel cardenolide UNBS1450 was evaluated in a melanoma brain metastasis model.  Our data show that all investigated human melanoma cell lines expressed high levels of the alpha1 sub-unit, and 33% of human melanomas displayed significant alpha1 sub-unit expression in correlation with the Breslow index.  Furthermore, cardenolides (notably UNBS1450; currently in Phase I clinical trials) displayed marked anti-tumour effects against melanomas in vitro.  This activity was closely paralleled by decreases in cMyc expression and by increases in apoptotic features.  UNBS1450 also displayed marked anti-tumour activity in the aggressive human metastatic brain melanoma model in vivo.  The alpha1 sodium pump sub-unit could represent a potential novel target for combating melanoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRCeneUQpTcEu_Q9URG6Dx8fW6udTcc2eaju8e9EzPRY7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3c7kvFChsA%253D%253D&md5=6079d92a5eb05e978a79319a3c4db2eb</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1111%2Fj.1582-4934.2009.00708.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1582-4934.2009.00708.x%26sid%3Dliteratum%253Aachs%26aulast%3DMathieu%26aufirst%3DV.%26aulast%3DPirker%26aufirst%3DC.%26aulast%3DMartin%2Bde%2BLassalle%26aufirst%3DE.%26aulast%3DVernier%26aufirst%3DM.%26aulast%3DMijatovic%26aufirst%3DT.%26aulast%3DDe%2BNeve%26aufirst%3DN.%26aulast%3DGaussin%26aufirst%3DJ.%2BF.%26aulast%3DDehoux%26aufirst%3DM.%26aulast%3DLefranc%26aufirst%3DF.%26aulast%3DBerger%26aufirst%3DW.%26aulast%3DKiss%26aufirst%3DR.%26atitle%3DThe%2520sodium%2520pump%2520alpha-1%2520subunit%253A%2520a%2520disease%2520progression-related%2520target%2520for%2520metastatic%2520melanoma%2520treatment%26jtitle%3DJ.%2520Cell%2520Mol.%2520Med.%26date%3D2009%26volume%3D13%26spage%3D3960%26epage%3D3972" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Dumont, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ingrassia, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rouzeau, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ribaucour, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roland, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Darro, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lefranc, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiss, R.</span><span> </span><span class="NLM_article-title">The <i>Amaryllidaceae</i> isocarbostyril narciclasine induces apoptosis by activation of the death receptor and/or mitochondrial pathways in cancer cells but not in normal fibroblasts</span> <span class="citation_source-journal">Neoplasia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">766</span><span class="NLM_x">–</span> <span class="NLM_lpage">776</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2007&pages=766-776&author=P.+Dumontauthor=L.+Ingrassiaauthor=S.+Rouzeauauthor=F.+Ribaucourauthor=S.+Thomasauthor=I.+Rolandauthor=F.+Darroauthor=F.+Lefrancauthor=R.+Kiss&title=The+Amaryllidaceae+isocarbostyril+narciclasine+induces+apoptosis+by+activation+of+the+death+receptor+and%2For+mitochondrial+pathways+in+cancer+cells+but+not+in+normal+fibroblasts"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDumont%26aufirst%3DP.%26aulast%3DIngrassia%26aufirst%3DL.%26aulast%3DRouzeau%26aufirst%3DS.%26aulast%3DRibaucour%26aufirst%3DF.%26aulast%3DThomas%26aufirst%3DS.%26aulast%3DRoland%26aufirst%3DI.%26aulast%3DDarro%26aufirst%3DF.%26aulast%3DLefranc%26aufirst%3DF.%26aulast%3DKiss%26aufirst%3DR.%26atitle%3DThe%2520Amaryllidaceae%2520isocarbostyril%2520narciclasine%2520induces%2520apoptosis%2520by%2520activation%2520of%2520the%2520death%2520receptor%2520and%252For%2520mitochondrial%2520pathways%2520in%2520cancer%2520cells%2520but%2520not%2520in%2520normal%2520fibroblasts%26jtitle%3DNeoplasia%26date%3D2007%26volume%3D9%26spage%3D766%26epage%3D776" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Gerber, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minna, J. D.</span><span> </span><span class="NLM_article-title">ALK inhibition for non-small cell lung cancer: from discovery to therapy in record time</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">548</span><span class="NLM_x">–</span> <span class="NLM_lpage">551</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2010&pages=548-551&author=D.+E.+Gerberauthor=J.+D.+Minna&title=ALK+inhibition+for+non-small+cell+lung+cancer%3A+from+discovery+to+therapy+in+record+time"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGerber%26aufirst%3DD.%2BE.%26aulast%3DMinna%26aufirst%3DJ.%2BD.%26atitle%3DALK%2520inhibition%2520for%2520non-small%2520cell%2520lung%2520cancer%253A%2520from%2520discovery%2520to%2520therapy%2520in%2520record%2520time%26jtitle%3DCancer%2520Cell%26date%3D2010%26volume%3D18%26spage%3D548%26epage%3D551" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Qiu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kung, H. J.</span><span> </span><span class="NLM_article-title">Signaling network of the Btk family kinases</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">5651</span><span class="NLM_x">–</span> <span class="NLM_lpage">5661</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2000&pages=5651-5661&author=Y.+Qiuauthor=H.+J.+Kung&title=Signaling+network+of+the+Btk+family+kinases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DQiu%26aufirst%3DY.%26aulast%3DKung%26aufirst%3DH.%2BJ.%26atitle%3DSignaling%2520network%2520of%2520the%2520Btk%2520family%2520kinases%26jtitle%3DOncogene%26date%3D2000%26volume%3D19%26spage%3D5651%26epage%3D5661" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Dopeso, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mateo-Lozano, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mazzolini, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodrigues, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lagares-Tena, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ceron, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romero, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Esteves, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Landolfi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hernandez-Losa, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castano, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramon y Cajal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mariadason, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwartz, S.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arango, D.</span><span> </span><span class="NLM_article-title">The receptor tyrosine kinase EPHB4 has tumor suppressor activities in intestinal tumorigenesis</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x">, </span> <span class="NLM_fpage">7430</span><span class="NLM_x">–</span> <span class="NLM_lpage">7438</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2009&pages=7430-7438&author=H.+Dopesoauthor=S.+Mateo-Lozanoauthor=R.+Mazzoliniauthor=P.+Rodriguesauthor=L.+Lagares-Tenaauthor=J.+Ceronauthor=J.+Romeroauthor=M.+Estevesauthor=S.+Landolfiauthor=J.+Hernandez-Losaauthor=J.+Castanoauthor=A.+J.+Wilsonauthor=S.+Ramon+y+Cajalauthor=J.+M.+Mariadasonauthor=S.+Schwartzauthor=D.+Arango&title=The+receptor+tyrosine+kinase+EPHB4+has+tumor+suppressor+activities+in+intestinal+tumorigenesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDopeso%26aufirst%3DH.%26aulast%3DMateo-Lozano%26aufirst%3DS.%26aulast%3DMazzolini%26aufirst%3DR.%26aulast%3DRodrigues%26aufirst%3DP.%26aulast%3DLagares-Tena%26aufirst%3DL.%26aulast%3DCeron%26aufirst%3DJ.%26aulast%3DRomero%26aufirst%3DJ.%26aulast%3DEsteves%26aufirst%3DM.%26aulast%3DLandolfi%26aufirst%3DS.%26aulast%3DHernandez-Losa%26aufirst%3DJ.%26aulast%3DCastano%26aufirst%3DJ.%26aulast%3DWilson%26aufirst%3DA.%2BJ.%26aulast%3DRamon%2By%2BCajal%26aufirst%3DS.%26aulast%3DMariadason%26aufirst%3DJ.%2BM.%26aulast%3DSchwartz%26aufirst%3DS.%26aulast%3DArango%26aufirst%3DD.%26atitle%3DThe%2520receptor%2520tyrosine%2520kinase%2520EPHB4%2520has%2520tumor%2520suppressor%2520activities%2520in%2520intestinal%2520tumorigenesis%26jtitle%3DCancer%2520Res.%26date%3D2009%26volume%3D69%26spage%3D7430%26epage%3D7438" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Herath, N. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyd, A. W.</span><span> </span><span class="NLM_article-title">The role of Eph receptors and ephrin ligands in colorectal cancer</span> <span class="citation_source-journal">Int. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">126</span><span class="NLM_x">, </span> <span class="NLM_fpage">2003</span><span class="NLM_x">–</span> <span class="NLM_lpage">2011</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Fjm200285z&amp;key=20039322" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Fjm200285z&amp;key=1%3ACAS%3A528%3ADC%252BC3cXisFemur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=126&publication_year=2010&pages=2003-2011&author=N.+I.+Herathauthor=A.+W.+Boyd&title=The+role+of+Eph+receptors+and+ephrin+ligands+in+colorectal+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">The role of Eph receptors and ephrin ligands in colorectal cancer</span></div><div class="casAuthors">Herath, Nirmitha I.; Boyd, Andrew W.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Cancer</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">126</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2003-2011</span>CODEN:
                <span class="NLM_cas:coden">IJCNAW</span>;
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">A review.  Eph receptors and their ephrin ligands constitute the largest subfamily of receptor tyrosine kinases and are components of the cell signaling pathways involved during development.  Eph and ephrin overexpression have been documented in a variety of human cancers including gastrointestinal malignancies and in particular colorectal malignancies.  EphB and ephrin B proteins have been implicated in the homeostasis of the gastrointestinal tract where EphB2- and EphB3-ephrin B signaling regulates cell sorting in the mature epithelium.  These proteins are also reported to be upregulated in colon carcinomas.  The EphA/ephrin A system has also been implicated in epithelial tissue structure and function.  More recently, EphA receptors and their corresponding ligands have been implicated in numerous malignancies.  Of these, EphA2 in particular has been intensively investigated and has been proposed as a therapeutic target.  An interesting observation emerging from these studies is the role for Ephs and ephrins in crit. aspects of cell adhesion, migration and positioning, and a crucial role in tumor progression and metastasis.  However, the underlying role of Ephs and ephrins in these processes has generally been studied on individual Eph or ephrin genes.  Given the multiplicity of Eph expression on gut epithelial cells, a more global approach is needed to define the precise role of Eph-ephrin interaction in malignant transformation.  Here, we will review the recent advances on the role of Eph-ephrin signaling in colorectal malignancies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUxkUFZRBWNLVg90H21EOLACvtfcHk0lhpthyO7pztBA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXisFemur8%253D&md5=df879b916c5476a76cbe9d934ed783e0</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHerath%26aufirst%3DN.%2BI.%26aulast%3DBoyd%26aufirst%3DA.%2BW.%26atitle%3DThe%2520role%2520of%2520Eph%2520receptors%2520and%2520ephrin%2520ligands%2520in%2520colorectal%2520cancer%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D2010%26volume%3D126%26spage%3D2003%26epage%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Smith, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samayawardhena, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Craig, A. W.</span><span> </span><span class="NLM_article-title">Fps/Fes protein-tyrosine kinase regulats mast cell adhesion and migration dowstrean of kit and beta1 integrin receptors</span> <span class="citation_source-journal">Cell Signal</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">427</span><span class="NLM_x">–</span> <span class="NLM_lpage">436</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Fjm200285z&amp;key=10.1016%2Fj.cellsig.2009.10.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Fjm200285z&amp;key=19892014" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Fjm200285z&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFGku7fN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2010&pages=427-436&author=J.+A.+Smithauthor=L.+A.+Samayawardhenaauthor=A.+W.+Craig&title=Fps%2FFes+protein-tyrosine+kinase+regulats+mast+cell+adhesion+and+migration+dowstrean+of+kit+and+beta1+integrin+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Fps/Fes protein-tyrosine kinase regulates mast cell adhesion and migration downstream of Kit and β1 integrin receptors</span></div><div class="casAuthors">Smith, Julie A.; Samayawardhena, Lionel A.; Craig, Andrew W. B.</div><div class="citationInfo"><span class="NLM_cas:title">Cellular Signalling</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">427-436</span>CODEN:
                <span class="NLM_cas:coden">CESIEY</span>;
        ISSN:<span class="NLM_cas:issn">0898-6568</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Activation of Kit receptor protein-tyrosine kinase (PTK) by its ligand Stem Cell Factor (SCF) is required for the development of mast cells, and for the regulation of mast cell proliferation, migration and modulation of inflammatory mediator release.  Recent studies have implicated the non-receptor PTK Fps/Fes (hereafter referred to as Fes) in signaling downstream of oncogenic Kit, however, the potential role of Fes in regulating Kit signaling is not well defined.  In this study, we show that SCF induces transient tyrosine phosphorylation of wild-type Fes as well as kinase-dead Fes in bone marrow-derived mast cells (BMMCs).  The latter finding implicates an upstream kinase acting on Fes, which we identified as Fyn PTK.  SCF treatment of BMMCs promoted recruitment of Fes to Kit, potentially via direct interaction of the Fes SH2 domain with phosphorylated Kit.  While Fes was not required for SCF-induced signaling to Akt and Erk kinases, Fes-deficient (fes-/-) BMMCs displayed a defect in sustained p38 kinase activation, compared to control cells.  SCF-treated Fes-deficient BMMCs also displayed elevated β1 integrin-mediated cell adhesion and spreading on fibronectin, compared to control cells, and a redn. in cell polarization at later times of SCF treatment.  Restoring Fes expression in fes-/- BMMCs by retroviral transduction was sufficient to rescue cell spreading and polarization defects.  Interestingly, SCF-induced chemotaxis of BMMCs was also defective in Fes-deficient BMMCs, and restored in Fes-rescue BMMCs.  Overall, these results implicate Fes in regulating cross-talk between Kit and β1 integrins to promote cytoskeletal reorganization and motility of mast cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7c9xicdwTbLVg90H21EOLACvtfcHk0lhpthyO7pztBA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFGku7fN&md5=a9b5a8a32c2e46a69fdba3c3205843a2</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1016%2Fj.cellsig.2009.10.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cellsig.2009.10.014%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DJ.%2BA.%26aulast%3DSamayawardhena%26aufirst%3DL.%2BA.%26aulast%3DCraig%26aufirst%3DA.%2BW.%26atitle%3DFps%252FFes%2520protein-tyrosine%2520kinase%2520regulats%2520mast%2520cell%2520adhesion%2520and%2520migration%2520dowstrean%2520of%2520kit%2520and%2520beta1%2520integrin%2520receptors%26jtitle%3DCell%2520Signal%26date%3D2010%26volume%3D22%26spage%3D427%26epage%3D436" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Saito, Y. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jensen, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salgia, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Posadas, E. M.</span><span> </span><span class="NLM_article-title">Fyn: a novel molecular target in cancer</span> <span class="citation_source-journal">Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">116</span><span class="NLM_x">, </span> <span class="NLM_fpage">1629</span><span class="NLM_x">–</span> <span class="NLM_lpage">1637</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=2010&pages=1629-1637&author=Y.+D.+Saitoauthor=A.+R.+Jensenauthor=R.+Salgiaauthor=E.+M.+Posadas&title=Fyn%3A+a+novel+molecular+target+in+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSaito%26aufirst%3DY.%2BD.%26aulast%3DJensen%26aufirst%3DA.%2BR.%26aulast%3DSalgia%26aufirst%3DR.%26aulast%3DPosadas%26aufirst%3DE.%2BM.%26atitle%3DFyn%253A%2520a%2520novel%2520molecular%2520target%2520in%2520cancer%26jtitle%3DCancer%26date%3D2010%26volume%3D116%26spage%3D1629%26epage%3D1637" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Katoh, M.</span><span> </span><span class="NLM_article-title">FGFR2 abnormalities underlies a spectrum of bone, skin, and cancer pathologies</span> <span class="citation_source-journal">J. Invest. Dermatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">129</span><span class="NLM_x">, </span> <span class="NLM_fpage">1861</span><span class="NLM_x">–</span> <span class="NLM_lpage">1867</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=129&publication_year=2009&pages=1861-1867&author=M.+Katoh&title=FGFR2+abnormalities+underlies+a+spectrum+of+bone%2C+skin%2C+and+cancer+pathologies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKatoh%26aufirst%3DM.%26atitle%3DFGFR2%2520abnormalities%2520underlies%2520a%2520spectrum%2520of%2520bone%252C%2520skin%252C%2520and%2520cancer%2520pathologies%26jtitle%3DJ.%2520Invest.%2520Dermatol.%26date%3D2009%26volume%3D129%26spage%3D1861%26epage%3D1867" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Scartozzi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bianconi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maccaroni, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giamperi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beradi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cascinu, S.</span><span> </span><span class="NLM_article-title">Dalotuzumab, a recombinant humanized mAb targeted against IGFR1 for the treatment of cancer</span> <span class="citation_source-journal">Curr. Opin. Mol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">361</span><span class="NLM_x">–</span> <span class="NLM_lpage">371</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Fjm200285z&amp;key=20521225" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Fjm200285z&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlaktLvF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2010&pages=361-371&author=M.+Scartozziauthor=M.+Bianconiauthor=E.+Maccaroniauthor=R.+Giamperiauthor=R.+Beradiauthor=S.+Cascinu&title=Dalotuzumab%2C+a+recombinant+humanized+mAb+targeted+against+IGFR1+for+the+treatment+of+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Dalotuzumab, a recombinant humanized mAb targeted against IGFR1 for the treatment of cancer</span></div><div class="casAuthors">Scartozzi, Mario; Bianconi, Maristella; Maccaroni, Elena; Giampieri, Riccardo; Berardi, Rossana; Cascinu, Stefano</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Molecular Therapeutics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">361-371</span>CODEN:
                <span class="NLM_cas:coden">CUOTFO</span>;
        ISSN:<span class="NLM_cas:issn">2040-3445</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">A review.  Dalotuzumab (MK-0646; h7C10), being developed by Merck & Co Inc under license from Pierre Fabre SA, is a recombinant humanized IgG1 mAb against the IGFR1 for the potential i.v. treatment of cancer.  Preclin. studies have demonstrated that dalotuzumab acts by inhibiting IGF-1- and IGF-2-mediated tumor cell proliferation, IGFR1 autophosphorylation and Akt phosphorylation.  In multiple cancer cell lines and in mouse xenograft models, dalotuzumab displayed significant antitumor activity, in particular against NSCLC and breast cancer.  In addn., coadministration of dalotuzumab with other anticancer agents, such as taxanes, enhanced the in vitro and in vivo antitumor activity of dalotuzumab.  Preliminary data from phase I clin. trials suggest that dalotuzumab is safe, well tolerated and significantly inhibits tumor proliferation.  At the time of publication, several clin. trials evaluating dalotuzumab, alone and in combination with other anticancer agents, were ongoing in patients with various types of solid tumor and in patients with multiple myeloma.  Although preliminary results appear promising, only future clin. and translational data will clarify the best clin. setting and treatment combinations for the optimal use of dolotuzumab in clin. practice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrn5qPjJ1HQ7bVg90H21EOLACvtfcHk0lgHe-DKbQ9c6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlaktLvF&md5=93055a6b2aa0c73efd755a6271eb8cd1</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DScartozzi%26aufirst%3DM.%26aulast%3DBianconi%26aufirst%3DM.%26aulast%3DMaccaroni%26aufirst%3DE.%26aulast%3DGiamperi%26aufirst%3DR.%26aulast%3DBeradi%26aufirst%3DR.%26aulast%3DCascinu%26aufirst%3DS.%26atitle%3DDalotuzumab%252C%2520a%2520recombinant%2520humanized%2520mAb%2520targeted%2520against%2520IGFR1%2520for%2520the%2520treatment%2520of%2520cancer%26jtitle%3DCurr.%2520Opin.%2520Mol.%2520Ther.%26date%3D2010%26volume%3D12%26spage%3D361%26epage%3D371" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Cockburn, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richardson, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gujral, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mulligan, L. M.</span><span> </span><span class="NLM_article-title">RET-mediated cell adhesion and migration require multiple integrin subunits</span> <span class="citation_source-journal">J. Clin. Endocrinol. Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">95</span><span class="NLM_x">, </span> <span class="NLM_fpage">E342</span><span class="NLM_x">–</span> <span class="NLM_lpage">E346</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=2010&pages=E342-E346&author=J.+G.+Cockburnauthor=D.+S.+Richardsonauthor=T.+S.+Gujralauthor=L.+M.+Mulligan&title=RET-mediated+cell+adhesion+and+migration+require+multiple+integrin+subunits"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCockburn%26aufirst%3DJ.%2BG.%26aulast%3DRichardson%26aufirst%3DD.%2BS.%26aulast%3DGujral%26aufirst%3DT.%2BS.%26aulast%3DMulligan%26aufirst%3DL.%2BM.%26atitle%3DRET-mediated%2520cell%2520adhesion%2520and%2520migration%2520require%2520multiple%2520integrin%2520subunits%26jtitle%3DJ.%2520Clin.%2520Endocrinol.%2520Metab.%26date%3D2010%26volume%3D95%26spage%3DE342%26epage%3DE346" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">Lee, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, T. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zagozdzon, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Avraham, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Usheva, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Avraham, H. K.</span><span> </span><span class="NLM_article-title">Carboxyl-terminal Src kinase homologous kinase negatively regulates the chemokine receptor CXCR4 through YY1 and impairs CXCR4/CXCL12 (SDF-1alpha)-mediated breast cancer cell migration</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">2840</span><span class="NLM_x">–</span> <span class="NLM_lpage">2845</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2005&pages=2840-2845&author=B.+C.+Leeauthor=T.+H.+Leeauthor=R.+Zagozdzonauthor=S.+Avrahamauthor=A.+Ushevaauthor=H.+K.+Avraham&title=Carboxyl-terminal+Src+kinase+homologous+kinase+negatively+regulates+the+chemokine+receptor+CXCR4+through+YY1+and+impairs+CXCR4%2FCXCL12+%28SDF-1alpha%29-mediated+breast+cancer+cell+migration"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DB.%2BC.%26aulast%3DLee%26aufirst%3DT.%2BH.%26aulast%3DZagozdzon%26aufirst%3DR.%26aulast%3DAvraham%26aufirst%3DS.%26aulast%3DUsheva%26aufirst%3DA.%26aulast%3DAvraham%26aufirst%3DH.%2BK.%26atitle%3DCarboxyl-terminal%2520Src%2520kinase%2520homologous%2520kinase%2520negatively%2520regulates%2520the%2520chemokine%2520receptor%2520CXCR4%2520through%2520YY1%2520and%2520impairs%2520CXCR4%252FCXCL12%2520%2528SDF-1alpha%2529-mediated%2520breast%2520cancer%2520cell%2520migration%26jtitle%3DCancer%2520Res.%26date%3D2005%26volume%3D65%26spage%3D2840%26epage%3D2845" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group">Coniglio, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zavarella, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Symons, M. H.</span><span> </span><span class="NLM_article-title">Pak1 and Pak2 mediate tumor cell invasion through distinct signaling mechanisms</span> <span class="citation_source-journal">Mol. Cell. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">4162</span><span class="NLM_x">–</span> <span class="NLM_lpage">4172</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Fjm200285z&amp;key=10.1128%2FMCB.01532-07" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Fjm200285z&amp;key=18411304" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Fjm200285z&amp;key=1%3ACAS%3A528%3ADC%252BD1cXntFamsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2008&pages=4162-4172&author=S.+J.+Coniglioauthor=S.+Zavarellaauthor=M.+H.+Symons&title=Pak1+and+Pak2+mediate+tumor+cell+invasion+through+distinct+signaling+mechanisms"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Pak1 and Pak2 mediate tumor cell invasion through distinct signaling mechanisms</span></div><div class="casAuthors">Coniglio, Salvatore J.; Zavarella, Salvatore; Symons, Marc H.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">4162-4172</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Pak kinases are thought to play crit. roles in cell migration and invasion.  Here, we analyze the roles of Pak1 and Pak2 in breast carcinoma cell invasion using the transient transfection of small interfering RNA.  We find that although both Pak1 and Pak2 contribute to breast carcinoma invasion stimulated by heregulin, these roles are mediated by distinct signaling mechanisms.  Thus, whereas the depletion of Pak1 interferes with the heregulin-mediated dephosphorylation of cofilin, the depletion of Pak2 does not.  The depletion of Pak1 also has a stronger inhibitory effect on lamellipodial protrusion than does the depletion of Pak2.  Interestingly, Pak1 and Pak2 play opposite roles in regulating the phosphorylation of the myosin light chain (MLC).  Whereas the depletion of Pak1 decreases phospho-MLC levels in heregulin-stimulated cells, the depletion of Pak2 enhances MLC phosphorylation.  Consistent with their opposite effects on MLC phosphorylation, Pak1 and Pak2 differentially modulate focal adhesions.  Pak2-depleted cells display an increase in focal adhesion size, whereas in Pak1-depleted cells, focal adhesions fail to mature.  We also found that the depletion of Pak2, but not Pak1, enhances RhoA activity and that the inhibition of RhoA signaling in Pak2-depleted cells decreases MLC phosphorylation and restores cell invasion.  In summary, this work presents the first comprehensive anal. of functional differences between the Pak1 and Pak2 isoforms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGre7mSDVtyMxrVg90H21EOLACvtfcHk0lgHe-DKbQ9c6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXntFamsro%253D&md5=aec34148f16ead02fa0cf54d855972cc</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1128%2FMCB.01532-07&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.01532-07%26sid%3Dliteratum%253Aachs%26aulast%3DConiglio%26aufirst%3DS.%2BJ.%26aulast%3DZavarella%26aufirst%3DS.%26aulast%3DSymons%26aufirst%3DM.%2BH.%26atitle%3DPak1%2520and%2520Pak2%2520mediate%2520tumor%2520cell%2520invasion%2520through%2520distinct%2520signaling%2520mechanisms%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2008%26volume%3D28%26spage%3D4162%26epage%3D4172" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group">Lee, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldberg, A. L.</span><span> </span><span class="NLM_article-title">Proteasome inhibitors: valuable new tools for cell biologists</span> <span class="citation_source-journal">Trends Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">397</span><span class="NLM_x">–</span> <span class="NLM_lpage">403</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Fjm200285z&amp;key=10.1016%2FS0962-8924%2898%2901346-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Fjm200285z&amp;key=9789328" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Fjm200285z&amp;key=1%3ACAS%3A528%3ADyaK1cXmvFWjtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=1998&pages=397-403&author=D.+H.+Leeauthor=A.+L.+Goldberg&title=Proteasome+inhibitors%3A+valuable+new+tools+for+cell+biologists"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Proteasome inhibitors: valuable new tools for cell biologists</span></div><div class="casAuthors">Lee, Do Hee; Goldberg, Alfred L.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Cell Biology</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">397-403</span>CODEN:
                <span class="NLM_cas:coden">TCBIEK</span>;
        ISSN:<span class="NLM_cas:issn">0962-8924</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review with 49 refs.  Proteasomes are major sites for protein degrdn. in eukaryotic cells.  The recent identification of selective proteasome inhibitors has allowed a definition of the roles of the ubiquitin-proteasome pathway in various cellular processes, such as antigen presentation and the degrdn. of regulatory or membrane proteins.  This review describes the actions of these inhibitors, how they can be used to investigate cellular responses, the functions of the proteasome demonstrated by such studies and their potential applications in the future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrA-ydl6asLAbVg90H21EOLACvtfcHk0lihVfL2hQ-BTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXmvFWjtbc%253D&md5=40053b67b418beff1f2c6bf4f293d195</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1016%2FS0962-8924%2898%2901346-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0962-8924%252898%252901346-4%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DD.%2BH.%26aulast%3DGoldberg%26aufirst%3DA.%2BL.%26atitle%3DProteasome%2520inhibitors%253A%2520valuable%2520new%2520tools%2520for%2520cell%2520biologists%26jtitle%3DTrends%2520Cell%2520Biol.%26date%3D1998%26volume%3D8%26spage%3D397%26epage%3D403" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group">Hines, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groll, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fahnestock, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crews, C. M.</span><span> </span><span class="NLM_article-title">Proteasome Inhibition by Fellutamide B Induces Nerve Growth Factor Synthesis</span> <span class="citation_source-journal">Chem. Biol. (Cambridge, MA, U. S.)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">501</span><span class="NLM_x">–</span> <span class="NLM_lpage">512</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Fjm200285z&amp;key=1%3ACAS%3A528%3ADC%252BD1cXmtVSjsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2008&pages=501-512&author=J.+Hinesauthor=M.+Grollauthor=M.+Fahnestockauthor=C.+M.+Crews&title=Proteasome+Inhibition+by+Fellutamide+B+Induces+Nerve+Growth+Factor+Synthesis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Proteasome Inhibition by Fellutamide B Induces Nerve Growth Factor Synthesis</span></div><div class="casAuthors">Hines, John; Groll, Michael; Fahnestock, Margaret; Crews, Craig M.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">501-512</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Neurotrophic small mols. have the potential to aid in the treatment of neuronal injury and neurodegenerative diseases.  The natural product fellutamide B, originally isolated from Penicillium fellutanum, potently induces nerve growth factor (NGF) release from fibroblasts and glial-derived cells, although the mechanism for this neurotrophic activity has not been elucidated.  Here, we report that fellutamide B potently inhibits proteasome catalytic activity.  High-resoln. structural information obtained from cocrystn. of the 20S proteasome reveals novel aspects regarding β-subunit binding and adduct formation by fellutamide B to inhibit their hydrolytic activity.  We demonstrate that fellutamide B and other proteasome inhibitors increased NGF gene transcription via a cis-acting element (or elements) in the promoter.  These results demonstrate an unrecognized connection between proteasome inhibition and NGF prodn., suggesting a possible new strategy in the development of neurotrophic agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpusW5B8CxRvLVg90H21EOLACvtfcHk0lihVfL2hQ-BTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXmtVSjsLg%253D&md5=4af67bc8ed8a76dbc935f615fa279b86</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHines%26aufirst%3DJ.%26aulast%3DGroll%26aufirst%3DM.%26aulast%3DFahnestock%26aufirst%3DM.%26aulast%3DCrews%26aufirst%3DC.%2BM.%26atitle%3DProteasome%2520Inhibition%2520by%2520Fellutamide%2520B%2520Induces%2520Nerve%2520Growth%2520Factor%2520Synthesis%26jtitle%3DChem.%2520Biol.%2520%2528Cambridge%252C%2520MA%252C%2520U.%2520S.%2529%26date%3D2008%26volume%3D15%26spage%3D501%26epage%3D512" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group">de Bettignies, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coux, O.</span><span> </span><span class="NLM_article-title">Proteasome inhibitors: Dozens of molecules and still counting</span> <span class="citation_source-journal">Biochimie</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">92</span><span class="NLM_x">, </span> <span class="NLM_fpage">1530</span><span class="NLM_x">–</span> <span class="NLM_lpage">1545</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=2010&pages=1530-1545&author=G.+de+Bettigniesauthor=O.+Coux&title=Proteasome+inhibitors%3A+Dozens+of+molecules+and+still+counting"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2BBettignies%26aufirst%3DG.%26aulast%3DCoux%26aufirst%3DO.%26atitle%3DProteasome%2520inhibitors%253A%2520Dozens%2520of%2520molecules%2520and%2520still%2520counting%26jtitle%3DBiochimie%26date%3D2010%26volume%3D92%26spage%3D1530%26epage%3D1545" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group">Blackburn, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gigstad, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hales, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruzzese, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrett, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soucy, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sappal, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bump, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olhava, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fleming, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dick, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sintchak, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blank, J. L.</span><span> </span><span class="NLM_article-title">Characterization of a new series of non-covalent proteasome inhibitors with exquisite potency and selectivity for the 20S beta 5-subunit</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">430</span><span class="NLM_x">, </span> <span class="NLM_fpage">461</span><span class="NLM_x">–</span> <span class="NLM_lpage">476</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=430&publication_year=2010&pages=461-476&author=C.+Blackburnauthor=K.+M.+Gigstadauthor=P.+Halesauthor=K.+Garciaauthor=M.+Jonesauthor=F.+J.+Bruzzeseauthor=C.+Barrettauthor=J.+X.+Liuauthor=T.+A.+Soucyauthor=D.+S.+Sappalauthor=N.+Bumpauthor=E.+J.+Olhavaauthor=P.+Flemingauthor=L.+R.+Dickauthor=C.+Tsuauthor=M.+D.+Sintchakauthor=J.+L.+Blank&title=Characterization+of+a+new+series+of+non-covalent+proteasome+inhibitors+with+exquisite+potency+and+selectivity+for+the+20S+beta+5-subunit"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBlackburn%26aufirst%3DC.%26aulast%3DGigstad%26aufirst%3DK.%2BM.%26aulast%3DHales%26aufirst%3DP.%26aulast%3DGarcia%26aufirst%3DK.%26aulast%3DJones%26aufirst%3DM.%26aulast%3DBruzzese%26aufirst%3DF.%2BJ.%26aulast%3DBarrett%26aufirst%3DC.%26aulast%3DLiu%26aufirst%3DJ.%2BX.%26aulast%3DSoucy%26aufirst%3DT.%2BA.%26aulast%3DSappal%26aufirst%3DD.%2BS.%26aulast%3DBump%26aufirst%3DN.%26aulast%3DOlhava%26aufirst%3DE.%2BJ.%26aulast%3DFleming%26aufirst%3DP.%26aulast%3DDick%26aufirst%3DL.%2BR.%26aulast%3DTsu%26aufirst%3DC.%26aulast%3DSintchak%26aufirst%3DM.%2BD.%26aulast%3DBlank%26aufirst%3DJ.%2BL.%26atitle%3DCharacterization%2520of%2520a%2520new%2520series%2520of%2520non-covalent%2520proteasome%2520inhibitors%2520with%2520exquisite%2520potency%2520and%2520selectivity%2520for%2520the%252020S%2520beta%25205-subunit%26jtitle%3DBiochem.%2520J.%26date%3D2010%26volume%3D430%26spage%3D461%26epage%3D476" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group">Geurink, P. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spaans, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Downey, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van den Nieuwendijk, A. M. C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van der Marel, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kisselev, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Florea, B. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Overkleeft, H. S.</span><span> </span><span class="NLM_article-title">Incorporation of fluorinated phenylalanine generates highly specific inhibitor of proteasome’s chymotrypsin-like sites</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">2319</span><span class="NLM_x">–</span> <span class="NLM_lpage">2323</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm9015685" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=2319-2323&author=P.+P.+Geurinkauthor=N.+Liuauthor=M.+P.+Spaansauthor=S.+L.+Downeyauthor=A.+M.+C.+H.+van+den+Nieuwendijkauthor=G.+A.+van+der+Marelauthor=A.+F.+Kisselevauthor=B.+I.+Floreaauthor=H.+S.+Overkleeft&title=Incorporation+of+fluorinated+phenylalanine+generates+highly+specific+inhibitor+of+proteasome%E2%80%99s+chymotrypsin-like+sites"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1021%2Fjm9015685&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9015685%26sid%3Dliteratum%253Aachs%26aulast%3DGeurink%26aufirst%3DP.%2BP.%26aulast%3DLiu%26aufirst%3DN.%26aulast%3DSpaans%26aufirst%3DM.%2BP.%26aulast%3DDowney%26aufirst%3DS.%2BL.%26aulast%3Dvan%2Bden%2BNieuwendijk%26aufirst%3DA.%2BM.%2BC.%2BH.%26aulast%3Dvan%2Bder%2BMarel%26aufirst%3DG.%2BA.%26aulast%3DKisselev%26aufirst%3DA.%2BF.%26aulast%3DFlorea%26aufirst%3DB.%2BI.%26aulast%3DOverkleeft%26aufirst%3DH.%2BS.%26atitle%3DIncorporation%2520of%2520fluorinated%2520phenylalanine%2520generates%2520highly%2520specific%2520inhibitor%2520of%2520proteasome%25E2%2580%2599s%2520chymotrypsin-like%2520sites%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D2319%26epage%3D2323" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group">Furet, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imbach, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noorani, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koeppler, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laumen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guagnano, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuerst, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roesel, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zimmermann, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia Echeverria, C.</span><span> </span><span class="NLM_article-title">Entry into a new class of potent proteasome inhibitors having high antiproliferative activity by structure-based design</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">4810</span><span class="NLM_x">–</span> <span class="NLM_lpage">4813</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm049660v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=4810-4813&author=P.+Furetauthor=P.+Imbachauthor=M.+Nooraniauthor=J.+Koepplerauthor=K.+Laumenauthor=M.+Langauthor=V.+Guagnanoauthor=P.+Fuerstauthor=J.+Roeselauthor=J.+Zimmermannauthor=C.+Garcia+Echeverria&title=Entry+into+a+new+class+of+potent+proteasome+inhibitors+having+high+antiproliferative+activity+by+structure-based+design"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1021%2Fjm049660v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm049660v%26sid%3Dliteratum%253Aachs%26aulast%3DFuret%26aufirst%3DP.%26aulast%3DImbach%26aufirst%3DP.%26aulast%3DNoorani%26aufirst%3DM.%26aulast%3DKoeppler%26aufirst%3DJ.%26aulast%3DLaumen%26aufirst%3DK.%26aulast%3DLang%26aufirst%3DM.%26aulast%3DGuagnano%26aufirst%3DV.%26aulast%3DFuerst%26aufirst%3DP.%26aulast%3DRoesel%26aufirst%3DJ.%26aulast%3DZimmermann%26aufirst%3DJ.%26aulast%3DGarcia%2BEcheverria%26aufirst%3DC.%26atitle%3DEntry%2520into%2520a%2520new%2520class%2520of%2520potent%2520proteasome%2520inhibitors%2520having%2520high%2520antiproliferative%2520activity%2520by%2520structure-based%2520design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D4810%26epage%3D4813" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group">Simpson, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anyiwe, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schimmer, A. D.</span><span> </span><span class="NLM_article-title">Anoikis resistance and tumor metastasis</span> <span class="citation_source-journal">Cancer Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">272</span><span class="NLM_x">, </span> <span class="NLM_fpage">177</span><span class="NLM_x">–</span> <span class="NLM_lpage">185</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Fjm200285z&amp;key=10.1016%2Fj.canlet.2008.05.029" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Fjm200285z&amp;key=18579285" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Fjm200285z&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtlyhtr%252FJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=272&publication_year=2008&pages=177-185&author=C.+D.+Simpsonauthor=K.+Anyiweauthor=A.+D.+Schimmer&title=Anoikis+resistance+and+tumor+metastasis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Anoikis resistance and tumor metastasis</span></div><div class="casAuthors">Simpson, Craig D.; Anyiwe, Kika; Schimmer, Aaron D.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (Shannon, Ireland)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">272</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">177-185</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ireland Ltd.</span>)
        </div><div class="casAbstract">A review.  As a barrier to metastases, cells normally undergo apoptosis after they lose contact with their extra cellular matrix or their neighboring cells.  This cell death process has been termed "anoikis".  Tumor cells that acquire malignant potential have developed mechanisms to resist anoikis and thereby survive after detachment from their primary site and while traveling through the lymphatic and circulatory systems.  Defects in the death receptor pathway of caspase activation, such as the over-expression of the caspase-8 inhibitor FLIP, can render cells resistant to anoikis.  Likewise, roadblocks in the mitochondrial pathway, such as over-expression of the Bcl-2 family of anti-apoptotic proteins, can also confer resistance to anoikis.  This review will focus on the roles of the death receptor and mitochondrial pathways in anoikis and anoikis resistance and how targeting defects in these pathways can restore sensitivity to anoikis and serve as the basis for therapeutic adjuncts that prevent metastasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprLWdjkl6g7LVg90H21EOLACvtfcHk0lhsrNx97qUEAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtlyhtr%252FJ&md5=b3d06d8e6deff2a650848a106480f50c</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1016%2Fj.canlet.2008.05.029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.canlet.2008.05.029%26sid%3Dliteratum%253Aachs%26aulast%3DSimpson%26aufirst%3DC.%2BD.%26aulast%3DAnyiwe%26aufirst%3DK.%26aulast%3DSchimmer%26aufirst%3DA.%2BD.%26atitle%3DAnoikis%2520resistance%2520and%2520tumor%2520metastasis%26jtitle%3DCancer%2520Lett.%26date%3D2008%26volume%3D272%26spage%3D177%26epage%3D185" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group">Savage, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stebbing, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bower, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crook, T.</span><span> </span><span class="NLM_article-title">Why does cytotoxic chemotherapy cure only some cancers?</span> <span class="citation_source-journal">Nat. Clin. Pract. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">43</span><span class="NLM_x">–</span> <span class="NLM_lpage">52</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Fjm200285z&amp;key=10.1038%2Fncponc1260" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Fjm200285z&amp;key=18982000" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Fjm200285z&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsFWkurzP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2009&pages=43-52&author=P.+Savageauthor=J.+Stebbingauthor=M.+Bowerauthor=T.+Crook&title=Why+does+cytotoxic+chemotherapy+cure+only+some+cancers%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Why does cytotoxic chemotherapy cure only some cancers?</span></div><div class="casAuthors">Savage, Philip; Stebbing, Justin; Bower, Mark; Crook, Tim</div><div class="citationInfo"><span class="NLM_cas:title">Nature Clinical Practice Oncology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">43-52</span>CODEN:
                <span class="NLM_cas:coden">NCPOB5</span>;
        ISSN:<span class="NLM_cas:issn">1743-4254</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Despite frequent responses to chemotherapy, curative treatment remains elusive for the majority of metastatic solid tumors.  By contrast, chemotherapy routinely cures patients with testicular cancers, gestational choriocarcinoma, Hodgkin's disease and high-grade lymphomas.  Savage et al. suggest that the chemo-curability of these malignancies results from an intrinsic 'locked-in' state of sensitivity to pro-apoptotic stresses in these particular cell types, and they discuss some of the characteristics shared by the curable cancers that might explain their curability.  Despite frequent responses to chemotherapy, curative treatment remains elusive for the majority of patients with metastatic solid tumors.  By contrast, in testicular cancer, gestational choriocarcinoma, Hodgkin disease and high-grade lymphomas, chemotherapy is routinely curative, even for patients who present with widely disseminated disease.  In the common advanced cancers, however, over 40 years of cytotoxic drug development has brought no significant change in cure rates.  One interpretation is that the intrinsic properties of the malignancies themselves, rather than the qualities of individual drugs or combination therapies, are primarily responsible for their curability with chemotherapy.  We suggest that the curability of these malignancies results from an intrinsic 'locked-in' state of sensitivity to proapoptotic stresses in these cells.  A common property of such curable malignancies is that they arise from cells that undergo major genetic rearrangements or recombination as part of their normal physiol.  The absence of further genetic and epigenetic changes in genes that regulate apoptosis, DNA repair and senescence allows these cells to maintain their intrinsic sensitivity to chemotherapy.  This process allows the cells, when challenged with chemotherapy, to undergo the natural apoptotic pathways that contribute to their intrinsic qualities of chemosensitivity and high curability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqov8Vi7LfVIrVg90H21EOLACvtfcHk0lhsrNx97qUEAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsFWkurzP&md5=1ac0fd31132140d612c789fe6bb99590</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1038%2Fncponc1260&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncponc1260%26sid%3Dliteratum%253Aachs%26aulast%3DSavage%26aufirst%3DP.%26aulast%3DStebbing%26aufirst%3DJ.%26aulast%3DBower%26aufirst%3DM.%26aulast%3DCrook%26aufirst%3DT.%26atitle%3DWhy%2520does%2520cytotoxic%2520chemotherapy%2520cure%2520only%2520some%2520cancers%253F%26jtitle%3DNat.%2520Clin.%2520Pract.%2520Oncol.%26date%3D2009%26volume%3D6%26spage%3D43%26epage%3D52" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group">Wilson, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnston, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Longley, D. B.</span><span> </span><span class="NLM_article-title">Anti-apoptotic mechanisms of drug resistance in cancer</span> <span class="citation_source-journal">Curr. Cancer Drug Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">307</span><span class="NLM_x">–</span> <span class="NLM_lpage">319</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Fjm200285z&amp;key=10.2174%2F156800909788166547" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Fjm200285z&amp;key=19442051" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Fjm200285z&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmslansLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2009&pages=307-319&author=T.+R.+Wilsonauthor=P.+G.+Johnstonauthor=D.+B.+Longley&title=Anti-apoptotic+mechanisms+of+drug+resistance+in+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Anti-apoptotic mechanisms of drug resistance in cancer</span></div><div class="casAuthors">Wilson, T. R.; Johnston, P. G.; Longley, D. B.</div><div class="citationInfo"><span class="NLM_cas:title">Current Cancer Drug Targets</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">307-319</span>CODEN:
                <span class="NLM_cas:coden">CCDTB9</span>;
        ISSN:<span class="NLM_cas:issn">1568-0096</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Resistance to chemotherapy is a major obstacle in the treatment of cancer.  Despite the advent of new chemotherapies and mol.-targeted therapies, approx. 90% of patients with metastatic cancer succumb to their disease.  Drug resistance, either acquired or intrinsic, often prevents tumor cells from undergoing sufficient levels of programmed cell death or apoptosis, resulting in cancer cell survival and treatment failure.  In pre-clin. disease models, agents that target the apoptotic pathway were shown to sensitize tumor cells to chemotherapy and radiotherapy.  Such therapies include small mol. inhibitors and antisense strategies that inhibit the activity of anti-apoptotic proteins, or treatment with recombinant pro-apoptotic proteins or antibodies that can activate the apoptotic pathway.  This review will discuss apoptosis and the mechanisms by which it can become dysregulated in human cancer.  In addn., novel therapeutic strategies that target key components of the apoptotic machinery will be discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkegczsL_lBrVg90H21EOLACvtfcHk0lhsrNx97qUEAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmslansLo%253D&md5=85b32e7e06a33942779c569f39f19252</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.2174%2F156800909788166547&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156800909788166547%26sid%3Dliteratum%253Aachs%26aulast%3DWilson%26aufirst%3DT.%2BR.%26aulast%3DJohnston%26aufirst%3DP.%2BG.%26aulast%3DLongley%26aufirst%3DD.%2BB.%26atitle%3DAnti-apoptotic%2520mechanisms%2520of%2520drug%2520resistance%2520in%2520cancer%26jtitle%3DCurr.%2520Cancer%2520Drug%2520Targets%26date%3D2009%26volume%3D9%26spage%3D307%26epage%3D319" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group">Bozec, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peyrade, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischel, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milano, G.</span><span> </span><span class="NLM_article-title">Emerging molecular targeted therapies in the treatment of head and neck cancer</span> <span class="citation_source-journal">Expert Opin. Emerg. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">299</span><span class="NLM_x">–</span> <span class="NLM_lpage">310</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Fjm200285z&amp;key=10.1517%2F14728210902997947" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Fjm200285z&amp;key=19519286" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Fjm200285z&amp;key=1%3ACAS%3A528%3ADC%252BD1MXnt1Shsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2009&pages=299-310&author=A.+Bozecauthor=F.+Peyradeauthor=J.+L.+Fischelauthor=G.+Milano&title=Emerging+molecular+targeted+therapies+in+the+treatment+of+head+and+neck+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Emerging molecular targeted therapies in the treatment of head and neck cancer</span></div><div class="casAuthors">Bozec, Alexandre; Peyrade, Frederic; Fischel, Jean-Louis; Milano, Gerard</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Emerging Drugs</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">299-310</span>CODEN:
                <span class="NLM_cas:coden">EOEDA3</span>;
        ISSN:<span class="NLM_cas:issn">1472-8214</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Current development of mol. targeted therapies in oncol. is particularly active.  The aim of this study is to review recent advances in the field of mol. targeted therapies for head and neck squamous cell carcinoma (HNSCC).  As EGFR signaling pathway and angiogenesis play a key role in the growth of HNSCC, EGFR with its downstream effectors and mol. factors implicated in the angiogenesis process, such as VEGF and its receptors, represent the main targets of the new therapeutic agents now in development.  Today, cetuximab, an anti-EGFR monoclonal antibody, is the only targeted therapy approved for the treatment of HNSCC in patients with locally advanced tumors, in assocn. with radiotherapy, and in patients with recurrent or metastatic diseases.  Future progress is expected with the integration of cetuximab into induction chemotherapeutic regimens or in assocn. with concurrent chemoradiotherapy for locally advanced tumors and with the development and evaluation of other mol. targeted therapies such as antiangiogenic drugs.  As these innovative mols. start to be used in clin. practice, the identification of predictive markers for efficacy and toxicity becomes a crucial issue.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8cIZqpAAUMLVg90H21EOLACvtfcHk0lgwn9mk7tw6xQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXnt1Shsr0%253D&md5=87f6d954b64df24539e38a2dc28400bb</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1517%2F14728210902997947&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14728210902997947%26sid%3Dliteratum%253Aachs%26aulast%3DBozec%26aufirst%3DA.%26aulast%3DPeyrade%26aufirst%3DF.%26aulast%3DFischel%26aufirst%3DJ.%2BL.%26aulast%3DMilano%26aufirst%3DG.%26atitle%3DEmerging%2520molecular%2520targeted%2520therapies%2520in%2520the%2520treatment%2520of%2520head%2520and%2520neck%2520cancer%26jtitle%3DExpert%2520Opin.%2520Emerg.%2520Drugs%26date%3D2009%26volume%3D14%26spage%3D299%26epage%3D310" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group">Han, S.; Roman, J.</span><span> </span><span class="NLM_article-title">Targeting apoptotic signaling pathways in human lung cancer</span>. Curr. Cancer Drug Targets<span class="NLM_x"> </span><span class="NLM_year">2010</span><span class="NLM_x">, </span>in press. </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Fjm200285z&amp;key=20482489" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=S.+Han&author=J.+Roman&title=Targeting+apoptotic+signaling+pathways+in+human+lung+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DHan%26aufirst%3DS.%26atitle%3DTargeting%2520apoptotic%2520signaling%2520pathways%2520in%2520human%2520lung%2520cancer%26jtitle%3DCurr.%2520Cancer%2520Drug%2520Targets%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group">Soengas, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lowe, S. W.</span><span> </span><span class="NLM_article-title">Apoptosis and melanoma chemoresistance</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">3138</span><span class="NLM_x">–</span> <span class="NLM_lpage">3151</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2003&pages=3138-3151&author=M.+S.+Soengasauthor=S.+W.+Lowe&title=Apoptosis+and+melanoma+chemoresistance"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSoengas%26aufirst%3DM.%2BS.%26aulast%3DLowe%26aufirst%3DS.%2BW.%26atitle%3DApoptosis%2520and%2520melanoma%2520chemoresistance%26jtitle%3DOncogene%26date%3D2003%26volume%3D22%26spage%3D3138%26epage%3D3151" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group">Wong, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lemoine, N. R.</span><span> </span><span class="NLM_article-title">Pancreatic cancer: molecular pathogenesis and new therapeutic targets</span> <span class="citation_source-journal">Nat. Rev. Gastroenterol. Hepatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">412</span><span class="NLM_x">–</span> <span class="NLM_lpage">422</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Fjm200285z&amp;key=10.1038%2Fnrgastro.2009.89" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Fjm200285z&amp;key=19506583" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Fjm200285z&amp;key=1%3ACAS%3A528%3ADC%252BD1MXot12ltLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2009&pages=412-422&author=H.+H.+Wongauthor=N.+R.+Lemoine&title=Pancreatic+cancer%3A+molecular+pathogenesis+and+new+therapeutic+targets"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Pancreatic cancer: molecular pathogenesis and new therapeutic targets</span></div><div class="casAuthors">Wong, Han H.; Lemoine, Nicholas R.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Gastroenterology & Hepatology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">412-422</span>CODEN:
                <span class="NLM_cas:coden">NRGHA9</span>;
        ISSN:<span class="NLM_cas:issn">1759-5045</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Pancreatic cancer is lethal and notoriously difficult to treat, therefore, there is an urgent need to develop new therapeutic and diagnostic modalities.  This Review discusses the agents that have been developed to target the pathways and processes involved in pancreatic tumorigenesis, and reviews the results of lab. and clin. trials of these agents.  Future therapeutic targets are also discussed.  Patients with pancreatic cancer normally present with advanced disease that is lethal and notoriously difficult to treat.  Survival has not improved dramatically despite routine use of chemotherapy and radiotherapy; this situation signifies an urgent need for novel therapeutic approaches.  Over the past decade, a large no. of studies have been published that aimed to target the mol. abnormalities implicated in pancreatic tumor growth, invasion, metastasis, angiogenesis and resistance to apoptosis.  This research is of particular importance, as data suggest that a large no. of genetic alterations affect only a few major signaling pathways and processes involved in pancreatic tumorigenesis.  Although lab. results of targeted therapies have been impressive, until now only erlotinib, an epidermal growth factor receptor tyrosine kinase inhibitor, has demonstrated modest survival benefit in combination with gemcitabine in a phase III clin. trial.  While the failures of targeted therapies in the clin. setting are discouraging, lessons have been learnt and new therapeutic targets that hold promise for the future management of the disease are continuously emerging.  This Review describes some of the important developments and targeted agents for pancreatic cancer that have been tested in clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpm5mtPxXGCSLVg90H21EOLACvtfcHk0lgwn9mk7tw6xQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXot12ltLo%253D&md5=61183be915ad65cab453c462f046d30d</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1038%2Fnrgastro.2009.89&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrgastro.2009.89%26sid%3Dliteratum%253Aachs%26aulast%3DWong%26aufirst%3DH.%2BH.%26aulast%3DLemoine%26aufirst%3DN.%2BR.%26atitle%3DPancreatic%2520cancer%253A%2520molecular%2520pathogenesis%2520and%2520new%2520therapeutic%2520targets%26jtitle%3DNat.%2520Rev.%2520Gastroenterol.%2520Hepatol.%26date%3D2009%26volume%3D6%26spage%3D412%26epage%3D422" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group">D’Amico, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harpole, D. H.,  Jr.</span><span> </span><span class="NLM_article-title">Molecular biology of esophageal cancer</span> <span class="citation_source-journal">Chest Surg. Clin. N. Am.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">451</span><span class="NLM_x">–</span> <span class="NLM_lpage">469</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Fjm200285z&amp;key=10967750" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Fjm200285z&amp;key=1%3ACAS%3A280%3ADC%252BD3M%252Fmt1CrsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2000&pages=451-469&author=T.+A.+D%E2%80%99Amicoauthor=D.+H.+Harpole&title=Molecular+biology+of+esophageal+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular biology of esophageal cancer</span></div><div class="casAuthors">D'Amico T A; Harpole D H Jr</div><div class="citationInfo"><span class="NLM_cas:title">Chest surgery clinics of North America</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">451-69</span>
        ISSN:<span class="NLM_cas:issn">1052-3359</span>.
    </div><div class="casAbstract">Several mechanisms of resistance to chemotherapy have been identified among the agents that are commonly used in the systemic treatment of patients with esophageal cancer: paclitaxel, platinum, and 5-FU.  A recent study from our laboratory evaluated the initial endoscopic biopsy material from patients who subsequently underwent trimodality therapy, including chemotherapy with cisplatin and 5-FU, radiation therapy, and surgery.  IHC analysis was performed on seven markers of chemotherapy or radiation therapy resistance: P-gp, GST-pi, MT (platinum inhibitors); EGF-R, TGF-alpha, erb-B2 (activation of cell growth cascade); and p53 (interferes with chemotherapy-induced apoptosis).  In this study, elevated expression of GST-pi and P-gp were associated with decreased survival and may be markers of treatment resistance.  Expression of erb-B2 was associated with enhanced survival and may be a marker of treatment sensitivity.  Assessment of the probability of chemoresistance of a particular tumor using the expression of molecular biologic markers may allow for the selection of a more favorable chemotherapeutic agent.  Furthermore, understanding the mechanisms of resistance, including the mechanisms of DNA repair, may provide insight into mechanisms to reverse or to inhibit resistance to chemotherapy.  DNA repair mechanisms are used by cells to protect themselves against mutagens and carcinogens.  DNA repair inhibitors may increase the mutagenicity associated with DNA damage and may prove to be an ineffective oncologic treatment strategy; however, the possibility exists that DNA repair inhibition may improve the efficacy of anticancer agents, and this should be tested.  The value of this strategy may be in allowing treatment doses to be decreased and lessening side effects while maintaining therapeutic efficacy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT2CsMTXq-wgNXdcedVHT5tfW6udTcc2eZ3l3GtQvgJorntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3M%252Fmt1CrsA%253D%253D&md5=9c0dddf3f5a7b976e6532ee7ff43de2f</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DD%25E2%2580%2599Amico%26aufirst%3DT.%2BA.%26aulast%3DHarpole%26aufirst%3DD.%2BH.%26atitle%3DMolecular%2520biology%2520of%2520esophageal%2520cancer%26jtitle%3DChest%2520Surg.%2520Clin.%2520N.%2520Am.%26date%3D2000%26volume%3D10%26spage%3D451%26epage%3D469" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group">Bruyère, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lonez, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duray, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cludts, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruysschaert, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saussez, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yeaton, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiss, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mijatovic, T.</span><span> </span><span class="NLM_article-title">Considering Temozolomide as a novel potential treatment for oesophageal cancer</span> <span class="citation_source-journal">Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">117</span><span class="NLM_x">, </span> <span class="NLM_fpage">2004</span><span class="NLM_x">–</span> <span class="NLM_lpage">2016</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=2011&pages=2004-2016&author=C.+Bruy%C3%A8reauthor=C.+Lonezauthor=A.+Durayauthor=S.+Cludtsauthor=J.+M.+Ruysschaertauthor=S.+Saussezauthor=P.+Yeatonauthor=R.+Kissauthor=T.+Mijatovic&title=Considering+Temozolomide+as+a+novel+potential+treatment+for+oesophageal+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBruy%25C3%25A8re%26aufirst%3DC.%26aulast%3DLonez%26aufirst%3DC.%26aulast%3DDuray%26aufirst%3DA.%26aulast%3DCludts%26aufirst%3DS.%26aulast%3DRuysschaert%26aufirst%3DJ.%2BM.%26aulast%3DSaussez%26aufirst%3DS.%26aulast%3DYeaton%26aufirst%3DP.%26aulast%3DKiss%26aufirst%3DR.%26aulast%3DMijatovic%26aufirst%3DT.%26atitle%3DConsidering%2520Temozolomide%2520as%2520a%2520novel%2520potential%2520treatment%2520for%2520oesophageal%2520cancer%26jtitle%3DCancer%26date%3D2011%26volume%3D117%26spage%3D2004%26epage%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group">Lefranc, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brotchi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiss, R.</span><span> </span><span class="NLM_article-title">Possible future issues in the treatment of glioblastomas, with a special emphasis on cell migration and the resistance of migrating glioblastoma cells to apoptosis</span> <span class="citation_source-journal">J. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">2411</span><span class="NLM_x">–</span> <span class="NLM_lpage">2422</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Fjm200285z&amp;key=10.1200%2FJCO.2005.03.089" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Fjm200285z&amp;key=15800333" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Fjm200285z&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjsVyhsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2005&pages=2411-2422&author=F.+Lefrancauthor=J.+Brotchiauthor=R.+Kiss&title=Possible+future+issues+in+the+treatment+of+glioblastomas%2C+with+a+special+emphasis+on+cell+migration+and+the+resistance+of+migrating+glioblastoma+cells+to+apoptosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Possible future issues in the treatment of glioblastomas: Special emphasis on cell migration and the resistance of migrating glioblastoma cells to apoptosis</span></div><div class="casAuthors">Lefranc, Florence; Brotchi, Jacques; Kiss, Robert</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Oncology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2411-2422</span>CODEN:
                <span class="NLM_cas:coden">JCONDN</span>;
        ISSN:<span class="NLM_cas:issn">0732-183X</span>.
    
            (<span class="NLM_cas:orgname">American Society of Clinical Oncology</span>)
        </div><div class="casAbstract">The present review aims to emphasize that malignant gliomas are characterized by the diffuse invasion of distant brain tissue by a myriad of single migrating cells that exhibit decreased levels of apoptosis (programmed cell death type I), thus a resistance to cytotoxic insult.  The present review surveys the mol. mechanisms of migration in malignant gliomas and potential issues arising from treatments, in addn. to relationships between glioma cell migration and resistance to apoptosis in terms of the mol. signaling pathways.  Clin. and exptl. data demonstrate that glioma cell migration is a complex combination of multiple mol. processes, including the alteration of tumor cell adhesion to a modified extracellular matrix, the secretion of proteases by the cells, and modifications to the actin cytoskeleton.  Intracellular signaling pathways involved in the acquisition of resistance to apoptosis by migrating glioma cells concern Pl3K, Akt, mTOR, NF-κB, and autophagy (programmed cell death type II).  A no. of signaling pathways can be constitutively activated in migrating glioma cells, thus rendering these cells resistant to cytotoxic insults.  However, these pathways are not all constitutively activated at the same time in any one glioma.  Particular inhibitors should therefore only be chosen if the target is present in the tumor tissue, but this is only possible if individual patients are submitted to the mol. profiling of their tumors before undergoing any treatment to combat their migratory glioma cells.  Specific antimigratory compds. should be added to conventional radio- and/or chemotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRxPKR4Wm5vbVg90H21EOLACvtfcHk0liBxiun3U3IDQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjsVyhsrY%253D&md5=9195f4ac3a7cccda1ca747dbb35f3023</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1200%2FJCO.2005.03.089&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2005.03.089%26sid%3Dliteratum%253Aachs%26aulast%3DLefranc%26aufirst%3DF.%26aulast%3DBrotchi%26aufirst%3DJ.%26aulast%3DKiss%26aufirst%3DR.%26atitle%3DPossible%2520future%2520issues%2520in%2520the%2520treatment%2520of%2520glioblastomas%252C%2520with%2520a%2520special%2520emphasis%2520on%2520cell%2520migration%2520and%2520the%2520resistance%2520of%2520migrating%2520glioblastoma%2520cells%2520to%2520apoptosis%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2005%26volume%3D23%26spage%3D2411%26epage%3D2422" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group">Landis-Piwowar, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milacic, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, T. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dou, Q. P.</span><span> </span><span class="NLM_article-title">The proteasome as a potential target for novel anticancer drugs and chemosensitizers</span> <span class="citation_source-journal">Drug Resist. Updates</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">263</span><span class="NLM_x">–</span> <span class="NLM_lpage">273</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Fjm200285z&amp;key=10.1016%2Fj.drup.2006.11.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Fjm200285z&amp;key=17197231" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Fjm200285z&amp;key=1%3ACAS%3A528%3ADC%252BD2sXislKhtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2006&pages=263-273&author=K.+R.+Landis-Piwowarauthor=V.+Milacicauthor=D.+Chenauthor=H.+Yangauthor=Y.+Zhaoauthor=T.+H.+Chanauthor=B.+Yanauthor=Q.+P.+Dou&title=The+proteasome+as+a+potential+target+for+novel+anticancer+drugs+and+chemosensitizers"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">The proteasome as a potential target for novel anticancer drugs and chemosensitizers</span></div><div class="casAuthors">Landis-Piwowar, Kristin R.; Milacic, Vesna; Chen, Di; Yang, Huanjie; Zhao, Yunfeng; Chan, Tak Hang; Yan, Bing; Dou, Q. Ping</div><div class="citationInfo"><span class="NLM_cas:title">Drug Resistance Updates</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">263-273</span>CODEN:
                <span class="NLM_cas:coden">DRUPFW</span>;
        ISSN:<span class="NLM_cas:issn">1368-7646</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  A major challenge in cancer therapy is tumor drug resistance.  To overcome it, it is essential to understand the mechanisms and identify the mols. involved, so that they can be specifically targeted in combination therapies.  The proteasome is such a validated target: it plays a key role in cancer cell proliferation, inhibition of chemotherapy-induced apoptosis and drug resistance development.  Bortezomib (Velcade, PS-341) was the first proteasome inhibitor to receive regulatory approval from the US Food and Drug Administration for the treatment of multiple myeloma.  Clin. combination trials have demonstrated a chemo-sensitizing effect of bortezomib on conventional agents in hematol. malignancies and some solid tumors such as androgen-independent prostate and ovarian cancer.  Although generally well-tolerated, bortezomib still generates toxicity which underscores the need for less toxic proteasome inhibitors.  Several naturally occurring products, such as green tea polyphenols and the antibiotic lactacystin, have been shown to be potent proteasome inhibitors.  Significantly, green tea polyphenols, as well as several flavonoids such as genistein, curcumin and resveratrol, have also been shown to have chemo-sensitizing properties in prostate, breast, hepatic, and lung tumors.  Further studies on natural proteasome inhibitors as chemo-sensitizers could lead to identification of more potent and less toxic compds. that could be used in combination therapies for drug-resistant tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGro3zJ4N37hC7Vg90H21EOLACvtfcHk0liBxiun3U3IDQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXislKhtr8%253D&md5=317f87f20a5293df3874ac19cbf81a04</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1016%2Fj.drup.2006.11.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drup.2006.11.001%26sid%3Dliteratum%253Aachs%26aulast%3DLandis-Piwowar%26aufirst%3DK.%2BR.%26aulast%3DMilacic%26aufirst%3DV.%26aulast%3DChen%26aufirst%3DD.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DChan%26aufirst%3DT.%2BH.%26aulast%3DYan%26aufirst%3DB.%26aulast%3DDou%26aufirst%3DQ.%2BP.%26atitle%3DThe%2520proteasome%2520as%2520a%2520potential%2520target%2520for%2520novel%2520anticancer%2520drugs%2520and%2520chemosensitizers%26jtitle%3DDrug%2520Resist.%2520Updates%26date%3D2006%26volume%3D9%26spage%3D263%26epage%3D273" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group">Guo, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, F.</span><span> </span><span class="NLM_article-title">Non-receptor tyrosine kinase Etk regulation of drug resistance in small-cell lung cancer</span> <span class="citation_source-journal">Eur. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">636</span><span class="NLM_x">–</span> <span class="NLM_lpage">641</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2010&pages=636-641&author=L.+Guoauthor=Y.+Zhouauthor=Y.+Sunauthor=F.+Zhang&title=Non-receptor+tyrosine+kinase+Etk+regulation+of+drug+resistance+in+small-cell+lung+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGuo%26aufirst%3DL.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DSun%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DF.%26atitle%3DNon-receptor%2520tyrosine%2520kinase%2520Etk%2520regulation%2520of%2520drug%2520resistance%2520in%2520small-cell%2520lung%2520cancer%26jtitle%3DEur.%2520J.%2520Cancer%26date%3D2010%26volume%3D46%26spage%3D636%26epage%3D641" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group">Chen, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dou, Q. P.</span><span> </span><span class="NLM_article-title">The ubiquitin-proteasome system as a prospective molecular target for cancer treatment and prevention</span> <span class="citation_source-journal">Curr. Protein Pept. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">459</span><span class="NLM_x">–</span> <span class="NLM_lpage">470</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Fjm200285z&amp;key=10.2174%2F138920310791824057" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Fjm200285z&amp;key=20491623" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Fjm200285z&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFersb7M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2010&pages=459-470&author=D.+Chenauthor=Q.+P.+Dou&title=The+ubiquitin-proteasome+system+as+a+prospective+molecular+target+for+cancer+treatment+and+prevention"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">The ubiquitin-proteasome system as a prospective molecular target for cancer treatment and prevention</span></div><div class="casAuthors">Chen, Di; Dou, Q. Ping</div><div class="citationInfo"><span class="NLM_cas:title">Current Protein and Peptide Science</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">459-470</span>CODEN:
                <span class="NLM_cas:coden">CPPSCM</span>;
        ISSN:<span class="NLM_cas:issn">1389-2037</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Proteasomes are large multicatalytic proteinase complexes located in the cytosol and the nucleus of eukaryotic cells.  The ubiquitin-proteasome system is responsible for the degrdn. of most intracellular proteins and therefore plays an essential regulatory role in crit. cellular processes including cell cycle progression, proliferation, differentiation, angiogenesis and apoptosis.  Besides involving in normal cellular functions and homeostasis, the alteration of proteasomal activity contributes to the pathol. states of several clin. disorders including inflammation, neurodegeneration and cancer.  It was reported that human cancer cells possess elevated level of proteasome activity and are more sensitive to proteasome inhibitors than normal cells, indicating that the inhibition of the ubiquitin-proteasome system could be used as a novel approach for cancer therapy.  In this review we summarize several specific aspects of research for the proteasome complex, including the structure and catalytic activities of the proteasome, properties and mechanisms of action of various proteasome inhibitors, and finally the clin. development of proteasome inhibitors as novel anticancer agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpHjveSFubzlrVg90H21EOLACvtfcHk0likXlwBztyUYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFersb7M&md5=ec916b485b1f5dd00ddadf74851d4f05</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.2174%2F138920310791824057&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138920310791824057%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DD.%26aulast%3DDou%26aufirst%3DQ.%2BP.%26atitle%3DThe%2520ubiquitin-proteasome%2520system%2520as%2520a%2520prospective%2520molecular%2520target%2520for%2520cancer%2520treatment%2520and%2520prevention%26jtitle%3DCurr.%2520Protein%2520Pept.%2520Sci.%26date%3D2010%26volume%3D11%26spage%3D459%26epage%3D470" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group">Tsukamoto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yokosawa, H.</span><span> </span><span class="NLM_article-title">Targeting the proteasome pathway</span> <span class="citation_source-journal">Expert Opin. Ther. Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">605</span><span class="NLM_x">–</span> <span class="NLM_lpage">621</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Fjm200285z&amp;key=10.1517%2F14728220902866851" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Fjm200285z&amp;key=19397479" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Fjm200285z&amp;key=1%3ACAS%3A528%3ADC%252BD1MXltVOmur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2009&pages=605-621&author=S.+Tsukamotoauthor=H.+Yokosawa&title=Targeting+the+proteasome+pathway"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the proteasome pathway</span></div><div class="casAuthors">Tsukamoto, Sachiko; Yokosawa, Hideyoshi</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Targets</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">605-621</span>CODEN:
                <span class="NLM_cas:coden">EOTTAO</span>;
        ISSN:<span class="NLM_cas:issn">1472-8222</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  The ubiquitin-proteasome pathway functions as a main pathway in intracellular protein degrdn. and plays a vital role in almost all cellular events.  Various inhibitors of this pathway have been developed for research purposes.  The recent approval of bortezomib (PS-341, Velcade), a proteasome inhibitor, for the treatment of multiple myeloma has opened the way to the discovery of drugs targeting the proteasome and other components of the ubiquitin-proteasome pathway.  We review the current understanding of the ubiquitin-proteasome pathway and inhibitors targeting this pathway, including proteasome inhibitors, as candidate drugs for chem. therapy.  Preclin. and clin. data for inhibitors of the proteasome and the ubiquitin-proteasome pathway are discussed.  The proteasome and other members in the ubiquitin-proteasome pathway have emerged as novel therapeutic targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqXJnen4u4mJ7Vg90H21EOLACvtfcHk0likXlwBztyUYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXltVOmur8%253D&md5=d7edb1be8977c72779cc49e1d96331db</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1517%2F14728220902866851&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14728220902866851%26sid%3Dliteratum%253Aachs%26aulast%3DTsukamoto%26aufirst%3DS.%26aulast%3DYokosawa%26aufirst%3DH.%26atitle%3DTargeting%2520the%2520proteasome%2520pathway%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Targets%26date%3D2009%26volume%3D13%26spage%3D605%26epage%3D621" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit70"><span><span class="NLM_contrib-group">Liggett, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crawford, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morris, T. C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Irvine, A. E.</span><span> </span><span class="NLM_article-title">Methods for measuring proteasome activity: Current limitations and future developments</span> <span class="citation_source-journal">Leukemia Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">1403</span><span class="NLM_x">–</span> <span class="NLM_lpage">1409</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Fjm200285z&amp;key=10.1016%2Fj.leukres.2010.07.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=8&amp;doi=10.1021%2Fjm200285z&amp;key=20674016" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Fjm200285z&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht1Wmur%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2010&pages=1403-1409&author=A.+Liggettauthor=L.+J.+Crawfordauthor=B.+Walkerauthor=T.+C.+M.+Morrisauthor=A.+E.+Irvine&title=Methods+for+measuring+proteasome+activity%3A+Current+limitations+and+future+developments"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Methods for measuring proteasome activity: Current limitations and future developments</span></div><div class="casAuthors">Liggett, A.; Crawford, L. J.; Walker, B.; Morris, T. C. M.; Irvine, A. E.</div><div class="citationInfo"><span class="NLM_cas:title">Leukemia Research</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1403-1409</span>CODEN:
                <span class="NLM_cas:coden">LEREDD</span>;
        ISSN:<span class="NLM_cas:issn">0145-2126</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  The proteasome has been validated as a therapeutic target, with proteasome inhibitors showing particular efficacy in the treatment of Multiple Myeloma.  A wide range of methods have been developed to profile proteasome activity.  These include the current method of choice fluorogenic peptide substrates, as well as bioluminescent imaging, immunol. methods, and more recently, site-specific fluorescent probes.  The aim of this review is to evaluate the currently available methods for profiling proteasome activity and their suitability for use in translational studies.  Ongoing development of techniques for profiling proteasome activity will facilitate future research into proteasome-related pathologies, thus accelerating the development of more specific drug regimes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqzuhH0FrpTkbVg90H21EOLACvtfcHk0likXlwBztyUYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht1Wmur%252FL&md5=4cdabb18f5523be9c90be9596cbd932b</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1016%2Fj.leukres.2010.07.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.leukres.2010.07.003%26sid%3Dliteratum%253Aachs%26aulast%3DLiggett%26aufirst%3DA.%26aulast%3DCrawford%26aufirst%3DL.%2BJ.%26aulast%3DWalker%26aufirst%3DB.%26aulast%3DMorris%26aufirst%3DT.%2BC.%2BM.%26aulast%3DIrvine%26aufirst%3DA.%2BE.%26atitle%3DMethods%2520for%2520measuring%2520proteasome%2520activity%253A%2520Current%2520limitations%2520and%2520future%2520developments%26jtitle%3DLeukemia%2520Res.%26date%3D2010%26volume%3D34%26spage%3D1403%26epage%3D1409" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref71"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref71'); return false;" data-citation="" class="refNumLink">71</a></strong><div class="NLM_citation" id="cit71"><span><span class="NLM_contrib-group">Lefranc, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Facchini, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiss, R.</span><span> </span><span class="NLM_article-title">Pro-autophagic drugs: A novel means to combat apoptosis-resistant cancers, with a special emphasis on glioblastomas</span> <span class="citation_source-journal">Oncologist</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">1395</span><span class="NLM_x">–</span> <span class="NLM_lpage">1403</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2007&pages=1395-1403&author=F.+Lefrancauthor=V.+Facchiniauthor=R.+Kiss&title=Pro-autophagic+drugs%3A+A+novel+means+to+combat+apoptosis-resistant+cancers%2C+with+a+special+emphasis+on+glioblastomas"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLefranc%26aufirst%3DF.%26aulast%3DFacchini%26aufirst%3DV.%26aulast%3DKiss%26aufirst%3DR.%26atitle%3DPro-autophagic%2520drugs%253A%2520A%2520novel%2520means%2520to%2520combat%2520apoptosis-resistant%2520cancers%252C%2520with%2520a%2520special%2520emphasis%2520on%2520glioblastomas%26jtitle%3DOncologist%26date%3D2007%26volume%3D12%26spage%3D1395%26epage%3D1403" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref72"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref72'); return false;" data-citation="" class="refNumLink">72</a></strong><div class="NLM_citation" id="cit72"><span><span class="NLM_contrib-group">Wu, W. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cho, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, K</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, D</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, J</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sung, J. J.</span><span> </span><span class="NLM_article-title">Proteasome inhibition: a new therapeutic strategy to cancer treatment</span> <span class="citation_source-journal">Cancer Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">293</span><span class="NLM_x">, </span> <span class="NLM_fpage">15</span><span class="NLM_x">–</span> <span class="NLM_lpage">22</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Fjm200285z&amp;key=10.1016%2Fj.canlet.2009.12.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=8&amp;doi=10.1021%2Fjm200285z&amp;key=20133049" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Fjm200285z&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlsVyitr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=293&publication_year=2010&pages=15-22&author=W.+K.+Wuauthor=C.+H.+Choauthor=C.+W.+Leeauthor=K+Wuauthor=D+Fanauthor=J+Yuauthor=J.+J.+Sung&title=Proteasome+inhibition%3A+a+new+therapeutic+strategy+to+cancer+treatment"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">Proteasome inhibition: A new therapeutic strategy to cancer treatment</span></div><div class="casAuthors">Wu, William Ka Kei; Cho, Chi Hin; Lee, Chung Wa; Wu, Kaichun; Fan, Daiming; Yu, Jun; Sung, Joseph Jao Yiu</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (Shannon, Ireland)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">293</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">15-22</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ireland Ltd.</span>)
        </div><div class="casAbstract">A review.  The ubiquitin-proteasome system is a major pathway for protein degrdn.  Targeting this pathway using proteasome inhibitors represents a novel approach for the treatment of cancer.  Proteasome inhibitors lower cell proliferation and induce apoptosis in solid and hematol. malignancies through multiple mechanisms, including stabilization of cell cycle regulators and pro-apoptotic factors, stimulation of bone morphogenetic protein signaling, inhibition of protein translation, and sensitization to ligand-induced apoptosis.  In this connection, proteasome inhibition activates macroautophagy, a compensatory protein degrdn. system, as well as other pro-survival signaling pathways.  Inhibition of these auto-protective responses sensitizes cancer cells to the anti-proliferative effects of proteasome inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpjYIKgkj-1yLVg90H21EOLACvtfcHk0lgdoRZeVMAY5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlsVyitr0%253D&md5=368256b32ef5255102f8b7ce641c871a</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1016%2Fj.canlet.2009.12.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.canlet.2009.12.002%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DW.%2BK.%26aulast%3DCho%26aufirst%3DC.%2BH.%26aulast%3DLee%26aufirst%3DC.%2BW.%26aulast%3DWu%26aufirst%3DK%26aulast%3DFan%26aufirst%3DD%26aulast%3DYu%26aufirst%3DJ%26aulast%3DSung%26aufirst%3DJ.%2BJ.%26atitle%3DProteasome%2520inhibition%253A%2520a%2520new%2520therapeutic%2520strategy%2520to%2520cancer%2520treatment%26jtitle%3DCancer%2520Lett.%26date%3D2010%26volume%3D293%26spage%3D15%26epage%3D22" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref73"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref73'); return false;" data-citation="" class="refNumLink">73</a></strong><div class="NLM_citation" id="cit73"><span><span class="NLM_contrib-group">Richardson, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barlogie, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berenson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singhal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jagannath, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Irwin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rajkumar, S. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Srkalovic, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alsina, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alexanian, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siegel, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orlowski, R. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuter, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Limentani, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hideshima, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Esseltine, D.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kauffman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schenkein, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, K. C.</span><span> </span><span class="NLM_article-title">A phase 2 study of bortezomib in relapsed, refractory myeloma</span> <span class="citation_source-journal">New Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">348</span><span class="NLM_x">, </span> <span class="NLM_fpage">2609</span><span class="NLM_x">–</span> <span class="NLM_lpage">2617</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Fjm200285z&amp;key=10.1056%2FNEJMoa030288" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=8&amp;doi=10.1021%2Fjm200285z&amp;key=12826635" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Fjm200285z&amp;key=1%3ACAS%3A528%3ADC%252BD3sXkvVSksLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=348&publication_year=2003&pages=2609-2617&author=P.+G.+Richardsonauthor=B.+Barlogieauthor=J.+Berensonauthor=S.+Singhalauthor=S.+Jagannathauthor=D.+Irwinauthor=S.+V.+Rajkumarauthor=G.+Srkalovicauthor=M.+Alsinaauthor=R.+Alexanianauthor=D.+Siegelauthor=R.+Z.+Orlowskiauthor=D.+Kuterauthor=S.+A.+Limentaniauthor=S.+Leeauthor=T.+Hideshimaauthor=D.-L.+Esseltineauthor=M.+Kauffmanauthor=J.+Adamsauthor=D.+P.+Schenkeinauthor=K.+C.+Anderson&title=A+phase+2+study+of+bortezomib+in+relapsed%2C+refractory+myeloma"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">A phase 2 study of bortezomib in relapsed, refractory myeloma</span></div><div class="casAuthors">Richardson, Paul G.; Barlogie, Bart; Berenson, James; Singhal, Seema; Jagannath, Sundar; Irwin, David; Rajkumar, S. Vincent; Srkalovic, Gordan; Alsina, Melissa; Alexanian, Raymond; Siegel, David; Orlowski, Robert Z.; Kuter, David; Limentani, Steven A.; Lee, Stephanie; Hideshima, Teru; Esseltine, Dixie-Lee; Kauffman, Michael; Adams, Julian; Schenkein, David P.; Anderson, Kenneth C.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">348</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">2609-2617</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Background: Bortezomib, a boronic acid dipeptide, is a novel proteasome inhibitor that has been shown in preclin. and phase 1 studies to have antimyeloma activity.  Methods: In this multicenter, open-label, nonrandomized, phase 2 trial, we enrolled 202 patients with relapsed myeloma that was refractory to the therapy they had received most recently.  Patients received 1.3 mg of bortezomib per square meter of body-surface area twice weekly for 2 wk, followed by 1 wk without treatment, for up to eight cycles (24 wk).  In patients with a suboptimal response, oral dexamethasone (20 mg daily, on the day of and the day after bortezomib administration) was added to the regimen.  The response was evaluated according to the criteria of the European Group for Blood and Marrow Transplantation and confirmed by an independent review committee.  Results: Of 193 patients who could be evaluated, 92 % had been treated with three or more of the major classes of agents for myeloma, and in 91 %, the myeloma was refractory to the therapy received most recently.  The rate of response to bortezomib was 35 %, and those with a response included 7 patients in whom myeloma protein became undetectable and 12 in whom myeloma protein was detectable only by immunofixation.  The median overall survival was 16 mo, with a median duration of response of 12 mo.  Grade 3 adverse events included thrombocytopenia (in 28 % of patients), fatigue (in 12 %), peripheral neuropathy (in 12 %), and neutropenia (in 11 %).  Grade 4 events occurred in 14 % of patients.  Conclusions: Bortezomib, a member of a new class of anticancer drugs, is active in patients with relapsed multiple myeloma that is refractory to conventional chemotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqrvlvB12o1xbVg90H21EOLACvtfcHk0lgdoRZeVMAY5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXkvVSksLs%253D&md5=7d7ef72077f270a421a538557b3bf9ca</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa030288&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa030288%26sid%3Dliteratum%253Aachs%26aulast%3DRichardson%26aufirst%3DP.%2BG.%26aulast%3DBarlogie%26aufirst%3DB.%26aulast%3DBerenson%26aufirst%3DJ.%26aulast%3DSinghal%26aufirst%3DS.%26aulast%3DJagannath%26aufirst%3DS.%26aulast%3DIrwin%26aufirst%3DD.%26aulast%3DRajkumar%26aufirst%3DS.%2BV.%26aulast%3DSrkalovic%26aufirst%3DG.%26aulast%3DAlsina%26aufirst%3DM.%26aulast%3DAlexanian%26aufirst%3DR.%26aulast%3DSiegel%26aufirst%3DD.%26aulast%3DOrlowski%26aufirst%3DR.%2BZ.%26aulast%3DKuter%26aufirst%3DD.%26aulast%3DLimentani%26aufirst%3DS.%2BA.%26aulast%3DLee%26aufirst%3DS.%26aulast%3DHideshima%26aufirst%3DT.%26aulast%3DEsseltine%26aufirst%3DD.-L.%26aulast%3DKauffman%26aufirst%3DM.%26aulast%3DAdams%26aufirst%3DJ.%26aulast%3DSchenkein%26aufirst%3DD.%2BP.%26aulast%3DAnderson%26aufirst%3DK.%2BC.%26atitle%3DA%2520phase%25202%2520study%2520of%2520bortezomib%2520in%2520relapsed%252C%2520refractory%2520myeloma%26jtitle%3DNew%2520Engl.%2520J.%2520Med.%26date%3D2003%26volume%3D348%26spage%3D2609%26epage%3D2617" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref74"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref74'); return false;" data-citation="" class="refNumLink">74</a></strong><div class="NLM_citation" id="cit74"><span><span class="NLM_contrib-group">Richardson, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Briemberg, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jagannath, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wen, P. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barlogie, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berenson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singhal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siegel, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Irwin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schuster, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Srkalovic, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alexanian, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rajkumar, S. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Limentani, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alsina, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orlowski, R. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Najarian, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Esseltine, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amato, A. A.</span><span> </span><span class="NLM_article-title">Frequency, characteristics, and reversibility of peripheral neuropathy during treatment of advanced multiple myeloma with bortezomib</span> <span class="citation_source-journal">J. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">3113</span><span class="NLM_x">–</span> <span class="NLM_lpage">3120</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Fjm200285z&amp;key=10.1200%2FJCO.2005.04.7779" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=8&amp;doi=10.1021%2Fjm200285z&amp;key=16754936" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Fjm200285z&amp;key=1%3ACAS%3A528%3ADC%252BD28XnslKhs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2006&pages=3113-3120&author=P.+G.+Richardsonauthor=H.+Briembergauthor=S.+Jagannathauthor=P.+Y.+Wenauthor=B.+Barlogieauthor=J.+Berensonauthor=S.+Singhalauthor=D.+S.+Siegelauthor=D.+Irwinauthor=M.+Schusterauthor=G.+Srkalovicauthor=R.+Alexanianauthor=S.+V.+Rajkumarauthor=S.+Limentaniauthor=M.+Alsinaauthor=R.+Z.+Orlowskiauthor=K.+Najarianauthor=D.+Esseltineauthor=K.+C.+Andersonauthor=A.+A.+Amato&title=Frequency%2C+characteristics%2C+and+reversibility+of+peripheral+neuropathy+during+treatment+of+advanced+multiple+myeloma+with+bortezomib"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">Frequency, characteristics, and reversibility of peripheral neuropathy during treatment of advanced multiple myeloma with bortezomib</span></div><div class="casAuthors">Richardson, Paul G.; Briemberg, Hannah; Jagannath, Sundar; Wen, Patrick Y.; Barlogie, Bart; Berenson, James; Singhal, Seema; Siegel, David S.; Irwin, David; Schuster, Michael; Srkalovic, Gordan; Alexanian, Raymond; Rajkumar, S. Vincent; Limentani, Steven; Alsina, Melissa; Orlowski, Robert Z.; Najarian, Kevin; Esseltine, Dixie; Anderson, Kenneth C.; Amato, Anthony A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Oncology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">3113-3120</span>CODEN:
                <span class="NLM_cas:coden">JCONDN</span>;
        ISSN:<span class="NLM_cas:issn">0732-183X</span>.
    
            (<span class="NLM_cas:orgname">American Society of Clinical Oncology</span>)
        </div><div class="casAbstract">Purpose: To det. the frequency, characteristics, and reversibility of peripheral neuropathy from bortezomib treatment of advanced multiple myeloma.  Patients and Methods: Peripheral neuropathy was assessed in two phase II studies in 256 patients with relapsed and/or refractory myeloma treated with bortezomib 1.0 or 1.3 mg/m2 i.v. bolus on days 1, 4, 8, and 11, every 21 days, for up to eight cycles.  Peripheral neuropathy was evaluated at baseline, during the study, and after the study by patient-reported symptoms using the Functional Assessment of Cancer Therapy Scale/Gynecol. Oncol. Group-Neurotoxicity (FACT/GOG-Ntx) questionnaire and neurol. examn.  During the study, peripheral neuropathy was also evaluated by investigator assessment.  A subset of patients underwent nerve conduction studies (n = 13).  Results: Before treatment, 194 (81%) of 239 patients had peripheral neuropathy by FACT/GOG-Ntx questionnaire, and 203 (83%) of 244 patients had peripheral neuropathy by neurol. examn.  Treatment-emergent neuropathy was reported in 35% of patients, including 37% (84 of 228 patients) receiving bortezomib 1.3 mg/m2 and 21% (six of 28 patients) receiving bortezomib 1.0 mg/m2.  Grade 1 or 2, 3, and 4 neuropathy occurred in 22%, 13%, and 0.4% of patients, resp.  The incidence of grade ≥ 3 neuropathy was higher among patients with baseline neuropathy by FACT/GOG-Ntx questionnaire compared with patients without baseline neuropathy (14% v 4%, resp.).  In all 256 patients, neuropathy led to dose redn. in 12% and discontinuation in 5%.  Of 35 patients with neuropathy ≥ grade 3 and/or requiring discontinuation, resoln. to baseline or improvement occurred in 71 %.  Conclusion: Bortezomib-assocd. peripheral neuropathy seemed reversible in the majority of patients after dose redn. or discontinuation.  Although severe neuropathy was more frequent in the presence of baseline neuropathy, the overall occurrence was independent of baseline neuropathy or type of prior therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5Y4e2anJT-bVg90H21EOLACvtfcHk0lgdoRZeVMAY5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XnslKhs7c%253D&md5=f2573ccd3f43fad31ad2f0bb8592a82b</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1200%2FJCO.2005.04.7779&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2005.04.7779%26sid%3Dliteratum%253Aachs%26aulast%3DRichardson%26aufirst%3DP.%2BG.%26aulast%3DBriemberg%26aufirst%3DH.%26aulast%3DJagannath%26aufirst%3DS.%26aulast%3DWen%26aufirst%3DP.%2BY.%26aulast%3DBarlogie%26aufirst%3DB.%26aulast%3DBerenson%26aufirst%3DJ.%26aulast%3DSinghal%26aufirst%3DS.%26aulast%3DSiegel%26aufirst%3DD.%2BS.%26aulast%3DIrwin%26aufirst%3DD.%26aulast%3DSchuster%26aufirst%3DM.%26aulast%3DSrkalovic%26aufirst%3DG.%26aulast%3DAlexanian%26aufirst%3DR.%26aulast%3DRajkumar%26aufirst%3DS.%2BV.%26aulast%3DLimentani%26aufirst%3DS.%26aulast%3DAlsina%26aufirst%3DM.%26aulast%3DOrlowski%26aufirst%3DR.%2BZ.%26aulast%3DNajarian%26aufirst%3DK.%26aulast%3DEsseltine%26aufirst%3DD.%26aulast%3DAnderson%26aufirst%3DK.%2BC.%26aulast%3DAmato%26aufirst%3DA.%2BA.%26atitle%3DFrequency%252C%2520characteristics%252C%2520and%2520reversibility%2520of%2520peripheral%2520neuropathy%2520during%2520treatment%2520of%2520advanced%2520multiple%2520myeloma%2520with%2520bortezomib%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2006%26volume%3D24%26spage%3D3113%26epage%3D3120" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref75"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref75'); return false;" data-citation="" class="refNumLink">75</a></strong><div class="NLM_citation" id="cit75"><span><span class="NLM_contrib-group">Lonial, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waller, E. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richardson, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jagannath, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orlowski, R. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giver, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jaye, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Francis, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giusti, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torre, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barlogie, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berenson, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sunghal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schenkein, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Esseltine, D. L. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heffner, L. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, K. C.</span><span> </span><span class="NLM_article-title">Risk factors and kinetics of thrombocytopenia associated with bortezomib for relapsed, refractory multiple myeloma</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">106</span><span class="NLM_x">, </span> <span class="NLM_fpage">3777</span><span class="NLM_x">–</span> <span class="NLM_lpage">3784</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2005&pages=3777-3784&author=S.+Lonialauthor=E.+K.+Wallerauthor=P.+G.+Richardsonauthor=S.+Jagannathauthor=R.+Z.+Orlowskiauthor=C.+R.+Giverauthor=D.+L.+Jayeauthor=D.+Francisauthor=S.+Giustiauthor=C.+Torreauthor=B.+Barlogieauthor=J.+R.+Berensonauthor=S.+Sunghalauthor=D.+P.+Schenkeinauthor=D.+L.+W.+Esseltineauthor=J.+Andersonauthor=H.+Xiaoauthor=L.+T.+Heffnerauthor=K.+C.+Anderson&title=Risk+factors+and+kinetics+of+thrombocytopenia+associated+with+bortezomib+for+relapsed%2C+refractory+multiple+myeloma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLonial%26aufirst%3DS.%26aulast%3DWaller%26aufirst%3DE.%2BK.%26aulast%3DRichardson%26aufirst%3DP.%2BG.%26aulast%3DJagannath%26aufirst%3DS.%26aulast%3DOrlowski%26aufirst%3DR.%2BZ.%26aulast%3DGiver%26aufirst%3DC.%2BR.%26aulast%3DJaye%26aufirst%3DD.%2BL.%26aulast%3DFrancis%26aufirst%3DD.%26aulast%3DGiusti%26aufirst%3DS.%26aulast%3DTorre%26aufirst%3DC.%26aulast%3DBarlogie%26aufirst%3DB.%26aulast%3DBerenson%26aufirst%3DJ.%2BR.%26aulast%3DSunghal%26aufirst%3DS.%26aulast%3DSchenkein%26aufirst%3DD.%2BP.%26aulast%3DEsseltine%26aufirst%3DD.%2BL.%2BW.%26aulast%3DAnderson%26aufirst%3DJ.%26aulast%3DXiao%26aufirst%3DH.%26aulast%3DHeffner%26aufirst%3DL.%2BT.%26aulast%3DAnderson%26aufirst%3DK.%2BC.%26atitle%3DRisk%2520factors%2520and%2520kinetics%2520of%2520thrombocytopenia%2520associated%2520with%2520bortezomib%2520for%2520relapsed%252C%2520refractory%2520multiple%2520myeloma%26jtitle%3DBlood%26date%3D2005%26volume%3D106%26spage%3D3777%26epage%3D3784" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref76"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref76'); return false;" data-citation="" class="refNumLink">76</a></strong><div class="NLM_citation" id="cit76"><span><span class="NLM_contrib-group">Blanquicett, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hart, C. M.</span><span> </span><span class="NLM_article-title">Thiazolidinediones as anti-cancer agents</span> <span class="citation_source-journal">Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">25</span><span class="NLM_x">–</span> <span class="NLM_lpage">34</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=8&amp;doi=10.1021%2Fjm200285z&amp;key=19079765" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Fjm200285z&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1KgsbfL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2008&pages=25-34&author=C.+Blanquicettauthor=J.+Romanauthor=C.+M.+Hart&title=Thiazolidinediones+as+anti-cancer+agents"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">Thiazolidinediones as anti-cancer agents</span></div><div class="casAuthors">Blanquicett, Carmelo; Roman, Jesse; Hart, C. Michael</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Therapy</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">25-34</span>CODEN:
                <span class="NLM_cas:coden">CTAHDB</span>;
        ISSN:<span class="NLM_cas:issn">1543-9143</span>.
    
            (<span class="NLM_cas:orgname">Gene Therapy Press</span>)
        </div><div class="casAbstract">A review.  The PPAR-gamma (PPAR-γ) activating thiazolidinedione (TZD) medications are a class of drugs used to improve lipid and glucose metab. in type-2 diabetes.  In addn. to their known insulin sensitization action, these drugs have been shown to suppress tumor development in several in vitro and in vivo models.  Among the proposed mechanisms for the anti-tumor effects of TZDs, apoptosis induction, cell cycle arrest, and differentiation have been extensively reported.  Interestingly, some of the obsd. anti-tumor effects are independent of PPAR-γ activation.  The following review will discuss studies employing TZDs as anti-cancer therapies for the most common types of cancers including, lung, breast, and colon and will explore the principal PPAR-γ-dependent and -independent mechanisms by which TZDs exert their anti-tumor effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCy2AgDJmXyLVg90H21EOLACvtfcHk0lh7xWPDdgA2Ig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1KgsbfL&md5=743f7e1d400d699f7712934b8e618fbf</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBlanquicett%26aufirst%3DC.%26aulast%3DRoman%26aufirst%3DJ.%26aulast%3DHart%26aufirst%3DC.%2BM.%26atitle%3DThiazolidinediones%2520as%2520anti-cancer%2520agents%26jtitle%3DCancer%2520Ther.%26date%3D2008%26volume%3D6%26spage%3D25%26epage%3D34" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref77"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref77'); return false;" data-citation="" class="refNumLink">77</a></strong><div class="NLM_citation" id="cit77"><span><span class="NLM_contrib-group">He, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zuo, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, B. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lei, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rastegar, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deng, Z. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luu, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haydon, R. C.</span><span> </span><span class="NLM_article-title">Synergistic antitumor effect of the activated PPARgamma and retinoid recptors on human osteosarcoma</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">2235</span><span class="NLM_x">–</span> <span class="NLM_lpage">2245</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Fjm200285z&amp;key=10.1158%2F1078-0432.CCR-09-2499" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=8&amp;doi=10.1021%2Fjm200285z&amp;key=20371684" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Fjm200285z&amp;key=1%3ACAS%3A528%3ADC%252BC3cXkslSmtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2010&pages=2235-2245&author=B.+C.+Heauthor=L.+Chenauthor=G.+W.+Zuoauthor=W.+Zhangauthor=Y.+Biauthor=J.+Huangauthor=Y.+Wangauthor=W.+Jiangauthor=Q.+Luoauthor=Q.+Shiauthor=B.+Q.+Zhangauthor=B.+Liuauthor=X.+Leiauthor=J.+Luoauthor=X.+Luoauthor=E.+R.+Wagnerauthor=S.+H.+Kimauthor=C.+J.+Heauthor=Y.+Huauthor=J.+Shenauthor=Q.+Zhouauthor=F.+Rastegarauthor=Z.+L.+Dengauthor=H.+H.+Luuauthor=T.+C.+Heauthor=R.+C.+Haydon&title=Synergistic+antitumor+effect+of+the+activated+PPARgamma+and+retinoid+recptors+on+human+osteosarcoma"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">Synergistic Antitumor Effect of the Activated PPARγ and Retinoid Receptors on Human Osteosarcoma</span></div><div class="casAuthors">He, Bai-Cheng; Chen, Liang; Zuo, Guo-Wei; Zhang, Wenli; Bi, Yang; Huang, Jiayi; Wang, Yi; Jiang, Wei; Luo, Qing; Shi, Qiong; Zhang, Bing-Qiang; Liu, Bo; Lei, Xia; Luo, Jinyong; Luo, Xiaoji; Wagner, Eric R.; Kim, Stephanie H.; He, Connie J.; Hu, Yawen; Shen, Jikun; Zhou, Qixin; Rastegar, Farbod; Deng, Zhong-Liang; Luu, Hue H.; He, Tong-Chuan; Haydon, Rex C.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2235-2245</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">PURPOSE: Osteosarcoma is the most common primary malignancy of bone.  The long-term survival of osteosarcoma patients hinges on our ability to prevent and/or treat recurrent and metastatic lesions.  Here, we investigated the activation of peroxisome proliferator-activated receptor γ (PPARγ) and retinoid receptors as a means of differentiation therapy for human osteosarcoma.  Exptl. Design: We examd. the endogenous expression of PPARγ and retinoid receptors in a panel of osteosarcoma cells.  Ligands or adenovirus-mediated overexpression of these receptors were tested to inhibit proliferation and induce apoptosis of osteosarcoma cells.  Osteosarcoma cells overexpressing the receptors were introduced into an orthotopic tumor model.  The effect of these ligands on osteoblastic differentiation was further investigated.  RESULTS: Endogenous expression of PPARγ and isotypes of retinoic acid receptor (RAR) and retinoid X receptor (RXR) is detected in most osteosarcoma cells.  Troglitazone, 9-cis retinoic acid (RA), and all-trans RA, as well as overexpression of PPARγ, RARα, and RXRα, inhibit osteosarcoma cell proliferation and induce apoptosis.  A synergistic inhibitory effect on osteosarcoma cell proliferation is obsd. between troglitazone and retinoids, as well as with the overexpression pairs of PPARγ/RARα, or PPARγ/RXRα.  Overexpression of PPARγ, RARα, RXRα, or in combinations inhibits osteosarcoma tumor growth and cell proliferation in vivo.  Retinoids (and to a lesser extent, troglitazone) are shown to promote osteogenic differentiation of osteosarcoma cells and mesenchymal stem cells.  CONCLUSIONS: Activation of PPARγ, RARα, and RXRα may act synergistically on inhibiting osteosarcoma cell proliferation and tumor growth, which is at least partially mediated by promoting osteoblastic differentiation of osteosarcoma cells.  Clin Cancer Res; 16(8); 2235-45.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBTaI2YHJNArVg90H21EOLACvtfcHk0lh7xWPDdgA2Ig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXkslSmtbs%253D&md5=71632e7a8c14faa697c822f84bcfd8f8</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-09-2499&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-09-2499%26sid%3Dliteratum%253Aachs%26aulast%3DHe%26aufirst%3DB.%2BC.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DZuo%26aufirst%3DG.%2BW.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DBi%26aufirst%3DY.%26aulast%3DHuang%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DJiang%26aufirst%3DW.%26aulast%3DLuo%26aufirst%3DQ.%26aulast%3DShi%26aufirst%3DQ.%26aulast%3DZhang%26aufirst%3DB.%2BQ.%26aulast%3DLiu%26aufirst%3DB.%26aulast%3DLei%26aufirst%3DX.%26aulast%3DLuo%26aufirst%3DJ.%26aulast%3DLuo%26aufirst%3DX.%26aulast%3DWagner%26aufirst%3DE.%2BR.%26aulast%3DKim%26aufirst%3DS.%2BH.%26aulast%3DHe%26aufirst%3DC.%2BJ.%26aulast%3DHu%26aufirst%3DY.%26aulast%3DShen%26aufirst%3DJ.%26aulast%3DZhou%26aufirst%3DQ.%26aulast%3DRastegar%26aufirst%3DF.%26aulast%3DDeng%26aufirst%3DZ.%2BL.%26aulast%3DLuu%26aufirst%3DH.%2BH.%26aulast%3DHe%26aufirst%3DT.%2BC.%26aulast%3DHaydon%26aufirst%3DR.%2BC.%26atitle%3DSynergistic%2520antitumor%2520effect%2520of%2520the%2520activated%2520PPARgamma%2520and%2520retinoid%2520recptors%2520on%2520human%2520osteosarcoma%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2010%26volume%3D16%26spage%3D2235%26epage%3D2245" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref78"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref78'); return false;" data-citation="" class="refNumLink">78</a></strong><div class="NLM_citation" id="cit78"><span><span class="NLM_contrib-group">Lee, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cho, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoon, D. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heo, Y. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, Y.</span><span> </span><span class="NLM_article-title">Cytotoxic flavonoids as agonists of peroxysome proliferator-activated receptor gamma on human cervical and prostate cancer cells</span> <span class="citation_source-journal">J. Nat. Prod.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">73</span><span class="NLM_x">, </span> <span class="NLM_fpage">1261</span><span class="NLM_x">–</span> <span class="NLM_lpage">1265</span></span><div class="citationLinks">[<a href="/doi/10.1021/np100148m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2010&pages=1261-1265&author=J.+Y.+Leeauthor=J.+K.+Kimauthor=M.+C.+Choauthor=S.+Shinauthor=D.+Y.+Yoonauthor=Y.+S.+Heoauthor=Y.+Kim&title=Cytotoxic+flavonoids+as+agonists+of+peroxysome+proliferator-activated+receptor+gamma+on+human+cervical+and+prostate+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1021%2Fnp100148m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fnp100148m%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DJ.%2BY.%26aulast%3DKim%26aufirst%3DJ.%2BK.%26aulast%3DCho%26aufirst%3DM.%2BC.%26aulast%3DShin%26aufirst%3DS.%26aulast%3DYoon%26aufirst%3DD.%2BY.%26aulast%3DHeo%26aufirst%3DY.%2BS.%26aulast%3DKim%26aufirst%3DY.%26atitle%3DCytotoxic%2520flavonoids%2520as%2520agonists%2520of%2520peroxysome%2520proliferator-activated%2520receptor%2520gamma%2520on%2520human%2520cervical%2520and%2520prostate%2520cancer%2520cells%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D2010%26volume%3D73%26spage%3D1261%26epage%3D1265" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref79"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref79'); return false;" data-citation="" class="refNumLink">79</a></strong><div class="NLM_citation" id="cit79"><span><span class="NLM_contrib-group">Reka, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurapati, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narala, V. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bommer, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Standiford, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keshamouni, V. G.</span><span> </span><span class="NLM_article-title">Peroxisome proliferator-activated receptor-gamma activation inhibits tumor metastasis by antagonizing Smad3-mediated epithelial-mesenchymal transition</span> <span class="citation_source-journal">Mol. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">3221</span><span class="NLM_x">–</span> <span class="NLM_lpage">3232</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Fjm200285z&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsFGrsLzN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2010&pages=3221-3232&author=A.+K.+Rekaauthor=H.+Kurapatiauthor=V.+R.+Naralaauthor=G.+Bommerauthor=J.+Chenauthor=T.+J.+Standifordauthor=V.+G.+Keshamouni&title=Peroxisome+proliferator-activated+receptor-gamma+activation+inhibits+tumor+metastasis+by+antagonizing+Smad3-mediated+epithelial-mesenchymal+transition"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">Peroxisome Proliferator-Activated Receptor-γ Activation Inhibits Tumor Metastasis by Antagonizing Smad3-Mediated Epithelial-Mesenchymal Transition</span></div><div class="casAuthors">Reka, Ajaya Kumar; Kurapati, Himabindu; Narala, Venkata R.; Bommer, Guido; Chen, Jun; Standiford, Theodore J.; Keshamouni, Venkateshwar G.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3221-3232</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Epithelial-mesenchymal transition (EMT) was shown to confer tumor cells with abilities essential for metastasis, including migratory phenotype, invasiveness, resistance to apoptosis, evading immune surveillance, and tumor stem cell traits.  Therefore, inhibition of EMT can be an important therapeutic strategy to inhibit tumor metastasis.  Here, we show that activation of peroxisome proliferator-activated receptor γ (PPAR-γ) inhibits transforming growth factor β (TGF-β)-induced EMT in lung cancer cells and prevents metastasis by antagonizing Smad3 function.  Activation of PPAR-γ by synthetic ligands (troglitazone and rosiglitazone) or by a constitutively active form of PPAR-γ prevents TGF-β-induced loss of E-cadherin expression and inhibits the induction of mesenchymal markers (vimentin, N-cadherin, fibronectin) and matrix metalloproteases.  Consistently, activation of PPAR-γ also inhibited EMT-induced migration and invasion of lung cancer cells.  Furthermore, effects of PPAR-γ ligands were attenuated by siRNA-mediated knockdown of PPAR-γ, indicating that the ligand-induced responses are PPAR-γ dependent.  Selective knockdown of Smad2 and Smad3 by siRNA showed that TGF-β-induced EMT is Smad3 dependent in lung cancer cells.  Activation of PPAR-γ inhibits TGF-β-induced Smad transcriptional activity but had no effect on the phosphorylation or nuclear translocation of Smads.  Consistently, PPAR-γ activation prevented TGF-β-induced transcriptional repression of E-cadherin promoter and inhibited transcriptional activation of N-cadherin promoter.  Finally, treatment of mice with troglitazone or knockdown of Smad3 in tumor cells significantly inhibited TGF-β-induced exptl. metastasis in SCID-Beige mice.  Together, with the low toxicity profile of PPAR-γ ligands, our data show that these ligands may serve as potential therapeutic agents to inhibit metastasis.  Mol Cancer Ther; 9(12); 3221-32.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpa-a3-3vvf3bVg90H21EOLACvtfcHk0lg1f4hyocDuaA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsFGrsLzN&md5=65d63d3f0b8aa7359be8dd2aa12e6d74</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DReka%26aufirst%3DA.%2BK.%26aulast%3DKurapati%26aufirst%3DH.%26aulast%3DNarala%26aufirst%3DV.%2BR.%26aulast%3DBommer%26aufirst%3DG.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DStandiford%26aufirst%3DT.%2BJ.%26aulast%3DKeshamouni%26aufirst%3DV.%2BG.%26atitle%3DPeroxisome%2520proliferator-activated%2520receptor-gamma%2520activation%2520inhibits%2520tumor%2520metastasis%2520by%2520antagonizing%2520Smad3-mediated%2520epithelial-mesenchymal%2520transition%26jtitle%3DMol.%2520Cancer%2520Res.%26date%3D2010%26volume%3D9%26spage%3D3221%26epage%3D3232" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref80"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref80'); return false;" data-citation="" class="refNumLink">80</a></strong><div class="NLM_citation" id="cit80"><span><span class="NLM_contrib-group">Voutsadakis, I. A.</span><span> </span><span class="NLM_article-title">Peroxisome proliferator activated receptor-gamma and the ubiquitin-proteasome system in colorectal cancer</span> <span class="citation_source-journal">World J. Gastrointest. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">235</span><span class="NLM_x">–</span> <span class="NLM_lpage">241</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=16&amp;doi=10.1021%2Fjm200285z&amp;key=10.4251%2Fwjgo.v2.i5.235" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=8&amp;doi=10.1021%2Fjm200285z&amp;key=21160623" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Fjm200285z&amp;key=1%3ACAS%3A280%3ADC%252BC3M%252Fks1Cltg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2010&pages=235-241&author=I.+A.+Voutsadakis&title=Peroxisome+proliferator+activated+receptor-gamma+and+the+ubiquitin-proteasome+system+in+colorectal+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">Peroxisome proliferator activated receptor-γ and the ubiquitin-proteasome system in colorectal cancer</span></div><div class="casAuthors">Voutsadakis Ioannis A</div><div class="citationInfo"><span class="NLM_cas:title">World journal of gastrointestinal oncology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">235-41</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Peroxisome proliferator activated receptor-γ (PPARγ), a transcription factor of the nuclear receptor superfamily plays a significant role in colorectal cancer pathogenesis.  In most experimental systems PPARγ activation has tumor suppressing effects in the colon.  PPARγ is regulated at multiple levels by the ubiquitin-proteasome system (UPS).  At a first level, UPS regulates PPARγ transcription.  This regulation involves both PPARγ transcription specific factors and the general transcription machinery.  At a second level UPS regulates PPARγ and its co-factors themselves, as PPARγ and many co-factors are proteasome substrates.  At a third level of regulation, transduction pathways working in parallel but also having interrelations with PPARγ are regulated by the UPS, creating a network of regulation in the colorectal carcinogenesis-related pathways that are under UPS control.  Activation of PPARγ transcription by direct pharmacologic activators and by stabilization of its molecule by proteasome inhibitors could be strategies to be exploited in colorectal cancer treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSu0K-PDwFr85ZoeNcnHOQ9fW6udTcc2ea_BDY7Y64g_bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3M%252Fks1Cltg%253D%253D&md5=4ae395e1622b890c3a638395de70fff2</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.4251%2Fwjgo.v2.i5.235&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4251%252Fwjgo.v2.i5.235%26sid%3Dliteratum%253Aachs%26aulast%3DVoutsadakis%26aufirst%3DI.%2BA.%26atitle%3DPeroxisome%2520proliferator%2520activated%2520receptor-gamma%2520and%2520the%2520ubiquitin-proteasome%2520system%2520in%2520colorectal%2520cancer%26jtitle%3DWorld%2520J.%2520Gastrointest.%2520Oncol.%26date%3D2010%26volume%3D2%26spage%3D235%26epage%3D241" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref81"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref81'); return false;" data-citation="" class="refNumLink">81</a></strong><div class="NLM_citation" id="cit81"><span><span class="NLM_contrib-group">Knight, Z. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shokat, K. M.</span><span> </span><span class="NLM_article-title">Targeting the cancer kinome through polypharmacology</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">130</span><span class="NLM_x">–</span> <span class="NLM_lpage">137</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Fjm200285z&amp;key=10.1038%2Fnrc2787" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=8&amp;doi=10.1021%2Fjm200285z&amp;key=20094047" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=32&amp;doi=10.1021%2Fjm200285z&amp;key=1%3ACAS%3A528%3ADC%252BC3cXps1Clug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2010&pages=130-137&author=Z.+A.+Knightauthor=H.+Linauthor=K.+M.+Shokat&title=Targeting+the+cancer+kinome+through+polypharmacology"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit81R"><div class="casContent"><span class="casTitleNuber">81</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the cancer kinome through polypharmacology</span></div><div class="casAuthors">Knight, Zachary A.; Lin, Henry; Shokat, Kevan M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">130-137</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Kinase inhibitors are the largest class of new cancer drugs.  However, it is already apparent that most tumors can escape from the inhibition of any single kinase.  If it is necessary to inhibit multiple kinases, how do we choose which ones.  In this Opinion article, we discuss some of the strategies that are currently being used to identify new therapeutic combinations of kinase targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpkDv2FeeH58rVg90H21EOLACvtfcHk0ljnzXT7tkTVcw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXps1Clug%253D%253D&md5=9aaa314e54b43889e147a9f11ac77072</span></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1038%2Fnrc2787&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc2787%26sid%3Dliteratum%253Aachs%26aulast%3DKnight%26aufirst%3DZ.%2BA.%26aulast%3DLin%26aufirst%3DH.%26aulast%3DShokat%26aufirst%3DK.%2BM.%26atitle%3DTargeting%2520the%2520cancer%2520kinome%2520through%2520polypharmacology%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2010%26volume%3D10%26spage%3D130%26epage%3D137" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref82"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref82'); return false;" data-citation="" class="refNumLink">82</a></strong><div class="NLM_citation" id="cit82"><span><span class="NLM_contrib-group">Fedorov, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, S.</span><span> </span><span class="NLM_article-title">The (un)target cancer kinome</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">166</span><span class="NLM_x">–</span> <span class="NLM_lpage">169</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=16&amp;doi=10.1021%2Fjm200285z&amp;key=10.1038%2Fnchembio.297" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=8&amp;doi=10.1021%2Fjm200285z&amp;key=20154661" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Fjm200285z&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhvFGntbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2010&pages=166-169&author=O.+Fedorovauthor=S.+M%C3%BCllerauthor=S.+Knapp&title=The+%28un%29target+cancer+kinome"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">The (un)targeted cancer kinome</span></div><div class="casAuthors">Fedorov, Oleg; Mueller, Susanne; Knapp, Stefan</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">166-169</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review and discussion.  The complexity of cancer signaling and the resulting difficulties in target selection have strongly biased kinase drug discovery towards clin. validated targets.  Recently, novel kinase targets that are uncharacterized have emerged from genome sequencing and RNAi studies.  Chem. probes are urgently needed to functionally annotate these kinases and to stimulate new drug discovery efforts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpwcnq0-qjPirVg90H21EOLACvtfcHk0ljnzXT7tkTVcw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhvFGntbk%253D&md5=198ae8d39d40247e17aef5e9de0f2a99</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.297&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.297%26sid%3Dliteratum%253Aachs%26aulast%3DFedorov%26aufirst%3DO.%26aulast%3DM%25C3%25BCller%26aufirst%3DS.%26aulast%3DKnapp%26aufirst%3DS.%26atitle%3DThe%2520%2528un%2529target%2520cancer%2520kinome%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2010%26volume%3D6%26spage%3D166%26epage%3D169" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref83"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref83'); return false;" data-citation="" class="refNumLink">83</a></strong><div class="NLM_citation" id="cit83"><span><span class="NLM_contrib-group">Gossage, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eisen, T.</span><span> </span><span class="NLM_article-title">Targeting multiple kinase pathways: a change in paradigm</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">1973</span><span class="NLM_x">–</span> <span class="NLM_lpage">1978</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=16&amp;doi=10.1021%2Fjm200285z&amp;key=10.1158%2F1078-0432.CCR-09-3182" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=8&amp;doi=10.1021%2Fjm200285z&amp;key=20215532" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Fjm200285z&amp;key=1%3ACAS%3A528%3ADC%252BC3cXktFygu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2010&pages=1973-1978&author=L.+Gossageauthor=T.+Eisen&title=Targeting+multiple+kinase+pathways%3A+a+change+in+paradigm"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting Multiple Kinase Pathways: A Change In Paradigm</span></div><div class="casAuthors">Gossage, Lucy; Eisen, Tim</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1973-1978</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A review.  Anticancer drugs that target protein kinases include small mol. inhibitors and monoclonal antibodies.  Feedback loops and cross talk between signaling pathways impact significantly on the efficacy of cancer therapeutics, and resistance to targeted agents is a major barrier to effective treatments.  Increasingly, therapies are being designed to target multiple kinase pathways.  This can be achieved using a single agent that inhibits multiple signaling pathways or a combination of highly selective agents.  In this review we discuss the principles of specifically targeting multiple kinase pathways with particular ref. to angiogenic signaling pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwTqIFjKKuX7Vg90H21EOLACvtfcHk0ljnzXT7tkTVcw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXktFygu7w%253D&md5=fc074fb853129324db0b36ec148f2401</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-09-3182&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-09-3182%26sid%3Dliteratum%253Aachs%26aulast%3DGossage%26aufirst%3DL.%26aulast%3DEisen%26aufirst%3DT.%26atitle%3DTargeting%2520multiple%2520kinase%2520pathways%253A%2520a%2520change%2520in%2520paradigm%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2010%26volume%3D16%26spage%3D1973%26epage%3D1978" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref84"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref84'); return false;" data-citation="" class="refNumLink">84</a></strong><div class="NLM_citation" id="cit84"><span><span class="NLM_contrib-group">Agrawal, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jain, D. C.</span><span> </span><span class="NLM_article-title"><sup>13</sup>C NMR spectroscopy of oleanane triterpenoids</span> <span class="citation_source-journal">Prog. NMR Spectrosc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">90</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=16&amp;doi=10.1021%2Fjm200285z&amp;key=10.1016%2F0079-6565%2892%2980011-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=32&amp;doi=10.1021%2Fjm200285z&amp;key=1%3ACAS%3A528%3ADyaK38XitFCks7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=1992&pages=1-90&author=P.+K.+Agrawalauthor=D.+C.+Jain&title=13C+NMR+spectroscopy+of+oleanane+triterpenoids"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit84R"><div class="casContent"><span class="casTitleNuber">84</span><div class="casTitle"><span class="NLM_cas:atitle">Carbon-13 NMR spectroscopy of oleanane triterpenoids</span></div><div class="casAuthors">Agrawal, Pawan K.; Jain, Dharam C.</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Nuclear Magnetic Resonance Spectroscopy</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-90</span>CODEN:
                <span class="NLM_cas:coden">PNMRAT</span>;
        ISSN:<span class="NLM_cas:issn">0079-6565</span>.
    </div><div class="casAbstract">Review with 406 refs. including the assignment of 13C-NMR spectra, chem. shifts and shielding behavior of 456 oleanane triterpenoids.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgg74AL9F5HbVg90H21EOLACvtfcHk0ljnzXT7tkTVcw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38XitFCks7s%253D&md5=492e1948d29e6f3fee14f2be2836b471</span></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1016%2F0079-6565%2892%2980011-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0079-6565%252892%252980011-4%26sid%3Dliteratum%253Aachs%26aulast%3DAgrawal%26aufirst%3DP.%2BK.%26aulast%3DJain%26aufirst%3DD.%2BC.%26atitle%3D13C%2520NMR%2520spectroscopy%2520of%2520oleanane%2520triterpenoids%26jtitle%3DProg.%2520NMR%2520Spectrosc.%26date%3D1992%26volume%3D24%26spage%3D1%26epage%3D90" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref85"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref85'); return false;" data-citation="" class="refNumLink">85</a></strong><div class="NLM_citation" id="cit85"><span><span class="NLM_contrib-group">Mahato, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kundu, A. P.</span><span> </span><span class="NLM_article-title"><sup>13</sup>C NMR spectra of pentacyclic triterpenoids – a compilation and some salient features</span> <span class="citation_source-journal">Phytochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">1517</span><span class="NLM_x">–</span> <span class="NLM_lpage">1575</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1994&pages=1517-1575&issue=6&author=S.+B.+Mahatoauthor=A.+P.+Kundu&title=13C+NMR+spectra+of+pentacyclic+triterpenoids+%E2%80%93+a+compilation+and+some+salient+features"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMahato%26aufirst%3DS.%2BB.%26aulast%3DKundu%26aufirst%3DA.%2BP.%26atitle%3D13C%2520NMR%2520spectra%2520of%2520pentacyclic%2520triterpenoids%2520%25E2%2580%2593%2520a%2520compilation%2520and%2520some%2520salient%2520features%26jtitle%3DPhytochemistry%26date%3D1994%26volume%3D37%26issue%3D6%26spage%3D1517%26epage%3D1575" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref86"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref86'); return false;" data-citation="" class="refNumLink">86</a></strong><div class="NLM_citation" id="cit86"><span><span class="NLM_contrib-group">Friesner, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Repasky, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frye, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenwood, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halgren, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanschagrin, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mainz, D. T.</span><span> </span><span class="NLM_article-title">Extra precision Glide: Docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">6177</span><span class="NLM_x">–</span> <span class="NLM_lpage">6196</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm051256o" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=32&amp;doi=10.1021%2Fjm200285z&amp;key=1%3ACAS%3A528%3ADC%252BD28XpvVGmurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=6177-6196&author=R.+A.+Friesnerauthor=R.+B.+Murphyauthor=M.+P.+Repaskyauthor=L.+L.+Fryeauthor=J.+R.+Greenwoodauthor=T.+A.+Halgrenauthor=P.+C.+Sanschagrinauthor=D.+T.+Mainz&title=Extra+precision+Glide%3A+Docking+and+scoring+incorporating+a+model+of+hydrophobic+enclosure+for+protein-ligand+complexes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit86R"><div class="casContent"><span class="casTitleNuber">86</span><div class="casTitle"><span class="NLM_cas:atitle">Extra Precision Glide: Docking and Scoring Incorporating a Model of Hydrophobic Enclosure for Protein-Ligand Complexes</span></div><div class="casAuthors">Friesner, Richard A.; Murphy, Robert B.; Repasky, Matthew P.; Frye, Leah L.; Greenwood, Jeremy R.; Halgren, Thomas A.; Sanschagrin, Paul C.; Mainz, Daniel T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6177-6196</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A novel scoring function to est. protein-ligand binding affinities has been developed and implemented as the Glide 4.0 XP scoring function and docking protocol.  In addn. to unique water desolvation energy terms, protein-ligand structural motifs leading to enhanced binding affinity are included:(1) hydrophobic enclosure where groups of lipophilic ligand atoms are enclosed on opposite faces by lipophilic protein atoms, (2) neutral-neutral single or correlated hydrogen bonds in a hydrophobically enclosed environment, and (3) five categories of charged-charged hydrogen bonds.  The XP scoring function and docking protocol have been developed to reproduce exptl. binding affinities for a set of 198 complexes (RMSDs of 2.26 and 1.73 kcal/mol over all and well-docked ligands, resp.) and to yield quality enrichments for a set of fifteen screens of pharmaceutical importance.  Enrichment results demonstrate the importance of the novel XP mol. recognition and water scoring in sepg. active and inactive ligands and avoiding false positives.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGohZiwN12vaY7Vg90H21EOLACvtfcHk0li-idxWW4_h2A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XpvVGmurg%253D&md5=ea428c82ead0d8c27f8c1a7b694a1edf</span></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1021%2Fjm051256o&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm051256o%26sid%3Dliteratum%253Aachs%26aulast%3DFriesner%26aufirst%3DR.%2BA.%26aulast%3DMurphy%26aufirst%3DR.%2BB.%26aulast%3DRepasky%26aufirst%3DM.%2BP.%26aulast%3DFrye%26aufirst%3DL.%2BL.%26aulast%3DGreenwood%26aufirst%3DJ.%2BR.%26aulast%3DHalgren%26aufirst%3DT.%2BA.%26aulast%3DSanschagrin%26aufirst%3DP.%2BC.%26aulast%3DMainz%26aufirst%3DD.%2BT.%26atitle%3DExtra%2520precision%2520Glide%253A%2520Docking%2520and%2520scoring%2520incorporating%2520a%2520model%2520of%2520hydrophobic%2520enclosure%2520for%2520protein-ligand%2520complexes%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D6177%26epage%3D6196" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref87"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref87'); return false;" data-citation="" class="refNumLink">87</a></strong><div class="NLM_citation" id="cit87"><span><span class="NLM_contrib-group">Arrigo, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldberg, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Welch, W. J.</span><span> </span><span class="NLM_article-title">Identity of the 19S ’prosome’ particle with the large multifunctional protease complex of mammalian cells (the proteasome)</span> <span class="citation_source-journal">Nature (London)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1988</span><span class="NLM_x">, </span> <span class="NLM_volume">331</span><span class="NLM_x">, </span> <span class="NLM_fpage">192</span><span class="NLM_x">–</span> <span class="NLM_lpage">194</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=16&amp;doi=10.1021%2Fjm200285z&amp;key=10.1038%2F331192a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=8&amp;doi=10.1021%2Fjm200285z&amp;key=3277060" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=32&amp;doi=10.1021%2Fjm200285z&amp;key=1%3ACAS%3A528%3ADyaL1MXptFSjug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=331&publication_year=1988&pages=192-194&author=A.+P.+Arrigoauthor=K.+Tanakaauthor=A.+L.+Goldbergauthor=W.+J.+Welch&title=Identity+of+the+19S+%E2%80%99prosome%E2%80%99+particle+with+the+large+multifunctional+protease+complex+of+mammalian+cells+%28the+proteasome%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit87R"><div class="casContent"><span class="casTitleNuber">87</span><div class="casTitle"><span class="NLM_cas:atitle">Identity of the 19S 'prosome' particle with the large multifunctional protease complex of mammalian cells (the proteasome)</span></div><div class="casAuthors">Arrigo, Andre Patrick; Tanaka, Keiji; Goldberg, Alfred L.; Welch, William J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">1988</span>),
    <span class="NLM_cas:volume">331</span>
        (<span class="NLM_cas:issue">6152</span>),
    <span class="NLM_cas:pages">192-4</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    </div><div class="casAbstract">Evidence is presented indicating that the previously described eukaryotic 19-20 S particle termed the prosome may actually be a high-mol.-wt. protease complex (designated LAMP for large alk. multi-functional protease).  The prosomes and these protease complexes are very similar or identical with respect to their size, polypeptide compn., immunol. cross-reactivity, appearance in the electron microscope, radial symmetry of subunits, subcellular localization, and proteolytic activities.  Therefore, the prosome probably plays a crit. role in intracellular protein breakdown, and it is proposed that it be renamed proteasome.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGryCVhvvnOZFrVg90H21EOLACvtfcHk0li-idxWW4_h2A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1MXptFSjug%253D%253D&md5=5e60a608bac706e7a9786636251b8cdc</span></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.1038%2F331192a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F331192a0%26sid%3Dliteratum%253Aachs%26aulast%3DArrigo%26aufirst%3DA.%2BP.%26aulast%3DTanaka%26aufirst%3DK.%26aulast%3DGoldberg%26aufirst%3DA.%2BL.%26aulast%3DWelch%26aufirst%3DW.%2BJ.%26atitle%3DIdentity%2520of%2520the%252019S%2520%25E2%2580%2599prosome%25E2%2580%2599%2520particle%2520with%2520the%2520large%2520multifunctional%2520protease%2520complex%2520of%2520mammalian%2520cells%2520%2528the%2520proteasome%2529%26jtitle%3DNature%2520%2528London%2529%26date%3D1988%26volume%3D331%26spage%3D192%26epage%3D194" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref88"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref88'); return false;" data-citation="" class="refNumLink">88</a></strong><div class="NLM_citation" id="cit88"><span><span class="NLM_contrib-group">Sadowski, J.</span><span> </span><span class="NLM_article-title">A hybrid approach for addressing ring flexibility in 3D database searching</span> <span class="citation_source-journal">J. Comput.-Aided Mol. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">53</span><span class="NLM_x">–</span> <span class="NLM_lpage">60</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=1997&pages=53-60&author=J.+Sadowski&title=A+hybrid+approach+for+addressing+ring+flexibility+in+3D+database+searching"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSadowski%26aufirst%3DJ.%26atitle%3DA%2520hybrid%2520approach%2520for%2520addressing%2520ring%2520flexibility%2520in%25203D%2520database%2520searching%26jtitle%3DJ.%2520Comput.-Aided%2520Mol.%2520Des.%26date%3D1997%26volume%3D11%26spage%3D53%26epage%3D60" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref89"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref89'); return false;" data-citation="" class="refNumLink">89</a></strong><div class="NLM_citation" id="cit89"><span><span class="NLM_contrib-group">Moravec, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Brien, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daily, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scurria, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernad, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riss, T. L.</span><span> </span><span class="NLM_article-title">Cell-based bioluminescent assays for all three proteasome activities in a homogeneous format</span> <span class="citation_source-journal">Anal. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">387</span><span class="NLM_x">, </span> <span class="NLM_fpage">294</span><span class="NLM_x">–</span> <span class="NLM_lpage">302</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=387&publication_year=2009&pages=294-302&author=R.+A.+Moravecauthor=M.+A.+O%E2%80%99Brienauthor=W.+J.+Dailyauthor=M.+A.+Scurriaauthor=L.+Bernadauthor=T.+L.+Riss&title=Cell-based+bioluminescent+assays+for+all+three+proteasome+activities+in+a+homogeneous+format"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMoravec%26aufirst%3DR.%2BA.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DM.%2BA.%26aulast%3DDaily%26aufirst%3DW.%2BJ.%26aulast%3DScurria%26aufirst%3DM.%2BA.%26aulast%3DBernad%26aufirst%3DL.%26aulast%3DRiss%26aufirst%3DT.%2BL.%26atitle%3DCell-based%2520bioluminescent%2520assays%2520for%2520all%2520three%2520proteasome%2520activities%2520in%2520a%2520homogeneous%2520format%26jtitle%3DAnal.%2520Biochem.%26date%3D2009%26volume%3D387%26spage%3D294%26epage%3D302" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref90"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref90'); return false;" data-citation="" class="refNumLink">90</a></strong><div class="NLM_citation" id="cit90"><span><span class="NLM_contrib-group">Lamoral-Theys, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pottier, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kerff, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dufrasne, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Proutière, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wauthoz, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neven, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ingrassia, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Antwerpen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lefranc, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gelbcke, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pirotte, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kraus, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nève, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kornienko, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiss, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dubois, J.</span><span> </span><span class="NLM_article-title">Simple di- and trivanillates exhibit cytostatic properties toward cancer cells resistant to pro-apoptotic stimuli</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">3823</span><span class="NLM_x">–</span> <span class="NLM_lpage">3833</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2010&pages=3823-3833&author=D.+Lamoral-Theysauthor=L.+Pottierauthor=F.+Kerffauthor=F.+Dufrasneauthor=F.+Prouti%C3%A8reauthor=N.+Wauthozauthor=P.+Nevenauthor=L.+Ingrassiaauthor=P.+Van+Antwerpenauthor=F.+Lefrancauthor=M.+Gelbckeauthor=B.+Pirotteauthor=J.+L.+Krausauthor=J.+N%C3%A8veauthor=A.+Kornienkoauthor=R.+Kissauthor=J.+Dubois&title=Simple+di-+and+trivanillates+exhibit+cytostatic+properties+toward+cancer+cells+resistant+to+pro-apoptotic+stimuli"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLamoral-Theys%26aufirst%3DD.%26aulast%3DPottier%26aufirst%3DL.%26aulast%3DKerff%26aufirst%3DF.%26aulast%3DDufrasne%26aufirst%3DF.%26aulast%3DProuti%25C3%25A8re%26aufirst%3DF.%26aulast%3DWauthoz%26aufirst%3DN.%26aulast%3DNeven%26aufirst%3DP.%26aulast%3DIngrassia%26aufirst%3DL.%26aulast%3DVan%2BAntwerpen%26aufirst%3DP.%26aulast%3DLefranc%26aufirst%3DF.%26aulast%3DGelbcke%26aufirst%3DM.%26aulast%3DPirotte%26aufirst%3DB.%26aulast%3DKraus%26aufirst%3DJ.%2BL.%26aulast%3DN%25C3%25A8ve%26aufirst%3DJ.%26aulast%3DKornienko%26aufirst%3DA.%26aulast%3DKiss%26aufirst%3DR.%26aulast%3DDubois%26aufirst%3DJ.%26atitle%3DSimple%2520di-%2520and%2520trivanillates%2520exhibit%2520cytostatic%2520properties%2520toward%2520cancer%2520cells%2520resistant%2520to%2520pro-apoptotic%2520stimuli%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2010%26volume%3D18%26spage%3D3823%26epage%3D3833" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69'],'ref70':['cit70'],'ref71':['cit71'],'ref72':['cit72'],'ref73':['cit73'],'ref74':['cit74'],'ref75':['cit75'],'ref76':['cit76'],'ref77':['cit77'],'ref78':['cit78'],'ref79':['cit79'],'ref80':['cit80'],'ref81':['cit81'],'ref82':['cit82'],'ref83':['cit83'],'ref84':['cit84'],'ref85':['cit85'],'ref86':['cit86'],'ref87':['cit87'],'ref88':['cit88'],'ref89':['cit89'],'ref90':['cit90']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 30 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Juan Sun, Han-Yu Liu, Cheng-Zhi Lv, Jie Qin, <span class="NLM_string-name hlFld-ContribAuthor">Yuan-Feng Wu</span>. </span><span class="cited-content_cbyCitation_article-title">Modification, Antitumor Activity, and Targeted PPARγ Study of 18β-Glycyrrhetinic Acid, an Important Active Ingredient of Licorice. </span><span class="cited-content_cbyCitation_journal-name">Journal of Agricultural and Food Chemistry</span><span> <strong>2019,</strong> <em>67 </em>
                                    (34)
                                     , 9643-9651. <a href="https://doi.org/10.1021/acs.jafc.9b03442" title="DOI URL">https://doi.org/10.1021/acs.jafc.9b03442</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jafc.9b03442&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jafc.9b03442%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Agricultural%2520and%2520Food%2520Chemistry%26atitle%3DModification%25252C%252BAntitumor%252BActivity%25252C%252Band%252BTargeted%252BPPAR%2525CE%2525B3%252BStudy%252Bof%252B18%2525CE%2525B2-Glycyrrhetinic%252BAcid%25252C%252Ban%252BImportant%252BActive%252BIngredient%252Bof%252BLicorice%26aulast%3DSun%26aufirst%3DJuan%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D02062019%26date%3D07082019%26date%3D22072019%26date%3D14082019%26date%3D07082019%26volume%3D67%26issue%3D34%26spage%3D9643%26epage%3D9651" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Xinhua Liu, Benlong Li, Zhen Zhang, Yujiao Wei, Zhongxin Xu, Shuanglin Qin, Ning Liu, Rui Zhao, Junya Peng, Guang Yang, Min Qi, Tongtong Liu, Maodun Xie, Shuangwei Liu, Xian Gao, Cheng Lu, Lijun Zhu, Xinyu Long, Hong Kang, Tao Sun, Honggang Zhou, Mingming Wei, Guang Yang, <span class="NLM_string-name hlFld-ContribAuthor">Cheng Yang</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and Discovery Novel Anti-Cancer Stem Cells Compounds Derived from the Natural Triterpenoic Acids. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (23)
                                     , 10814-10833. <a href="https://doi.org/10.1021/acs.jmedchem.8b01445" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b01445</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b01445&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b01445%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252BDiscovery%252BNovel%252BAnti-Cancer%252BStem%252BCells%252BCompounds%252BDerived%252Bfrom%252Bthe%252BNatural%252BTriterpenoic%252BAcids%26aulast%3DLiu%26aufirst%3DXinhua%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D18092018%26date%3D29112018%26date%3D15112018%26volume%3D61%26issue%3D23%26spage%3D10814%26epage%3D10833" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Shivakrishna Kallepu, Karekar Sanjeev, Rambabu Chegondi, Prathama S. Mainkar, <span class="NLM_string-name hlFld-ContribAuthor">Srivari Chandrasekhar</span>. </span><span class="cited-content_cbyCitation_article-title">Benzyne Insertion onto β-Keto Esters of Polycyclic Natural Products: Synthesis of Benzo Octacyclo Scaffolds. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2018,</strong> <em>20 </em>
                                    (22)
                                     , 7121-7124. <a href="https://doi.org/10.1021/acs.orglett.8b03070" title="DOI URL">https://doi.org/10.1021/acs.orglett.8b03070</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.8b03070&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.8b03070%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DBenzyne%252BInsertion%252Bonto%252B%2525CE%2525B2-Keto%252BEsters%252Bof%252BPolycyclic%252BNatural%252BProducts%25253A%252BSynthesis%252Bof%252BBenzo%252BOctacyclo%252BScaffolds%26aulast%3DKallepu%26aufirst%3DShivakrishna%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D25092018%26date%3D05112018%26volume%3D20%26issue%3D22%26spage%3D7121%26epage%3D7124" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Irina Yu.  Strobykina</span>, <span class="hlFld-ContribAuthor ">Mayya G.  Belenok</span>, <span class="hlFld-ContribAuthor ">Marina N.  Semenova</span>, <span class="hlFld-ContribAuthor ">Victor V.  Semenov</span>, <span class="hlFld-ContribAuthor ">Vasiliy M.  Babaev</span>, <span class="hlFld-ContribAuthor ">Ildar Kh.  Rizvanov</span>, <span class="hlFld-ContribAuthor ">Vladimir F.  Mironov</span>, and <span class="hlFld-ContribAuthor ">Vladimir E.  Kataev</span>  . </span><span class="cited-content_cbyCitation_article-title">Triphenylphosphonium Cations of the Diterpenoid Isosteviol: Synthesis and Antimitotic Activity in a Sea Urchin Embryo Model. </span><span class="cited-content_cbyCitation_journal-name">Journal of Natural Products</span><span> <strong>2015,</strong> <em>78 </em>
                                    (6)
                                     , 1300-1308. <a href="https://doi.org/10.1021/acs.jnatprod.5b00124" title="DOI URL">https://doi.org/10.1021/acs.jnatprod.5b00124</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jnatprod.5b00124&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jnatprod.5b00124%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Natural%2520Products%26atitle%3DTriphenylphosphonium%252BCations%252Bof%252Bthe%252BDiterpenoid%252BIsosteviol%25253A%252BSynthesis%252Band%252BAntimitotic%252BActivity%252Bin%252Ba%252BSea%252BUrchin%252BEmbryo%252BModel%26aulast%3DStrobykina%26aufirst%3DIrina%2BYu.%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D06022015%26date%3D04062015%26date%3D26062015%26volume%3D78%26issue%3D6%26spage%3D1300%26epage%3D1308" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hidayat  Hussain</span>, <span class="hlFld-ContribAuthor ">Iftikhar  Ali</span>, <span class="hlFld-ContribAuthor ">Daijie  Wang</span>, <span class="hlFld-ContribAuthor ">Faruck L.  Hakkim</span>, <span class="hlFld-ContribAuthor ">Bernhard  Westermann</span>, <span class="hlFld-ContribAuthor ">Ishtiaq  Ahmed</span>, <span class="hlFld-ContribAuthor ">Ahmed M.  Ashour</span>, <span class="hlFld-ContribAuthor ">Amjad  Khan</span>, <span class="hlFld-ContribAuthor ">Amjad  Hussain</span>, <span class="hlFld-ContribAuthor ">Ivan R.  Green</span>, <span class="hlFld-ContribAuthor ">Syed Tasadaque Ali  Shah</span>. </span><span class="cited-content_cbyCitation_article-title">Glycyrrhetinic acid: a promising scaffold for the discovery of anticancer agents. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Drug Discovery</span><span> <strong>2021,</strong> <em>65 </em>, 1-20. <a href="https://doi.org/10.1080/17460441.2021.1956901" title="DOI URL">https://doi.org/10.1080/17460441.2021.1956901</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/17460441.2021.1956901&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F17460441.2021.1956901%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Drug%2520Discovery%26atitle%3DGlycyrrhetinic%252Bacid%25253A%252Ba%252Bpromising%252Bscaffold%252Bfor%252Bthe%252Bdiscovery%252Bof%252Banticancer%252Bagents%26aulast%3DHussain%26aufirst%3DHidayat%26date%3D2021%26date%3D2021%26volume%3D65%26spage%3D1%26epage%3D20" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">László  Petri</span>, <span class="hlFld-ContribAuthor ">Péter  Ábrányi‐Balogh</span>, <span class="hlFld-ContribAuthor ">Imre  Tímea</span>, <span class="hlFld-ContribAuthor ">Gyula  Pálfy</span>, <span class="hlFld-ContribAuthor ">András  Perczel</span>, <span class="hlFld-ContribAuthor ">Damijan  Knez</span>, <span class="hlFld-ContribAuthor ">Martina  Hrast</span>, <span class="hlFld-ContribAuthor ">Martina  Gobec</span>, <span class="hlFld-ContribAuthor ">Izidor  Sosič</span>, <span class="hlFld-ContribAuthor ">Kinga  Nyíri</span>, <span class="hlFld-ContribAuthor ">Beáta G.  Vértessy</span>, <span class="hlFld-ContribAuthor ">Niklas  Jänsch</span>, <span class="hlFld-ContribAuthor ">Charlotte  Desczyk</span>, <span class="hlFld-ContribAuthor ">Franz‐Josef  Meyer‐Almes</span>, <span class="hlFld-ContribAuthor ">Iza  Ogris</span>, <span class="hlFld-ContribAuthor ">Simona  Golič Grdadolnik</span>, <span class="hlFld-ContribAuthor ">Luca Giacinto  Iacovino</span>, <span class="hlFld-ContribAuthor ">Claudia  Binda</span>, <span class="hlFld-ContribAuthor ">Stanislav  Gobec</span>, <span class="hlFld-ContribAuthor ">György M.  Keserű</span>. </span><span class="cited-content_cbyCitation_article-title">Assessment of Tractable Cysteines for Covalent Targeting by Screening Covalent Fragments. </span><span class="cited-content_cbyCitation_journal-name">ChemBioChem</span><span> <strong>2021,</strong> <em>22 </em>
                                    (4)
                                     , 743-753. <a href="https://doi.org/10.1002/cbic.202000700" title="DOI URL">https://doi.org/10.1002/cbic.202000700</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cbic.202000700&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcbic.202000700%26sid%3Dliteratum%253Aachs%26jtitle%3DChemBioChem%26atitle%3DAssessment%252Bof%252BTractable%252BCysteines%252Bfor%252BCovalent%252BTargeting%252Bby%252BScreening%252BCovalent%252BFragments%26aulast%3DPetri%26aufirst%3DL%25C3%25A1szl%25C3%25B3%26date%3D2021%26date%3D2020%26volume%3D22%26issue%3D4%26spage%3D743%26epage%3D753" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Min  Huang</span>, <span class="hlFld-ContribAuthor ">Ping  Gong</span>, <span class="hlFld-ContribAuthor ">Yuetong  Wang</span>, <span class="hlFld-ContribAuthor ">Xiaorui  Xie</span>, <span class="hlFld-ContribAuthor ">Zhuangshi  Ma</span>, <span class="hlFld-ContribAuthor ">Qihao  Xu</span>, <span class="hlFld-ContribAuthor ">Dan  Liu</span>, <span class="hlFld-ContribAuthor ">Yongkui  Jing</span>, <span class="hlFld-ContribAuthor ">Linxiang  Zhao</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and antitumor effects of novel 18β-glycyrrhetinic acid derivatives featuring an exocyclic α,β-unsaturated carbonyl moiety in ring A. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2020,</strong> <em>103 </em>, 104187. <a href="https://doi.org/10.1016/j.bioorg.2020.104187" title="DOI URL">https://doi.org/10.1016/j.bioorg.2020.104187</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2020.104187&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2020.104187%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DSynthesis%252Band%252Bantitumor%252Beffects%252Bof%252Bnovel%252B18%2525CE%2525B2-glycyrrhetinic%252Bacid%252Bderivatives%252Bfeaturing%252Ban%252Bexocyclic%252B%2525CE%2525B1%25252C%2525CE%2525B2-unsaturated%252Bcarbonyl%252Bmoiety%252Bin%252Bring%252BA%26aulast%3DHuang%26aufirst%3DMin%26date%3D2020%26volume%3D103%26spage%3D104187" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Khalid A.  Agha</span>, <span class="hlFld-ContribAuthor ">Nader E.  Abo-Dya</span>, <span class="hlFld-ContribAuthor ">Tarek S.  Ibrahim</span>, <span class="hlFld-ContribAuthor ">Eatedal H.  Abdel-Aal</span>, <span class="hlFld-ContribAuthor ">Zakaria K.  Abdel-Samii</span>. </span><span class="cited-content_cbyCitation_article-title">N-Acylbenzotriazole: convenient approach for protecting group-free monoacylation of symmetric diamines. </span><span class="cited-content_cbyCitation_journal-name">Monatshefte für Chemie - Chemical Monthly</span><span> <strong>2020,</strong> <em>151 </em>
                                    (4)
                                     , 589-598. <a href="https://doi.org/10.1007/s00706-020-02579-5" title="DOI URL">https://doi.org/10.1007/s00706-020-02579-5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00706-020-02579-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00706-020-02579-5%26sid%3Dliteratum%253Aachs%26jtitle%3DMonatshefte%2520f%25C3%25BCr%2520Chemie%2520-%2520Chemical%2520Monthly%26atitle%3DN-Acylbenzotriazole%25253A%252Bconvenient%252Bapproach%252Bfor%252Bprotecting%252Bgroup-free%252Bmonoacylation%252Bof%252Bsymmetric%252Bdiamines%26aulast%3DAgha%26aufirst%3DKhalid%2BA.%26date%3D2020%26date%3D2020%26volume%3D151%26issue%3D4%26spage%3D589%26epage%3D598" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dong  Cai</span>, <span class="hlFld-ContribAuthor ">Zhi hua  Zhang</span>, <span class="hlFld-ContribAuthor ">Yu  Chen</span>, <span class="hlFld-ContribAuthor ">Chao  Ruan</span>, <span class="hlFld-ContribAuthor ">Sheng qiang  Li</span>, <span class="hlFld-ContribAuthor ">Shi qin  Chen</span>, <span class="hlFld-ContribAuthor ">Lian shan  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological evaluation of novel amide-linked 18β-glycyrrhetinic acid derivatives as novel ALK inhibitors. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2020,</strong> <em>10 </em>
                                    (20)
                                     , 11694-11706. <a href="https://doi.org/10.1039/D0RA00681E" title="DOI URL">https://doi.org/10.1039/D0RA00681E</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0RA00681E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0RA00681E%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bnovel%252Bamide-linked%252B18%2525CE%2525B2-glycyrrhetinic%252Bacid%252Bderivatives%252Bas%252Bnovel%252BALK%252Binhibitors%26aulast%3DCai%26aufirst%3DDong%26date%3D2020%26date%3D2020%26volume%3D10%26issue%3D20%26spage%3D11694%26epage%3D11706" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Min  Huang</span>, <span class="hlFld-ContribAuthor ">Xiaorui  Xie</span>, <span class="hlFld-ContribAuthor ">Ping  Gong</span>, <span class="hlFld-ContribAuthor ">Yunfei  Wei</span>, <span class="hlFld-ContribAuthor ">Heliang  Du</span>, <span class="hlFld-ContribAuthor ">Yuanbo  Xu</span>, <span class="hlFld-ContribAuthor ">Qihao  Xu</span>, <span class="hlFld-ContribAuthor ">Yongkui  Jing</span>, <span class="hlFld-ContribAuthor ">Linxiang  Zhao</span>. </span><span class="cited-content_cbyCitation_article-title">A 18β-glycyrrhetinic acid conjugate with Vorinostat degrades HDAC3 and HDAC6 with improved antitumor effects. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>188 </em>, 111991. <a href="https://doi.org/10.1016/j.ejmech.2019.111991" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.111991</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.111991&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.111991%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DA%252B18%2525CE%2525B2-glycyrrhetinic%252Bacid%252Bconjugate%252Bwith%252BVorinostat%252Bdegrades%252BHDAC3%252Band%252BHDAC6%252Bwith%252Bimproved%252Bantitumor%252Beffects%26aulast%3DHuang%26aufirst%3DMin%26date%3D2020%26volume%3D188%26spage%3D111991" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dong  Cai</span>, <span class="hlFld-ContribAuthor ">ZhiHua  Zhang</span>, <span class="hlFld-ContribAuthor ">Yufan  Meng</span>, <span class="hlFld-ContribAuthor ">KaiLi  Zhu</span>, <span class="hlFld-ContribAuthor ">LiYi  Chen</span>, <span class="hlFld-ContribAuthor ">ChangXiang  Yu</span>, <span class="hlFld-ContribAuthor ">ChangWei  Yu</span>, <span class="hlFld-ContribAuthor ">ZiYi  Fu</span>, <span class="hlFld-ContribAuthor ">DianShen  Yang</span>, <span class="hlFld-ContribAuthor ">YiXia  Gong</span>. </span><span class="cited-content_cbyCitation_article-title">Efficient synthesis of piperazinyl amides of 18β-glycyrrhetinic acid. </span><span class="cited-content_cbyCitation_journal-name">Beilstein Journal of Organic Chemistry</span><span> <strong>2020,</strong> <em>16 </em>, 798-808. <a href="https://doi.org/10.3762/bjoc.16.73" title="DOI URL">https://doi.org/10.3762/bjoc.16.73</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3762/bjoc.16.73&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3762%2Fbjoc.16.73%26sid%3Dliteratum%253Aachs%26jtitle%3DBeilstein%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DEfficient%252Bsynthesis%252Bof%252Bpiperazinyl%252Bamides%252Bof%252B18%2525CE%2525B2-glycyrrhetinic%252Bacid%26aulast%3DCai%26aufirst%3DDong%26date%3D2020%26date%3D2020%26volume%3D16%26spage%3D798%26epage%3D808" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yaqiong  Kong</span>, <span class="hlFld-ContribAuthor ">Feng  Chen</span>, <span class="hlFld-ContribAuthor ">Zhi  Su</span>, <span class="hlFld-ContribAuthor ">Yong  Qian</span>, <span class="hlFld-ContribAuthor ">Fang-xin  Wang</span>, <span class="hlFld-ContribAuthor ">Xiuxiu  Wang</span>, <span class="hlFld-ContribAuthor ">Jing  Zhao</span>, <span class="hlFld-ContribAuthor ">Zong-Wan  Mao</span>, <span class="hlFld-ContribAuthor ">Hong-Ke  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Bioactive ruthenium(II)-arene complexes containing modified 18β-glycyrrhetinic acid ligands. </span><span class="cited-content_cbyCitation_journal-name">Journal of Inorganic Biochemistry</span><span> <strong>2018,</strong> <em>182 </em>, 194-199. <a href="https://doi.org/10.1016/j.jinorgbio.2018.02.004" title="DOI URL">https://doi.org/10.1016/j.jinorgbio.2018.02.004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jinorgbio.2018.02.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jinorgbio.2018.02.004%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Inorganic%2520Biochemistry%26atitle%3DBioactive%252Bruthenium%252528II%252529-arene%252Bcomplexes%252Bcontaining%252Bmodified%252B18%2525CE%2525B2-glycyrrhetinic%252Bacid%252Bligands%26aulast%3DKong%26aufirst%3DYaqiong%26date%3D2018%26volume%3D182%26spage%3D194%26epage%3D199" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Florence  Lefranc</span>, <span class="hlFld-ContribAuthor ">Nurhayat  Tabanca</span>, <span class="hlFld-ContribAuthor ">Robert  Kiss</span>. </span><span class="cited-content_cbyCitation_article-title">Assessing the anticancer effects associated with food products and/or nutraceuticals using in vitro and in vivo preclinical development-related pharmacological tests. </span><span class="cited-content_cbyCitation_journal-name">Seminars in Cancer Biology</span><span> <strong>2017,</strong> <em>46 </em>, 14-32. <a href="https://doi.org/10.1016/j.semcancer.2017.06.004" title="DOI URL">https://doi.org/10.1016/j.semcancer.2017.06.004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.semcancer.2017.06.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.semcancer.2017.06.004%26sid%3Dliteratum%253Aachs%26jtitle%3DSeminars%2520in%2520Cancer%2520Biology%26atitle%3DAssessing%252Bthe%252Banticancer%252Beffects%252Bassociated%252Bwith%252Bfood%252Bproducts%252Band%25252For%252Bnutraceuticals%252Busing%252Bin%252Bvitro%252Band%252Bin%252Bvivo%252Bpreclinical%252Bdevelopment-related%252Bpharmacological%252Btests%26aulast%3DLefranc%26aufirst%3DFlorence%26date%3D2017%26volume%3D46%26spage%3D14%26epage%3D32" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bing  Xu</span>, <span class="hlFld-ContribAuthor ">Gao-Rong  Wu</span>, <span class="hlFld-ContribAuthor ">Xin-Yu  Zhang</span>, <span class="hlFld-ContribAuthor ">Meng-Meng  Yan</span>, <span class="hlFld-ContribAuthor ">Rui  Zhao</span>, <span class="hlFld-ContribAuthor ">Nan-Nan  Xue</span>, <span class="hlFld-ContribAuthor ">Kang  Fang</span>, <span class="hlFld-ContribAuthor ">Hui  Wang</span>, <span class="hlFld-ContribAuthor ">Meng  Chen</span>, <span class="hlFld-ContribAuthor ">Wen-Bo  Guo</span>, <span class="hlFld-ContribAuthor ">Peng-Long  Wang</span>, <span class="hlFld-ContribAuthor ">Hai-Min  Lei</span>. </span><span class="cited-content_cbyCitation_article-title">An Overview of Structurally Modified Glycyrrhetinic Acid Derivatives as Antitumor Agents. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2017,</strong> <em>22 </em>
                                    (6)
                                     , 924. <a href="https://doi.org/10.3390/molecules22060924" title="DOI URL">https://doi.org/10.3390/molecules22060924</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules22060924&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules22060924%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DAn%252BOverview%252Bof%252BStructurally%252BModified%252BGlycyrrhetinic%252BAcid%252BDerivatives%252Bas%252BAntitumor%252BAgents%26aulast%3DXu%26aufirst%3DBing%26date%3D2017%26date%3D2017%26volume%3D22%26issue%3D6%26spage%3D924" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Katsushi  Kumata</span>, <span class="hlFld-ContribAuthor ">Joji  Yui</span>, <span class="hlFld-ContribAuthor ">Lin  Xie</span>, <span class="hlFld-ContribAuthor ">Yiding  Zhang</span>, <span class="hlFld-ContribAuthor ">Nobuki  Nengaki</span>, <span class="hlFld-ContribAuthor ">Masayuki  Fujinaga</span>, <span class="hlFld-ContribAuthor ">Tomoteru  Yamasaki</span>, <span class="hlFld-ContribAuthor ">Yoko  Shimoda</span>, <span class="hlFld-ContribAuthor ">Ming-Rong  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Radiosynthesis and preliminary PET evaluation of glycogen synthase kinase 3β (GSK-3β) inhibitors containing [11C]methylsulfanyl, [11C]methylsulfinyl or [11C]methylsulfonyl groups. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2015,</strong> <em>25 </em>
                                    (16)
                                     , 3230-3233. <a href="https://doi.org/10.1016/j.bmcl.2015.05.085" title="DOI URL">https://doi.org/10.1016/j.bmcl.2015.05.085</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2015.05.085&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2015.05.085%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DRadiosynthesis%252Band%252Bpreliminary%252BPET%252Bevaluation%252Bof%252Bglycogen%252Bsynthase%252Bkinase%252B3%2525CE%2525B2%252B%252528GSK-3%2525CE%2525B2%252529%252Binhibitors%252Bcontaining%252B%25255B11C%25255Dmethylsulfanyl%25252C%252B%25255B11C%25255Dmethylsulfinyl%252Bor%252B%25255B11C%25255Dmethylsulfonyl%252Bgroups%26aulast%3DKumata%26aufirst%3DKatsushi%26date%3D2015%26volume%3D25%26issue%3D16%26spage%3D3230%26epage%3D3233" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hong-En  Qu</span>, <span class="hlFld-ContribAuthor ">Ri-Zhen  Huang</span>, <span class="hlFld-ContribAuthor ">Gui-Yang  Yao</span>, <span class="hlFld-ContribAuthor ">Jiu-Ling  Li</span>, <span class="hlFld-ContribAuthor ">Man-Yi  Ye</span>, <span class="hlFld-ContribAuthor ">Heng-Shan  Wang</span>, <span class="hlFld-ContribAuthor ">Liangxian  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and pharmacological evaluation of novel bisindole derivatives bearing oximes moiety: Identification of novel proapoptotic agents. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>95 </em>, 400-415. <a href="https://doi.org/10.1016/j.ejmech.2015.03.058" title="DOI URL">https://doi.org/10.1016/j.ejmech.2015.03.058</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2015.03.058&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2015.03.058%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Bpharmacological%252Bevaluation%252Bof%252Bnovel%252Bbisindole%252Bderivatives%252Bbearing%252Boximes%252Bmoiety%25253A%252BIdentification%252Bof%252Bnovel%252Bproapoptotic%252Bagents%26aulast%3DQu%26aufirst%3DHong-En%26date%3D2015%26volume%3D95%26spage%3D400%26epage%3D415" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rajni  Sharma</span>, <span class="hlFld-ContribAuthor ">Santosh K.  Guru</span>, <span class="hlFld-ContribAuthor ">Shreyans K.  Jain</span>, <span class="hlFld-ContribAuthor ">Anup Singh  Pathania</span>, <span class="hlFld-ContribAuthor ">Ram A.  Vishwakarma</span>, <span class="hlFld-ContribAuthor ">Shashi  Bhushan</span>, <span class="hlFld-ContribAuthor ">Sandip B.  Bharate</span>. </span><span class="cited-content_cbyCitation_article-title">3-(2,6-Dichloro-benzyloxy)-11-oxo-olean-12-ene-29-oic acid, a semisynthetic derivative of glycyrrhetic acid: synthesis, antiproliferative, apoptotic and anti-angiogenesis activity. </span><span class="cited-content_cbyCitation_journal-name">MedChemComm</span><span> <strong>2015,</strong> <em>6 </em>
                                    (4)
                                     , 564-575. <a href="https://doi.org/10.1039/C4MD00344F" title="DOI URL">https://doi.org/10.1039/C4MD00344F</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C4MD00344F&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC4MD00344F%26sid%3Dliteratum%253Aachs%26jtitle%3DMedChemComm%26atitle%3D3-%2525282%25252C6-Dichloro-benzyloxy%252529-11-oxo-olean-12-ene-29-oic%252Bacid%25252C%252Ba%252Bsemisynthetic%252Bderivative%252Bof%252Bglycyrrhetic%252Bacid%25253A%252Bsynthesis%25252C%252Bantiproliferative%25252C%252Bapoptotic%252Band%252Banti-angiogenesis%252Bactivity%26aulast%3DSharma%26aufirst%3DRajni%26date%3D2015%26date%3D2015%26volume%3D6%26issue%3D4%26spage%3D564%26epage%3D575" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Cheng  Gao</span>, <span class="hlFld-ContribAuthor ">Fu-Jun  Dai</span>, <span class="hlFld-ContribAuthor ">Hai-Wei  Cui</span>, <span class="hlFld-ContribAuthor ">Shi-Hong  Peng</span>, <span class="hlFld-ContribAuthor ">Yuan  He</span>, <span class="hlFld-ContribAuthor ">Xue  Wang</span>, <span class="hlFld-ContribAuthor ">Zheng-Fang  Yi</span>, <span class="hlFld-ContribAuthor ">Wen-Wei  Qiu</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of Novel Heterocyclic Ring-Fused 18
              β
              -Glycyrrhetinic Acid Derivatives with Antitumor and Antimetastatic Activity. </span><span class="cited-content_cbyCitation_journal-name">Chemical Biology & Drug Design</span><span> <strong>2014,</strong> <em>84 </em>
                                    (2)
                                     , 223-233. <a href="https://doi.org/10.1111/cbdd.12308" title="DOI URL">https://doi.org/10.1111/cbdd.12308</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/cbdd.12308&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fcbdd.12308%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Biology%2520%2526%2520Drug%2520Design%26atitle%3DSynthesis%252Bof%252BNovel%252BHeterocyclic%252BRing-Fused%252B18%252B%2525CE%2525B2%252B-Glycyrrhetinic%252BAcid%252BDerivatives%252Bwith%252BAntitumor%252Band%252BAntimetastatic%252BActivity%26aulast%3DGao%26aufirst%3DCheng%26date%3D2014%26date%3D2014%26volume%3D84%26issue%3D2%26spage%3D223%26epage%3D233" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zong-Jiang  Xia</span>, <span class="hlFld-ContribAuthor ">Wei  Hu</span>, <span class="hlFld-ContribAuthor ">Yue-Bin  Wang</span>, <span class="hlFld-ContribAuthor ">Kun  Zhou</span>, <span class="hlFld-ContribAuthor ">Guo-Ju  Sun</span>. </span><span class="cited-content_cbyCitation_article-title">Expression heterogeneity research of ITGB3 and BCL-2 in lung adenocarcinoma tissue and adenocarcinoma cell line. </span><span class="cited-content_cbyCitation_journal-name">Asian Pacific Journal of Tropical Medicine</span><span> <strong>2014,</strong> <em>7 </em>
                                    (6)
                                     , 473-477. <a href="https://doi.org/10.1016/S1995-7645(14)60077-8" title="DOI URL">https://doi.org/10.1016/S1995-7645(14)60077-8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/S1995-7645(14)60077-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FS1995-7645%2814%2960077-8%26sid%3Dliteratum%253Aachs%26jtitle%3DAsian%2520Pacific%2520Journal%2520of%2520Tropical%2520Medicine%26atitle%3DExpression%252Bheterogeneity%252Bresearch%252Bof%252BITGB3%252Band%252BBCL-2%252Bin%252Blung%252Badenocarcinoma%252Btissue%252Band%252Badenocarcinoma%252Bcell%252Bline%26aulast%3DXia%26aufirst%3DZong-Jiang%26date%3D2014%26volume%3D7%26issue%3D6%26spage%3D473%26epage%3D477" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ji-Wen  Yuan</span>, <span class="hlFld-ContribAuthor ">She-Feng  Wang</span>, <span class="hlFld-ContribAuthor ">Zhong-Liang  Luo</span>, <span class="hlFld-ContribAuthor ">Han-Yue  Qiu</span>, <span class="hlFld-ContribAuthor ">Peng-Fei  Wang</span>, <span class="hlFld-ContribAuthor ">Xin  Zhang</span>, <span class="hlFld-ContribAuthor ">Yong-An  Yang</span>, <span class="hlFld-ContribAuthor ">Yong  Yin</span>, <span class="hlFld-ContribAuthor ">Fei  Zhang</span>, <span class="hlFld-ContribAuthor ">Hai-Liang  Zhu</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and biological evaluation of compounds which contain pyrazole, thiazole and naphthalene ring as antitumor agents. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2014,</strong> <em>24 </em>
                                    (10)
                                     , 2324-2328. <a href="https://doi.org/10.1016/j.bmcl.2014.03.072" title="DOI URL">https://doi.org/10.1016/j.bmcl.2014.03.072</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2014.03.072&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2014.03.072%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bcompounds%252Bwhich%252Bcontain%252Bpyrazole%25252C%252Bthiazole%252Band%252Bnaphthalene%252Bring%252Bas%252Bantitumor%252Bagents%26aulast%3DYuan%26aufirst%3DJi-Wen%26date%3D2014%26volume%3D24%26issue%3D10%26spage%3D2324%26epage%3D2328" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Masaru  Katoh</span>, <span class="hlFld-ContribAuthor ">Hitoshi  Nakagama</span>. </span><span class="cited-content_cbyCitation_article-title">FGF Receptors: Cancer Biology and Therapeutics. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Research Reviews</span><span> <strong>2014,</strong> <em>34 </em>
                                    (2)
                                     , 280-300. <a href="https://doi.org/10.1002/med.21288" title="DOI URL">https://doi.org/10.1002/med.21288</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/med.21288&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fmed.21288%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Research%2520Reviews%26atitle%3DFGF%252BReceptors%25253A%252BCancer%252BBiology%252Band%252BTherapeutics%26aulast%3DKatoh%26aufirst%3DMasaru%26date%3D2014%26date%3D2013%26volume%3D34%26issue%3D2%26spage%3D280%26epage%3D300" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bianka  Siewert</span>, <span class="hlFld-ContribAuthor ">René  Csuk</span>. </span><span class="cited-content_cbyCitation_article-title">Membrane damaging activity of a maslinic acid analog. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>74 </em>, 1-6. <a href="https://doi.org/10.1016/j.ejmech.2013.12.031" title="DOI URL">https://doi.org/10.1016/j.ejmech.2013.12.031</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2013.12.031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2013.12.031%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DMembrane%252Bdamaging%252Bactivity%252Bof%252Ba%252Bmaslinic%252Bacid%252Banalog%26aulast%3DSiewert%26aufirst%3DBianka%26date%3D2014%26volume%3D74%26spage%3D1%26epage%3D6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sohely  Sikdar</span>, <span class="hlFld-ContribAuthor ">Benjamin  Lallemand</span>, <span class="hlFld-ContribAuthor ">Jacques  Dubois</span>. </span><span class="cited-content_cbyCitation_article-title">Induction of Phase II Enzymes Glutathione-S-Transferase and NADPH: Quinone Oxydoreductase 1 with Novel Sulforaphane Derivatives in Human Keratinocytes: Evaluation of the Intracellular GSH Level. </span><span class="cited-content_cbyCitation_journal-name">Pharmacology & Pharmacy</span><span> <strong>2014,</strong> <em>05 </em>
                                    (10)
                                     , 937-943. <a href="https://doi.org/10.4236/pp.2014.510105" title="DOI URL">https://doi.org/10.4236/pp.2014.510105</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4236/pp.2014.510105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4236%2Fpp.2014.510105%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacology%2520%2526%2520Pharmacy%26atitle%3DInduction%252Bof%252BPhase%252BII%252BEnzymes%252BGlutathione-S-Transferase%252Band%252BNADPH%25253A%252BQuinone%252BOxydoreductase%252B1%252Bwith%252BNovel%252BSulforaphane%252BDerivatives%252Bin%252BHuman%252BKeratinocytes%25253A%252BEvaluation%252Bof%252Bthe%252BIntracellular%252BGSH%252BLevel%26aulast%3DSikdar%26aufirst%3DSohely%26date%3D2014%26volume%3D05%26issue%3D10%26spage%3D937%26epage%3D943" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Vânia M.  Moreira</span>, <span class="hlFld-ContribAuthor ">Jorge A.R.  Salvador</span>, <span class="hlFld-ContribAuthor ">Sérgio  Simões</span>, <span class="hlFld-ContribAuthor ">Federica  Destro</span>, <span class="hlFld-ContribAuthor ">Riccardo  Gavioli</span>. </span><span class="cited-content_cbyCitation_article-title">Novel oleanolic vinyl boronates: Synthesis and antitumor activity. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2013,</strong> <em>63 </em>, 46-56. <a href="https://doi.org/10.1016/j.ejmech.2013.01.040" title="DOI URL">https://doi.org/10.1016/j.ejmech.2013.01.040</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2013.01.040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2013.01.040%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNovel%252Boleanolic%252Bvinyl%252Bboronates%25253A%252BSynthesis%252Band%252Bantitumor%252Bactivity%26aulast%3DMoreira%26aufirst%3DV%25C3%25A2nia%2BM.%26date%3D2013%26volume%3D63%26spage%3D46%26epage%3D56" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marina  Bury</span>, <span class="hlFld-ContribAuthor ">Anna  Andolfi</span>, <span class="hlFld-ContribAuthor ">Bernard  Rogister</span>, <span class="hlFld-ContribAuthor ">Alessio  Cimmino</span>, <span class="hlFld-ContribAuthor ">Véronique  Mégalizzi</span>, <span class="hlFld-ContribAuthor ">Véronique  Mathieu</span>, <span class="hlFld-ContribAuthor ">Olivier  Feron</span>, <span class="hlFld-ContribAuthor ">Antonio  Evidente</span>, <span class="hlFld-ContribAuthor ">Robert  Kiss</span>. </span><span class="cited-content_cbyCitation_article-title">Fusicoccin A, a Phytotoxic Carbotricyclic Diterpene Glucoside of Fungal Origin, Reduces Proliferation and Invasion of Glioblastoma Cells by Targeting Multiple Tyrosine Kinases. </span><span class="cited-content_cbyCitation_journal-name">Translational Oncology</span><span> <strong>2013,</strong> <em>6 </em>
                                    (2)
                                     , 112-123. <a href="https://doi.org/10.1593/tlo.12409" title="DOI URL">https://doi.org/10.1593/tlo.12409</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1593/tlo.12409&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1593%2Ftlo.12409%26sid%3Dliteratum%253Aachs%26jtitle%3DTranslational%2520Oncology%26atitle%3DFusicoccin%252BA%25252C%252Ba%252BPhytotoxic%252BCarbotricyclic%252BDiterpene%252BGlucoside%252Bof%252BFungal%252BOrigin%25252C%252BReduces%252BProliferation%252Band%252BInvasion%252Bof%252BGlioblastoma%252BCells%252Bby%252BTargeting%252BMultiple%252BTyrosine%252BKinases%26aulast%3DBury%26aufirst%3DMarina%26date%3D2013%26volume%3D6%26issue%3D2%26spage%3D112%26epage%3D123" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">M  Bury</span>, <span class="hlFld-ContribAuthor ">A  Girault</span>, <span class="hlFld-ContribAuthor ">V  Mégalizzi</span>, <span class="hlFld-ContribAuthor ">S  Spiegl-Kreinecker</span>, <span class="hlFld-ContribAuthor ">V  Mathieu</span>, <span class="hlFld-ContribAuthor ">W  Berger</span>, <span class="hlFld-ContribAuthor ">A  Evidente</span>, <span class="hlFld-ContribAuthor ">A  Kornienko</span>, <span class="hlFld-ContribAuthor ">P  Gailly</span>, <span class="hlFld-ContribAuthor ">C  Vandier</span>, <span class="hlFld-ContribAuthor ">R  Kiss</span>. </span><span class="cited-content_cbyCitation_article-title">Ophiobolin A induces paraptosis-like cell death in human glioblastoma cells by decreasing BKCa channel activity. </span><span class="cited-content_cbyCitation_journal-name">Cell Death & Disease</span><span> <strong>2013,</strong> <em>4 </em>
                                    (3)
                                     , e561-e561. <a href="https://doi.org/10.1038/cddis.2013.85" title="DOI URL">https://doi.org/10.1038/cddis.2013.85</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/cddis.2013.85&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fcddis.2013.85%26sid%3Dliteratum%253Aachs%26jtitle%3DCell%2520Death%2520%2526%2520Disease%26atitle%3DOphiobolin%252BA%252Binduces%252Bparaptosis-like%252Bcell%252Bdeath%252Bin%252Bhuman%252Bglioblastoma%252Bcells%252Bby%252Bdecreasing%252BBKCa%252Bchannel%252Bactivity%26aulast%3DBury%26aufirst%3DM%26date%3D2013%26date%3D2013%26volume%3D4%26issue%3D3%26spage%3De561%26epage%3De561" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Benjamin  Lallemand</span>, <span class="hlFld-ContribAuthor ">Moustapha  Ouedraogo</span>, <span class="hlFld-ContribAuthor ">Nathalie  Wauthoz</span>, <span class="hlFld-ContribAuthor ">Touria  Lamkami</span>, <span class="hlFld-ContribAuthor ">Veronique  Mathieu</span>, <span class="hlFld-ContribAuthor ">Ivan  Jabin</span>, <span class="hlFld-ContribAuthor ">Karim  Amighi</span>, <span class="hlFld-ContribAuthor ">Robert  Kiss</span>, <span class="hlFld-ContribAuthor ">Jacques  Dubois</span>, <span class="hlFld-ContribAuthor ">Jonathan  Goole</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and plasma pharmacokinetics in CD-1 mice of a 18β-glycyrrhetinic acid derivative displaying anti-cancer activity. </span><span class="cited-content_cbyCitation_journal-name">Journal of Pharmacy and Pharmacology</span><span> <strong>2013,</strong> <em>65 </em>
                                    (3)
                                     , 402-410. <a href="https://doi.org/10.1111/j.2042-7158.2012.01603.x" title="DOI URL">https://doi.org/10.1111/j.2042-7158.2012.01603.x</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/j.2042-7158.2012.01603.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fj.2042-7158.2012.01603.x%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Pharmacy%2520and%2520Pharmacology%26atitle%3DSynthesis%252Band%252Bplasma%252Bpharmacokinetics%252Bin%252BCD-1%252Bmice%252Bof%252Ba%252B18%2525CE%2525B2-glycyrrhetinic%252Bacid%252Bderivative%252Bdisplaying%252Banti-cancer%252Bactivity%26aulast%3DLallemand%26aufirst%3DBenjamin%26date%3D2013%26date%3D2012%26volume%3D65%26issue%3D3%26spage%3D402%26epage%3D410" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Monica Rosa  Loizzo</span>, <span class="hlFld-ContribAuthor ">Francesco  Menichini</span>, <span class="hlFld-ContribAuthor ">Rosa  Tundis</span>. </span><span class="cited-content_cbyCitation_article-title">Recent Insights into the Emerging Role of Triterpenoids in Cancer Therapy. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2013,</strong>,, 1-31. <a href="https://doi.org/10.1016/B978-0-444-59603-1.00001-1" title="DOI URL">https://doi.org/10.1016/B978-0-444-59603-1.00001-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-444-59603-1.00001-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-444-59603-1.00001-1%26sid%3Dliteratum%253Aachs%26atitle%3DRecent%252BInsights%252Binto%252Bthe%252BEmerging%252BRole%252Bof%252BTriterpenoids%252Bin%252BCancer%252BTherapy%26aulast%3DLoizzo%26aufirst%3DMonica%2BRosa%26date%3D2013%26spage%3D1%26epage%3D31%26pub%3DElsevier%26date%3D2013%26volume%3D40" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jun  Hu</span>, <span class="hlFld-ContribAuthor ">Jindan  Wu</span>, <span class="hlFld-ContribAuthor ">Jinrong  Lu</span>, <span class="hlFld-ContribAuthor ">Yong  Ju</span>. </span><span class="cited-content_cbyCitation_article-title">A dual-responsive macrocycle based on glycyrrhetinic acid. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2012,</strong> <em>53 </em>
                                    (49)
                                     , 6705-6709. <a href="https://doi.org/10.1016/j.tetlet.2012.09.118" title="DOI URL">https://doi.org/10.1016/j.tetlet.2012.09.118</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2012.09.118&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2012.09.118%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DA%252Bdual-responsive%252Bmacrocycle%252Bbased%252Bon%252Bglycyrrhetinic%252Bacid%26aulast%3DHu%26aufirst%3DJun%26date%3D2012%26volume%3D53%26issue%3D49%26spage%3D6705%26epage%3D6709" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chiharu  Asakawa</span>, <span class="hlFld-ContribAuthor ">Masanao  Ogawa</span>, <span class="hlFld-ContribAuthor ">Masayuki  Fujinaga</span>, <span class="hlFld-ContribAuthor ">Katsushi  Kumata</span>, <span class="hlFld-ContribAuthor ">Lin  Xie</span>, <span class="hlFld-ContribAuthor ">Tomoteru  Yamasaki</span>, <span class="hlFld-ContribAuthor ">Joji  Yui</span>, <span class="hlFld-ContribAuthor ">Toshimitsu  Fukumura</span>, <span class="hlFld-ContribAuthor ">Ming-Rong  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Utilization of [11C]phosgene for radiosynthesis of N-(2-{3-[3,5-bis(trifluoromethyl)]phenyl[11C]ureido}ethyl)glycyrrhetinamide, an inhibitory agent for proteasome and kinase in tumors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2012,</strong> <em>22 </em>
                                    (11)
                                     , 3594-3597. <a href="https://doi.org/10.1016/j.bmcl.2012.04.049" title="DOI URL">https://doi.org/10.1016/j.bmcl.2012.04.049</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2012.04.049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2012.04.049%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DUtilization%252Bof%252B%25255B11C%25255Dphosgene%252Bfor%252Bradiosynthesis%252Bof%252BN-%2525282-%25257B3-%25255B3%25252C5-bis%252528trifluoromethyl%252529%25255Dphenyl%25255B11C%25255Dureido%25257Dethyl%252529glycyrrhetinamide%25252C%252Ban%252Binhibitory%252Bagent%252Bfor%252Bproteasome%252Band%252Bkinase%252Bin%252Btumors%26aulast%3DAsakawa%26aufirst%3DChiharu%26date%3D2012%26volume%3D22%26issue%3D11%26spage%3D3594%26epage%3D3597" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-19/jm200285z/production/images/medium/jm-2011-00285z_0006.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-19/jm200285z/production/images/large/jm-2011-00285z_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200285z&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-19/jm200285z/production/images/medium/jm-2011-00285z_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-19/jm200285z/production/images/large/jm-2011-00285z_0008.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Chemical structure of GA (<b>1</b>) illustrating the R1 and R2 sites on which modifications were carried out (see Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-19/jm200285z/production/images/large/jm-2011-00285z_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200285z&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-19/jm200285z/production/images/medium/jm-2011-00285z_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-19/jm200285z/production/images/large/jm-2011-00285z_0005.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. <sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-19/jm200285z/production/images/large/jm-2011-00285z_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200285z&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 1°. DCC, HOBt, DIPEA, DMF, RT, 30 min; 2°. R<sub>1</sub>NH<sub>2</sub>, RT, overnight; (b) 1°. DCC, HOBt, DIPEA, DMF, RT, 30 min; 2°. H<sub>2</sub>N(CH<sub>2</sub>)<sub>2</sub>NHBoc, RT, overnight, 64%; (c) TFA, DCM, 0 °C, 3 h, 97%; (d) DMAP, RCOCl, DCM; (e) THF, RNCO, RT, 20 h; (f) THF, RNCS, RT, 20 h; (g) Jones reagent, acetone, 0 °C, 45 min, 98%.</p></p></figure><figure data-id="fig2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-19/jm200285z/production/images/medium/jm-2011-00285z_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-19/jm200285z/production/images/large/jm-2011-00285z_0001.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. (A) Determination of the percentages of A549 NSCLC and U373 GBM cells undergoing apoptosis during 48 and 72 h of treatment with 80 (U373 cells) and 100 (A549 cells) μM for compound <b>1</b> and 10 μM (for both cell lines) for compound <b>6b</b>. Negative (Ct<sup>–</sup>) and positive (Ct<sup>+</sup>) controls available in the kit were used along with 1 μM narciclasine-treated human PC-3 prostate cancer cells as controls for this experiment. (B) Growth rate determination (i.e., the determination of the % of cells in the G1 phase of the cell cycle) for the U373 GBM and A549 NSCLC cells treated as in (C). Each experimental condition was performed in triplicate, and the data are presented as the mean ± SD values.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-19/jm200285z/production/images/large/jm-2011-00285z_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200285z&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-19/jm200285z/production/images/medium/jm-2011-00285z_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-19/jm200285z/production/images/large/jm-2011-00285z_0002.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. (A) Determination of the effects of the 10 compounds in this study on the proteolytic activity of the proteasome in human U373 GBM cells treated with each compound at their IC<sub>50</sub><i>in vitro</i> growth inhibitory concentrations, which are detailed in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>. MG-132 (0.5 μM) was used as a reference compound. The data are presented as mean ± SD values calculated in triplicate for each experimental condition. The <i>Y</i>-axis is on a logarithmic scale. (B) Ribbon representation of the 20S proteasome crystallographic structure bound to the fellutamide B ligand in the three pairs of binding sites (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3D29">3D29</a>): chymotrypsin-like sites (CT-L), trypsin-like sites (T-L), caspase-like sites (C-L). Fellutamide B is depicted as balls. (C,D) Comparison of the predicted best affinity binding modes of compounds <b>6b</b> (C) and <b>3e</b> (D) in the chymotrypsin-like site of the 3D29 crystal structure. The ligands are depicted as sticks and the protein is represented by its molecular surface. The S3 specificity pocket is indicated.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-19/jm200285z/production/images/large/jm-2011-00285z_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200285z&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-19/jm200285z/production/images/medium/jm-2011-00285z_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-19/jm200285z/production/images/large/jm-2011-00285z_0003.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Determination of activating versus inhibiting effects of the 10 compounds in this study (the same as those used for proteasome-related studies; see Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>A) on PPAR-γ. Each compound has been analyzed at its IC<sub>50</sub> in vitro growth inhibitory concentration in the human U373 GBM cell line (see Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a> and its legend) treated for 6 h with the compound. The data are presented as mean ± SD values calculated in triplicate for each experimental condition. Determination of the effects of the 10 compounds after 6 h of treatment of human U373 GBM cells.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-19/jm200285z/production/images/large/jm-2011-00285z_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200285z&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i34">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_07376" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_07376" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 90 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Obolentseva, G. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Litvinenko, V. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ammosov, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Popova, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sampiev, A. M.</span><span> </span><span class="NLM_article-title">Pharmacological and therapeutic properties of licorice preparations</span> <span class="citation_source-journal">Pharm. Chem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">427</span><span class="NLM_x">–</span> <span class="NLM_lpage">434</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm200285z&amp;key=10.1007%2FBF02510095" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm200285z&amp;key=1%3ACAS%3A528%3ADC%252BD3cXitlaiurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=1999&pages=427-434&author=G.+V.+Obolentsevaauthor=V.+I.+Litvinenkoauthor=A.+S.+Ammosovauthor=T.+P.+Popovaauthor=A.+M.+Sampiev&title=Pharmacological+and+therapeutic+properties+of+licorice+preparations"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological and therapeutic properties of licorice preparations</span></div><div class="casAuthors">Obolentseva, G. V.; Litvinenko, V. I.; Ammosov, A. S.; Popova, T. P.; Sampiev, A. M.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmaceutical Chemistry Journal (Translation of Khimiko-Farmatsevticheskii Zhurnal)</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">427-434</span>CODEN:
                <span class="NLM_cas:coden">PCJOAU</span>;
        ISSN:<span class="NLM_cas:issn">0091-150X</span>.
    
            (<span class="NLM_cas:orgname">Consultants Bureau</span>)
        </div><div class="casAbstract">A review with 233 refs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqdYml3W0b_7Vg90H21EOLACvtfcHk0lhIoiEn7vYYNQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXitlaiurk%253D&md5=7c25467d53fe60468cb26a24c9310b2d</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1007%2FBF02510095&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF02510095%26sid%3Dliteratum%253Aachs%26aulast%3DObolentseva%26aufirst%3DG.%2BV.%26aulast%3DLitvinenko%26aufirst%3DV.%2BI.%26aulast%3DAmmosov%26aufirst%3DA.%2BS.%26aulast%3DPopova%26aufirst%3DT.%2BP.%26aulast%3DSampiev%26aufirst%3DA.%2BM.%26atitle%3DPharmacological%2520and%2520therapeutic%2520properties%2520of%2520licorice%2520preparations%26jtitle%3DPharm.%2520Chem.%2520J.%26date%3D1999%26volume%3D33%26spage%3D427%26epage%3D434" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Abe, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohya, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamoto, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shibuya, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arichi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Odashima, S.</span><span> </span><span class="NLM_article-title">Effects of glycyrrhizin and glycyrrhetinic acid on growth and melanogenesis in cultured B16 melanoma cells</span> <span class="citation_source-journal">Eur. J. Cancer Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1987</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">1549</span><span class="NLM_x">–</span> <span class="NLM_lpage">1555</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm200285z&amp;key=10.1016%2F0277-5379%2887%2990099-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm200285z&amp;key=3678319" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm200285z&amp;key=1%3ACAS%3A528%3ADyaL1cXivFw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=1987&pages=1549-1555&author=H.+Abeauthor=N.+Ohyaauthor=K.+F.+Yamamotoauthor=T.+Shibuyaauthor=S.+Arichiauthor=S.+Odashima&title=Effects+of+glycyrrhizin+and+glycyrrhetinic+acid+on+growth+and+melanogenesis+in+cultured+B16+melanoma+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of glycyrrhizin and glycyrrhetinic acid on growth and melanogenesis in cultured B16 melanoma cells</span></div><div class="casAuthors">Abe, Hiroko; Ohya, Nobuo; Yamamoto, Kohzaburo Fujikawa; Shibuya, Tomonori; Arichi, Shigeru; Odashima, Shizuo</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Cancer & Clinical Oncology</span>
        (<span class="NLM_cas:date">1987</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1549-55</span>CODEN:
                <span class="NLM_cas:coden">EJCODS</span>;
        ISSN:<span class="NLM_cas:issn">0277-5379</span>.
    </div><div class="casAbstract">The effects of glycyrrhizin (I) and its aglycon, glycyrrhetinic acid (II), on the growth and differentiation of mouse melanoma (B16) cells in culture were studied.  II inhibited the growth of B16 melanoma cells, caused morphol. alterations and stimulated melanogenesis.  I also resulted in the same changes but only when the concn. was 20 times more than that needed for II.  When II was removed after 84 h of treatment, the growth rate recovered slightly, but the doubling time was about twice that of the control.  Cytofluorometric anal. showed that the growth inhibition of II is the result of inhibition of the transfer from G1 to S phase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpVCR6Z17EnGLVg90H21EOLACvtfcHk0lhIoiEn7vYYNQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1cXivFw%253D&md5=cc74670d01b03337319c8d1a38a05571</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2F0277-5379%2887%2990099-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0277-5379%252887%252990099-X%26sid%3Dliteratum%253Aachs%26aulast%3DAbe%26aufirst%3DH.%26aulast%3DOhya%26aufirst%3DN.%26aulast%3DYamamoto%26aufirst%3DK.%2BF.%26aulast%3DShibuya%26aufirst%3DT.%26aulast%3DArichi%26aufirst%3DS.%26aulast%3DOdashima%26aufirst%3DS.%26atitle%3DEffects%2520of%2520glycyrrhizin%2520and%2520glycyrrhetinic%2520acid%2520on%2520growth%2520and%2520melanogenesis%2520in%2520cultured%2520B16%2520melanoma%2520cells%26jtitle%3DEur.%2520J.%2520Cancer%2520Clin.%2520Oncol.%26date%3D1987%26volume%3D23%26spage%3D1549%26epage%3D1555" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Okamoto, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshida, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mizusaki, S.</span><span> </span><span class="NLM_article-title">Inhibition of 12-O-tetradecanoylphorbol-13-acetate-induced induction in Epstein-Barr virus early antigen in Raji cells</span> <span class="citation_source-journal">Cancer Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1983</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">47</span><span class="NLM_x">–</span> <span class="NLM_lpage">53</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm200285z&amp;key=10.1016%2F0304-3835%2883%2990134-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm200285z&amp;key=6850568" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm200285z&amp;key=1%3ACAS%3A528%3ADyaL3sXktVWlsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=1983&pages=47-53&author=H.+Okamotoauthor=D.+Yoshidaauthor=S.+Mizusaki&title=Inhibition+of+12-O-tetradecanoylphorbol-13-acetate-induced+induction+in+Epstein-Barr+virus+early+antigen+in+Raji+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of 12-O-tetradecanoylphorbol-13-acetate-induced induction in Epstein-Barr virus early antigen in Raji cells</span></div><div class="casAuthors">Okamoto, Hitoshi; Yoshida, Daisuke; Mizusaki, Shigenobu</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (Shannon, Ireland)</span>
        (<span class="NLM_cas:date">1983</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">47-53</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    </div><div class="casAbstract">Retinol  [68-26-8], 5 flavonoids, 3 steroids, and 7 sweetening agents were studied for their effects on TPA (I)  [16561-29-8]-induced early antigen (EA) of Epstein-Barr virus (EBV) in Raji cells.  Concomitant treatment of Raji cells with TPA and retinol inhibited EA induction.  Among flavonoids, quercetin  [117-39-5] resulted in effective inhibition of EA induction by TPA and α-naphthoflavone  [604-59-1] showed a weakly inhibitory effect.  None of the other flavonoids such as rutin  [153-18-4], catechin  [154-23-4] and β-naphthoflavone  [6051-87-2] affected the induction of EBV-EA by TPA.  β-Estradiol  [50-28-2] obviously inhibited EBV-EA induction by TPA, but hydrocortisone  [50-23-7] did not show any inhibitory effect.  Glycyrrhetinic acid, steviol, phyllodulcin and perrillartine also strongly inhibited EBV-EA induction.  Glycyrrhizin  [1405-86-3] and stevioside  [57817-89-7], glycosides of glycyrrhetinic acid  [471-53-4] and steviol  [471-80-7], did not inhibit the induction of EBV-EA by TPA.  Some of these inhibitors may be effective in inhibiting the in vivo tumor promotion by TPA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMhn98hrIvc7Vg90H21EOLACvtfcHk0lhIoiEn7vYYNQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3sXktVWlsrY%253D&md5=6edaa2eb895927ef70549c0aaf189f74</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2F0304-3835%2883%2990134-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0304-3835%252883%252990134-9%26sid%3Dliteratum%253Aachs%26aulast%3DOkamoto%26aufirst%3DH.%26aulast%3DYoshida%26aufirst%3DD.%26aulast%3DMizusaki%26aufirst%3DS.%26atitle%3DInhibition%2520of%252012-O-tetradecanoylphorbol-13-acetate-induced%2520induction%2520in%2520Epstein-Barr%2520virus%2520early%2520antigen%2520in%2520Raji%2520cells%26jtitle%3DCancer%2520Lett.%26date%3D1983%26volume%3D19%26spage%3D47%26epage%3D53" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Hibasami, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwase, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshioka, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takahashi, H.</span><span> </span><span class="NLM_article-title">Glycyrrhetic acid (a metabolic substance and aglycon of glycyrrhizin) induces apoptosis in human hepatoma, promyelotic leukemia and stomach cancer cells</span> <span class="citation_source-journal">Int. J. Mol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">215</span><span class="NLM_x">–</span> <span class="NLM_lpage">219</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm200285z&amp;key=16391818" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm200285z&amp;key=1%3ACAS%3A528%3ADC%252BD28XhsVems74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2006&pages=215-219&author=H.+Hibasamiauthor=H.+Iwaseauthor=K.+Yoshiokaauthor=H.+Takahashi&title=Glycyrrhetic+acid+%28a+metabolic+substance+and+aglycon+of+glycyrrhizin%29+induces+apoptosis+in+human+hepatoma%2C+promyelotic+leukemia+and+stomach+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Glycyrrhetic acid (a metabolic substance and aglycon of glycyrrhizin) induces apoptosis in human hepatoma, promyelotic leukemia and stomach cancer cells</span></div><div class="casAuthors">Hibasami, Hiroshige; Iwase, Hirosi; Yoshioka, Kazumi; Takahashi, Hidehisa</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Molecular Medicine</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">215-219</span>CODEN:
                <span class="NLM_cas:coden">IJMMFG</span>;
        ISSN:<span class="NLM_cas:issn">1107-3756</span>.
    
            (<span class="NLM_cas:orgname">International Journal of Molecular Medicine</span>)
        </div><div class="casAbstract">We have investigated the effect of glycyrrhetic acid (GR) which is metabolic substance of glycyrrhizin, on DNA of human hepatoma (HLE), promyelotic leukemia (HL-60) and stomach cancer (KATO III) cells.  GR displayed apoptotic effects against HLE, HL-60 and KATO III cells.  The fragmentation of DNA by GR to oligonucleosomal-sized fragments, a characteristic of apoptosis, was dose- and time-dependent in these cell lines.  These findings suggest that growth inhibition of these cell lines by GR result from the induction of apoptosis by the compd.  Inhibitors of caspases did not suppress the DNA fragmentation caused by GR.  N-acetyl-L-cysteine, an antioxidant drug, weakly inhibited the DNA fragmentation caused by GR suggesting that active oxidants work partly as an apoptosis-inducing transfer substance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpm5LSdAeap-LVg90H21EOLACvtfcHk0lhIoiEn7vYYNQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhsVems74%253D&md5=dc50bcb99f77068ea8765fa4352a754f</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHibasami%26aufirst%3DH.%26aulast%3DIwase%26aufirst%3DH.%26aulast%3DYoshioka%26aufirst%3DK.%26aulast%3DTakahashi%26aufirst%3DH.%26atitle%3DGlycyrrhetic%2520acid%2520%2528a%2520metabolic%2520substance%2520and%2520aglycon%2520of%2520glycyrrhizin%2529%2520induces%2520apoptosis%2520in%2520human%2520hepatoma%252C%2520promyelotic%2520leukemia%2520and%2520stomach%2520cancer%2520cells%26jtitle%3DInt.%2520J.%2520Mol.%2520Med.%26date%3D2006%26volume%3D17%26spage%3D215%26epage%3D219" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Isbrucker, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burdock, G. A.</span><span> </span><span class="NLM_article-title">Risk and safety assessment on the consumption of licorice root (Glycyrrhiza sp.), its extract and powder as a food ingredient, with emphasis on the pharmacology and toxicology of glycyrrhizin</span> <span class="citation_source-journal">Regul. Toxicol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">167</span><span class="NLM_x">–</span> <span class="NLM_lpage">192</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm200285z&amp;key=10.1016%2Fj.yrtph.2006.06.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm200285z&amp;key=16884839" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm200285z&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1Shu7nO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2006&pages=167-192&author=R.+A.+Isbruckerauthor=G.+A.+Burdock&title=Risk+and+safety+assessment+on+the+consumption+of+licorice+root+%28Glycyrrhiza+sp.%29%2C+its+extract+and+powder+as+a+food+ingredient%2C+with+emphasis+on+the+pharmacology+and+toxicology+of+glycyrrhizin"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Risk and safety assessment on the consumption of licorice root (Glycyrrhiza sp.), its extract and powder as a food ingredient, with emphasis on the pharmacology and toxicology of glycyrrhizin</span></div><div class="casAuthors">Isbrucker, R. A.; Burdock, G. A.</div><div class="citationInfo"><span class="NLM_cas:title">Regulatory Toxicology and Pharmacology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">167-192</span>CODEN:
                <span class="NLM_cas:coden">RTOPDW</span>;
        ISSN:<span class="NLM_cas:issn">0273-2300</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Licorice (or 'liquorice') is a plant of ancient origin and steeped in history.  Licorice exts. and its principal component, glycyrrhizin, have extensive use in foods, tobacco and in both traditional and herbal medicine.  As a result, there is a high level of use of licorice and glycyrrhizin in the US with an estd. consumption of 0.027-3.6 mg glycyrrhizin/kg/day.  Both products have been approved for use in foods by most national and supranational regulatory agencies.  Biochem. studies indicate that glycyrrhizinates inhibit 11β-hydroxysteroid dehydrogenase, the enzyme responsible for inactivating cortisol.  As a result, the continuous, high level exposure to glycyrrhizin compds. can produce hypermineralocorticoid-like effects in both animals and humans.  These effects are reversible upon withdrawal of licorice or glycyrrhizin.  Other in vivo and clin. studies have reported beneficial effects of both licorice and glycyrrhizin consumption including anti-ulcer, anti-viral, and hepatoprotective responses.  Various genotoxic studies have indicated that glycyrrhizin is neither teratogenic nor mutagenic, and may possess anti-genotoxic properties under certain conditions.  The pharmacokinetics of glycyrrhizin have been described and show that its bioavailability is reduced when consumed as licorice; this has hampered attempts to establish clear dose-effect levels in animals and humans.  Based on the in vivo and clin. evidence, we propose an acceptable daily intake of 0.015-0.229 mg glycyrrhizin/kg body wt./day.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqjZnEsEDY27LVg90H21EOLACvtfcHk0ljxHyJ7tEfw5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1Shu7nO&md5=2327dc6295670decb4904d60b393c3b2</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.yrtph.2006.06.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.yrtph.2006.06.002%26sid%3Dliteratum%253Aachs%26aulast%3DIsbrucker%26aufirst%3DR.%2BA.%26aulast%3DBurdock%26aufirst%3DG.%2BA.%26atitle%3DRisk%2520and%2520safety%2520assessment%2520on%2520the%2520consumption%2520of%2520licorice%2520root%2520%2528Glycyrrhiza%2520sp.%2529%252C%2520its%2520extract%2520and%2520powder%2520as%2520a%2520food%2520ingredient%252C%2520with%2520emphasis%2520on%2520the%2520pharmacology%2520and%2520toxicology%2520of%2520glycyrrhizin%26jtitle%3DRegul.%2520Toxicol.%2520Pharmacol.%26date%3D2006%26volume%3D46%26spage%3D167%26epage%3D192" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Zhang, M.-Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yin, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shrubsole, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kon, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pozzi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, R. C.</span><span> </span><span class="NLM_article-title">Inhibition of 11beta-hydroxysteroid dehydrogenase type II selectively blocks the tumor COX-2 pathway and suppresses colon carcinogenesis in mice and humans</span> <span class="citation_source-journal">J. Clin. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">119</span><span class="NLM_x">, </span> <span class="NLM_fpage">876</span><span class="NLM_x">–</span> <span class="NLM_lpage">885</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=119&publication_year=2009&pages=876-885&author=M.-Z.+Zhangauthor=J.+Xuauthor=B.+Yaoauthor=H.+Yinauthor=Q.+Caiauthor=M.+J.+Shrubsoleauthor=X.+Chenauthor=V.+Konauthor=W.+Zhengauthor=A.+Pozziauthor=R.+C.+Harris&title=Inhibition+of+11beta-hydroxysteroid+dehydrogenase+type+II+selectively+blocks+the+tumor+COX-2+pathway+and+suppresses+colon+carcinogenesis+in+mice+and+humans"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DM.-Z.%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DYao%26aufirst%3DB.%26aulast%3DYin%26aufirst%3DH.%26aulast%3DCai%26aufirst%3DQ.%26aulast%3DShrubsole%26aufirst%3DM.%2BJ.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DKon%26aufirst%3DV.%26aulast%3DZheng%26aufirst%3DW.%26aulast%3DPozzi%26aufirst%3DA.%26aulast%3DHarris%26aufirst%3DR.%2BC.%26atitle%3DInhibition%2520of%252011beta-hydroxysteroid%2520dehydrogenase%2520type%2520II%2520selectively%2520blocks%2520the%2520tumor%2520COX-2%2520pathway%2520and%2520suppresses%2520colon%2520carcinogenesis%2520in%2520mice%2520and%2520humans%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2009%26volume%3D119%26spage%3D876%26epage%3D885" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Satomi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishino, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shibata, S.</span><span> </span><span class="NLM_article-title">Glycyrrhetinic acid and related compounds induce G1 arrest and apoptosis in human hepatocellular carcinoma HepG2</span> <span class="citation_source-journal">Anticancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">4043</span><span class="NLM_x">–</span> <span class="NLM_lpage">4047</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm200285z&amp;key=16309197" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm200285z&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht12it7zE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2005&pages=4043-4047&author=Y.+Satomiauthor=H.+Nishinoauthor=S.+Shibata&title=Glycyrrhetinic+acid+and+related+compounds+induce+G1+arrest+and+apoptosis+in+human+hepatocellular+carcinoma+HepG2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Glycyrrhetinic acid and related compounds induce G1 arrest and apoptosis in human hepatocellular carcinoma HepG2</span></div><div class="casAuthors">Satomi, Yoshiko; Nishino, Hoyoku; Shibata, Shoji</div><div class="citationInfo"><span class="NLM_cas:title">Anticancer Research</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">6B</span>),
    <span class="NLM_cas:pages">4043-4047</span>CODEN:
                <span class="NLM_cas:coden">ANTRD4</span>;
        ISSN:<span class="NLM_cas:issn">0250-7005</span>.
    
            (<span class="NLM_cas:orgname">International Institute of Anticancer Research</span>)
        </div><div class="casAbstract">Glycyrrhetinic acid (GA) and its related compds. are known to have anti-inflammatory activity and also to inhibit liver carcinogenesis and tumor growth.  GA and related compds. inhibited cell proliferation of the human hepatoma cell line, HepG2.  Among five compds. tested, ursolic acid and 18β-olean-12-ene-3β, 23, 28-triol (18β-erythrotriol) were comparatively effective, where the 50% ID was 20 μM and 25 μM, resp.  Flow-cytometric anal. showed that GA and the related compds. arrested the cell cycle in the G1-phase; in addn., GA-related compds. induced apoptosis at high dose.  Western blot anal. indicated that the induction of apoptosis by GA and ursolic acid was accompanied with an activation of caspase-8 and a redn. in the anti-apoptotic proteins, Bcl-2 and Bcl-xL, although the pro-apoptotic proteins, Box and Bak, remained unaffected.  These results suggest that GA and its related compds. may be potent agents in liver cancer treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqweWdvqUmqKLVg90H21EOLACvtfcHk0ljxHyJ7tEfw5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht12it7zE&md5=f094cb71d69c29db07311c71ac052675</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSatomi%26aufirst%3DY.%26aulast%3DNishino%26aufirst%3DH.%26aulast%3DShibata%26aufirst%3DS.%26atitle%3DGlycyrrhetinic%2520acid%2520and%2520related%2520compounds%2520induce%2520G1%2520arrest%2520and%2520apoptosis%2520in%2520human%2520hepatocellular%2520carcinoma%2520HepG2%26jtitle%3DAnticancer%2520Res.%26date%3D2005%26volume%3D25%26spage%3D4043%26epage%3D4047" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Hawthorne, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallagher, S.</span><span> </span><span class="NLM_article-title">Effects of glycyrrhetinic acid and liquorice extract on cell proliferation and prostate-specific antigen secretion in LNCaP prostate cancer cells</span> <span class="citation_source-journal">J. Pharm. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">661</span><span class="NLM_x">–</span> <span class="NLM_lpage">666</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm200285z&amp;key=10.1211%2Fjpp.60.5.0013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm200285z&amp;key=18416944" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm200285z&amp;key=1%3ACAS%3A528%3ADC%252BD1cXltlemt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2008&pages=661-666&author=S.+Hawthorneauthor=S.+Gallagher&title=Effects+of+glycyrrhetinic+acid+and+liquorice+extract+on+cell+proliferation+and+prostate-specific+antigen+secretion+in+LNCaP+prostate+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of glycyrrhetinic acid and liquorice extract on cell proliferation and prostate-specific antigen secretion in LNCaP prostate cancer cells</span></div><div class="casAuthors">Hawthorne, Susan; Gallagher, Sandra</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacy and Pharmacology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">661-666</span>CODEN:
                <span class="NLM_cas:coden">JPPMAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3573</span>.
    
            (<span class="NLM_cas:orgname">Pharmaceutical Press</span>)
        </div><div class="casAbstract">Glycyrrhetinic acid (GA) is the active metabolite of glycyrrhizic acid, one of the components of liquorice ext.  It has been shown to possess anti-inflammatory activity and to inhibit hepatic tumor growth.  In this preliminary study, we have shown that GA could significantly reduce the rate of proliferation of LNCaP androgen dependent prostate cancer cells, whereas it had no effect on proliferation of PC3 and DU145 androgen-independent prostate cancer cells.  Addnl., GA could significantly reduce the prodn. of prostate-specific antigen by LNCaP cells maintained in-vitro.  This study provides a sound platform for further investigation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGql68cUY2StxbVg90H21EOLACvtfcHk0ljxHyJ7tEfw5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXltlemt78%253D&md5=c5273eca1b0923d075201b4ad8c61166</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1211%2Fjpp.60.5.0013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1211%252Fjpp.60.5.0013%26sid%3Dliteratum%253Aachs%26aulast%3DHawthorne%26aufirst%3DS.%26aulast%3DGallagher%26aufirst%3DS.%26atitle%3DEffects%2520of%2520glycyrrhetinic%2520acid%2520and%2520liquorice%2520extract%2520on%2520cell%2520proliferation%2520and%2520prostate-specific%2520antigen%2520secretion%2520in%2520LNCaP%2520prostate%2520cancer%2520cells%26jtitle%3DJ.%2520Pharm.%2520Pharmacol.%26date%3D2008%26volume%3D60%26spage%3D661%26epage%3D666" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Lee, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, Y. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jang, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Myung, S. C.</span><span> </span><span class="NLM_article-title">18beta-glycyrrhetinic acid potentiates apoptotic effect of trichostatin A on human epithelial ovarian carcinoma cell lines</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">649</span><span class="NLM_x">, </span> <span class="NLM_fpage">354</span><span class="NLM_x">–</span> <span class="NLM_lpage">361</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm200285z&amp;key=10.1016%2Fj.ejphar.2010.09.047" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm200285z&amp;key=20868669" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm200285z&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlKktbvN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=649&publication_year=2010&pages=354-361&author=C.+S.+Leeauthor=J.+C.+Yangauthor=Y.+J.+Kimauthor=E.+R.+Jangauthor=W.+Kimauthor=S.+C.+Myung&title=18beta-glycyrrhetinic+acid+potentiates+apoptotic+effect+of+trichostatin+A+on+human+epithelial+ovarian+carcinoma+cell+lines"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">18β-Glycyrrhetinic acid potentiates apoptotic effect of trichostatin A on human epithelial ovarian carcinoma cell lines</span></div><div class="casAuthors">Lee, Chung Soo; Yang, Jae Chon; Kim, Yun Jeong; Jang, Eun-Ra; Kim, Wonyong; Myung, Soon Chul</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">649</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">354-361</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The licorice-derived compds. glycyrrhizin and 18β-glycyrrhetinic acid have been shown to induce apoptosis in various cancer cells.  However, the effect of these licorice compds. on the apoptotic effect of histone deacetylase inhibitors in epithelial ovarian carcinoma cells has not been detd.  We assessed the effect of 18β-glycyrrhetinic acid on trichostatin A-induced apoptosis in the human epithelial carcinoma cell lines OVCAR-3 and SK-OV-3.  Trichostatin A induced nuclear damage, decreased Bid and Bcl-2 protein levels, increased in Bax levels, induced cytochrome c release, activated caspase-8, -9 and -3, and increased tumor suppressor p53 levels.  18β-Glycyrrhetinic acid potentiated the trichostatin A-induced apoptosis-related protein activation and cell death.  Unlike 18β-glycyrrhetinic acid, up to 25 μM of the pro-compd. glycyrrhizin did not induce cell death and did not affect trichostatin A-induced apoptosis.  The results suggest that 18β-glycyrrhetinic acid may potentiate the apoptotic effects of trichostatin A against ovarian carcinoma cell lines by increasing the activation of the caspase-8-dependent pathway as well as the activation of the mitochondria-mediated cell death pathway, leading to activation of caspases.  18β-Glycyrrhetinic acid may enhance the therapeutic effect of trichostatin A against epithelial ovarian adenocarcinoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr6Aljw6v9VHLVg90H21EOLACvtfcHk0ljSnxx7MOyDFw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlKktbvN&md5=80d249cac36f2502e9f25c7cd1a05bbd</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2010.09.047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2010.09.047%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DC.%2BS.%26aulast%3DYang%26aufirst%3DJ.%2BC.%26aulast%3DKim%26aufirst%3DY.%2BJ.%26aulast%3DJang%26aufirst%3DE.%2BR.%26aulast%3DKim%26aufirst%3DW.%26aulast%3DMyung%26aufirst%3DS.%2BC.%26atitle%3D18beta-glycyrrhetinic%2520acid%2520potentiates%2520apoptotic%2520effect%2520of%2520trichostatin%2520A%2520on%2520human%2520epithelial%2520ovarian%2520carcinoma%2520cell%2520lines%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2010%26volume%3D649%26spage%3D354%26epage%3D361" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Salvi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fiore, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Armanini, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toninello, A.</span><span> </span><span class="NLM_article-title">Glycyrrhetinic acid-induced permeability transition in rat liver mitochondria</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">2375</span><span class="NLM_x">–</span> <span class="NLM_lpage">2379</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2003&pages=2375-2379&author=M.+Salviauthor=C.+Fioreauthor=D.+Armaniniauthor=A.+Toninello&title=Glycyrrhetinic+acid-induced+permeability+transition+in+rat+liver+mitochondria"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSalvi%26aufirst%3DM.%26aulast%3DFiore%26aufirst%3DC.%26aulast%3DArmanini%26aufirst%3DD.%26aulast%3DToninello%26aufirst%3DA.%26atitle%3DGlycyrrhetinic%2520acid-induced%2520permeability%2520transition%2520in%2520rat%2520liver%2520mitochondria%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2003%26volume%3D66%26spage%3D2375%26epage%3D2379" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Lee, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, Y. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, S. J.</span><span> </span><span class="NLM_article-title">18beta-Glycyrrhetinic acid induces apoptotic cell death in SiHa cells and exhibits a synergistic effect against antibiotic anti-cancer drug toxicity</span> <span class="citation_source-journal">Life Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">83</span><span class="NLM_x">, </span> <span class="NLM_fpage">481</span><span class="NLM_x">–</span> <span class="NLM_lpage">489</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=2008&pages=481-489&author=C.+S.+Leeauthor=Y.+J.+Kimauthor=M.+S.+Leeauthor=E.+S.+Hanauthor=S.+J.+Lee&title=18beta-Glycyrrhetinic+acid+induces+apoptotic+cell+death+in+SiHa+cells+and+exhibits+a+synergistic+effect+against+antibiotic+anti-cancer+drug+toxicity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DC.%2BS.%26aulast%3DKim%26aufirst%3DY.%2BJ.%26aulast%3DLee%26aufirst%3DM.%2BS.%26aulast%3DHan%26aufirst%3DE.%2BS.%26aulast%3DLee%26aufirst%3DS.%2BJ.%26atitle%3D18beta-Glycyrrhetinic%2520acid%2520induces%2520apoptotic%2520cell%2520death%2520in%2520SiHa%2520cells%2520and%2520exhibits%2520a%2520synergistic%2520effect%2520against%2520antibiotic%2520anti-cancer%2520drug%2520toxicity%26jtitle%3DLife%2520Sci.%26date%3D2008%26volume%3D83%26spage%3D481%26epage%3D489" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Schwarz, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Csuk, R.</span><span> </span><span class="NLM_article-title">Synthesis and antitumour activity of glycyrrhetinic acid derivatives</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">7458</span><span class="NLM_x">–</span> <span class="NLM_lpage">7474</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2010&pages=7458-7474&author=S.+Schwarzauthor=R.+Csuk&title=Synthesis+and+antitumour+activity+of+glycyrrhetinic+acid+derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSchwarz%26aufirst%3DS.%26aulast%3DCsuk%26aufirst%3DR.%26atitle%3DSynthesis%2520and%2520antitumour%2520activity%2520of%2520glycyrrhetinic%2520acid%2520derivatives%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2010%26volume%3D18%26spage%3D7458%26epage%3D7474" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Anuchapreeda, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leechanachai, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ambudkar, S. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Limtrakul, P. N.</span><span> </span><span class="NLM_article-title">Modulation of P-glycoprotein expression and function by curcumin in multidrug-resistant human KB cells</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">573</span><span class="NLM_x">–</span> <span class="NLM_lpage">582</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm200285z&amp;key=10.1016%2FS0006-2952%2802%2901224-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm200285z&amp;key=12167476" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm200285z&amp;key=1%3ACAS%3A528%3ADC%252BD38XmtVWls7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2002&pages=573-582&author=S.+Anuchapreedaauthor=P.+Leechanachaiauthor=M.+M.+Smithauthor=S.+V.+Ambudkarauthor=P.+N.+Limtrakul&title=Modulation+of+P-glycoprotein+expression+and+function+by+curcumin+in+multidrug-resistant+human+KB+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Modulation of P-glycoprotein expression and function by curcumin in multidrug-resistant human KB cells</span></div><div class="casAuthors">Anuchapreeda, Songyot; Leechanachai, Pranee; Smith, Melissa M.; Ambudkar, Suresh V.; Limtrakul, Porn-ngarm</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">573-582</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">Multidrug resistance (MDR) is a phenomenon that is often assocd. with decreased intracellular drug accumulation in the tumor cells of a patient, resulting from enhanced drug efflux.  It is often related to the overexpression of P-glycoprotein (Pgp) on the surface of tumor cells, thereby reducing drug cytotoxicity.  In this study, curcumin was tested for its potential ability to modulate the expression and function of Pgp in the multidrug-resistant human cervical carcinoma cell line KB-V1.  Western blot anal. and reverse transcription-polymerase chain reaction (RT-PCR) showed that treatment with 1, 5, and 10 μM curcumin for up to 72 h was able to significantly lower Pgp expression in KB-V1 cells.  Curcumin (1-10 μM) decreased Pgp expression in a concn.-dependent manner and was also found to have the same effect on MDR1 mRNA levels.  The effect of curcumin on Pgp function was demonstrated by rhodamine 123 (Rh123) accumulation and efflux in Pgp-expressing KB-V1 cells.  Curcumin increased Rh123 accumulation in a concn.-dependent manner (1-55 μM) and inhibited the efflux of Rh123 from these cells, but did not affect the efflux of Rh123 from the wild-type drug-sensitive KB-3-1 cells.  Treatment of drug-resistant KB-V1 cells with curcumin increased their sensitivity to vinblastine, which was consistent with an increased intracellular accumulation of Rh123.  In addn., curcumin inhibited verapamil-stimulated ATPase activity and the photoaffinity labeling of Pgp with the prazosin analog [125I]iodoarylazidoprazosin in a concn.-dependent manner, demonstrating that curcumin interacts directly with the transporter.  Thus, curcumin seems to be able to modulate the in vitro expression and function of Pgp in multidrug-resistant human KB-V1 cells.  In summary, this study describes the duel modulation of MDR1 expression and Pgp function by the phytochem. curcumin, which may be an attractive new agent for the chemosensitization of cancer cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqISvxyjK1_XrVg90H21EOLACvtfcHk0ljSnxx7MOyDFw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XmtVWls7g%253D&md5=38eee74912cd894d85ebc666bb38b967</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2FS0006-2952%2802%2901224-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0006-2952%252802%252901224-8%26sid%3Dliteratum%253Aachs%26aulast%3DAnuchapreeda%26aufirst%3DS.%26aulast%3DLeechanachai%26aufirst%3DP.%26aulast%3DSmith%26aufirst%3DM.%2BM.%26aulast%3DAmbudkar%26aufirst%3DS.%2BV.%26aulast%3DLimtrakul%26aufirst%3DP.%2BN.%26atitle%3DModulation%2520of%2520P-glycoprotein%2520expression%2520and%2520function%2520by%2520curcumin%2520in%2520multidrug-resistant%2520human%2520KB%2520cells%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2002%26volume%3D64%26spage%3D573%26epage%3D582" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Mayur, Y. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peters, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prasad, V. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lemo, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sathish, N. K.</span><span> </span><span class="NLM_article-title">Design of new drug molecules to be used in reversing multidrug resistance in cancer cells</span> <span class="citation_source-journal">Curr. Cancer Drug Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">298</span><span class="NLM_x">–</span> <span class="NLM_lpage">306</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm200285z&amp;key=10.2174%2F156800909788166619" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm200285z&amp;key=19442050" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm200285z&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmslansL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2009&pages=298-306&author=Y.+C.+Mayurauthor=G.+J.+Petersauthor=V.+V.+Prasadauthor=C.+Lemoauthor=N.+K.+Sathish&title=Design+of+new+drug+molecules+to+be+used+in+reversing+multidrug+resistance+in+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Design of new drug molecules to be used in reversing multidrug resistance in cancer cells</span></div><div class="casAuthors">Mayur, Y. C.; Peters, G. J.; Prasad, V. V. S. Rajendra; Lemos, C.; Sathish, N. K.</div><div class="citationInfo"><span class="NLM_cas:title">Current Cancer Drug Targets</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">298-306</span>CODEN:
                <span class="NLM_cas:coden">CCDTB9</span>;
        ISSN:<span class="NLM_cas:issn">1568-0096</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Over the past two decades, a no. of chem. entities have been investigated in the continuing quest to reverse P-glycoprotein (P-gp) mediated multidrug resistance (MDR) in cancer cells and some have undergone clin. trials, but currently none are in clin. use.  Unfortunately, most of these agents suffer clin. from their intrinsic toxicity or from undesired effects on the pharmacokinetics of the accompanying anti-cancer drugs.  An acridonecarboxamide (GF120918), Imidazo acridone (C1311) and timethylene acridone deriv. 1,3-bis(9-oxoacridin-10-yl)-propane (PBA) have already been shown to be among the group of compds. known to modify P-gp mediated MDR in cancer.  In the recent past it has been identified that various N10-substituted acridones can reverse the multidrug resistance (MDR) in cancer by selectively inhibiting the multidrug resistance assocd. protein (MRP) and calmodulin dependent cAMP phosphodiesterase.  This article envisages the various drugs being developed for treating MDR in cancer cells and esp. the acridone derivs. which are being developed by the author.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZfok-7B596LVg90H21EOLACvtfcHk0lgUjbCIO1AHvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmslansL0%253D&md5=2403c3c2eac28dca5ebb7a6944a7d5a1</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.2174%2F156800909788166619&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156800909788166619%26sid%3Dliteratum%253Aachs%26aulast%3DMayur%26aufirst%3DY.%2BC.%26aulast%3DPeters%26aufirst%3DG.%2BJ.%26aulast%3DPrasad%26aufirst%3DV.%2BV.%26aulast%3DLemo%26aufirst%3DC.%26aulast%3DSathish%26aufirst%3DN.%2BK.%26atitle%3DDesign%2520of%2520new%2520drug%2520molecules%2520to%2520be%2520used%2520in%2520reversing%2520multidrug%2520resistance%2520in%2520cancer%2520cells%26jtitle%3DCurr.%2520Cancer%2520Drug%2520Targets%26date%3D2009%26volume%3D9%26spage%3D298%26epage%3D306" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Jutooru, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chadalapaka, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chintharlapalli, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Papineni, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Safe, S.</span><span> </span><span class="NLM_article-title">Induction of apoptosis and nonsteroidal anti-inflammatory drug-activated gene 1 in pancreatic cancer cells by a glycyrrhetinic acid derivative</span> <span class="citation_source-journal">Mol. Carcinog.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">692</span><span class="NLM_x">–</span> <span class="NLM_lpage">702</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm200285z&amp;key=10.1002%2Fmc.20518" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm200285z&amp;key=19125423" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm200285z&amp;key=1%3ACAS%3A528%3ADC%252BD1MXpt1Wlsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2009&pages=692-702&author=I.+Jutooruauthor=G.+Chadalapakaauthor=S.+Chintharlapalliauthor=S.+Papineniauthor=S.+Safe&title=Induction+of+apoptosis+and+nonsteroidal+anti-inflammatory+drug-activated+gene+1+in+pancreatic+cancer+cells+by+a+glycyrrhetinic+acid+derivative"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Induction of apoptosis and nonsteroidal anti-inflammatory drug-activated gene 1 in pancreatic cancer cells by a glycyrrhetinic acid derivative</span></div><div class="casAuthors">Jutooru, Indira; Chadalapaka, Gayathri; Chintharlapalli, Sudhakar; Papineni, Sabitha; Safe, Stephen</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Carcinogenesis</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">692-702</span>CODEN:
                <span class="NLM_cas:coden">MOCAE8</span>;
        ISSN:<span class="NLM_cas:issn">0899-1987</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Me 2-cyano-3,11-dioxo-18β-olean-1,12-dien-30-oate (CDODA-Me) is a synthetic triterpenoid derived from glycyrrhetinic acid, a bioactive phytochem. in licorice, CDODA-Me inhibits growth of Panc1 and Panc28 pancreatic cancer cell lines and activates peroxisome proliferator-activated receptor γ (PPARγ)-dependent transactivation in these cells.  CDODA-Me also induced p21 and p27 protein expression and down regulates cyclin D1; however, these responses were receptor-independent.  CDODA-Me induced apoptosis in Panc1 and Panc28 cells, and this was accompanied by receptor-independent induction of the proapoptotic proteins early growth response-1 (Egr-1), nonsteroidal anti-inflammatory drug-activated gene-1 (NAG-1), and activating transcription factor-3 (ATF3).  Induction of NAG-1 and Egr-1 by CDODA-Me was dependent on activation of phosphatidylinositol-3-kinase (PI3-K) and/or p42 and p38 mitogen-activated protein kinase (MAPK) pathways but there were differences between Panc28 and Panc1 cells.  Induction of NAG-1 in Panc28 cells was p38-MAPK- and PI3-K-dependent but Egr-1-independent, whereas induction in Panc1 cells was assocd. with activation of p38-MAPK, PI3-K, and p42-MAPK and was only partially Egr-1-dependent.  This is the first report of the induction of the proapoptotic protein NAG-1 in pancreatic cancer cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhzVZfoBgDl7Vg90H21EOLACvtfcHk0lgUjbCIO1AHvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXpt1Wlsbs%253D&md5=7cea4c3a96a1108f892675231a0053b8</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1002%2Fmc.20518&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmc.20518%26sid%3Dliteratum%253Aachs%26aulast%3DJutooru%26aufirst%3DI.%26aulast%3DChadalapaka%26aufirst%3DG.%26aulast%3DChintharlapalli%26aufirst%3DS.%26aulast%3DPapineni%26aufirst%3DS.%26aulast%3DSafe%26aufirst%3DS.%26atitle%3DInduction%2520of%2520apoptosis%2520and%2520nonsteroidal%2520anti-inflammatory%2520drug-activated%2520gene%25201%2520in%2520pancreatic%2520cancer%2520cells%2520by%2520a%2520glycyrrhetinic%2520acid%2520derivative%26jtitle%3DMol.%2520Carcinog.%26date%3D2009%26volume%3D48%26spage%3D692%26epage%3D702" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Chung, T. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, Y. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J. C.</span><span> </span><span class="NLM_article-title">18beta-glycyrrhetinic acid promotes src interaction with connexin43 in rat cardiomyocytes</span> <span class="citation_source-journal">J. Cell Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">100</span><span class="NLM_x">, </span> <span class="NLM_fpage">653</span><span class="NLM_x">–</span> <span class="NLM_lpage">664</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2007&pages=653-664&author=T.+H.+Chungauthor=S.+M.+Wangauthor=Y.+C.+Changauthor=Y.+L.+Chenauthor=J.+C.+Wu&title=18beta-glycyrrhetinic+acid+promotes+src+interaction+with+connexin43+in+rat+cardiomyocytes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChung%26aufirst%3DT.%2BH.%26aulast%3DWang%26aufirst%3DS.%2BM.%26aulast%3DChang%26aufirst%3DY.%2BC.%26aulast%3DChen%26aufirst%3DY.%2BL.%26aulast%3DWu%26aufirst%3DJ.%2BC.%26atitle%3D18beta-glycyrrhetinic%2520acid%2520promotes%2520src%2520interaction%2520with%2520connexin43%2520in%2520rat%2520cardiomyocytes%26jtitle%3DJ.%2520Cell%2520Biochem.%26date%3D2007%26volume%3D100%26spage%3D653%26epage%3D664" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Kawakami, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ikarashi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kase, Y.</span><span> </span><span class="NLM_article-title">Glycyrrhizin and its metabolite 18beta-glycyrhetinic acid in glycyrrhiza, a constituent herb of yokukansan, ameliorate thiamine deficiency-induced dysfunction of glutamate transport in cultured rat cortical astrocytes</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">626</span><span class="NLM_x">, </span> <span class="NLM_fpage">154</span><span class="NLM_x">–</span> <span class="NLM_lpage">158</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm200285z&amp;key=10.1016%2Fj.ejphar.2009.09.046" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm200285z&amp;key=19818347" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm200285z&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsV2mtLrK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=626&publication_year=2010&pages=154-158&author=Z.+Kawakamiauthor=Y.+Ikarashiauthor=Y.+Kase&title=Glycyrrhizin+and+its+metabolite+18beta-glycyrhetinic+acid+in+glycyrrhiza%2C+a+constituent+herb+of+yokukansan%2C+ameliorate+thiamine+deficiency-induced+dysfunction+of+glutamate+transport+in+cultured+rat+cortical+astrocytes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Glycyrrhizin and its metabolite 18β-glycyrrhetinic acid in glycyrrhiza, a constituent herb of yokukansan, ameliorate thiamine deficiency-induced dysfunction of glutamate transport in cultured rat cortical astrocytes</span></div><div class="casAuthors">Kawakami, Zenji; Ikarashi, Yasushi; Kase, Yoshio</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">626</span>
        (<span class="NLM_cas:issue">2-3</span>),
    <span class="NLM_cas:pages">154-158</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Effects of yokukansan, a traditional Japanese medicine, on thiamin deficiency (TD)-induced decrease of glutamate uptake were examd. in cultured rat cortical astrocytes.  Yokukansan (100-500 μg/mL) ameliorated the TD-induced decrease in glutamate uptake by astrocytes, implying that yokukansan may contain active herbs and compds. possessing this effect.  Among the seven constituent herbs of yokukansan, significant effects were found for glycyrrhiza.  Furthermore, glycyrrhizin and its metabolite 18β-glycyrrhetinic acid (10-7-10-4 M), among the eight components of glycyrrhiza, ameliorated the TD-induced decrease of glutamate uptake in astrocytes in a concn.-dependent manner.  These substances inhibited protein kinase C (PKC) activity under the in vitro conditions.  These lines of evidence suggest that glycyrrhizin, a main component of glycyrrhiza, and its metabolite 18β-glycyrrhetinic acid are likely responsible for amelioration of dysfunction of glutamate transport in astrocytes.  The inhibition of the PKC activity might be related to the pharmacol. efficacy of these substances.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrtH42Ko_m777Vg90H21EOLACvtfcHk0lgUjbCIO1AHvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsV2mtLrK&md5=aec534c27c07d2acc0690348747b96bf</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2009.09.046&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2009.09.046%26sid%3Dliteratum%253Aachs%26aulast%3DKawakami%26aufirst%3DZ.%26aulast%3DIkarashi%26aufirst%3DY.%26aulast%3DKase%26aufirst%3DY.%26atitle%3DGlycyrrhizin%2520and%2520its%2520metabolite%252018beta-glycyrhetinic%2520acid%2520in%2520glycyrrhiza%252C%2520a%2520constituent%2520herb%2520of%2520yokukansan%252C%2520ameliorate%2520thiamine%2520deficiency-induced%2520dysfunction%2520of%2520glutamate%2520transport%2520in%2520cultured%2520rat%2520cortical%2520astrocytes%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2010%26volume%3D626%26spage%3D154%26epage%3D158" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Pang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Safe, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, M.</span><span> </span><span class="NLM_article-title">Methyl 2-cyano-3,11-dioxo-18-olean-1,12-dien-30-oate (CDODA-Me), a derivative of glycyrrhetinic acid, functions as a potent angiogenesis inhibitor</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">335</span><span class="NLM_x">, </span> <span class="NLM_fpage">172</span><span class="NLM_x">–</span> <span class="NLM_lpage">179</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm200285z&amp;key=10.1124%2Fjpet.110.171066" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm200285z&amp;key=20631299" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm200285z&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht1GisrrL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=335&publication_year=2010&pages=172-179&author=X.+Pangauthor=L.+Zhangauthor=Y.+Wuauthor=L.+Linauthor=J.+Liauthor=W.+Quauthor=S.+Safeauthor=M.+Liu&title=Methyl+2-cyano-3%2C11-dioxo-18-olean-1%2C12-dien-30-oate+%28CDODA-Me%29%2C+a+derivative+of+glycyrrhetinic+acid%2C+functions+as+a+potent+angiogenesis+inhibitor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Methyl 2-cyano-3,11-dioxo-18-olean-1,12-dien-30-oate (CDODA-Me), a derivative of glycyrrhetinic acid, functions as a potent angiogenesis inhibitor</span></div><div class="casAuthors">Pang, Xiufeng; Zhang, Li; Wu, Yougen; Lin, Lei; Li, Jingjie; Qu, Weijing; Safe, Stephen; Liu, Mingyao</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">335</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">172-179</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Me 2-cyano-3,11-dioxo-18-olean-1,12-dien-30-oate (CDODA-Me), a triterpenoid acid derived synthetically from glycyrrhetinic acid, has been characterized as a peroxisome proliferator-activated receptor γ agonist with a broad range of receptor-dependent and -independent anticancer activities.  Although CDODA-Me decreases the expression of some angiogenic genes in cancer cells, the direct effects of this compd. on angiogenesis have not been defined.  In this study, we have extensively investigated the activities of CDODA-Me in multiple angiogenesis assays.  Our results showed that this agent inhibited vascular endothelial growth factor (VEGF)-induced proliferation, migration, invasion, and lamellipodium and capillary-like structure formation of human umbilical endothelial cells (HUVECs) in a concn.-dependent manner.  Moreover, CDODA-Me abrogated VEGF-induced sprouting of microvessels from rat aortic rings ex vivo and inhibited the generation of new vasculature in the Matrigel plugs in vivo, where CDODA-Me significantly decreased the no. of infiltrating von Willebrand factor-pos. endothelial cells.  To understand the mol. basis of this antiangiogenic activity, we examd. the signaling pathways in CDODA-Me-treated HUVECs.  Our results showed that CDODA-Me significantly suppressed the activation of VEGF receptor 2 (VEGFR2) and interfered with the mammalian target of rapamycin (mTOR) signaling, including mTOR kinase and its downstream ribosomal S6 kinase (S6K), but had little effect on the activities of extracellular signal-regulated protein kinase and AKT.  Taken together, CDODA-Me blocks several key steps of angiogenesis by inhibiting VEGF/VEGFR2 and mTOR/S6K signaling pathways, making the compd. a promising agent for the treatment of cancer and angiogenesis-related pathologies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQ0xXkgJvMW7Vg90H21EOLACvtfcHk0lh42d56wo7kaw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht1GisrrL&md5=b767a2e223baaadee95c91943300c3ac</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1124%2Fjpet.110.171066&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.110.171066%26sid%3Dliteratum%253Aachs%26aulast%3DPang%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DLin%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DQu%26aufirst%3DW.%26aulast%3DSafe%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DM.%26atitle%3DMethyl%25202-cyano-3%252C11-dioxo-18-olean-1%252C12-dien-30-oate%2520%2528CDODA-Me%2529%252C%2520a%2520derivative%2520of%2520glycyrrhetinic%2520acid%252C%2520functions%2520as%2520a%2520potent%2520angiogenesis%2520inhibitor%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2010%26volume%3D335%26spage%3D172%26epage%3D179" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Kao, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shyu, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yen, G. C.</span><span> </span><span class="NLM_article-title">Glycyrrhizic acid and 18beta-glycyrrhetinic acid inhibit inflammation via PI3K/Akt/GSK3beta signaling and glucocorticoid receptor activation</span> <span class="citation_source-journal">J. Agric. Food Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">8623</span><span class="NLM_x">–</span> <span class="NLM_lpage">8629</span></span><div class="citationLinks">[<a href="/doi/10.1021/jf101841r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2010&pages=8623-8629&author=T.+Kaoauthor=M.+H.+Shyuauthor=G.+C.+Yen&title=Glycyrrhizic+acid+and+18beta-glycyrrhetinic+acid+inhibit+inflammation+via+PI3K%2FAkt%2FGSK3beta+signaling+and+glucocorticoid+receptor+activation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fjf101841r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjf101841r%26sid%3Dliteratum%253Aachs%26aulast%3DKao%26aufirst%3DT.%26aulast%3DShyu%26aufirst%3DM.%2BH.%26aulast%3DYen%26aufirst%3DG.%2BC.%26atitle%3DGlycyrrhizic%2520acid%2520and%252018beta-glycyrrhetinic%2520acid%2520inhibit%2520inflammation%2520via%2520PI3K%252FAkt%252FGSK3beta%2520signaling%2520and%2520glucocorticoid%2520receptor%2520activation%26jtitle%3DJ.%2520Agric.%2520Food%2520Chem.%26date%3D2010%26volume%3D58%26spage%3D8623%26epage%3D8629" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Huang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qian, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, C. H.</span><span> </span><span class="NLM_article-title">Synthesis and proteasome inhibition of glycyrrhetinic acid derivatives</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">6696</span><span class="NLM_x">–</span> <span class="NLM_lpage">6701</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2008&pages=6696-6701&author=L.+Huangauthor=D.+Yuauthor=P.+Hoauthor=K.+Qianauthor=K.+H.+Leeauthor=C.+H.+Chen&title=Synthesis+and+proteasome+inhibition+of+glycyrrhetinic+acid+derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DL.%26aulast%3DYu%26aufirst%3DD.%26aulast%3DHo%26aufirst%3DP.%26aulast%3DQian%26aufirst%3DK.%26aulast%3DLee%26aufirst%3DK.%2BH.%26aulast%3DChen%26aufirst%3DC.%2BH.%26atitle%3DSynthesis%2520and%2520proteasome%2520inhibition%2520of%2520glycyrrhetinic%2520acid%2520derivatives%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2008%26volume%3D16%26spage%3D6696%26epage%3D6701" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Chintharlapalli, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Papineni, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jutooru, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McAlees, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Safe, S.</span><span> </span><span class="NLM_article-title">Structure-dependent activity of glycyrrhetinic acid derivatives as peroxisome proliferator-activated receptor gamma agonists in colon cancer cells</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">1588</span><span class="NLM_x">–</span> <span class="NLM_lpage">1598</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm200285z&amp;key=10.1158%2F1535-7163.MCT-07-0022" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Fjm200285z&amp;key=17513608" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm200285z&amp;key=1%3ACAS%3A528%3ADC%252BD2sXotFaltLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=1588-1598&author=S.+Chintharlapalliauthor=S.+Papineniauthor=I.+Jutooruauthor=A.+McAleesauthor=S.+Safe&title=Structure-dependent+activity+of+glycyrrhetinic+acid+derivatives+as+peroxisome+proliferator-activated+receptor+gamma+agonists+in+colon+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-dependent activity of glycyrrhetinic acid derivatives as peroxisome proliferator-activated receptor γ agonists in colon cancer cells</span></div><div class="casAuthors">Chintharlapalli, Sudhakar; Papineni, Sabitha; Jutooru, Indira; McAlees, Alan; Safe, Stephen</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1588-1598</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Glycyrrhizin, a pentacyclic triterpene glycoside, is the major phytochem. in licorice.  This compd. and its hydrolysis product glycyrrhetinic acid have been assocd. with the multiple therapeutic properties of licorice exts.  We have investigated the effects of 2-cyano substituted analogs of glycyrrhetinic acid on their cytotoxicities and activity as selective peroxisome proliferator-activated receptor γ (PPARγ) agonists.  Me 2-cyano-3,11-dioxo-18β-olean-1,12-dien-30-oate (β-CDODA-Me) and Me 2-cyano-3,11-dioxo-18α-olean-1,12-dien-30-oate (α-CDODA-Me) were more cytotoxic to colon cancer cells than their descyano analogs and introduction of the 2-cyano group into the pentacyclic ring system was necessary for the PPARγ agonist activity of α-CDODA-Me and β-CDODA-Me isomers.  However, in mammalian two-hybrid assays, both compds. differentially induced interactions of PPARγ with coactivators, suggesting that these isomers, which differ only in the stereochem. at C18 which affects conformation of the E-ring, are selective receptor modulators.  This selectivity in colon cancer cells was shown for the induction of two proapoptotic proteins, namely caveolin-1 and the tumor-suppressor gene Kruppel-like factor-4 (KLF-4).  β-CDODA-Me but not α-CDODA-Me induced caveolin-1 in SW480 colon cancer cells, whereas caveolin-1 was induced by both compds. in HT-29 and HCT-15 colon cancer cells.  The CDODA-Me isomers induced KLF-4 mRNA levels in HT-29 and SW480 cells but had minimal effects on KLF-4 expression in HCT-15 cells.  These induced responses were inhibited by cotreatment with a PPARγ antagonist.  This shows for the first time that PPARγ agonists derived from glycyrrhetinic acid induced cell-dependent caveolin-1 and KLF-4 expression through receptor-dependent pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvJmHLJ_RNV7Vg90H21EOLACvtfcHk0lh42d56wo7kaw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXotFaltLc%253D&md5=aa8edc5fb5085357b784555ed17088ed</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-07-0022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-07-0022%26sid%3Dliteratum%253Aachs%26aulast%3DChintharlapalli%26aufirst%3DS.%26aulast%3DPapineni%26aufirst%3DS.%26aulast%3DJutooru%26aufirst%3DI.%26aulast%3DMcAlees%26aufirst%3DA.%26aulast%3DSafe%26aufirst%3DS.%26atitle%3DStructure-dependent%2520activity%2520of%2520glycyrrhetinic%2520acid%2520derivatives%2520as%2520peroxisome%2520proliferator-activated%2520receptor%2520gamma%2520agonists%2520in%2520colon%2520cancer%2520cells%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2007%26volume%3D6%26spage%3D1588%26epage%3D1598" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Chintharlapalli, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Papineni, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Konopleva, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andreef, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samudio, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Safe, S.</span><span> </span><span class="NLM_article-title">2-cyano-3,12-dioxoolean-1,9-dien-28-oic acid and related compounds inhibit growth of colon cancer cells through peroxisome proliferator-activated receptor gamma-dependent and -independent pathways</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">119</span><span class="NLM_x">–</span> <span class="NLM_lpage">128</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2005&pages=119-128&author=S.+Chintharlapalliauthor=S.+Papineniauthor=M.+Konoplevaauthor=M.+Andreefauthor=I.+Samudioauthor=S.+Safe&title=2-cyano-3%2C12-dioxoolean-1%2C9-dien-28-oic+acid+and+related+compounds+inhibit+growth+of+colon+cancer+cells+through+peroxisome+proliferator-activated+receptor+gamma-dependent+and+-independent+pathways"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChintharlapalli%26aufirst%3DS.%26aulast%3DPapineni%26aufirst%3DS.%26aulast%3DKonopleva%26aufirst%3DM.%26aulast%3DAndreef%26aufirst%3DM.%26aulast%3DSamudio%26aufirst%3DI.%26aulast%3DSafe%26aufirst%3DS.%26atitle%3D2-cyano-3%252C12-dioxoolean-1%252C9-dien-28-oic%2520acid%2520and%2520related%2520compounds%2520inhibit%2520growth%2520of%2520colon%2520cancer%2520cells%2520through%2520peroxisome%2520proliferator-activated%2520receptor%2520gamma-dependent%2520and%2520-independent%2520pathways%26jtitle%3DMol.%2520Pharmacol.%26date%3D2005%26volume%3D68%26spage%3D119%26epage%3D128" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Papineni, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chintharlapalli, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Safe, S.</span><span> </span><span class="NLM_article-title">Methyl 2-cyano-3,11-dioxo-18beta -olean-1,12-dien-30-oate is a peroxisome proliferator-activated receptor-gamma agonist that induces receptor-independent apoptosis in LNCaP prostate cancer cells</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">73</span><span class="NLM_x">, </span> <span class="NLM_fpage">553</span><span class="NLM_x">–</span> <span class="NLM_lpage">565</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2008&pages=553-565&author=S.+Papineniauthor=S.+Chintharlapalliauthor=S.+Safe&title=Methyl+2-cyano-3%2C11-dioxo-18beta+-olean-1%2C12-dien-30-oate+is+a+peroxisome+proliferator-activated+receptor-gamma+agonist+that+induces+receptor-independent+apoptosis+in+LNCaP+prostate+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPapineni%26aufirst%3DS.%26aulast%3DChintharlapalli%26aufirst%3DS.%26aulast%3DSafe%26aufirst%3DS.%26atitle%3DMethyl%25202-cyano-3%252C11-dioxo-18beta%2520-olean-1%252C12-dien-30-oate%2520is%2520a%2520peroxisome%2520proliferator-activated%2520receptor-gamma%2520agonist%2520that%2520induces%2520receptor-independent%2520apoptosis%2520in%2520LNCaP%2520prostate%2520cancer%2520cells%26jtitle%3DMol.%2520Pharmacol.%26date%3D2008%26volume%3D73%26spage%3D553%26epage%3D565" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Chadalapaka, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jutooru, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McAlees, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stefanac, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Safe, S.</span><span> </span><span class="NLM_article-title">Structure-dependent inhibition of bladder and pancreatic cancer cell growth by 2-substituted glycyrrhetinic and ursolic acid derivatives</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">2633</span><span class="NLM_x">–</span> <span class="NLM_lpage">2639</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Fjm200285z&amp;key=10.1016%2Fj.bmcl.2008.03.031" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Fjm200285z&amp;key=18359628" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Fjm200285z&amp;key=1%3ACAS%3A528%3ADC%252BD1cXks1akt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=2633-2639&author=G.+Chadalapakaauthor=I.+Jutooruauthor=A.+McAleesauthor=T.+Stefanacauthor=S.+Safe&title=Structure-dependent+inhibition+of+bladder+and+pancreatic+cancer+cell+growth+by+2-substituted+glycyrrhetinic+and+ursolic+acid+derivatives"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-dependent inhibition of bladder and pancreatic cancer cell growth by 2-substituted glycyrrhetinic and ursolic acid derivatives</span></div><div class="casAuthors">Chadalapaka, Gayathri; Jutooru, Indira; McAlees, Alan; Stefanac, Tom; Safe, Stephen</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2633-2639</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Derivs. of oleanolic acid, ursolic acid and glycyrrhetinic acid substituted with electron-withdrawing groups at the 2-position in the A-ring which also contains a 1-en-3-one structure are potent inhibitors of cancer cell growth.  In this study, the authors have compared the effects of several 2-substituted analogs of triterpenoid acid Me esters derived from ursolic and glycyrrhetinic acid on proliferation of KU7 and 253JB-V bladder and Panc-1 and Panc-28 pancreatic cancer cells.  The results show that the 2-cyano and 2-trifluoromethyl derivs. were the most active compds.  The glycyrrhetinic acid derivs. with the rearranged C-ring contg. the 9(11)-en-12-one structure were generally more active than the corresponding 12-en-11-one isomers.  However, differences in growth inhibitory IC50 values were highly variable and dependent on the 2-substituent (CN vs. CF3) and cancer cell context.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmwh5uCbF087Vg90H21EOLACvtfcHk0lgEWxaiF1KEQQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXks1akt7k%253D&md5=771ec0944a2ae699d7448d46d27db90b</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2008.03.031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2008.03.031%26sid%3Dliteratum%253Aachs%26aulast%3DChadalapaka%26aufirst%3DG.%26aulast%3DJutooru%26aufirst%3DI.%26aulast%3DMcAlees%26aufirst%3DA.%26aulast%3DStefanac%26aufirst%3DT.%26aulast%3DSafe%26aufirst%3DS.%26atitle%3DStructure-dependent%2520inhibition%2520of%2520bladder%2520and%2520pancreatic%2520cancer%2520cell%2520growth%2520by%25202-substituted%2520glycyrrhetinic%2520and%2520ursolic%2520acid%2520derivatives%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D2633%26epage%3D2639" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Michalik, L.; Wahli, W.</span><span> </span><span class="NLM_article-title">PPARs mediate lipid signaling in inflammation and cancer</span>.  <span class="citation_source-journal">PPAR Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span>ID 134059, doi:<span class="refDoi"> DOI: 10.1155/2008/134059</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Fjm200285z&amp;key=10.1155%2F2008%2F134059" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Fjm200285z&amp;key=19125181" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=L.+Michalik&author=W.+Wahli&title=PPARs+mediate+lipid+signaling+in+inflammation+and+cancer&doi=10.1155%2F2008%2F134059"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1155%2F2008%2F134059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2008%252F134059%26sid%3Dliteratum%253Aachs%26aulast%3DMichalik%26aufirst%3DL.%26atitle%3DPPARs%2520mediate%2520lipid%2520signaling%2520in%2520inflammation%2520and%2520cancer%26jtitle%3DPPAR%2520Res.%26date%3D2008%26doi%3D10.1155%2F2008%2F134059" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Bundscherer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reichle, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hafner, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vogt, T.</span><span> </span><span class="NLM_article-title">Targeting the tumor stroma with peroxisome proliferator activated receptor (PPAR) agonists</span> <span class="citation_source-journal">Anticancer Agents Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">816</span><span class="NLM_x">–</span> <span class="NLM_lpage">821</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Fjm200285z&amp;key=10.2174%2F187152009789056912" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Fjm200285z&amp;key=19594413" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Fjm200285z&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtVWnt7vJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2009&pages=816-821&author=A.+Bundschererauthor=A.+Reichleauthor=C.+Hafnerauthor=S.+Meyerauthor=T.+Vogt&title=Targeting+the+tumor+stroma+with+peroxisome+proliferator+activated+receptor+%28PPAR%29+agonists"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the tumor stroma with peroxisome proliferator activated receptor (PPAR) agonists</span></div><div class="casAuthors">Bundscherer, Annika; Reichle, Albrecht; Hafner, Christian; Meyer, Stefanie; Vogt, Thomas</div><div class="citationInfo"><span class="NLM_cas:title">Anti-Cancer Agents in Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">816-821</span>CODEN:
                <span class="NLM_cas:coden">AAMCE4</span>;
        ISSN:<span class="NLM_cas:issn">1871-5206</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Tumor cells depend on and are able to modulate the tumor stroma establishing a permissive and supportive environment of their own.  Targeting the tumor stroma has evolved as a novel concept that has attracted attention of cancer researchers aiming at the treatment of metastatic cancer.  The novel paradigm is that modulating the stroma will possibly not cure the cancer, but will make it a manageable disease for long periods of time by prohibiting the cancer from growing beyond a certain mass.  Accordingly, in the last years, a multitude of stroma-targeting agents were developed comprising either classic small mol. drugs (e.g. sorafenib, an inhibitor of multiple tyrosine kinases) or recombinant antibodies (e.g. anti-VEGF) for targeting of tumor angiogenesis.  Apart from these specifically targeted drugs, some well established drugs, primarily designed for non-oncol. diseases, have revealed antitumor activity on the basis of nuclear receptor modulation unfolding pleiotropic biol. effects including stroma modulation.  Peroxisome Proliferator Activated Receptor (PPAR) agonists, particularly thiazolidinedione derivs. such as pioglitazone and ciglitazone, are promising examples as they exert both a direct antitumoral and a broad spectrum of anti-stromal, antiangiogenic and immuno-modulating activities.  This review will focus on the stroma-mediated anticancer activities of PPAR agonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpgmcPYNkI_97Vg90H21EOLACvtfcHk0lgEWxaiF1KEQQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVWnt7vJ&md5=6f0d53556a4459df9785d05992ad55ab</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.2174%2F187152009789056912&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F187152009789056912%26sid%3Dliteratum%253Aachs%26aulast%3DBundscherer%26aufirst%3DA.%26aulast%3DReichle%26aufirst%3DA.%26aulast%3DHafner%26aufirst%3DC.%26aulast%3DMeyer%26aufirst%3DS.%26aulast%3DVogt%26aufirst%3DT.%26atitle%3DTargeting%2520the%2520tumor%2520stroma%2520with%2520peroxisome%2520proliferator%2520activated%2520receptor%2520%2528PPAR%2529%2520agonists%26jtitle%3DAnticancer%2520Agents%2520Med.%2520Chem.%26date%3D2009%26volume%3D9%26spage%3D816%26epage%3D821" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">He, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dong, Y. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, L.</span><span> </span><span class="NLM_article-title">Preparation and properties of a novel thermo-responsive poly(N-isopropylacrylamide) hydrogel containing glycyrrhetinic acid</span> <span class="citation_source-journal">J. Mater. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">4078</span><span class="NLM_x">–</span> <span class="NLM_lpage">4086</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Fjm200285z&amp;key=10.1007%2Fs10853-009-3588-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm200285z&amp;key=1%3ACAS%3A528%3ADC%252BD1MXms1alurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2009&pages=4078-4086&author=X.+Heauthor=S.+Yuauthor=Y.+Y.+Dongauthor=F.+Yanauthor=L.+Chen&title=Preparation+and+properties+of+a+novel+thermo-responsive+poly%28N-isopropylacrylamide%29+hydrogel+containing+glycyrrhetinic+acid"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Preparation and properties of a novel thermo-responsive poly(N-isopropylacrylamide) hydrogel containing glycyrrhetinic acid</span></div><div class="casAuthors">He, Xiaoling; Yu, Shen; Dong, You Yu; Yan, Fanyong; Chen, Li</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Materials Science</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">4078-4086</span>CODEN:
                <span class="NLM_cas:coden">JMTSAS</span>;
        ISSN:<span class="NLM_cas:issn">0022-2461</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A novel thermo-responsive poly(N-isopropylacrylamide) (PNIPAAm) hydrogel contg. glycyrrhetinic acid(GA) was synthesized by free radical copolymn.  The structure of the product was confirmed by FT-IR and 1H-NMR spectra.  The temp. responsibility and swelling properties of the copolymd. hydrogel were investigated by differential scanning calorimetry (DSC) and gravimetric methods.  The results indicated that GA-incorporated hydrogel was still temp. responsive and the swelling ratio decreased with the increasing of temp.  The lower crit. soln. temp. (LCST) of GA-incorporated hydrogel and poly(N-isopropylacrylamide) hydrogel was 30.00 °C and 31.21 °C, resp., in distd. water.  However, these two values were shifted to 28.22 °C and 29.16 °C in cell culture media.  The novel hydrogel also exhibited reversible temp. responsibility.  Deswelling kinetics indicated that the copolymd. hydrogel deswelled more rapidly than poly(N-isopropylacrylamide) hydrogel.  Since GA has specific binding capacity to asialoglycoprotein receptors on the membrane of hepatocyte, this novel hydrogel with GA could be expected as good candidate for hepatic cell culture.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDGUyALHOzXLVg90H21EOLACvtfcHk0lgXNMLgshm71w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXms1alurk%253D&md5=a446cc48144f20254d88ae39a0a02892</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1007%2Fs10853-009-3588-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10853-009-3588-3%26sid%3Dliteratum%253Aachs%26aulast%3DHe%26aufirst%3DX.%26aulast%3DYu%26aufirst%3DS.%26aulast%3DDong%26aufirst%3DY.%2BY.%26aulast%3DYan%26aufirst%3DF.%26aulast%3DChen%26aufirst%3DL.%26atitle%3DPreparation%2520and%2520properties%2520of%2520a%2520novel%2520thermo-responsive%2520poly%2528N-isopropylacrylamide%2529%2520hydrogel%2520containing%2520glycyrrhetinic%2520acid%26jtitle%3DJ.%2520Mater.%2520Sci.%26date%3D2009%26volume%3D44%26spage%3D4078%26epage%3D4086" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Tatsuzaki, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taniguchi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bastow, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakagawa-Goto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morris-Natschke, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Itokawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baba, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, K.-H.</span><span> </span><span class="NLM_article-title">Anti-tumor agents: Novel glycyrrhetinic acid-dehydrozingerone conjugates as cytotoxic agents</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">6193</span><span class="NLM_x">–</span> <span class="NLM_lpage">6199</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2007&pages=6193-6199&author=J.+Tatsuzakiauthor=M.+Taniguchiauthor=K.+F.+Bastowauthor=K.+Nakagawa-Gotoauthor=S.+L.+Morris-Natschkeauthor=H.+Itokawaauthor=K.+Babaauthor=K.-H.+Lee&title=Anti-tumor+agents%3A+Novel+glycyrrhetinic+acid-dehydrozingerone+conjugates+as+cytotoxic+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTatsuzaki%26aufirst%3DJ.%26aulast%3DTaniguchi%26aufirst%3DM.%26aulast%3DBastow%26aufirst%3DK.%2BF.%26aulast%3DNakagawa-Goto%26aufirst%3DK.%26aulast%3DMorris-Natschke%26aufirst%3DS.%2BL.%26aulast%3DItokawa%26aufirst%3DH.%26aulast%3DBaba%26aufirst%3DK.%26aulast%3DLee%26aufirst%3DK.-H.%26atitle%3DAnti-tumor%2520agents%253A%2520Novel%2520glycyrrhetinic%2520acid-dehydrozingerone%2520conjugates%2520as%2520cytotoxic%2520agents%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2007%26volume%3D15%26spage%3D6193%26epage%3D6199" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Fukuoka, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kida, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakajima, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsumagari, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watanabe, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inaba, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mori, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsumura, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakano, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takeshita, K.</span><span> </span><span class="NLM_article-title">Thermo-responsive extraction of cadmium(II) ion with TPEN-NIPA gel. Effect of the number of polymerizable double bond toward gel formation and the extracting behavior</span> <span class="citation_source-journal">Tetrahedron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">1721</span><span class="NLM_x">–</span> <span class="NLM_lpage">1727</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=1721-1727&author=S.+Fukuokaauthor=T.+Kidaauthor=Y.+Nakajimaauthor=T.+Tsumagariauthor=W.+Watanabeauthor=Y.+Inabaauthor=A.+Moriauthor=T.+Matsumuraauthor=Y.+Nakanoauthor=K.+Takeshita&title=Thermo-responsive+extraction+of+cadmium%28II%29+ion+with+TPEN-NIPA+gel.+Effect+of+the+number+of+polymerizable+double+bond+toward+gel+formation+and+the+extracting+behavior"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFukuoka%26aufirst%3DS.%26aulast%3DKida%26aufirst%3DT.%26aulast%3DNakajima%26aufirst%3DY.%26aulast%3DTsumagari%26aufirst%3DT.%26aulast%3DWatanabe%26aufirst%3DW.%26aulast%3DInaba%26aufirst%3DY.%26aulast%3DMori%26aufirst%3DA.%26aulast%3DMatsumura%26aufirst%3DT.%26aulast%3DNakano%26aufirst%3DY.%26aulast%3DTakeshita%26aufirst%3DK.%26atitle%3DThermo-responsive%2520extraction%2520of%2520cadmium%2528II%2529%2520ion%2520with%2520TPEN-NIPA%2520gel.%2520Effect%2520of%2520the%2520number%2520of%2520polymerizable%2520double%2520bond%2520toward%2520gel%2520formation%2520and%2520the%2520extracting%2520behavior%26jtitle%3DTetrahedron%26date%3D2010%26volume%3D66%26spage%3D1721%26epage%3D1727" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Joseph, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Darro, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Béliard, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lesur, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collignon, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Decaestecker, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frydman, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guillaumet, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiss, R.</span><span> </span><span class="NLM_article-title">3-aryl-2-quinolone derivatives: synthesis and characterization of <i>in vitro</i> and <i>in vivo</i> anti-tumor effects with emphasis on a new therapeutical target connected with cell migration</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">2543</span><span class="NLM_x">–</span> <span class="NLM_lpage">2555</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm010978m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=2543-2555&author=B.+Josephauthor=F.+Darroauthor=A.+B%C3%A9liardauthor=B.+Lesurauthor=F.+Collignonauthor=C.+Decaesteckerauthor=A.+Frydmanauthor=G.+Guillaumetauthor=R.+Kiss&title=3-aryl-2-quinolone+derivatives%3A+synthesis+and+characterization+of+in+vitro+and+in+vivo+anti-tumor+effects+with+emphasis+on+a+new+therapeutical+target+connected+with+cell+migration"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fjm010978m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm010978m%26sid%3Dliteratum%253Aachs%26aulast%3DJoseph%26aufirst%3DB.%26aulast%3DDarro%26aufirst%3DF.%26aulast%3DB%25C3%25A9liard%26aufirst%3DA.%26aulast%3DLesur%26aufirst%3DB.%26aulast%3DCollignon%26aufirst%3DF.%26aulast%3DDecaestecker%26aufirst%3DC.%26aulast%3DFrydman%26aufirst%3DA.%26aulast%3DGuillaumet%26aufirst%3DG.%26aulast%3DKiss%26aufirst%3DR.%26atitle%3D3-aryl-2-quinolone%2520derivatives%253A%2520synthesis%2520and%2520characterization%2520of%2520in%2520vitro%2520and%2520in%2520vivo%2520anti-tumor%2520effects%2520with%2520emphasis%2520on%2520a%2520new%2520therapeutical%2520target%2520connected%2520with%2520cell%2520migration%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26spage%3D2543%26epage%3D2555" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Ozap-Yaman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Hoog, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amadei, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pitié, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gamez, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dewelle, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mijatovic, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meunier, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiss, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reedijk, J.</span><span> </span><span class="NLM_article-title">Platined copper (3-clip-phen) complexes as effective DNA-cleaving and cytotoxic agents</span> <span class="citation_source-journal">Chem.—Eur. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">3418</span><span class="NLM_x">–</span> <span class="NLM_lpage">3426</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Fjm200285z&amp;key=10.1002%2Fchem.200702021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Fjm200285z&amp;key=18293353" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2008&pages=3418-3426&author=S.+Ozap-Yamanauthor=P.+de+Hoogauthor=G.+Amadeiauthor=M.+Piti%C3%A9author=P.+Gamezauthor=J.+Dewelleauthor=T.+Mijatovicauthor=B.+Meunierauthor=R.+Kissauthor=J.+Reedijk&title=Platined+copper+%283-clip-phen%29+complexes+as+effective+DNA-cleaving+and+cytotoxic+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1002%2Fchem.200702021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fchem.200702021%26sid%3Dliteratum%253Aachs%26aulast%3DOzap-Yaman%26aufirst%3DS.%26aulast%3Dde%2BHoog%26aufirst%3DP.%26aulast%3DAmadei%26aufirst%3DG.%26aulast%3DPiti%25C3%25A9%26aufirst%3DM.%26aulast%3DGamez%26aufirst%3DP.%26aulast%3DDewelle%26aufirst%3DJ.%26aulast%3DMijatovic%26aufirst%3DT.%26aulast%3DMeunier%26aufirst%3DB.%26aulast%3DKiss%26aufirst%3DR.%26aulast%3DReedijk%26aufirst%3DJ.%26atitle%3DPlatined%2520copper%2520%25283-clip-phen%2529%2520complexes%2520as%2520effective%2520DNA-cleaving%2520and%2520cytotoxic%2520agents%26jtitle%3DChem.%25E2%2580%2594Eur.%2520J.%26date%3D2008%26volume%3D14%26spage%3D3418%26epage%3D3426" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Lamoral-Theys, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andolfi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Goietsenoven, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cimmino, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Calvé, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wauthoz, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mégalizzi, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gras, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruyère, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dubois, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathieu, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kornienko, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiss, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evidente, A.</span><span> </span><span class="NLM_article-title">Lycorine, the main phenanthridine Amaryllidaceae alkaloid, exhibits significant antitumor activity in cancer cells that display resistance to proapoptotic stimuli: An investigation of structure-activity relationship and mechanistic insight</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">6244</span><span class="NLM_x">–</span> <span class="NLM_lpage">6256</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm901031h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=6244-6256&author=D.+Lamoral-Theysauthor=A.+Andolfiauthor=G.+Van+Goietsenovenauthor=A.+Cimminoauthor=B.+Le+Calv%C3%A9author=N.+Wauthozauthor=V.+M%C3%A9galizziauthor=T.+Grasauthor=C.+Bruy%C3%A8reauthor=J.+Duboisauthor=V.+Mathieuauthor=A.+Kornienkoauthor=R.+Kissauthor=A.+Evidente&title=Lycorine%2C+the+main+phenanthridine+Amaryllidaceae+alkaloid%2C+exhibits+significant+antitumor+activity+in+cancer+cells+that+display+resistance+to+proapoptotic+stimuli%3A+An+investigation+of+structure-activity+relationship+and+mechanistic+insight"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fjm901031h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901031h%26sid%3Dliteratum%253Aachs%26aulast%3DLamoral-Theys%26aufirst%3DD.%26aulast%3DAndolfi%26aufirst%3DA.%26aulast%3DVan%2BGoietsenoven%26aufirst%3DG.%26aulast%3DCimmino%26aufirst%3DA.%26aulast%3DLe%2BCalv%25C3%25A9%26aufirst%3DB.%26aulast%3DWauthoz%26aufirst%3DN.%26aulast%3DM%25C3%25A9galizzi%26aufirst%3DV.%26aulast%3DGras%26aufirst%3DT.%26aulast%3DBruy%25C3%25A8re%26aufirst%3DC.%26aulast%3DDubois%26aufirst%3DJ.%26aulast%3DMathieu%26aufirst%3DV.%26aulast%3DKornienko%26aufirst%3DA.%26aulast%3DKiss%26aufirst%3DR.%26aulast%3DEvidente%26aufirst%3DA.%26atitle%3DLycorine%252C%2520the%2520main%2520phenanthridine%2520Amaryllidaceae%2520alkaloid%252C%2520exhibits%2520significant%2520antitumor%2520activity%2520in%2520cancer%2520cells%2520that%2520display%2520resistance%2520to%2520proapoptotic%2520stimuli%253A%2520An%2520investigation%2520of%2520structure-activity%2520relationship%2520and%2520mechanistic%2520insight%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D6244%26epage%3D6256" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Ingrassia, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lefranc, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dewelle, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pottier, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathieu, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spiegl-Kreinecker, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sauvage, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">El Yazidi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dehoux, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berger, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Quaquebeke, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiss, R.</span><span> </span><span class="NLM_article-title">Structure-activity relationship analysis of novel derivatives of narciclasine (an Amaryllidaceae isocarbostyril derivative) as potential anticancer agents</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">1100</span><span class="NLM_x">–</span> <span class="NLM_lpage">1114</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm8013585" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=1100-1114&author=L.+Ingrassiaauthor=F.+Lefrancauthor=J.+Dewelleauthor=L.+Pottierauthor=V.+Mathieuauthor=S.+Spiegl-Kreineckerauthor=S.+Sauvageauthor=M.+El+Yazidiauthor=M.+Dehouxauthor=W.+Bergerauthor=E.+Van+Quaquebekeauthor=R.+Kiss&title=Structure-activity+relationship+analysis+of+novel+derivatives+of+narciclasine+%28an+Amaryllidaceae+isocarbostyril+derivative%29+as+potential+anticancer+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fjm8013585&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm8013585%26sid%3Dliteratum%253Aachs%26aulast%3DIngrassia%26aufirst%3DL.%26aulast%3DLefranc%26aufirst%3DF.%26aulast%3DDewelle%26aufirst%3DJ.%26aulast%3DPottier%26aufirst%3DL.%26aulast%3DMathieu%26aufirst%3DV.%26aulast%3DSpiegl-Kreinecker%26aufirst%3DS.%26aulast%3DSauvage%26aufirst%3DS.%26aulast%3DEl%2BYazidi%26aufirst%3DM.%26aulast%3DDehoux%26aufirst%3DM.%26aulast%3DBerger%26aufirst%3DW.%26aulast%3DVan%2BQuaquebeke%26aufirst%3DE.%26aulast%3DKiss%26aufirst%3DR.%26atitle%3DStructure-activity%2520relationship%2520analysis%2520of%2520novel%2520derivatives%2520of%2520narciclasine%2520%2528an%2520Amaryllidaceae%2520isocarbostyril%2520derivative%2529%2520as%2520potential%2520anticancer%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D1100%26epage%3D1114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Branle, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lefranc, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Camby, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeuken, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geurts-Moespot, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sprenger, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sweep, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiss, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salmon, I.</span><span> </span><span class="NLM_article-title">Evaluation of the efficiency of chemotherapy in <i>in vivo</i> orthotopic models of human glioma cells with and without 1p19q deletions and in C6 rat orthotopic allografts serving for the evaluation of surgery combined with chemotherapy</span> <span class="citation_source-journal">Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">95</span><span class="NLM_x">, </span> <span class="NLM_fpage">641</span><span class="NLM_x">–</span> <span class="NLM_lpage">655</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=2002&pages=641-655&author=F.+Branleauthor=F.+Lefrancauthor=I.+Cambyauthor=J.+Jeukenauthor=A.+Geurts-Moespotauthor=S.+Sprengerauthor=F.+Sweepauthor=R.+Kissauthor=I.+Salmon&title=Evaluation+of+the+efficiency+of+chemotherapy+in+in+vivo+orthotopic+models+of+human+glioma+cells+with+and+without+1p19q+deletions+and+in+C6+rat+orthotopic+allografts+serving+for+the+evaluation+of+surgery+combined+with+chemotherapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBranle%26aufirst%3DF.%26aulast%3DLefranc%26aufirst%3DF.%26aulast%3DCamby%26aufirst%3DI.%26aulast%3DJeuken%26aufirst%3DJ.%26aulast%3DGeurts-Moespot%26aufirst%3DA.%26aulast%3DSprenger%26aufirst%3DS.%26aulast%3DSweep%26aufirst%3DF.%26aulast%3DKiss%26aufirst%3DR.%26aulast%3DSalmon%26aufirst%3DI.%26atitle%3DEvaluation%2520of%2520the%2520efficiency%2520of%2520chemotherapy%2520in%2520in%2520vivo%2520orthotopic%2520models%2520of%2520human%2520glioma%2520cells%2520with%2520and%2520without%25201p19q%2520deletions%2520and%2520in%2520C6%2520rat%2520orthotopic%2520allografts%2520serving%2520for%2520the%2520evaluation%2520of%2520surgery%2520combined%2520with%2520chemotherapy%26jtitle%3DCancer%26date%3D2002%26volume%3D95%26spage%3D641%26epage%3D655" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Mathieu, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Remmelink, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Haene, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Penant, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaussin, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Ginckel, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Darro, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiss, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salmon, I.</span><span> </span><span class="NLM_article-title">Development of a chemoresistant orthotopic human nonsmall cell lung carcinoma model in nude mice</span> <span class="citation_source-journal">Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">101</span><span class="NLM_x">, </span> <span class="NLM_fpage">1908</span><span class="NLM_x">–</span> <span class="NLM_lpage">1918</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2004&pages=1908-1918&author=A.+Mathieuauthor=M.+Remmelinkauthor=N.+D%E2%80%99Haeneauthor=S.+Penantauthor=J.+F.+Gaussinauthor=R.+Van+Ginckelauthor=F.+Darroauthor=R.+Kissauthor=I.+Salmon&title=Development+of+a+chemoresistant+orthotopic+human+nonsmall+cell+lung+carcinoma+model+in+nude+mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMathieu%26aufirst%3DA.%26aulast%3DRemmelink%26aufirst%3DM.%26aulast%3DD%25E2%2580%2599Haene%26aufirst%3DN.%26aulast%3DPenant%26aufirst%3DS.%26aulast%3DGaussin%26aufirst%3DJ.%2BF.%26aulast%3DVan%2BGinckel%26aufirst%3DR.%26aulast%3DDarro%26aufirst%3DF.%26aulast%3DKiss%26aufirst%3DR.%26aulast%3DSalmon%26aufirst%3DI.%26atitle%3DDevelopment%2520of%2520a%2520chemoresistant%2520orthotopic%2520human%2520nonsmall%2520cell%2520lung%2520carcinoma%2520model%2520in%2520nude%2520mice%26jtitle%3DCancer%26date%3D2004%26volume%3D101%26spage%3D1908%26epage%3D1918" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Mijatovic, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathieu, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaussin, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Nève, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ribaucour, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Quaquebeke, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dumont, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Darro, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiss, R.</span><span> </span><span class="NLM_article-title">Cardenolide-induced lysosomal membrane permeabilization demonstrates therapeutic benefits in experimental human non-small cell lung cancers</span> <span class="citation_source-journal">Neoplasia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">402</span><span class="NLM_x">–</span> <span class="NLM_lpage">412</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2006&pages=402-412&author=T.+Mijatovicauthor=V.+Mathieuauthor=J.+F.+Gaussinauthor=N.+De+N%C3%A8veauthor=F.+Ribaucourauthor=E.+Van+Quaquebekeauthor=P.+Dumontauthor=F.+Darroauthor=R.+Kiss&title=Cardenolide-induced+lysosomal+membrane+permeabilization+demonstrates+therapeutic+benefits+in+experimental+human+non-small+cell+lung+cancers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMijatovic%26aufirst%3DT.%26aulast%3DMathieu%26aufirst%3DV.%26aulast%3DGaussin%26aufirst%3DJ.%2BF.%26aulast%3DDe%2BN%25C3%25A8ve%26aufirst%3DN.%26aulast%3DRibaucour%26aufirst%3DF.%26aulast%3DVan%2BQuaquebeke%26aufirst%3DE.%26aulast%3DDumont%26aufirst%3DP.%26aulast%3DDarro%26aufirst%3DF.%26aulast%3DKiss%26aufirst%3DR.%26atitle%3DCardenolide-induced%2520lysosomal%2520membrane%2520permeabilization%2520demonstrates%2520therapeutic%2520benefits%2520in%2520experimental%2520human%2520non-small%2520cell%2520lung%2520cancers%26jtitle%3DNeoplasia%26date%3D2006%26volume%3D5%26spage%3D402%26epage%3D412" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Mathieu, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pirker, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin de Lassalle, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vernier, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mijatovic, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Neve, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaussin, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dehoux, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lefranc, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berger, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiss, R.</span><span> </span><span class="NLM_article-title">The sodium pump alpha-1 subunit: a disease progression-related target for metastatic melanoma treatment</span> <span class="citation_source-journal">J. Cell Mol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">3960</span><span class="NLM_x">–</span> <span class="NLM_lpage">3972</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Fjm200285z&amp;key=10.1111%2Fj.1582-4934.2009.00708.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Fjm200285z&amp;key=19243476" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Fjm200285z&amp;key=1%3ACAS%3A280%3ADC%252BC3c7kvFChsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2009&pages=3960-3972&author=V.+Mathieuauthor=C.+Pirkerauthor=E.+Martin+de+Lassalleauthor=M.+Vernierauthor=T.+Mijatovicauthor=N.+De+Neveauthor=J.+F.+Gaussinauthor=M.+Dehouxauthor=F.+Lefrancauthor=W.+Bergerauthor=R.+Kiss&title=The+sodium+pump+alpha-1+subunit%3A+a+disease+progression-related+target+for+metastatic+melanoma+treatment"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">The sodium pump alpha1 sub-unit: a disease progression-related target for metastatic melanoma treatment</span></div><div class="casAuthors">Mathieu Veronique; Pirker Christine; Martin de Lassalle Elisabeth; Vernier Mathieu; Mijatovic Tatjana; DeNeve Nancy; Gaussin Jean-Francois; Dehoux Mischael; Lefranc Florence; Berger Walter; Kiss Robert</div><div class="citationInfo"><span class="NLM_cas:title">Journal of cellular and molecular medicine</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">9B</span>),
    <span class="NLM_cas:pages">3960-72</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Melanomas remain associated with dismal prognosis because they are naturally resistant to apoptosis and they markedly metastasize.  Up-regulated expression of sodium pump alpha sub-units has previously been demonstrated when comparing metastatic to non-metastatic melanomas.  Our previous data revealed that impairing sodium pump alpha1 activity by means of selective ligands, that are cardiotonic steroids, markedly impairs cell migration and kills apoptosis-resistant cancer cells.  The objective of this study was to determine the expression levels of sodium pump alpha sub-units in melanoma clinical samples and cell lines and also to characterize the role of alpha1 sub-units in melanoma cell biology.  Quantitative RT-PCR, Western blotting and immunohistochemistry were used to determine the expression levels of sodium pump alpha sub-units.  In vitro cytotoxicity of various cardenolides and of an anti-alpha1 siRNA was evaluated by means of MTT assay, quantitative videomicroscopy and through apoptosis assays.  The in vivo activity of a novel cardenolide UNBS1450 was evaluated in a melanoma brain metastasis model.  Our data show that all investigated human melanoma cell lines expressed high levels of the alpha1 sub-unit, and 33% of human melanomas displayed significant alpha1 sub-unit expression in correlation with the Breslow index.  Furthermore, cardenolides (notably UNBS1450; currently in Phase I clinical trials) displayed marked anti-tumour effects against melanomas in vitro.  This activity was closely paralleled by decreases in cMyc expression and by increases in apoptotic features.  UNBS1450 also displayed marked anti-tumour activity in the aggressive human metastatic brain melanoma model in vivo.  The alpha1 sodium pump sub-unit could represent a potential novel target for combating melanoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRCeneUQpTcEu_Q9URG6Dx8fW6udTcc2ebAtua1BWt_Dbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3c7kvFChsA%253D%253D&md5=6079d92a5eb05e978a79319a3c4db2eb</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1111%2Fj.1582-4934.2009.00708.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1582-4934.2009.00708.x%26sid%3Dliteratum%253Aachs%26aulast%3DMathieu%26aufirst%3DV.%26aulast%3DPirker%26aufirst%3DC.%26aulast%3DMartin%2Bde%2BLassalle%26aufirst%3DE.%26aulast%3DVernier%26aufirst%3DM.%26aulast%3DMijatovic%26aufirst%3DT.%26aulast%3DDe%2BNeve%26aufirst%3DN.%26aulast%3DGaussin%26aufirst%3DJ.%2BF.%26aulast%3DDehoux%26aufirst%3DM.%26aulast%3DLefranc%26aufirst%3DF.%26aulast%3DBerger%26aufirst%3DW.%26aulast%3DKiss%26aufirst%3DR.%26atitle%3DThe%2520sodium%2520pump%2520alpha-1%2520subunit%253A%2520a%2520disease%2520progression-related%2520target%2520for%2520metastatic%2520melanoma%2520treatment%26jtitle%3DJ.%2520Cell%2520Mol.%2520Med.%26date%3D2009%26volume%3D13%26spage%3D3960%26epage%3D3972" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Dumont, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ingrassia, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rouzeau, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ribaucour, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roland, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Darro, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lefranc, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiss, R.</span><span> </span><span class="NLM_article-title">The <i>Amaryllidaceae</i> isocarbostyril narciclasine induces apoptosis by activation of the death receptor and/or mitochondrial pathways in cancer cells but not in normal fibroblasts</span> <span class="citation_source-journal">Neoplasia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">766</span><span class="NLM_x">–</span> <span class="NLM_lpage">776</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2007&pages=766-776&author=P.+Dumontauthor=L.+Ingrassiaauthor=S.+Rouzeauauthor=F.+Ribaucourauthor=S.+Thomasauthor=I.+Rolandauthor=F.+Darroauthor=F.+Lefrancauthor=R.+Kiss&title=The+Amaryllidaceae+isocarbostyril+narciclasine+induces+apoptosis+by+activation+of+the+death+receptor+and%2For+mitochondrial+pathways+in+cancer+cells+but+not+in+normal+fibroblasts"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDumont%26aufirst%3DP.%26aulast%3DIngrassia%26aufirst%3DL.%26aulast%3DRouzeau%26aufirst%3DS.%26aulast%3DRibaucour%26aufirst%3DF.%26aulast%3DThomas%26aufirst%3DS.%26aulast%3DRoland%26aufirst%3DI.%26aulast%3DDarro%26aufirst%3DF.%26aulast%3DLefranc%26aufirst%3DF.%26aulast%3DKiss%26aufirst%3DR.%26atitle%3DThe%2520Amaryllidaceae%2520isocarbostyril%2520narciclasine%2520induces%2520apoptosis%2520by%2520activation%2520of%2520the%2520death%2520receptor%2520and%252For%2520mitochondrial%2520pathways%2520in%2520cancer%2520cells%2520but%2520not%2520in%2520normal%2520fibroblasts%26jtitle%3DNeoplasia%26date%3D2007%26volume%3D9%26spage%3D766%26epage%3D776" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Gerber, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minna, J. D.</span><span> </span><span class="NLM_article-title">ALK inhibition for non-small cell lung cancer: from discovery to therapy in record time</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">548</span><span class="NLM_x">–</span> <span class="NLM_lpage">551</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2010&pages=548-551&author=D.+E.+Gerberauthor=J.+D.+Minna&title=ALK+inhibition+for+non-small+cell+lung+cancer%3A+from+discovery+to+therapy+in+record+time"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGerber%26aufirst%3DD.%2BE.%26aulast%3DMinna%26aufirst%3DJ.%2BD.%26atitle%3DALK%2520inhibition%2520for%2520non-small%2520cell%2520lung%2520cancer%253A%2520from%2520discovery%2520to%2520therapy%2520in%2520record%2520time%26jtitle%3DCancer%2520Cell%26date%3D2010%26volume%3D18%26spage%3D548%26epage%3D551" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Qiu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kung, H. J.</span><span> </span><span class="NLM_article-title">Signaling network of the Btk family kinases</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">5651</span><span class="NLM_x">–</span> <span class="NLM_lpage">5661</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2000&pages=5651-5661&author=Y.+Qiuauthor=H.+J.+Kung&title=Signaling+network+of+the+Btk+family+kinases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DQiu%26aufirst%3DY.%26aulast%3DKung%26aufirst%3DH.%2BJ.%26atitle%3DSignaling%2520network%2520of%2520the%2520Btk%2520family%2520kinases%26jtitle%3DOncogene%26date%3D2000%26volume%3D19%26spage%3D5651%26epage%3D5661" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Dopeso, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mateo-Lozano, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mazzolini, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodrigues, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lagares-Tena, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ceron, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romero, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Esteves, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Landolfi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hernandez-Losa, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castano, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramon y Cajal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mariadason, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwartz, S.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arango, D.</span><span> </span><span class="NLM_article-title">The receptor tyrosine kinase EPHB4 has tumor suppressor activities in intestinal tumorigenesis</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x">, </span> <span class="NLM_fpage">7430</span><span class="NLM_x">–</span> <span class="NLM_lpage">7438</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2009&pages=7430-7438&author=H.+Dopesoauthor=S.+Mateo-Lozanoauthor=R.+Mazzoliniauthor=P.+Rodriguesauthor=L.+Lagares-Tenaauthor=J.+Ceronauthor=J.+Romeroauthor=M.+Estevesauthor=S.+Landolfiauthor=J.+Hernandez-Losaauthor=J.+Castanoauthor=A.+J.+Wilsonauthor=S.+Ramon+y+Cajalauthor=J.+M.+Mariadasonauthor=S.+Schwartzauthor=D.+Arango&title=The+receptor+tyrosine+kinase+EPHB4+has+tumor+suppressor+activities+in+intestinal+tumorigenesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDopeso%26aufirst%3DH.%26aulast%3DMateo-Lozano%26aufirst%3DS.%26aulast%3DMazzolini%26aufirst%3DR.%26aulast%3DRodrigues%26aufirst%3DP.%26aulast%3DLagares-Tena%26aufirst%3DL.%26aulast%3DCeron%26aufirst%3DJ.%26aulast%3DRomero%26aufirst%3DJ.%26aulast%3DEsteves%26aufirst%3DM.%26aulast%3DLandolfi%26aufirst%3DS.%26aulast%3DHernandez-Losa%26aufirst%3DJ.%26aulast%3DCastano%26aufirst%3DJ.%26aulast%3DWilson%26aufirst%3DA.%2BJ.%26aulast%3DRamon%2By%2BCajal%26aufirst%3DS.%26aulast%3DMariadason%26aufirst%3DJ.%2BM.%26aulast%3DSchwartz%26aufirst%3DS.%26aulast%3DArango%26aufirst%3DD.%26atitle%3DThe%2520receptor%2520tyrosine%2520kinase%2520EPHB4%2520has%2520tumor%2520suppressor%2520activities%2520in%2520intestinal%2520tumorigenesis%26jtitle%3DCancer%2520Res.%26date%3D2009%26volume%3D69%26spage%3D7430%26epage%3D7438" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Herath, N. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyd, A. W.</span><span> </span><span class="NLM_article-title">The role of Eph receptors and ephrin ligands in colorectal cancer</span> <span class="citation_source-journal">Int. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">126</span><span class="NLM_x">, </span> <span class="NLM_fpage">2003</span><span class="NLM_x">–</span> <span class="NLM_lpage">2011</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Fjm200285z&amp;key=20039322" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Fjm200285z&amp;key=1%3ACAS%3A528%3ADC%252BC3cXisFemur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=126&publication_year=2010&pages=2003-2011&author=N.+I.+Herathauthor=A.+W.+Boyd&title=The+role+of+Eph+receptors+and+ephrin+ligands+in+colorectal+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">The role of Eph receptors and ephrin ligands in colorectal cancer</span></div><div class="casAuthors">Herath, Nirmitha I.; Boyd, Andrew W.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Cancer</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">126</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2003-2011</span>CODEN:
                <span class="NLM_cas:coden">IJCNAW</span>;
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">A review.  Eph receptors and their ephrin ligands constitute the largest subfamily of receptor tyrosine kinases and are components of the cell signaling pathways involved during development.  Eph and ephrin overexpression have been documented in a variety of human cancers including gastrointestinal malignancies and in particular colorectal malignancies.  EphB and ephrin B proteins have been implicated in the homeostasis of the gastrointestinal tract where EphB2- and EphB3-ephrin B signaling regulates cell sorting in the mature epithelium.  These proteins are also reported to be upregulated in colon carcinomas.  The EphA/ephrin A system has also been implicated in epithelial tissue structure and function.  More recently, EphA receptors and their corresponding ligands have been implicated in numerous malignancies.  Of these, EphA2 in particular has been intensively investigated and has been proposed as a therapeutic target.  An interesting observation emerging from these studies is the role for Ephs and ephrins in crit. aspects of cell adhesion, migration and positioning, and a crucial role in tumor progression and metastasis.  However, the underlying role of Ephs and ephrins in these processes has generally been studied on individual Eph or ephrin genes.  Given the multiplicity of Eph expression on gut epithelial cells, a more global approach is needed to define the precise role of Eph-ephrin interaction in malignant transformation.  Here, we will review the recent advances on the role of Eph-ephrin signaling in colorectal malignancies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUxkUFZRBWNLVg90H21EOLACvtfcHk0ljs7Iu6jyolAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXisFemur8%253D&md5=df879b916c5476a76cbe9d934ed783e0</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHerath%26aufirst%3DN.%2BI.%26aulast%3DBoyd%26aufirst%3DA.%2BW.%26atitle%3DThe%2520role%2520of%2520Eph%2520receptors%2520and%2520ephrin%2520ligands%2520in%2520colorectal%2520cancer%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D2010%26volume%3D126%26spage%3D2003%26epage%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Smith, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samayawardhena, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Craig, A. W.</span><span> </span><span class="NLM_article-title">Fps/Fes protein-tyrosine kinase regulats mast cell adhesion and migration dowstrean of kit and beta1 integrin receptors</span> <span class="citation_source-journal">Cell Signal</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">427</span><span class="NLM_x">–</span> <span class="NLM_lpage">436</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Fjm200285z&amp;key=10.1016%2Fj.cellsig.2009.10.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Fjm200285z&amp;key=19892014" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Fjm200285z&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFGku7fN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2010&pages=427-436&author=J.+A.+Smithauthor=L.+A.+Samayawardhenaauthor=A.+W.+Craig&title=Fps%2FFes+protein-tyrosine+kinase+regulats+mast+cell+adhesion+and+migration+dowstrean+of+kit+and+beta1+integrin+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Fps/Fes protein-tyrosine kinase regulates mast cell adhesion and migration downstream of Kit and β1 integrin receptors</span></div><div class="casAuthors">Smith, Julie A.; Samayawardhena, Lionel A.; Craig, Andrew W. B.</div><div class="citationInfo"><span class="NLM_cas:title">Cellular Signalling</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">427-436</span>CODEN:
                <span class="NLM_cas:coden">CESIEY</span>;
        ISSN:<span class="NLM_cas:issn">0898-6568</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Activation of Kit receptor protein-tyrosine kinase (PTK) by its ligand Stem Cell Factor (SCF) is required for the development of mast cells, and for the regulation of mast cell proliferation, migration and modulation of inflammatory mediator release.  Recent studies have implicated the non-receptor PTK Fps/Fes (hereafter referred to as Fes) in signaling downstream of oncogenic Kit, however, the potential role of Fes in regulating Kit signaling is not well defined.  In this study, we show that SCF induces transient tyrosine phosphorylation of wild-type Fes as well as kinase-dead Fes in bone marrow-derived mast cells (BMMCs).  The latter finding implicates an upstream kinase acting on Fes, which we identified as Fyn PTK.  SCF treatment of BMMCs promoted recruitment of Fes to Kit, potentially via direct interaction of the Fes SH2 domain with phosphorylated Kit.  While Fes was not required for SCF-induced signaling to Akt and Erk kinases, Fes-deficient (fes-/-) BMMCs displayed a defect in sustained p38 kinase activation, compared to control cells.  SCF-treated Fes-deficient BMMCs also displayed elevated β1 integrin-mediated cell adhesion and spreading on fibronectin, compared to control cells, and a redn. in cell polarization at later times of SCF treatment.  Restoring Fes expression in fes-/- BMMCs by retroviral transduction was sufficient to rescue cell spreading and polarization defects.  Interestingly, SCF-induced chemotaxis of BMMCs was also defective in Fes-deficient BMMCs, and restored in Fes-rescue BMMCs.  Overall, these results implicate Fes in regulating cross-talk between Kit and β1 integrins to promote cytoskeletal reorganization and motility of mast cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7c9xicdwTbLVg90H21EOLACvtfcHk0ljs7Iu6jyolAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFGku7fN&md5=a9b5a8a32c2e46a69fdba3c3205843a2</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1016%2Fj.cellsig.2009.10.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cellsig.2009.10.014%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DJ.%2BA.%26aulast%3DSamayawardhena%26aufirst%3DL.%2BA.%26aulast%3DCraig%26aufirst%3DA.%2BW.%26atitle%3DFps%252FFes%2520protein-tyrosine%2520kinase%2520regulats%2520mast%2520cell%2520adhesion%2520and%2520migration%2520dowstrean%2520of%2520kit%2520and%2520beta1%2520integrin%2520receptors%26jtitle%3DCell%2520Signal%26date%3D2010%26volume%3D22%26spage%3D427%26epage%3D436" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Saito, Y. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jensen, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salgia, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Posadas, E. M.</span><span> </span><span class="NLM_article-title">Fyn: a novel molecular target in cancer</span> <span class="citation_source-journal">Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">116</span><span class="NLM_x">, </span> <span class="NLM_fpage">1629</span><span class="NLM_x">–</span> <span class="NLM_lpage">1637</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=2010&pages=1629-1637&author=Y.+D.+Saitoauthor=A.+R.+Jensenauthor=R.+Salgiaauthor=E.+M.+Posadas&title=Fyn%3A+a+novel+molecular+target+in+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSaito%26aufirst%3DY.%2BD.%26aulast%3DJensen%26aufirst%3DA.%2BR.%26aulast%3DSalgia%26aufirst%3DR.%26aulast%3DPosadas%26aufirst%3DE.%2BM.%26atitle%3DFyn%253A%2520a%2520novel%2520molecular%2520target%2520in%2520cancer%26jtitle%3DCancer%26date%3D2010%26volume%3D116%26spage%3D1629%26epage%3D1637" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Katoh, M.</span><span> </span><span class="NLM_article-title">FGFR2 abnormalities underlies a spectrum of bone, skin, and cancer pathologies</span> <span class="citation_source-journal">J. Invest. Dermatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">129</span><span class="NLM_x">, </span> <span class="NLM_fpage">1861</span><span class="NLM_x">–</span> <span class="NLM_lpage">1867</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=129&publication_year=2009&pages=1861-1867&author=M.+Katoh&title=FGFR2+abnormalities+underlies+a+spectrum+of+bone%2C+skin%2C+and+cancer+pathologies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKatoh%26aufirst%3DM.%26atitle%3DFGFR2%2520abnormalities%2520underlies%2520a%2520spectrum%2520of%2520bone%252C%2520skin%252C%2520and%2520cancer%2520pathologies%26jtitle%3DJ.%2520Invest.%2520Dermatol.%26date%3D2009%26volume%3D129%26spage%3D1861%26epage%3D1867" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Scartozzi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bianconi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maccaroni, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giamperi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beradi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cascinu, S.</span><span> </span><span class="NLM_article-title">Dalotuzumab, a recombinant humanized mAb targeted against IGFR1 for the treatment of cancer</span> <span class="citation_source-journal">Curr. Opin. Mol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">361</span><span class="NLM_x">–</span> <span class="NLM_lpage">371</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Fjm200285z&amp;key=20521225" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Fjm200285z&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlaktLvF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2010&pages=361-371&author=M.+Scartozziauthor=M.+Bianconiauthor=E.+Maccaroniauthor=R.+Giamperiauthor=R.+Beradiauthor=S.+Cascinu&title=Dalotuzumab%2C+a+recombinant+humanized+mAb+targeted+against+IGFR1+for+the+treatment+of+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Dalotuzumab, a recombinant humanized mAb targeted against IGFR1 for the treatment of cancer</span></div><div class="casAuthors">Scartozzi, Mario; Bianconi, Maristella; Maccaroni, Elena; Giampieri, Riccardo; Berardi, Rossana; Cascinu, Stefano</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Molecular Therapeutics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">361-371</span>CODEN:
                <span class="NLM_cas:coden">CUOTFO</span>;
        ISSN:<span class="NLM_cas:issn">2040-3445</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">A review.  Dalotuzumab (MK-0646; h7C10), being developed by Merck & Co Inc under license from Pierre Fabre SA, is a recombinant humanized IgG1 mAb against the IGFR1 for the potential i.v. treatment of cancer.  Preclin. studies have demonstrated that dalotuzumab acts by inhibiting IGF-1- and IGF-2-mediated tumor cell proliferation, IGFR1 autophosphorylation and Akt phosphorylation.  In multiple cancer cell lines and in mouse xenograft models, dalotuzumab displayed significant antitumor activity, in particular against NSCLC and breast cancer.  In addn., coadministration of dalotuzumab with other anticancer agents, such as taxanes, enhanced the in vitro and in vivo antitumor activity of dalotuzumab.  Preliminary data from phase I clin. trials suggest that dalotuzumab is safe, well tolerated and significantly inhibits tumor proliferation.  At the time of publication, several clin. trials evaluating dalotuzumab, alone and in combination with other anticancer agents, were ongoing in patients with various types of solid tumor and in patients with multiple myeloma.  Although preliminary results appear promising, only future clin. and translational data will clarify the best clin. setting and treatment combinations for the optimal use of dolotuzumab in clin. practice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrn5qPjJ1HQ7bVg90H21EOLACvtfcHk0lhd2MI0gYxYLQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlaktLvF&md5=93055a6b2aa0c73efd755a6271eb8cd1</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DScartozzi%26aufirst%3DM.%26aulast%3DBianconi%26aufirst%3DM.%26aulast%3DMaccaroni%26aufirst%3DE.%26aulast%3DGiamperi%26aufirst%3DR.%26aulast%3DBeradi%26aufirst%3DR.%26aulast%3DCascinu%26aufirst%3DS.%26atitle%3DDalotuzumab%252C%2520a%2520recombinant%2520humanized%2520mAb%2520targeted%2520against%2520IGFR1%2520for%2520the%2520treatment%2520of%2520cancer%26jtitle%3DCurr.%2520Opin.%2520Mol.%2520Ther.%26date%3D2010%26volume%3D12%26spage%3D361%26epage%3D371" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Cockburn, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richardson, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gujral, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mulligan, L. M.</span><span> </span><span class="NLM_article-title">RET-mediated cell adhesion and migration require multiple integrin subunits</span> <span class="citation_source-journal">J. Clin. Endocrinol. Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">95</span><span class="NLM_x">, </span> <span class="NLM_fpage">E342</span><span class="NLM_x">–</span> <span class="NLM_lpage">E346</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=2010&pages=E342-E346&author=J.+G.+Cockburnauthor=D.+S.+Richardsonauthor=T.+S.+Gujralauthor=L.+M.+Mulligan&title=RET-mediated+cell+adhesion+and+migration+require+multiple+integrin+subunits"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCockburn%26aufirst%3DJ.%2BG.%26aulast%3DRichardson%26aufirst%3DD.%2BS.%26aulast%3DGujral%26aufirst%3DT.%2BS.%26aulast%3DMulligan%26aufirst%3DL.%2BM.%26atitle%3DRET-mediated%2520cell%2520adhesion%2520and%2520migration%2520require%2520multiple%2520integrin%2520subunits%26jtitle%3DJ.%2520Clin.%2520Endocrinol.%2520Metab.%26date%3D2010%26volume%3D95%26spage%3DE342%26epage%3DE346" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">Lee, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, T. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zagozdzon, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Avraham, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Usheva, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Avraham, H. K.</span><span> </span><span class="NLM_article-title">Carboxyl-terminal Src kinase homologous kinase negatively regulates the chemokine receptor CXCR4 through YY1 and impairs CXCR4/CXCL12 (SDF-1alpha)-mediated breast cancer cell migration</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">2840</span><span class="NLM_x">–</span> <span class="NLM_lpage">2845</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2005&pages=2840-2845&author=B.+C.+Leeauthor=T.+H.+Leeauthor=R.+Zagozdzonauthor=S.+Avrahamauthor=A.+Ushevaauthor=H.+K.+Avraham&title=Carboxyl-terminal+Src+kinase+homologous+kinase+negatively+regulates+the+chemokine+receptor+CXCR4+through+YY1+and+impairs+CXCR4%2FCXCL12+%28SDF-1alpha%29-mediated+breast+cancer+cell+migration"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DB.%2BC.%26aulast%3DLee%26aufirst%3DT.%2BH.%26aulast%3DZagozdzon%26aufirst%3DR.%26aulast%3DAvraham%26aufirst%3DS.%26aulast%3DUsheva%26aufirst%3DA.%26aulast%3DAvraham%26aufirst%3DH.%2BK.%26atitle%3DCarboxyl-terminal%2520Src%2520kinase%2520homologous%2520kinase%2520negatively%2520regulates%2520the%2520chemokine%2520receptor%2520CXCR4%2520through%2520YY1%2520and%2520impairs%2520CXCR4%252FCXCL12%2520%2528SDF-1alpha%2529-mediated%2520breast%2520cancer%2520cell%2520migration%26jtitle%3DCancer%2520Res.%26date%3D2005%26volume%3D65%26spage%3D2840%26epage%3D2845" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group">Coniglio, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zavarella, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Symons, M. H.</span><span> </span><span class="NLM_article-title">Pak1 and Pak2 mediate tumor cell invasion through distinct signaling mechanisms</span> <span class="citation_source-journal">Mol. Cell. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">4162</span><span class="NLM_x">–</span> <span class="NLM_lpage">4172</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Fjm200285z&amp;key=10.1128%2FMCB.01532-07" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Fjm200285z&amp;key=18411304" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Fjm200285z&amp;key=1%3ACAS%3A528%3ADC%252BD1cXntFamsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2008&pages=4162-4172&author=S.+J.+Coniglioauthor=S.+Zavarellaauthor=M.+H.+Symons&title=Pak1+and+Pak2+mediate+tumor+cell+invasion+through+distinct+signaling+mechanisms"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Pak1 and Pak2 mediate tumor cell invasion through distinct signaling mechanisms</span></div><div class="casAuthors">Coniglio, Salvatore J.; Zavarella, Salvatore; Symons, Marc H.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">4162-4172</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Pak kinases are thought to play crit. roles in cell migration and invasion.  Here, we analyze the roles of Pak1 and Pak2 in breast carcinoma cell invasion using the transient transfection of small interfering RNA.  We find that although both Pak1 and Pak2 contribute to breast carcinoma invasion stimulated by heregulin, these roles are mediated by distinct signaling mechanisms.  Thus, whereas the depletion of Pak1 interferes with the heregulin-mediated dephosphorylation of cofilin, the depletion of Pak2 does not.  The depletion of Pak1 also has a stronger inhibitory effect on lamellipodial protrusion than does the depletion of Pak2.  Interestingly, Pak1 and Pak2 play opposite roles in regulating the phosphorylation of the myosin light chain (MLC).  Whereas the depletion of Pak1 decreases phospho-MLC levels in heregulin-stimulated cells, the depletion of Pak2 enhances MLC phosphorylation.  Consistent with their opposite effects on MLC phosphorylation, Pak1 and Pak2 differentially modulate focal adhesions.  Pak2-depleted cells display an increase in focal adhesion size, whereas in Pak1-depleted cells, focal adhesions fail to mature.  We also found that the depletion of Pak2, but not Pak1, enhances RhoA activity and that the inhibition of RhoA signaling in Pak2-depleted cells decreases MLC phosphorylation and restores cell invasion.  In summary, this work presents the first comprehensive anal. of functional differences between the Pak1 and Pak2 isoforms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGre7mSDVtyMxrVg90H21EOLACvtfcHk0lhd2MI0gYxYLQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXntFamsro%253D&md5=aec34148f16ead02fa0cf54d855972cc</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1128%2FMCB.01532-07&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.01532-07%26sid%3Dliteratum%253Aachs%26aulast%3DConiglio%26aufirst%3DS.%2BJ.%26aulast%3DZavarella%26aufirst%3DS.%26aulast%3DSymons%26aufirst%3DM.%2BH.%26atitle%3DPak1%2520and%2520Pak2%2520mediate%2520tumor%2520cell%2520invasion%2520through%2520distinct%2520signaling%2520mechanisms%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2008%26volume%3D28%26spage%3D4162%26epage%3D4172" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group">Lee, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldberg, A. L.</span><span> </span><span class="NLM_article-title">Proteasome inhibitors: valuable new tools for cell biologists</span> <span class="citation_source-journal">Trends Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">397</span><span class="NLM_x">–</span> <span class="NLM_lpage">403</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Fjm200285z&amp;key=10.1016%2FS0962-8924%2898%2901346-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Fjm200285z&amp;key=9789328" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Fjm200285z&amp;key=1%3ACAS%3A528%3ADyaK1cXmvFWjtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=1998&pages=397-403&author=D.+H.+Leeauthor=A.+L.+Goldberg&title=Proteasome+inhibitors%3A+valuable+new+tools+for+cell+biologists"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Proteasome inhibitors: valuable new tools for cell biologists</span></div><div class="casAuthors">Lee, Do Hee; Goldberg, Alfred L.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Cell Biology</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">397-403</span>CODEN:
                <span class="NLM_cas:coden">TCBIEK</span>;
        ISSN:<span class="NLM_cas:issn">0962-8924</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review with 49 refs.  Proteasomes are major sites for protein degrdn. in eukaryotic cells.  The recent identification of selective proteasome inhibitors has allowed a definition of the roles of the ubiquitin-proteasome pathway in various cellular processes, such as antigen presentation and the degrdn. of regulatory or membrane proteins.  This review describes the actions of these inhibitors, how they can be used to investigate cellular responses, the functions of the proteasome demonstrated by such studies and their potential applications in the future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrA-ydl6asLAbVg90H21EOLACvtfcHk0liyBHOGUcza-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXmvFWjtbc%253D&md5=40053b67b418beff1f2c6bf4f293d195</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1016%2FS0962-8924%2898%2901346-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0962-8924%252898%252901346-4%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DD.%2BH.%26aulast%3DGoldberg%26aufirst%3DA.%2BL.%26atitle%3DProteasome%2520inhibitors%253A%2520valuable%2520new%2520tools%2520for%2520cell%2520biologists%26jtitle%3DTrends%2520Cell%2520Biol.%26date%3D1998%26volume%3D8%26spage%3D397%26epage%3D403" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group">Hines, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groll, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fahnestock, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crews, C. M.</span><span> </span><span class="NLM_article-title">Proteasome Inhibition by Fellutamide B Induces Nerve Growth Factor Synthesis</span> <span class="citation_source-journal">Chem. Biol. (Cambridge, MA, U. S.)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">501</span><span class="NLM_x">–</span> <span class="NLM_lpage">512</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Fjm200285z&amp;key=1%3ACAS%3A528%3ADC%252BD1cXmtVSjsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2008&pages=501-512&author=J.+Hinesauthor=M.+Grollauthor=M.+Fahnestockauthor=C.+M.+Crews&title=Proteasome+Inhibition+by+Fellutamide+B+Induces+Nerve+Growth+Factor+Synthesis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Proteasome Inhibition by Fellutamide B Induces Nerve Growth Factor Synthesis</span></div><div class="casAuthors">Hines, John; Groll, Michael; Fahnestock, Margaret; Crews, Craig M.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">501-512</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Neurotrophic small mols. have the potential to aid in the treatment of neuronal injury and neurodegenerative diseases.  The natural product fellutamide B, originally isolated from Penicillium fellutanum, potently induces nerve growth factor (NGF) release from fibroblasts and glial-derived cells, although the mechanism for this neurotrophic activity has not been elucidated.  Here, we report that fellutamide B potently inhibits proteasome catalytic activity.  High-resoln. structural information obtained from cocrystn. of the 20S proteasome reveals novel aspects regarding β-subunit binding and adduct formation by fellutamide B to inhibit their hydrolytic activity.  We demonstrate that fellutamide B and other proteasome inhibitors increased NGF gene transcription via a cis-acting element (or elements) in the promoter.  These results demonstrate an unrecognized connection between proteasome inhibition and NGF prodn., suggesting a possible new strategy in the development of neurotrophic agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpusW5B8CxRvLVg90H21EOLACvtfcHk0liyBHOGUcza-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXmtVSjsLg%253D&md5=4af67bc8ed8a76dbc935f615fa279b86</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHines%26aufirst%3DJ.%26aulast%3DGroll%26aufirst%3DM.%26aulast%3DFahnestock%26aufirst%3DM.%26aulast%3DCrews%26aufirst%3DC.%2BM.%26atitle%3DProteasome%2520Inhibition%2520by%2520Fellutamide%2520B%2520Induces%2520Nerve%2520Growth%2520Factor%2520Synthesis%26jtitle%3DChem.%2520Biol.%2520%2528Cambridge%252C%2520MA%252C%2520U.%2520S.%2529%26date%3D2008%26volume%3D15%26spage%3D501%26epage%3D512" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group">de Bettignies, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coux, O.</span><span> </span><span class="NLM_article-title">Proteasome inhibitors: Dozens of molecules and still counting</span> <span class="citation_source-journal">Biochimie</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">92</span><span class="NLM_x">, </span> <span class="NLM_fpage">1530</span><span class="NLM_x">–</span> <span class="NLM_lpage">1545</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=2010&pages=1530-1545&author=G.+de+Bettigniesauthor=O.+Coux&title=Proteasome+inhibitors%3A+Dozens+of+molecules+and+still+counting"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2BBettignies%26aufirst%3DG.%26aulast%3DCoux%26aufirst%3DO.%26atitle%3DProteasome%2520inhibitors%253A%2520Dozens%2520of%2520molecules%2520and%2520still%2520counting%26jtitle%3DBiochimie%26date%3D2010%26volume%3D92%26spage%3D1530%26epage%3D1545" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group">Blackburn, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gigstad, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hales, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruzzese, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrett, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soucy, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sappal, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bump, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olhava, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fleming, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dick, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sintchak, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blank, J. L.</span><span> </span><span class="NLM_article-title">Characterization of a new series of non-covalent proteasome inhibitors with exquisite potency and selectivity for the 20S beta 5-subunit</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">430</span><span class="NLM_x">, </span> <span class="NLM_fpage">461</span><span class="NLM_x">–</span> <span class="NLM_lpage">476</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=430&publication_year=2010&pages=461-476&author=C.+Blackburnauthor=K.+M.+Gigstadauthor=P.+Halesauthor=K.+Garciaauthor=M.+Jonesauthor=F.+J.+Bruzzeseauthor=C.+Barrettauthor=J.+X.+Liuauthor=T.+A.+Soucyauthor=D.+S.+Sappalauthor=N.+Bumpauthor=E.+J.+Olhavaauthor=P.+Flemingauthor=L.+R.+Dickauthor=C.+Tsuauthor=M.+D.+Sintchakauthor=J.+L.+Blank&title=Characterization+of+a+new+series+of+non-covalent+proteasome+inhibitors+with+exquisite+potency+and+selectivity+for+the+20S+beta+5-subunit"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBlackburn%26aufirst%3DC.%26aulast%3DGigstad%26aufirst%3DK.%2BM.%26aulast%3DHales%26aufirst%3DP.%26aulast%3DGarcia%26aufirst%3DK.%26aulast%3DJones%26aufirst%3DM.%26aulast%3DBruzzese%26aufirst%3DF.%2BJ.%26aulast%3DBarrett%26aufirst%3DC.%26aulast%3DLiu%26aufirst%3DJ.%2BX.%26aulast%3DSoucy%26aufirst%3DT.%2BA.%26aulast%3DSappal%26aufirst%3DD.%2BS.%26aulast%3DBump%26aufirst%3DN.%26aulast%3DOlhava%26aufirst%3DE.%2BJ.%26aulast%3DFleming%26aufirst%3DP.%26aulast%3DDick%26aufirst%3DL.%2BR.%26aulast%3DTsu%26aufirst%3DC.%26aulast%3DSintchak%26aufirst%3DM.%2BD.%26aulast%3DBlank%26aufirst%3DJ.%2BL.%26atitle%3DCharacterization%2520of%2520a%2520new%2520series%2520of%2520non-covalent%2520proteasome%2520inhibitors%2520with%2520exquisite%2520potency%2520and%2520selectivity%2520for%2520the%252020S%2520beta%25205-subunit%26jtitle%3DBiochem.%2520J.%26date%3D2010%26volume%3D430%26spage%3D461%26epage%3D476" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group">Geurink, P. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spaans, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Downey, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van den Nieuwendijk, A. M. C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van der Marel, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kisselev, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Florea, B. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Overkleeft, H. S.</span><span> </span><span class="NLM_article-title">Incorporation of fluorinated phenylalanine generates highly specific inhibitor of proteasome’s chymotrypsin-like sites</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">2319</span><span class="NLM_x">–</span> <span class="NLM_lpage">2323</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm9015685" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=2319-2323&author=P.+P.+Geurinkauthor=N.+Liuauthor=M.+P.+Spaansauthor=S.+L.+Downeyauthor=A.+M.+C.+H.+van+den+Nieuwendijkauthor=G.+A.+van+der+Marelauthor=A.+F.+Kisselevauthor=B.+I.+Floreaauthor=H.+S.+Overkleeft&title=Incorporation+of+fluorinated+phenylalanine+generates+highly+specific+inhibitor+of+proteasome%E2%80%99s+chymotrypsin-like+sites"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1021%2Fjm9015685&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9015685%26sid%3Dliteratum%253Aachs%26aulast%3DGeurink%26aufirst%3DP.%2BP.%26aulast%3DLiu%26aufirst%3DN.%26aulast%3DSpaans%26aufirst%3DM.%2BP.%26aulast%3DDowney%26aufirst%3DS.%2BL.%26aulast%3Dvan%2Bden%2BNieuwendijk%26aufirst%3DA.%2BM.%2BC.%2BH.%26aulast%3Dvan%2Bder%2BMarel%26aufirst%3DG.%2BA.%26aulast%3DKisselev%26aufirst%3DA.%2BF.%26aulast%3DFlorea%26aufirst%3DB.%2BI.%26aulast%3DOverkleeft%26aufirst%3DH.%2BS.%26atitle%3DIncorporation%2520of%2520fluorinated%2520phenylalanine%2520generates%2520highly%2520specific%2520inhibitor%2520of%2520proteasome%25E2%2580%2599s%2520chymotrypsin-like%2520sites%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D2319%26epage%3D2323" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group">Furet, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imbach, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noorani, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koeppler, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laumen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guagnano, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuerst, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roesel, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zimmermann, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia Echeverria, C.</span><span> </span><span class="NLM_article-title">Entry into a new class of potent proteasome inhibitors having high antiproliferative activity by structure-based design</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">4810</span><span class="NLM_x">–</span> <span class="NLM_lpage">4813</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm049660v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=4810-4813&author=P.+Furetauthor=P.+Imbachauthor=M.+Nooraniauthor=J.+Koepplerauthor=K.+Laumenauthor=M.+Langauthor=V.+Guagnanoauthor=P.+Fuerstauthor=J.+Roeselauthor=J.+Zimmermannauthor=C.+Garcia+Echeverria&title=Entry+into+a+new+class+of+potent+proteasome+inhibitors+having+high+antiproliferative+activity+by+structure-based+design"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1021%2Fjm049660v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm049660v%26sid%3Dliteratum%253Aachs%26aulast%3DFuret%26aufirst%3DP.%26aulast%3DImbach%26aufirst%3DP.%26aulast%3DNoorani%26aufirst%3DM.%26aulast%3DKoeppler%26aufirst%3DJ.%26aulast%3DLaumen%26aufirst%3DK.%26aulast%3DLang%26aufirst%3DM.%26aulast%3DGuagnano%26aufirst%3DV.%26aulast%3DFuerst%26aufirst%3DP.%26aulast%3DRoesel%26aufirst%3DJ.%26aulast%3DZimmermann%26aufirst%3DJ.%26aulast%3DGarcia%2BEcheverria%26aufirst%3DC.%26atitle%3DEntry%2520into%2520a%2520new%2520class%2520of%2520potent%2520proteasome%2520inhibitors%2520having%2520high%2520antiproliferative%2520activity%2520by%2520structure-based%2520design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D4810%26epage%3D4813" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group">Simpson, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anyiwe, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schimmer, A. D.</span><span> </span><span class="NLM_article-title">Anoikis resistance and tumor metastasis</span> <span class="citation_source-journal">Cancer Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">272</span><span class="NLM_x">, </span> <span class="NLM_fpage">177</span><span class="NLM_x">–</span> <span class="NLM_lpage">185</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Fjm200285z&amp;key=10.1016%2Fj.canlet.2008.05.029" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Fjm200285z&amp;key=18579285" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Fjm200285z&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtlyhtr%252FJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=272&publication_year=2008&pages=177-185&author=C.+D.+Simpsonauthor=K.+Anyiweauthor=A.+D.+Schimmer&title=Anoikis+resistance+and+tumor+metastasis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Anoikis resistance and tumor metastasis</span></div><div class="casAuthors">Simpson, Craig D.; Anyiwe, Kika; Schimmer, Aaron D.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (Shannon, Ireland)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">272</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">177-185</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ireland Ltd.</span>)
        </div><div class="casAbstract">A review.  As a barrier to metastases, cells normally undergo apoptosis after they lose contact with their extra cellular matrix or their neighboring cells.  This cell death process has been termed "anoikis".  Tumor cells that acquire malignant potential have developed mechanisms to resist anoikis and thereby survive after detachment from their primary site and while traveling through the lymphatic and circulatory systems.  Defects in the death receptor pathway of caspase activation, such as the over-expression of the caspase-8 inhibitor FLIP, can render cells resistant to anoikis.  Likewise, roadblocks in the mitochondrial pathway, such as over-expression of the Bcl-2 family of anti-apoptotic proteins, can also confer resistance to anoikis.  This review will focus on the roles of the death receptor and mitochondrial pathways in anoikis and anoikis resistance and how targeting defects in these pathways can restore sensitivity to anoikis and serve as the basis for therapeutic adjuncts that prevent metastasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprLWdjkl6g7LVg90H21EOLACvtfcHk0lgVqCRvcQt0IQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtlyhtr%252FJ&md5=b3d06d8e6deff2a650848a106480f50c</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1016%2Fj.canlet.2008.05.029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.canlet.2008.05.029%26sid%3Dliteratum%253Aachs%26aulast%3DSimpson%26aufirst%3DC.%2BD.%26aulast%3DAnyiwe%26aufirst%3DK.%26aulast%3DSchimmer%26aufirst%3DA.%2BD.%26atitle%3DAnoikis%2520resistance%2520and%2520tumor%2520metastasis%26jtitle%3DCancer%2520Lett.%26date%3D2008%26volume%3D272%26spage%3D177%26epage%3D185" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group">Savage, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stebbing, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bower, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crook, T.</span><span> </span><span class="NLM_article-title">Why does cytotoxic chemotherapy cure only some cancers?</span> <span class="citation_source-journal">Nat. Clin. Pract. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">43</span><span class="NLM_x">–</span> <span class="NLM_lpage">52</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Fjm200285z&amp;key=10.1038%2Fncponc1260" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Fjm200285z&amp;key=18982000" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Fjm200285z&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsFWkurzP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2009&pages=43-52&author=P.+Savageauthor=J.+Stebbingauthor=M.+Bowerauthor=T.+Crook&title=Why+does+cytotoxic+chemotherapy+cure+only+some+cancers%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Why does cytotoxic chemotherapy cure only some cancers?</span></div><div class="casAuthors">Savage, Philip; Stebbing, Justin; Bower, Mark; Crook, Tim</div><div class="citationInfo"><span class="NLM_cas:title">Nature Clinical Practice Oncology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">43-52</span>CODEN:
                <span class="NLM_cas:coden">NCPOB5</span>;
        ISSN:<span class="NLM_cas:issn">1743-4254</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Despite frequent responses to chemotherapy, curative treatment remains elusive for the majority of metastatic solid tumors.  By contrast, chemotherapy routinely cures patients with testicular cancers, gestational choriocarcinoma, Hodgkin's disease and high-grade lymphomas.  Savage et al. suggest that the chemo-curability of these malignancies results from an intrinsic 'locked-in' state of sensitivity to pro-apoptotic stresses in these particular cell types, and they discuss some of the characteristics shared by the curable cancers that might explain their curability.  Despite frequent responses to chemotherapy, curative treatment remains elusive for the majority of patients with metastatic solid tumors.  By contrast, in testicular cancer, gestational choriocarcinoma, Hodgkin disease and high-grade lymphomas, chemotherapy is routinely curative, even for patients who present with widely disseminated disease.  In the common advanced cancers, however, over 40 years of cytotoxic drug development has brought no significant change in cure rates.  One interpretation is that the intrinsic properties of the malignancies themselves, rather than the qualities of individual drugs or combination therapies, are primarily responsible for their curability with chemotherapy.  We suggest that the curability of these malignancies results from an intrinsic 'locked-in' state of sensitivity to proapoptotic stresses in these cells.  A common property of such curable malignancies is that they arise from cells that undergo major genetic rearrangements or recombination as part of their normal physiol.  The absence of further genetic and epigenetic changes in genes that regulate apoptosis, DNA repair and senescence allows these cells to maintain their intrinsic sensitivity to chemotherapy.  This process allows the cells, when challenged with chemotherapy, to undergo the natural apoptotic pathways that contribute to their intrinsic qualities of chemosensitivity and high curability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqov8Vi7LfVIrVg90H21EOLACvtfcHk0lgVqCRvcQt0IQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsFWkurzP&md5=1ac0fd31132140d612c789fe6bb99590</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1038%2Fncponc1260&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncponc1260%26sid%3Dliteratum%253Aachs%26aulast%3DSavage%26aufirst%3DP.%26aulast%3DStebbing%26aufirst%3DJ.%26aulast%3DBower%26aufirst%3DM.%26aulast%3DCrook%26aufirst%3DT.%26atitle%3DWhy%2520does%2520cytotoxic%2520chemotherapy%2520cure%2520only%2520some%2520cancers%253F%26jtitle%3DNat.%2520Clin.%2520Pract.%2520Oncol.%26date%3D2009%26volume%3D6%26spage%3D43%26epage%3D52" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group">Wilson, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnston, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Longley, D. B.</span><span> </span><span class="NLM_article-title">Anti-apoptotic mechanisms of drug resistance in cancer</span> <span class="citation_source-journal">Curr. Cancer Drug Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">307</span><span class="NLM_x">–</span> <span class="NLM_lpage">319</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Fjm200285z&amp;key=10.2174%2F156800909788166547" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Fjm200285z&amp;key=19442051" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Fjm200285z&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmslansLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2009&pages=307-319&author=T.+R.+Wilsonauthor=P.+G.+Johnstonauthor=D.+B.+Longley&title=Anti-apoptotic+mechanisms+of+drug+resistance+in+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Anti-apoptotic mechanisms of drug resistance in cancer</span></div><div class="casAuthors">Wilson, T. R.; Johnston, P. G.; Longley, D. B.</div><div class="citationInfo"><span class="NLM_cas:title">Current Cancer Drug Targets</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">307-319</span>CODEN:
                <span class="NLM_cas:coden">CCDTB9</span>;
        ISSN:<span class="NLM_cas:issn">1568-0096</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Resistance to chemotherapy is a major obstacle in the treatment of cancer.  Despite the advent of new chemotherapies and mol.-targeted therapies, approx. 90% of patients with metastatic cancer succumb to their disease.  Drug resistance, either acquired or intrinsic, often prevents tumor cells from undergoing sufficient levels of programmed cell death or apoptosis, resulting in cancer cell survival and treatment failure.  In pre-clin. disease models, agents that target the apoptotic pathway were shown to sensitize tumor cells to chemotherapy and radiotherapy.  Such therapies include small mol. inhibitors and antisense strategies that inhibit the activity of anti-apoptotic proteins, or treatment with recombinant pro-apoptotic proteins or antibodies that can activate the apoptotic pathway.  This review will discuss apoptosis and the mechanisms by which it can become dysregulated in human cancer.  In addn., novel therapeutic strategies that target key components of the apoptotic machinery will be discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkegczsL_lBrVg90H21EOLACvtfcHk0lgVqCRvcQt0IQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmslansLo%253D&md5=85b32e7e06a33942779c569f39f19252</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.2174%2F156800909788166547&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156800909788166547%26sid%3Dliteratum%253Aachs%26aulast%3DWilson%26aufirst%3DT.%2BR.%26aulast%3DJohnston%26aufirst%3DP.%2BG.%26aulast%3DLongley%26aufirst%3DD.%2BB.%26atitle%3DAnti-apoptotic%2520mechanisms%2520of%2520drug%2520resistance%2520in%2520cancer%26jtitle%3DCurr.%2520Cancer%2520Drug%2520Targets%26date%3D2009%26volume%3D9%26spage%3D307%26epage%3D319" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group">Bozec, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peyrade, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischel, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milano, G.</span><span> </span><span class="NLM_article-title">Emerging molecular targeted therapies in the treatment of head and neck cancer</span> <span class="citation_source-journal">Expert Opin. Emerg. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">299</span><span class="NLM_x">–</span> <span class="NLM_lpage">310</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Fjm200285z&amp;key=10.1517%2F14728210902997947" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Fjm200285z&amp;key=19519286" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Fjm200285z&amp;key=1%3ACAS%3A528%3ADC%252BD1MXnt1Shsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2009&pages=299-310&author=A.+Bozecauthor=F.+Peyradeauthor=J.+L.+Fischelauthor=G.+Milano&title=Emerging+molecular+targeted+therapies+in+the+treatment+of+head+and+neck+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Emerging molecular targeted therapies in the treatment of head and neck cancer</span></div><div class="casAuthors">Bozec, Alexandre; Peyrade, Frederic; Fischel, Jean-Louis; Milano, Gerard</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Emerging Drugs</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">299-310</span>CODEN:
                <span class="NLM_cas:coden">EOEDA3</span>;
        ISSN:<span class="NLM_cas:issn">1472-8214</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Current development of mol. targeted therapies in oncol. is particularly active.  The aim of this study is to review recent advances in the field of mol. targeted therapies for head and neck squamous cell carcinoma (HNSCC).  As EGFR signaling pathway and angiogenesis play a key role in the growth of HNSCC, EGFR with its downstream effectors and mol. factors implicated in the angiogenesis process, such as VEGF and its receptors, represent the main targets of the new therapeutic agents now in development.  Today, cetuximab, an anti-EGFR monoclonal antibody, is the only targeted therapy approved for the treatment of HNSCC in patients with locally advanced tumors, in assocn. with radiotherapy, and in patients with recurrent or metastatic diseases.  Future progress is expected with the integration of cetuximab into induction chemotherapeutic regimens or in assocn. with concurrent chemoradiotherapy for locally advanced tumors and with the development and evaluation of other mol. targeted therapies such as antiangiogenic drugs.  As these innovative mols. start to be used in clin. practice, the identification of predictive markers for efficacy and toxicity becomes a crucial issue.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8cIZqpAAUMLVg90H21EOLACvtfcHk0lhhO-e8CQsADA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXnt1Shsr0%253D&md5=87f6d954b64df24539e38a2dc28400bb</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1517%2F14728210902997947&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14728210902997947%26sid%3Dliteratum%253Aachs%26aulast%3DBozec%26aufirst%3DA.%26aulast%3DPeyrade%26aufirst%3DF.%26aulast%3DFischel%26aufirst%3DJ.%2BL.%26aulast%3DMilano%26aufirst%3DG.%26atitle%3DEmerging%2520molecular%2520targeted%2520therapies%2520in%2520the%2520treatment%2520of%2520head%2520and%2520neck%2520cancer%26jtitle%3DExpert%2520Opin.%2520Emerg.%2520Drugs%26date%3D2009%26volume%3D14%26spage%3D299%26epage%3D310" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group">Han, S.; Roman, J.</span><span> </span><span class="NLM_article-title">Targeting apoptotic signaling pathways in human lung cancer</span>. Curr. Cancer Drug Targets<span class="NLM_x"> </span><span class="NLM_year">2010</span><span class="NLM_x">, </span>in press. </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Fjm200285z&amp;key=20482489" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=S.+Han&author=J.+Roman&title=Targeting+apoptotic+signaling+pathways+in+human+lung+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DHan%26aufirst%3DS.%26atitle%3DTargeting%2520apoptotic%2520signaling%2520pathways%2520in%2520human%2520lung%2520cancer%26jtitle%3DCurr.%2520Cancer%2520Drug%2520Targets%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group">Soengas, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lowe, S. W.</span><span> </span><span class="NLM_article-title">Apoptosis and melanoma chemoresistance</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">3138</span><span class="NLM_x">–</span> <span class="NLM_lpage">3151</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2003&pages=3138-3151&author=M.+S.+Soengasauthor=S.+W.+Lowe&title=Apoptosis+and+melanoma+chemoresistance"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSoengas%26aufirst%3DM.%2BS.%26aulast%3DLowe%26aufirst%3DS.%2BW.%26atitle%3DApoptosis%2520and%2520melanoma%2520chemoresistance%26jtitle%3DOncogene%26date%3D2003%26volume%3D22%26spage%3D3138%26epage%3D3151" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group">Wong, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lemoine, N. R.</span><span> </span><span class="NLM_article-title">Pancreatic cancer: molecular pathogenesis and new therapeutic targets</span> <span class="citation_source-journal">Nat. Rev. Gastroenterol. Hepatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">412</span><span class="NLM_x">–</span> <span class="NLM_lpage">422</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Fjm200285z&amp;key=10.1038%2Fnrgastro.2009.89" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Fjm200285z&amp;key=19506583" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Fjm200285z&amp;key=1%3ACAS%3A528%3ADC%252BD1MXot12ltLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2009&pages=412-422&author=H.+H.+Wongauthor=N.+R.+Lemoine&title=Pancreatic+cancer%3A+molecular+pathogenesis+and+new+therapeutic+targets"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Pancreatic cancer: molecular pathogenesis and new therapeutic targets</span></div><div class="casAuthors">Wong, Han H.; Lemoine, Nicholas R.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Gastroenterology & Hepatology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">412-422</span>CODEN:
                <span class="NLM_cas:coden">NRGHA9</span>;
        ISSN:<span class="NLM_cas:issn">1759-5045</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Pancreatic cancer is lethal and notoriously difficult to treat, therefore, there is an urgent need to develop new therapeutic and diagnostic modalities.  This Review discusses the agents that have been developed to target the pathways and processes involved in pancreatic tumorigenesis, and reviews the results of lab. and clin. trials of these agents.  Future therapeutic targets are also discussed.  Patients with pancreatic cancer normally present with advanced disease that is lethal and notoriously difficult to treat.  Survival has not improved dramatically despite routine use of chemotherapy and radiotherapy; this situation signifies an urgent need for novel therapeutic approaches.  Over the past decade, a large no. of studies have been published that aimed to target the mol. abnormalities implicated in pancreatic tumor growth, invasion, metastasis, angiogenesis and resistance to apoptosis.  This research is of particular importance, as data suggest that a large no. of genetic alterations affect only a few major signaling pathways and processes involved in pancreatic tumorigenesis.  Although lab. results of targeted therapies have been impressive, until now only erlotinib, an epidermal growth factor receptor tyrosine kinase inhibitor, has demonstrated modest survival benefit in combination with gemcitabine in a phase III clin. trial.  While the failures of targeted therapies in the clin. setting are discouraging, lessons have been learnt and new therapeutic targets that hold promise for the future management of the disease are continuously emerging.  This Review describes some of the important developments and targeted agents for pancreatic cancer that have been tested in clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpm5mtPxXGCSLVg90H21EOLACvtfcHk0lhhO-e8CQsADA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXot12ltLo%253D&md5=61183be915ad65cab453c462f046d30d</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1038%2Fnrgastro.2009.89&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrgastro.2009.89%26sid%3Dliteratum%253Aachs%26aulast%3DWong%26aufirst%3DH.%2BH.%26aulast%3DLemoine%26aufirst%3DN.%2BR.%26atitle%3DPancreatic%2520cancer%253A%2520molecular%2520pathogenesis%2520and%2520new%2520therapeutic%2520targets%26jtitle%3DNat.%2520Rev.%2520Gastroenterol.%2520Hepatol.%26date%3D2009%26volume%3D6%26spage%3D412%26epage%3D422" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group">D’Amico, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harpole, D. H.,  Jr.</span><span> </span><span class="NLM_article-title">Molecular biology of esophageal cancer</span> <span class="citation_source-journal">Chest Surg. Clin. N. Am.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">451</span><span class="NLM_x">–</span> <span class="NLM_lpage">469</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Fjm200285z&amp;key=10967750" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Fjm200285z&amp;key=1%3ACAS%3A280%3ADC%252BD3M%252Fmt1CrsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2000&pages=451-469&author=T.+A.+D%E2%80%99Amicoauthor=D.+H.+Harpole&title=Molecular+biology+of+esophageal+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular biology of esophageal cancer</span></div><div class="casAuthors">D'Amico T A; Harpole D H Jr</div><div class="citationInfo"><span class="NLM_cas:title">Chest surgery clinics of North America</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">451-69</span>
        ISSN:<span class="NLM_cas:issn">1052-3359</span>.
    </div><div class="casAbstract">Several mechanisms of resistance to chemotherapy have been identified among the agents that are commonly used in the systemic treatment of patients with esophageal cancer: paclitaxel, platinum, and 5-FU.  A recent study from our laboratory evaluated the initial endoscopic biopsy material from patients who subsequently underwent trimodality therapy, including chemotherapy with cisplatin and 5-FU, radiation therapy, and surgery.  IHC analysis was performed on seven markers of chemotherapy or radiation therapy resistance: P-gp, GST-pi, MT (platinum inhibitors); EGF-R, TGF-alpha, erb-B2 (activation of cell growth cascade); and p53 (interferes with chemotherapy-induced apoptosis).  In this study, elevated expression of GST-pi and P-gp were associated with decreased survival and may be markers of treatment resistance.  Expression of erb-B2 was associated with enhanced survival and may be a marker of treatment sensitivity.  Assessment of the probability of chemoresistance of a particular tumor using the expression of molecular biologic markers may allow for the selection of a more favorable chemotherapeutic agent.  Furthermore, understanding the mechanisms of resistance, including the mechanisms of DNA repair, may provide insight into mechanisms to reverse or to inhibit resistance to chemotherapy.  DNA repair mechanisms are used by cells to protect themselves against mutagens and carcinogens.  DNA repair inhibitors may increase the mutagenicity associated with DNA damage and may prove to be an ineffective oncologic treatment strategy; however, the possibility exists that DNA repair inhibition may improve the efficacy of anticancer agents, and this should be tested.  The value of this strategy may be in allowing treatment doses to be decreased and lessening side effects while maintaining therapeutic efficacy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT2CsMTXq-wgNXdcedVHT5tfW6udTcc2ebFG0nU4Tu0vbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3M%252Fmt1CrsA%253D%253D&md5=9c0dddf3f5a7b976e6532ee7ff43de2f</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DD%25E2%2580%2599Amico%26aufirst%3DT.%2BA.%26aulast%3DHarpole%26aufirst%3DD.%2BH.%26atitle%3DMolecular%2520biology%2520of%2520esophageal%2520cancer%26jtitle%3DChest%2520Surg.%2520Clin.%2520N.%2520Am.%26date%3D2000%26volume%3D10%26spage%3D451%26epage%3D469" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group">Bruyère, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lonez, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duray, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cludts, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruysschaert, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saussez, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yeaton, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiss, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mijatovic, T.</span><span> </span><span class="NLM_article-title">Considering Temozolomide as a novel potential treatment for oesophageal cancer</span> <span class="citation_source-journal">Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">117</span><span class="NLM_x">, </span> <span class="NLM_fpage">2004</span><span class="NLM_x">–</span> <span class="NLM_lpage">2016</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=2011&pages=2004-2016&author=C.+Bruy%C3%A8reauthor=C.+Lonezauthor=A.+Durayauthor=S.+Cludtsauthor=J.+M.+Ruysschaertauthor=S.+Saussezauthor=P.+Yeatonauthor=R.+Kissauthor=T.+Mijatovic&title=Considering+Temozolomide+as+a+novel+potential+treatment+for+oesophageal+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBruy%25C3%25A8re%26aufirst%3DC.%26aulast%3DLonez%26aufirst%3DC.%26aulast%3DDuray%26aufirst%3DA.%26aulast%3DCludts%26aufirst%3DS.%26aulast%3DRuysschaert%26aufirst%3DJ.%2BM.%26aulast%3DSaussez%26aufirst%3DS.%26aulast%3DYeaton%26aufirst%3DP.%26aulast%3DKiss%26aufirst%3DR.%26aulast%3DMijatovic%26aufirst%3DT.%26atitle%3DConsidering%2520Temozolomide%2520as%2520a%2520novel%2520potential%2520treatment%2520for%2520oesophageal%2520cancer%26jtitle%3DCancer%26date%3D2011%26volume%3D117%26spage%3D2004%26epage%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group">Lefranc, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brotchi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiss, R.</span><span> </span><span class="NLM_article-title">Possible future issues in the treatment of glioblastomas, with a special emphasis on cell migration and the resistance of migrating glioblastoma cells to apoptosis</span> <span class="citation_source-journal">J. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">2411</span><span class="NLM_x">–</span> <span class="NLM_lpage">2422</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Fjm200285z&amp;key=10.1200%2FJCO.2005.03.089" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Fjm200285z&amp;key=15800333" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Fjm200285z&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjsVyhsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2005&pages=2411-2422&author=F.+Lefrancauthor=J.+Brotchiauthor=R.+Kiss&title=Possible+future+issues+in+the+treatment+of+glioblastomas%2C+with+a+special+emphasis+on+cell+migration+and+the+resistance+of+migrating+glioblastoma+cells+to+apoptosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Possible future issues in the treatment of glioblastomas: Special emphasis on cell migration and the resistance of migrating glioblastoma cells to apoptosis</span></div><div class="casAuthors">Lefranc, Florence; Brotchi, Jacques; Kiss, Robert</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Oncology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2411-2422</span>CODEN:
                <span class="NLM_cas:coden">JCONDN</span>;
        ISSN:<span class="NLM_cas:issn">0732-183X</span>.
    
            (<span class="NLM_cas:orgname">American Society of Clinical Oncology</span>)
        </div><div class="casAbstract">The present review aims to emphasize that malignant gliomas are characterized by the diffuse invasion of distant brain tissue by a myriad of single migrating cells that exhibit decreased levels of apoptosis (programmed cell death type I), thus a resistance to cytotoxic insult.  The present review surveys the mol. mechanisms of migration in malignant gliomas and potential issues arising from treatments, in addn. to relationships between glioma cell migration and resistance to apoptosis in terms of the mol. signaling pathways.  Clin. and exptl. data demonstrate that glioma cell migration is a complex combination of multiple mol. processes, including the alteration of tumor cell adhesion to a modified extracellular matrix, the secretion of proteases by the cells, and modifications to the actin cytoskeleton.  Intracellular signaling pathways involved in the acquisition of resistance to apoptosis by migrating glioma cells concern Pl3K, Akt, mTOR, NF-κB, and autophagy (programmed cell death type II).  A no. of signaling pathways can be constitutively activated in migrating glioma cells, thus rendering these cells resistant to cytotoxic insults.  However, these pathways are not all constitutively activated at the same time in any one glioma.  Particular inhibitors should therefore only be chosen if the target is present in the tumor tissue, but this is only possible if individual patients are submitted to the mol. profiling of their tumors before undergoing any treatment to combat their migratory glioma cells.  Specific antimigratory compds. should be added to conventional radio- and/or chemotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRxPKR4Wm5vbVg90H21EOLACvtfcHk0li9fYsaOsHo7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjsVyhsrY%253D&md5=9195f4ac3a7cccda1ca747dbb35f3023</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1200%2FJCO.2005.03.089&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2005.03.089%26sid%3Dliteratum%253Aachs%26aulast%3DLefranc%26aufirst%3DF.%26aulast%3DBrotchi%26aufirst%3DJ.%26aulast%3DKiss%26aufirst%3DR.%26atitle%3DPossible%2520future%2520issues%2520in%2520the%2520treatment%2520of%2520glioblastomas%252C%2520with%2520a%2520special%2520emphasis%2520on%2520cell%2520migration%2520and%2520the%2520resistance%2520of%2520migrating%2520glioblastoma%2520cells%2520to%2520apoptosis%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2005%26volume%3D23%26spage%3D2411%26epage%3D2422" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group">Landis-Piwowar, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milacic, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, T. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dou, Q. P.</span><span> </span><span class="NLM_article-title">The proteasome as a potential target for novel anticancer drugs and chemosensitizers</span> <span class="citation_source-journal">Drug Resist. Updates</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">263</span><span class="NLM_x">–</span> <span class="NLM_lpage">273</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Fjm200285z&amp;key=10.1016%2Fj.drup.2006.11.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Fjm200285z&amp;key=17197231" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Fjm200285z&amp;key=1%3ACAS%3A528%3ADC%252BD2sXislKhtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2006&pages=263-273&author=K.+R.+Landis-Piwowarauthor=V.+Milacicauthor=D.+Chenauthor=H.+Yangauthor=Y.+Zhaoauthor=T.+H.+Chanauthor=B.+Yanauthor=Q.+P.+Dou&title=The+proteasome+as+a+potential+target+for+novel+anticancer+drugs+and+chemosensitizers"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">The proteasome as a potential target for novel anticancer drugs and chemosensitizers</span></div><div class="casAuthors">Landis-Piwowar, Kristin R.; Milacic, Vesna; Chen, Di; Yang, Huanjie; Zhao, Yunfeng; Chan, Tak Hang; Yan, Bing; Dou, Q. Ping</div><div class="citationInfo"><span class="NLM_cas:title">Drug Resistance Updates</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">263-273</span>CODEN:
                <span class="NLM_cas:coden">DRUPFW</span>;
        ISSN:<span class="NLM_cas:issn">1368-7646</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  A major challenge in cancer therapy is tumor drug resistance.  To overcome it, it is essential to understand the mechanisms and identify the mols. involved, so that they can be specifically targeted in combination therapies.  The proteasome is such a validated target: it plays a key role in cancer cell proliferation, inhibition of chemotherapy-induced apoptosis and drug resistance development.  Bortezomib (Velcade, PS-341) was the first proteasome inhibitor to receive regulatory approval from the US Food and Drug Administration for the treatment of multiple myeloma.  Clin. combination trials have demonstrated a chemo-sensitizing effect of bortezomib on conventional agents in hematol. malignancies and some solid tumors such as androgen-independent prostate and ovarian cancer.  Although generally well-tolerated, bortezomib still generates toxicity which underscores the need for less toxic proteasome inhibitors.  Several naturally occurring products, such as green tea polyphenols and the antibiotic lactacystin, have been shown to be potent proteasome inhibitors.  Significantly, green tea polyphenols, as well as several flavonoids such as genistein, curcumin and resveratrol, have also been shown to have chemo-sensitizing properties in prostate, breast, hepatic, and lung tumors.  Further studies on natural proteasome inhibitors as chemo-sensitizers could lead to identification of more potent and less toxic compds. that could be used in combination therapies for drug-resistant tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGro3zJ4N37hC7Vg90H21EOLACvtfcHk0lid7vwsOpLMAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXislKhtr8%253D&md5=317f87f20a5293df3874ac19cbf81a04</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1016%2Fj.drup.2006.11.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drup.2006.11.001%26sid%3Dliteratum%253Aachs%26aulast%3DLandis-Piwowar%26aufirst%3DK.%2BR.%26aulast%3DMilacic%26aufirst%3DV.%26aulast%3DChen%26aufirst%3DD.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DChan%26aufirst%3DT.%2BH.%26aulast%3DYan%26aufirst%3DB.%26aulast%3DDou%26aufirst%3DQ.%2BP.%26atitle%3DThe%2520proteasome%2520as%2520a%2520potential%2520target%2520for%2520novel%2520anticancer%2520drugs%2520and%2520chemosensitizers%26jtitle%3DDrug%2520Resist.%2520Updates%26date%3D2006%26volume%3D9%26spage%3D263%26epage%3D273" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group">Guo, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, F.</span><span> </span><span class="NLM_article-title">Non-receptor tyrosine kinase Etk regulation of drug resistance in small-cell lung cancer</span> <span class="citation_source-journal">Eur. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">636</span><span class="NLM_x">–</span> <span class="NLM_lpage">641</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2010&pages=636-641&author=L.+Guoauthor=Y.+Zhouauthor=Y.+Sunauthor=F.+Zhang&title=Non-receptor+tyrosine+kinase+Etk+regulation+of+drug+resistance+in+small-cell+lung+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGuo%26aufirst%3DL.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DSun%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DF.%26atitle%3DNon-receptor%2520tyrosine%2520kinase%2520Etk%2520regulation%2520of%2520drug%2520resistance%2520in%2520small-cell%2520lung%2520cancer%26jtitle%3DEur.%2520J.%2520Cancer%26date%3D2010%26volume%3D46%26spage%3D636%26epage%3D641" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group">Chen, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dou, Q. P.</span><span> </span><span class="NLM_article-title">The ubiquitin-proteasome system as a prospective molecular target for cancer treatment and prevention</span> <span class="citation_source-journal">Curr. Protein Pept. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">459</span><span class="NLM_x">–</span> <span class="NLM_lpage">470</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Fjm200285z&amp;key=10.2174%2F138920310791824057" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Fjm200285z&amp;key=20491623" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Fjm200285z&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFersb7M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2010&pages=459-470&author=D.+Chenauthor=Q.+P.+Dou&title=The+ubiquitin-proteasome+system+as+a+prospective+molecular+target+for+cancer+treatment+and+prevention"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">The ubiquitin-proteasome system as a prospective molecular target for cancer treatment and prevention</span></div><div class="casAuthors">Chen, Di; Dou, Q. Ping</div><div class="citationInfo"><span class="NLM_cas:title">Current Protein and Peptide Science</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">459-470</span>CODEN:
                <span class="NLM_cas:coden">CPPSCM</span>;
        ISSN:<span class="NLM_cas:issn">1389-2037</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Proteasomes are large multicatalytic proteinase complexes located in the cytosol and the nucleus of eukaryotic cells.  The ubiquitin-proteasome system is responsible for the degrdn. of most intracellular proteins and therefore plays an essential regulatory role in crit. cellular processes including cell cycle progression, proliferation, differentiation, angiogenesis and apoptosis.  Besides involving in normal cellular functions and homeostasis, the alteration of proteasomal activity contributes to the pathol. states of several clin. disorders including inflammation, neurodegeneration and cancer.  It was reported that human cancer cells possess elevated level of proteasome activity and are more sensitive to proteasome inhibitors than normal cells, indicating that the inhibition of the ubiquitin-proteasome system could be used as a novel approach for cancer therapy.  In this review we summarize several specific aspects of research for the proteasome complex, including the structure and catalytic activities of the proteasome, properties and mechanisms of action of various proteasome inhibitors, and finally the clin. development of proteasome inhibitors as novel anticancer agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpHjveSFubzlrVg90H21EOLACvtfcHk0lid7vwsOpLMAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFersb7M&md5=ec916b485b1f5dd00ddadf74851d4f05</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.2174%2F138920310791824057&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138920310791824057%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DD.%26aulast%3DDou%26aufirst%3DQ.%2BP.%26atitle%3DThe%2520ubiquitin-proteasome%2520system%2520as%2520a%2520prospective%2520molecular%2520target%2520for%2520cancer%2520treatment%2520and%2520prevention%26jtitle%3DCurr.%2520Protein%2520Pept.%2520Sci.%26date%3D2010%26volume%3D11%26spage%3D459%26epage%3D470" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group">Tsukamoto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yokosawa, H.</span><span> </span><span class="NLM_article-title">Targeting the proteasome pathway</span> <span class="citation_source-journal">Expert Opin. Ther. Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">605</span><span class="NLM_x">–</span> <span class="NLM_lpage">621</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Fjm200285z&amp;key=10.1517%2F14728220902866851" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Fjm200285z&amp;key=19397479" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Fjm200285z&amp;key=1%3ACAS%3A528%3ADC%252BD1MXltVOmur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2009&pages=605-621&author=S.+Tsukamotoauthor=H.+Yokosawa&title=Targeting+the+proteasome+pathway"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the proteasome pathway</span></div><div class="casAuthors">Tsukamoto, Sachiko; Yokosawa, Hideyoshi</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Targets</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">605-621</span>CODEN:
                <span class="NLM_cas:coden">EOTTAO</span>;
        ISSN:<span class="NLM_cas:issn">1472-8222</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  The ubiquitin-proteasome pathway functions as a main pathway in intracellular protein degrdn. and plays a vital role in almost all cellular events.  Various inhibitors of this pathway have been developed for research purposes.  The recent approval of bortezomib (PS-341, Velcade), a proteasome inhibitor, for the treatment of multiple myeloma has opened the way to the discovery of drugs targeting the proteasome and other components of the ubiquitin-proteasome pathway.  We review the current understanding of the ubiquitin-proteasome pathway and inhibitors targeting this pathway, including proteasome inhibitors, as candidate drugs for chem. therapy.  Preclin. and clin. data for inhibitors of the proteasome and the ubiquitin-proteasome pathway are discussed.  The proteasome and other members in the ubiquitin-proteasome pathway have emerged as novel therapeutic targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqXJnen4u4mJ7Vg90H21EOLACvtfcHk0liaCY79M6Dg8Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXltVOmur8%253D&md5=d7edb1be8977c72779cc49e1d96331db</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1517%2F14728220902866851&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14728220902866851%26sid%3Dliteratum%253Aachs%26aulast%3DTsukamoto%26aufirst%3DS.%26aulast%3DYokosawa%26aufirst%3DH.%26atitle%3DTargeting%2520the%2520proteasome%2520pathway%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Targets%26date%3D2009%26volume%3D13%26spage%3D605%26epage%3D621" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit70"><span><span class="NLM_contrib-group">Liggett, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crawford, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morris, T. C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Irvine, A. E.</span><span> </span><span class="NLM_article-title">Methods for measuring proteasome activity: Current limitations and future developments</span> <span class="citation_source-journal">Leukemia Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">1403</span><span class="NLM_x">–</span> <span class="NLM_lpage">1409</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Fjm200285z&amp;key=10.1016%2Fj.leukres.2010.07.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=8&amp;doi=10.1021%2Fjm200285z&amp;key=20674016" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Fjm200285z&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht1Wmur%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2010&pages=1403-1409&author=A.+Liggettauthor=L.+J.+Crawfordauthor=B.+Walkerauthor=T.+C.+M.+Morrisauthor=A.+E.+Irvine&title=Methods+for+measuring+proteasome+activity%3A+Current+limitations+and+future+developments"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Methods for measuring proteasome activity: Current limitations and future developments</span></div><div class="casAuthors">Liggett, A.; Crawford, L. J.; Walker, B.; Morris, T. C. M.; Irvine, A. E.</div><div class="citationInfo"><span class="NLM_cas:title">Leukemia Research</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1403-1409</span>CODEN:
                <span class="NLM_cas:coden">LEREDD</span>;
        ISSN:<span class="NLM_cas:issn">0145-2126</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  The proteasome has been validated as a therapeutic target, with proteasome inhibitors showing particular efficacy in the treatment of Multiple Myeloma.  A wide range of methods have been developed to profile proteasome activity.  These include the current method of choice fluorogenic peptide substrates, as well as bioluminescent imaging, immunol. methods, and more recently, site-specific fluorescent probes.  The aim of this review is to evaluate the currently available methods for profiling proteasome activity and their suitability for use in translational studies.  Ongoing development of techniques for profiling proteasome activity will facilitate future research into proteasome-related pathologies, thus accelerating the development of more specific drug regimes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqzuhH0FrpTkbVg90H21EOLACvtfcHk0liaCY79M6Dg8Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht1Wmur%252FL&md5=4cdabb18f5523be9c90be9596cbd932b</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1016%2Fj.leukres.2010.07.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.leukres.2010.07.003%26sid%3Dliteratum%253Aachs%26aulast%3DLiggett%26aufirst%3DA.%26aulast%3DCrawford%26aufirst%3DL.%2BJ.%26aulast%3DWalker%26aufirst%3DB.%26aulast%3DMorris%26aufirst%3DT.%2BC.%2BM.%26aulast%3DIrvine%26aufirst%3DA.%2BE.%26atitle%3DMethods%2520for%2520measuring%2520proteasome%2520activity%253A%2520Current%2520limitations%2520and%2520future%2520developments%26jtitle%3DLeukemia%2520Res.%26date%3D2010%26volume%3D34%26spage%3D1403%26epage%3D1409" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref71"><div class="reference"><strong class="refLabel"><a href="#ref71" class="rightTabRefNumLink">71</a></strong><div class="NLM_citation" id="rightTab-cit71"><span><span class="NLM_contrib-group">Lefranc, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Facchini, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiss, R.</span><span> </span><span class="NLM_article-title">Pro-autophagic drugs: A novel means to combat apoptosis-resistant cancers, with a special emphasis on glioblastomas</span> <span class="citation_source-journal">Oncologist</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">1395</span><span class="NLM_x">–</span> <span class="NLM_lpage">1403</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2007&pages=1395-1403&author=F.+Lefrancauthor=V.+Facchiniauthor=R.+Kiss&title=Pro-autophagic+drugs%3A+A+novel+means+to+combat+apoptosis-resistant+cancers%2C+with+a+special+emphasis+on+glioblastomas"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLefranc%26aufirst%3DF.%26aulast%3DFacchini%26aufirst%3DV.%26aulast%3DKiss%26aufirst%3DR.%26atitle%3DPro-autophagic%2520drugs%253A%2520A%2520novel%2520means%2520to%2520combat%2520apoptosis-resistant%2520cancers%252C%2520with%2520a%2520special%2520emphasis%2520on%2520glioblastomas%26jtitle%3DOncologist%26date%3D2007%26volume%3D12%26spage%3D1395%26epage%3D1403" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref72"><div class="reference"><strong class="refLabel"><a href="#ref72" class="rightTabRefNumLink">72</a></strong><div class="NLM_citation" id="rightTab-cit72"><span><span class="NLM_contrib-group">Wu, W. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cho, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, K</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, D</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, J</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sung, J. J.</span><span> </span><span class="NLM_article-title">Proteasome inhibition: a new therapeutic strategy to cancer treatment</span> <span class="citation_source-journal">Cancer Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">293</span><span class="NLM_x">, </span> <span class="NLM_fpage">15</span><span class="NLM_x">–</span> <span class="NLM_lpage">22</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Fjm200285z&amp;key=10.1016%2Fj.canlet.2009.12.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=8&amp;doi=10.1021%2Fjm200285z&amp;key=20133049" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Fjm200285z&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlsVyitr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=293&publication_year=2010&pages=15-22&author=W.+K.+Wuauthor=C.+H.+Choauthor=C.+W.+Leeauthor=K+Wuauthor=D+Fanauthor=J+Yuauthor=J.+J.+Sung&title=Proteasome+inhibition%3A+a+new+therapeutic+strategy+to+cancer+treatment"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">Proteasome inhibition: A new therapeutic strategy to cancer treatment</span></div><div class="casAuthors">Wu, William Ka Kei; Cho, Chi Hin; Lee, Chung Wa; Wu, Kaichun; Fan, Daiming; Yu, Jun; Sung, Joseph Jao Yiu</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (Shannon, Ireland)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">293</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">15-22</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ireland Ltd.</span>)
        </div><div class="casAbstract">A review.  The ubiquitin-proteasome system is a major pathway for protein degrdn.  Targeting this pathway using proteasome inhibitors represents a novel approach for the treatment of cancer.  Proteasome inhibitors lower cell proliferation and induce apoptosis in solid and hematol. malignancies through multiple mechanisms, including stabilization of cell cycle regulators and pro-apoptotic factors, stimulation of bone morphogenetic protein signaling, inhibition of protein translation, and sensitization to ligand-induced apoptosis.  In this connection, proteasome inhibition activates macroautophagy, a compensatory protein degrdn. system, as well as other pro-survival signaling pathways.  Inhibition of these auto-protective responses sensitizes cancer cells to the anti-proliferative effects of proteasome inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpjYIKgkj-1yLVg90H21EOLACvtfcHk0liUlZnmz_QVUg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlsVyitr0%253D&md5=368256b32ef5255102f8b7ce641c871a</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1016%2Fj.canlet.2009.12.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.canlet.2009.12.002%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DW.%2BK.%26aulast%3DCho%26aufirst%3DC.%2BH.%26aulast%3DLee%26aufirst%3DC.%2BW.%26aulast%3DWu%26aufirst%3DK%26aulast%3DFan%26aufirst%3DD%26aulast%3DYu%26aufirst%3DJ%26aulast%3DSung%26aufirst%3DJ.%2BJ.%26atitle%3DProteasome%2520inhibition%253A%2520a%2520new%2520therapeutic%2520strategy%2520to%2520cancer%2520treatment%26jtitle%3DCancer%2520Lett.%26date%3D2010%26volume%3D293%26spage%3D15%26epage%3D22" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref73"><div class="reference"><strong class="refLabel"><a href="#ref73" class="rightTabRefNumLink">73</a></strong><div class="NLM_citation" id="rightTab-cit73"><span><span class="NLM_contrib-group">Richardson, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barlogie, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berenson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singhal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jagannath, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Irwin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rajkumar, S. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Srkalovic, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alsina, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alexanian, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siegel, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orlowski, R. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuter, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Limentani, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hideshima, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Esseltine, D.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kauffman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schenkein, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, K. C.</span><span> </span><span class="NLM_article-title">A phase 2 study of bortezomib in relapsed, refractory myeloma</span> <span class="citation_source-journal">New Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">348</span><span class="NLM_x">, </span> <span class="NLM_fpage">2609</span><span class="NLM_x">–</span> <span class="NLM_lpage">2617</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Fjm200285z&amp;key=10.1056%2FNEJMoa030288" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=8&amp;doi=10.1021%2Fjm200285z&amp;key=12826635" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Fjm200285z&amp;key=1%3ACAS%3A528%3ADC%252BD3sXkvVSksLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=348&publication_year=2003&pages=2609-2617&author=P.+G.+Richardsonauthor=B.+Barlogieauthor=J.+Berensonauthor=S.+Singhalauthor=S.+Jagannathauthor=D.+Irwinauthor=S.+V.+Rajkumarauthor=G.+Srkalovicauthor=M.+Alsinaauthor=R.+Alexanianauthor=D.+Siegelauthor=R.+Z.+Orlowskiauthor=D.+Kuterauthor=S.+A.+Limentaniauthor=S.+Leeauthor=T.+Hideshimaauthor=D.-L.+Esseltineauthor=M.+Kauffmanauthor=J.+Adamsauthor=D.+P.+Schenkeinauthor=K.+C.+Anderson&title=A+phase+2+study+of+bortezomib+in+relapsed%2C+refractory+myeloma"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">A phase 2 study of bortezomib in relapsed, refractory myeloma</span></div><div class="casAuthors">Richardson, Paul G.; Barlogie, Bart; Berenson, James; Singhal, Seema; Jagannath, Sundar; Irwin, David; Rajkumar, S. Vincent; Srkalovic, Gordan; Alsina, Melissa; Alexanian, Raymond; Siegel, David; Orlowski, Robert Z.; Kuter, David; Limentani, Steven A.; Lee, Stephanie; Hideshima, Teru; Esseltine, Dixie-Lee; Kauffman, Michael; Adams, Julian; Schenkein, David P.; Anderson, Kenneth C.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">348</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">2609-2617</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Background: Bortezomib, a boronic acid dipeptide, is a novel proteasome inhibitor that has been shown in preclin. and phase 1 studies to have antimyeloma activity.  Methods: In this multicenter, open-label, nonrandomized, phase 2 trial, we enrolled 202 patients with relapsed myeloma that was refractory to the therapy they had received most recently.  Patients received 1.3 mg of bortezomib per square meter of body-surface area twice weekly for 2 wk, followed by 1 wk without treatment, for up to eight cycles (24 wk).  In patients with a suboptimal response, oral dexamethasone (20 mg daily, on the day of and the day after bortezomib administration) was added to the regimen.  The response was evaluated according to the criteria of the European Group for Blood and Marrow Transplantation and confirmed by an independent review committee.  Results: Of 193 patients who could be evaluated, 92 % had been treated with three or more of the major classes of agents for myeloma, and in 91 %, the myeloma was refractory to the therapy received most recently.  The rate of response to bortezomib was 35 %, and those with a response included 7 patients in whom myeloma protein became undetectable and 12 in whom myeloma protein was detectable only by immunofixation.  The median overall survival was 16 mo, with a median duration of response of 12 mo.  Grade 3 adverse events included thrombocytopenia (in 28 % of patients), fatigue (in 12 %), peripheral neuropathy (in 12 %), and neutropenia (in 11 %).  Grade 4 events occurred in 14 % of patients.  Conclusions: Bortezomib, a member of a new class of anticancer drugs, is active in patients with relapsed multiple myeloma that is refractory to conventional chemotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqrvlvB12o1xbVg90H21EOLACvtfcHk0liUlZnmz_QVUg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXkvVSksLs%253D&md5=7d7ef72077f270a421a538557b3bf9ca</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa030288&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa030288%26sid%3Dliteratum%253Aachs%26aulast%3DRichardson%26aufirst%3DP.%2BG.%26aulast%3DBarlogie%26aufirst%3DB.%26aulast%3DBerenson%26aufirst%3DJ.%26aulast%3DSinghal%26aufirst%3DS.%26aulast%3DJagannath%26aufirst%3DS.%26aulast%3DIrwin%26aufirst%3DD.%26aulast%3DRajkumar%26aufirst%3DS.%2BV.%26aulast%3DSrkalovic%26aufirst%3DG.%26aulast%3DAlsina%26aufirst%3DM.%26aulast%3DAlexanian%26aufirst%3DR.%26aulast%3DSiegel%26aufirst%3DD.%26aulast%3DOrlowski%26aufirst%3DR.%2BZ.%26aulast%3DKuter%26aufirst%3DD.%26aulast%3DLimentani%26aufirst%3DS.%2BA.%26aulast%3DLee%26aufirst%3DS.%26aulast%3DHideshima%26aufirst%3DT.%26aulast%3DEsseltine%26aufirst%3DD.-L.%26aulast%3DKauffman%26aufirst%3DM.%26aulast%3DAdams%26aufirst%3DJ.%26aulast%3DSchenkein%26aufirst%3DD.%2BP.%26aulast%3DAnderson%26aufirst%3DK.%2BC.%26atitle%3DA%2520phase%25202%2520study%2520of%2520bortezomib%2520in%2520relapsed%252C%2520refractory%2520myeloma%26jtitle%3DNew%2520Engl.%2520J.%2520Med.%26date%3D2003%26volume%3D348%26spage%3D2609%26epage%3D2617" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref74"><div class="reference"><strong class="refLabel"><a href="#ref74" class="rightTabRefNumLink">74</a></strong><div class="NLM_citation" id="rightTab-cit74"><span><span class="NLM_contrib-group">Richardson, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Briemberg, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jagannath, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wen, P. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barlogie, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berenson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singhal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siegel, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Irwin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schuster, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Srkalovic, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alexanian, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rajkumar, S. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Limentani, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alsina, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orlowski, R. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Najarian, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Esseltine, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amato, A. A.</span><span> </span><span class="NLM_article-title">Frequency, characteristics, and reversibility of peripheral neuropathy during treatment of advanced multiple myeloma with bortezomib</span> <span class="citation_source-journal">J. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">3113</span><span class="NLM_x">–</span> <span class="NLM_lpage">3120</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Fjm200285z&amp;key=10.1200%2FJCO.2005.04.7779" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=8&amp;doi=10.1021%2Fjm200285z&amp;key=16754936" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Fjm200285z&amp;key=1%3ACAS%3A528%3ADC%252BD28XnslKhs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2006&pages=3113-3120&author=P.+G.+Richardsonauthor=H.+Briembergauthor=S.+Jagannathauthor=P.+Y.+Wenauthor=B.+Barlogieauthor=J.+Berensonauthor=S.+Singhalauthor=D.+S.+Siegelauthor=D.+Irwinauthor=M.+Schusterauthor=G.+Srkalovicauthor=R.+Alexanianauthor=S.+V.+Rajkumarauthor=S.+Limentaniauthor=M.+Alsinaauthor=R.+Z.+Orlowskiauthor=K.+Najarianauthor=D.+Esseltineauthor=K.+C.+Andersonauthor=A.+A.+Amato&title=Frequency%2C+characteristics%2C+and+reversibility+of+peripheral+neuropathy+during+treatment+of+advanced+multiple+myeloma+with+bortezomib"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">Frequency, characteristics, and reversibility of peripheral neuropathy during treatment of advanced multiple myeloma with bortezomib</span></div><div class="casAuthors">Richardson, Paul G.; Briemberg, Hannah; Jagannath, Sundar; Wen, Patrick Y.; Barlogie, Bart; Berenson, James; Singhal, Seema; Siegel, David S.; Irwin, David; Schuster, Michael; Srkalovic, Gordan; Alexanian, Raymond; Rajkumar, S. Vincent; Limentani, Steven; Alsina, Melissa; Orlowski, Robert Z.; Najarian, Kevin; Esseltine, Dixie; Anderson, Kenneth C.; Amato, Anthony A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Oncology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">3113-3120</span>CODEN:
                <span class="NLM_cas:coden">JCONDN</span>;
        ISSN:<span class="NLM_cas:issn">0732-183X</span>.
    
            (<span class="NLM_cas:orgname">American Society of Clinical Oncology</span>)
        </div><div class="casAbstract">Purpose: To det. the frequency, characteristics, and reversibility of peripheral neuropathy from bortezomib treatment of advanced multiple myeloma.  Patients and Methods: Peripheral neuropathy was assessed in two phase II studies in 256 patients with relapsed and/or refractory myeloma treated with bortezomib 1.0 or 1.3 mg/m2 i.v. bolus on days 1, 4, 8, and 11, every 21 days, for up to eight cycles.  Peripheral neuropathy was evaluated at baseline, during the study, and after the study by patient-reported symptoms using the Functional Assessment of Cancer Therapy Scale/Gynecol. Oncol. Group-Neurotoxicity (FACT/GOG-Ntx) questionnaire and neurol. examn.  During the study, peripheral neuropathy was also evaluated by investigator assessment.  A subset of patients underwent nerve conduction studies (n = 13).  Results: Before treatment, 194 (81%) of 239 patients had peripheral neuropathy by FACT/GOG-Ntx questionnaire, and 203 (83%) of 244 patients had peripheral neuropathy by neurol. examn.  Treatment-emergent neuropathy was reported in 35% of patients, including 37% (84 of 228 patients) receiving bortezomib 1.3 mg/m2 and 21% (six of 28 patients) receiving bortezomib 1.0 mg/m2.  Grade 1 or 2, 3, and 4 neuropathy occurred in 22%, 13%, and 0.4% of patients, resp.  The incidence of grade ≥ 3 neuropathy was higher among patients with baseline neuropathy by FACT/GOG-Ntx questionnaire compared with patients without baseline neuropathy (14% v 4%, resp.).  In all 256 patients, neuropathy led to dose redn. in 12% and discontinuation in 5%.  Of 35 patients with neuropathy ≥ grade 3 and/or requiring discontinuation, resoln. to baseline or improvement occurred in 71 %.  Conclusion: Bortezomib-assocd. peripheral neuropathy seemed reversible in the majority of patients after dose redn. or discontinuation.  Although severe neuropathy was more frequent in the presence of baseline neuropathy, the overall occurrence was independent of baseline neuropathy or type of prior therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5Y4e2anJT-bVg90H21EOLACvtfcHk0lhaz28MZbMO2g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XnslKhs7c%253D&md5=f2573ccd3f43fad31ad2f0bb8592a82b</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1200%2FJCO.2005.04.7779&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2005.04.7779%26sid%3Dliteratum%253Aachs%26aulast%3DRichardson%26aufirst%3DP.%2BG.%26aulast%3DBriemberg%26aufirst%3DH.%26aulast%3DJagannath%26aufirst%3DS.%26aulast%3DWen%26aufirst%3DP.%2BY.%26aulast%3DBarlogie%26aufirst%3DB.%26aulast%3DBerenson%26aufirst%3DJ.%26aulast%3DSinghal%26aufirst%3DS.%26aulast%3DSiegel%26aufirst%3DD.%2BS.%26aulast%3DIrwin%26aufirst%3DD.%26aulast%3DSchuster%26aufirst%3DM.%26aulast%3DSrkalovic%26aufirst%3DG.%26aulast%3DAlexanian%26aufirst%3DR.%26aulast%3DRajkumar%26aufirst%3DS.%2BV.%26aulast%3DLimentani%26aufirst%3DS.%26aulast%3DAlsina%26aufirst%3DM.%26aulast%3DOrlowski%26aufirst%3DR.%2BZ.%26aulast%3DNajarian%26aufirst%3DK.%26aulast%3DEsseltine%26aufirst%3DD.%26aulast%3DAnderson%26aufirst%3DK.%2BC.%26aulast%3DAmato%26aufirst%3DA.%2BA.%26atitle%3DFrequency%252C%2520characteristics%252C%2520and%2520reversibility%2520of%2520peripheral%2520neuropathy%2520during%2520treatment%2520of%2520advanced%2520multiple%2520myeloma%2520with%2520bortezomib%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2006%26volume%3D24%26spage%3D3113%26epage%3D3120" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref75"><div class="reference"><strong class="refLabel"><a href="#ref75" class="rightTabRefNumLink">75</a></strong><div class="NLM_citation" id="rightTab-cit75"><span><span class="NLM_contrib-group">Lonial, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waller, E. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richardson, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jagannath, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orlowski, R. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giver, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jaye, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Francis, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giusti, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torre, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barlogie, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berenson, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sunghal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schenkein, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Esseltine, D. L. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heffner, L. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, K. C.</span><span> </span><span class="NLM_article-title">Risk factors and kinetics of thrombocytopenia associated with bortezomib for relapsed, refractory multiple myeloma</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">106</span><span class="NLM_x">, </span> <span class="NLM_fpage">3777</span><span class="NLM_x">–</span> <span class="NLM_lpage">3784</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2005&pages=3777-3784&author=S.+Lonialauthor=E.+K.+Wallerauthor=P.+G.+Richardsonauthor=S.+Jagannathauthor=R.+Z.+Orlowskiauthor=C.+R.+Giverauthor=D.+L.+Jayeauthor=D.+Francisauthor=S.+Giustiauthor=C.+Torreauthor=B.+Barlogieauthor=J.+R.+Berensonauthor=S.+Sunghalauthor=D.+P.+Schenkeinauthor=D.+L.+W.+Esseltineauthor=J.+Andersonauthor=H.+Xiaoauthor=L.+T.+Heffnerauthor=K.+C.+Anderson&title=Risk+factors+and+kinetics+of+thrombocytopenia+associated+with+bortezomib+for+relapsed%2C+refractory+multiple+myeloma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLonial%26aufirst%3DS.%26aulast%3DWaller%26aufirst%3DE.%2BK.%26aulast%3DRichardson%26aufirst%3DP.%2BG.%26aulast%3DJagannath%26aufirst%3DS.%26aulast%3DOrlowski%26aufirst%3DR.%2BZ.%26aulast%3DGiver%26aufirst%3DC.%2BR.%26aulast%3DJaye%26aufirst%3DD.%2BL.%26aulast%3DFrancis%26aufirst%3DD.%26aulast%3DGiusti%26aufirst%3DS.%26aulast%3DTorre%26aufirst%3DC.%26aulast%3DBarlogie%26aufirst%3DB.%26aulast%3DBerenson%26aufirst%3DJ.%2BR.%26aulast%3DSunghal%26aufirst%3DS.%26aulast%3DSchenkein%26aufirst%3DD.%2BP.%26aulast%3DEsseltine%26aufirst%3DD.%2BL.%2BW.%26aulast%3DAnderson%26aufirst%3DJ.%26aulast%3DXiao%26aufirst%3DH.%26aulast%3DHeffner%26aufirst%3DL.%2BT.%26aulast%3DAnderson%26aufirst%3DK.%2BC.%26atitle%3DRisk%2520factors%2520and%2520kinetics%2520of%2520thrombocytopenia%2520associated%2520with%2520bortezomib%2520for%2520relapsed%252C%2520refractory%2520multiple%2520myeloma%26jtitle%3DBlood%26date%3D2005%26volume%3D106%26spage%3D3777%26epage%3D3784" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref76"><div class="reference"><strong class="refLabel"><a href="#ref76" class="rightTabRefNumLink">76</a></strong><div class="NLM_citation" id="rightTab-cit76"><span><span class="NLM_contrib-group">Blanquicett, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hart, C. M.</span><span> </span><span class="NLM_article-title">Thiazolidinediones as anti-cancer agents</span> <span class="citation_source-journal">Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">25</span><span class="NLM_x">–</span> <span class="NLM_lpage">34</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=8&amp;doi=10.1021%2Fjm200285z&amp;key=19079765" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Fjm200285z&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1KgsbfL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2008&pages=25-34&author=C.+Blanquicettauthor=J.+Romanauthor=C.+M.+Hart&title=Thiazolidinediones+as+anti-cancer+agents"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">Thiazolidinediones as anti-cancer agents</span></div><div class="casAuthors">Blanquicett, Carmelo; Roman, Jesse; Hart, C. Michael</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Therapy</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">25-34</span>CODEN:
                <span class="NLM_cas:coden">CTAHDB</span>;
        ISSN:<span class="NLM_cas:issn">1543-9143</span>.
    
            (<span class="NLM_cas:orgname">Gene Therapy Press</span>)
        </div><div class="casAbstract">A review.  The PPAR-gamma (PPAR-γ) activating thiazolidinedione (TZD) medications are a class of drugs used to improve lipid and glucose metab. in type-2 diabetes.  In addn. to their known insulin sensitization action, these drugs have been shown to suppress tumor development in several in vitro and in vivo models.  Among the proposed mechanisms for the anti-tumor effects of TZDs, apoptosis induction, cell cycle arrest, and differentiation have been extensively reported.  Interestingly, some of the obsd. anti-tumor effects are independent of PPAR-γ activation.  The following review will discuss studies employing TZDs as anti-cancer therapies for the most common types of cancers including, lung, breast, and colon and will explore the principal PPAR-γ-dependent and -independent mechanisms by which TZDs exert their anti-tumor effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCy2AgDJmXyLVg90H21EOLACvtfcHk0ljK_Uosgg0BaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1KgsbfL&md5=743f7e1d400d699f7712934b8e618fbf</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBlanquicett%26aufirst%3DC.%26aulast%3DRoman%26aufirst%3DJ.%26aulast%3DHart%26aufirst%3DC.%2BM.%26atitle%3DThiazolidinediones%2520as%2520anti-cancer%2520agents%26jtitle%3DCancer%2520Ther.%26date%3D2008%26volume%3D6%26spage%3D25%26epage%3D34" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref77"><div class="reference"><strong class="refLabel"><a href="#ref77" class="rightTabRefNumLink">77</a></strong><div class="NLM_citation" id="rightTab-cit77"><span><span class="NLM_contrib-group">He, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zuo, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, B. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lei, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rastegar, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deng, Z. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luu, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haydon, R. C.</span><span> </span><span class="NLM_article-title">Synergistic antitumor effect of the activated PPARgamma and retinoid recptors on human osteosarcoma</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">2235</span><span class="NLM_x">–</span> <span class="NLM_lpage">2245</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Fjm200285z&amp;key=10.1158%2F1078-0432.CCR-09-2499" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=8&amp;doi=10.1021%2Fjm200285z&amp;key=20371684" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Fjm200285z&amp;key=1%3ACAS%3A528%3ADC%252BC3cXkslSmtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2010&pages=2235-2245&author=B.+C.+Heauthor=L.+Chenauthor=G.+W.+Zuoauthor=W.+Zhangauthor=Y.+Biauthor=J.+Huangauthor=Y.+Wangauthor=W.+Jiangauthor=Q.+Luoauthor=Q.+Shiauthor=B.+Q.+Zhangauthor=B.+Liuauthor=X.+Leiauthor=J.+Luoauthor=X.+Luoauthor=E.+R.+Wagnerauthor=S.+H.+Kimauthor=C.+J.+Heauthor=Y.+Huauthor=J.+Shenauthor=Q.+Zhouauthor=F.+Rastegarauthor=Z.+L.+Dengauthor=H.+H.+Luuauthor=T.+C.+Heauthor=R.+C.+Haydon&title=Synergistic+antitumor+effect+of+the+activated+PPARgamma+and+retinoid+recptors+on+human+osteosarcoma"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">Synergistic Antitumor Effect of the Activated PPARγ and Retinoid Receptors on Human Osteosarcoma</span></div><div class="casAuthors">He, Bai-Cheng; Chen, Liang; Zuo, Guo-Wei; Zhang, Wenli; Bi, Yang; Huang, Jiayi; Wang, Yi; Jiang, Wei; Luo, Qing; Shi, Qiong; Zhang, Bing-Qiang; Liu, Bo; Lei, Xia; Luo, Jinyong; Luo, Xiaoji; Wagner, Eric R.; Kim, Stephanie H.; He, Connie J.; Hu, Yawen; Shen, Jikun; Zhou, Qixin; Rastegar, Farbod; Deng, Zhong-Liang; Luu, Hue H.; He, Tong-Chuan; Haydon, Rex C.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2235-2245</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">PURPOSE: Osteosarcoma is the most common primary malignancy of bone.  The long-term survival of osteosarcoma patients hinges on our ability to prevent and/or treat recurrent and metastatic lesions.  Here, we investigated the activation of peroxisome proliferator-activated receptor γ (PPARγ) and retinoid receptors as a means of differentiation therapy for human osteosarcoma.  Exptl. Design: We examd. the endogenous expression of PPARγ and retinoid receptors in a panel of osteosarcoma cells.  Ligands or adenovirus-mediated overexpression of these receptors were tested to inhibit proliferation and induce apoptosis of osteosarcoma cells.  Osteosarcoma cells overexpressing the receptors were introduced into an orthotopic tumor model.  The effect of these ligands on osteoblastic differentiation was further investigated.  RESULTS: Endogenous expression of PPARγ and isotypes of retinoic acid receptor (RAR) and retinoid X receptor (RXR) is detected in most osteosarcoma cells.  Troglitazone, 9-cis retinoic acid (RA), and all-trans RA, as well as overexpression of PPARγ, RARα, and RXRα, inhibit osteosarcoma cell proliferation and induce apoptosis.  A synergistic inhibitory effect on osteosarcoma cell proliferation is obsd. between troglitazone and retinoids, as well as with the overexpression pairs of PPARγ/RARα, or PPARγ/RXRα.  Overexpression of PPARγ, RARα, RXRα, or in combinations inhibits osteosarcoma tumor growth and cell proliferation in vivo.  Retinoids (and to a lesser extent, troglitazone) are shown to promote osteogenic differentiation of osteosarcoma cells and mesenchymal stem cells.  CONCLUSIONS: Activation of PPARγ, RARα, and RXRα may act synergistically on inhibiting osteosarcoma cell proliferation and tumor growth, which is at least partially mediated by promoting osteoblastic differentiation of osteosarcoma cells.  Clin Cancer Res; 16(8); 2235-45.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBTaI2YHJNArVg90H21EOLACvtfcHk0ljK_Uosgg0BaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXkslSmtbs%253D&md5=71632e7a8c14faa697c822f84bcfd8f8</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-09-2499&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-09-2499%26sid%3Dliteratum%253Aachs%26aulast%3DHe%26aufirst%3DB.%2BC.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DZuo%26aufirst%3DG.%2BW.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DBi%26aufirst%3DY.%26aulast%3DHuang%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DJiang%26aufirst%3DW.%26aulast%3DLuo%26aufirst%3DQ.%26aulast%3DShi%26aufirst%3DQ.%26aulast%3DZhang%26aufirst%3DB.%2BQ.%26aulast%3DLiu%26aufirst%3DB.%26aulast%3DLei%26aufirst%3DX.%26aulast%3DLuo%26aufirst%3DJ.%26aulast%3DLuo%26aufirst%3DX.%26aulast%3DWagner%26aufirst%3DE.%2BR.%26aulast%3DKim%26aufirst%3DS.%2BH.%26aulast%3DHe%26aufirst%3DC.%2BJ.%26aulast%3DHu%26aufirst%3DY.%26aulast%3DShen%26aufirst%3DJ.%26aulast%3DZhou%26aufirst%3DQ.%26aulast%3DRastegar%26aufirst%3DF.%26aulast%3DDeng%26aufirst%3DZ.%2BL.%26aulast%3DLuu%26aufirst%3DH.%2BH.%26aulast%3DHe%26aufirst%3DT.%2BC.%26aulast%3DHaydon%26aufirst%3DR.%2BC.%26atitle%3DSynergistic%2520antitumor%2520effect%2520of%2520the%2520activated%2520PPARgamma%2520and%2520retinoid%2520recptors%2520on%2520human%2520osteosarcoma%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2010%26volume%3D16%26spage%3D2235%26epage%3D2245" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref78"><div class="reference"><strong class="refLabel"><a href="#ref78" class="rightTabRefNumLink">78</a></strong><div class="NLM_citation" id="rightTab-cit78"><span><span class="NLM_contrib-group">Lee, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cho, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoon, D. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heo, Y. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, Y.</span><span> </span><span class="NLM_article-title">Cytotoxic flavonoids as agonists of peroxysome proliferator-activated receptor gamma on human cervical and prostate cancer cells</span> <span class="citation_source-journal">J. Nat. Prod.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">73</span><span class="NLM_x">, </span> <span class="NLM_fpage">1261</span><span class="NLM_x">–</span> <span class="NLM_lpage">1265</span></span><div class="citationLinks">[<a href="/doi/10.1021/np100148m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2010&pages=1261-1265&author=J.+Y.+Leeauthor=J.+K.+Kimauthor=M.+C.+Choauthor=S.+Shinauthor=D.+Y.+Yoonauthor=Y.+S.+Heoauthor=Y.+Kim&title=Cytotoxic+flavonoids+as+agonists+of+peroxysome+proliferator-activated+receptor+gamma+on+human+cervical+and+prostate+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1021%2Fnp100148m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fnp100148m%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DJ.%2BY.%26aulast%3DKim%26aufirst%3DJ.%2BK.%26aulast%3DCho%26aufirst%3DM.%2BC.%26aulast%3DShin%26aufirst%3DS.%26aulast%3DYoon%26aufirst%3DD.%2BY.%26aulast%3DHeo%26aufirst%3DY.%2BS.%26aulast%3DKim%26aufirst%3DY.%26atitle%3DCytotoxic%2520flavonoids%2520as%2520agonists%2520of%2520peroxysome%2520proliferator-activated%2520receptor%2520gamma%2520on%2520human%2520cervical%2520and%2520prostate%2520cancer%2520cells%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D2010%26volume%3D73%26spage%3D1261%26epage%3D1265" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref79"><div class="reference"><strong class="refLabel"><a href="#ref79" class="rightTabRefNumLink">79</a></strong><div class="NLM_citation" id="rightTab-cit79"><span><span class="NLM_contrib-group">Reka, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurapati, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narala, V. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bommer, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Standiford, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keshamouni, V. G.</span><span> </span><span class="NLM_article-title">Peroxisome proliferator-activated receptor-gamma activation inhibits tumor metastasis by antagonizing Smad3-mediated epithelial-mesenchymal transition</span> <span class="citation_source-journal">Mol. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">3221</span><span class="NLM_x">–</span> <span class="NLM_lpage">3232</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Fjm200285z&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsFGrsLzN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2010&pages=3221-3232&author=A.+K.+Rekaauthor=H.+Kurapatiauthor=V.+R.+Naralaauthor=G.+Bommerauthor=J.+Chenauthor=T.+J.+Standifordauthor=V.+G.+Keshamouni&title=Peroxisome+proliferator-activated+receptor-gamma+activation+inhibits+tumor+metastasis+by+antagonizing+Smad3-mediated+epithelial-mesenchymal+transition"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">Peroxisome Proliferator-Activated Receptor-γ Activation Inhibits Tumor Metastasis by Antagonizing Smad3-Mediated Epithelial-Mesenchymal Transition</span></div><div class="casAuthors">Reka, Ajaya Kumar; Kurapati, Himabindu; Narala, Venkata R.; Bommer, Guido; Chen, Jun; Standiford, Theodore J.; Keshamouni, Venkateshwar G.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3221-3232</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Epithelial-mesenchymal transition (EMT) was shown to confer tumor cells with abilities essential for metastasis, including migratory phenotype, invasiveness, resistance to apoptosis, evading immune surveillance, and tumor stem cell traits.  Therefore, inhibition of EMT can be an important therapeutic strategy to inhibit tumor metastasis.  Here, we show that activation of peroxisome proliferator-activated receptor γ (PPAR-γ) inhibits transforming growth factor β (TGF-β)-induced EMT in lung cancer cells and prevents metastasis by antagonizing Smad3 function.  Activation of PPAR-γ by synthetic ligands (troglitazone and rosiglitazone) or by a constitutively active form of PPAR-γ prevents TGF-β-induced loss of E-cadherin expression and inhibits the induction of mesenchymal markers (vimentin, N-cadherin, fibronectin) and matrix metalloproteases.  Consistently, activation of PPAR-γ also inhibited EMT-induced migration and invasion of lung cancer cells.  Furthermore, effects of PPAR-γ ligands were attenuated by siRNA-mediated knockdown of PPAR-γ, indicating that the ligand-induced responses are PPAR-γ dependent.  Selective knockdown of Smad2 and Smad3 by siRNA showed that TGF-β-induced EMT is Smad3 dependent in lung cancer cells.  Activation of PPAR-γ inhibits TGF-β-induced Smad transcriptional activity but had no effect on the phosphorylation or nuclear translocation of Smads.  Consistently, PPAR-γ activation prevented TGF-β-induced transcriptional repression of E-cadherin promoter and inhibited transcriptional activation of N-cadherin promoter.  Finally, treatment of mice with troglitazone or knockdown of Smad3 in tumor cells significantly inhibited TGF-β-induced exptl. metastasis in SCID-Beige mice.  Together, with the low toxicity profile of PPAR-γ ligands, our data show that these ligands may serve as potential therapeutic agents to inhibit metastasis.  Mol Cancer Ther; 9(12); 3221-32.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpa-a3-3vvf3bVg90H21EOLACvtfcHk0lhs4ZtDEPkXcg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsFGrsLzN&md5=65d63d3f0b8aa7359be8dd2aa12e6d74</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DReka%26aufirst%3DA.%2BK.%26aulast%3DKurapati%26aufirst%3DH.%26aulast%3DNarala%26aufirst%3DV.%2BR.%26aulast%3DBommer%26aufirst%3DG.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DStandiford%26aufirst%3DT.%2BJ.%26aulast%3DKeshamouni%26aufirst%3DV.%2BG.%26atitle%3DPeroxisome%2520proliferator-activated%2520receptor-gamma%2520activation%2520inhibits%2520tumor%2520metastasis%2520by%2520antagonizing%2520Smad3-mediated%2520epithelial-mesenchymal%2520transition%26jtitle%3DMol.%2520Cancer%2520Res.%26date%3D2010%26volume%3D9%26spage%3D3221%26epage%3D3232" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref80"><div class="reference"><strong class="refLabel"><a href="#ref80" class="rightTabRefNumLink">80</a></strong><div class="NLM_citation" id="rightTab-cit80"><span><span class="NLM_contrib-group">Voutsadakis, I. A.</span><span> </span><span class="NLM_article-title">Peroxisome proliferator activated receptor-gamma and the ubiquitin-proteasome system in colorectal cancer</span> <span class="citation_source-journal">World J. Gastrointest. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">235</span><span class="NLM_x">–</span> <span class="NLM_lpage">241</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=16&amp;doi=10.1021%2Fjm200285z&amp;key=10.4251%2Fwjgo.v2.i5.235" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=8&amp;doi=10.1021%2Fjm200285z&amp;key=21160623" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Fjm200285z&amp;key=1%3ACAS%3A280%3ADC%252BC3M%252Fks1Cltg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2010&pages=235-241&author=I.+A.+Voutsadakis&title=Peroxisome+proliferator+activated+receptor-gamma+and+the+ubiquitin-proteasome+system+in+colorectal+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">Peroxisome proliferator activated receptor-γ and the ubiquitin-proteasome system in colorectal cancer</span></div><div class="casAuthors">Voutsadakis Ioannis A</div><div class="citationInfo"><span class="NLM_cas:title">World journal of gastrointestinal oncology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">235-41</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Peroxisome proliferator activated receptor-γ (PPARγ), a transcription factor of the nuclear receptor superfamily plays a significant role in colorectal cancer pathogenesis.  In most experimental systems PPARγ activation has tumor suppressing effects in the colon.  PPARγ is regulated at multiple levels by the ubiquitin-proteasome system (UPS).  At a first level, UPS regulates PPARγ transcription.  This regulation involves both PPARγ transcription specific factors and the general transcription machinery.  At a second level UPS regulates PPARγ and its co-factors themselves, as PPARγ and many co-factors are proteasome substrates.  At a third level of regulation, transduction pathways working in parallel but also having interrelations with PPARγ are regulated by the UPS, creating a network of regulation in the colorectal carcinogenesis-related pathways that are under UPS control.  Activation of PPARγ transcription by direct pharmacologic activators and by stabilization of its molecule by proteasome inhibitors could be strategies to be exploited in colorectal cancer treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSu0K-PDwFr85ZoeNcnHOQ9fW6udTcc2eb7RttSWel-aLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3M%252Fks1Cltg%253D%253D&md5=4ae395e1622b890c3a638395de70fff2</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.4251%2Fwjgo.v2.i5.235&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4251%252Fwjgo.v2.i5.235%26sid%3Dliteratum%253Aachs%26aulast%3DVoutsadakis%26aufirst%3DI.%2BA.%26atitle%3DPeroxisome%2520proliferator%2520activated%2520receptor-gamma%2520and%2520the%2520ubiquitin-proteasome%2520system%2520in%2520colorectal%2520cancer%26jtitle%3DWorld%2520J.%2520Gastrointest.%2520Oncol.%26date%3D2010%26volume%3D2%26spage%3D235%26epage%3D241" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref81"><div class="reference"><strong class="refLabel"><a href="#ref81" class="rightTabRefNumLink">81</a></strong><div class="NLM_citation" id="rightTab-cit81"><span><span class="NLM_contrib-group">Knight, Z. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shokat, K. M.</span><span> </span><span class="NLM_article-title">Targeting the cancer kinome through polypharmacology</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">130</span><span class="NLM_x">–</span> <span class="NLM_lpage">137</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Fjm200285z&amp;key=10.1038%2Fnrc2787" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=8&amp;doi=10.1021%2Fjm200285z&amp;key=20094047" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=32&amp;doi=10.1021%2Fjm200285z&amp;key=1%3ACAS%3A528%3ADC%252BC3cXps1Clug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2010&pages=130-137&author=Z.+A.+Knightauthor=H.+Linauthor=K.+M.+Shokat&title=Targeting+the+cancer+kinome+through+polypharmacology"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit81R"><div class="casContent"><span class="casTitleNuber">81</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the cancer kinome through polypharmacology</span></div><div class="casAuthors">Knight, Zachary A.; Lin, Henry; Shokat, Kevan M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">130-137</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Kinase inhibitors are the largest class of new cancer drugs.  However, it is already apparent that most tumors can escape from the inhibition of any single kinase.  If it is necessary to inhibit multiple kinases, how do we choose which ones.  In this Opinion article, we discuss some of the strategies that are currently being used to identify new therapeutic combinations of kinase targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpkDv2FeeH58rVg90H21EOLACvtfcHk0liLlj8xMnKPjw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXps1Clug%253D%253D&md5=9aaa314e54b43889e147a9f11ac77072</span></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1038%2Fnrc2787&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc2787%26sid%3Dliteratum%253Aachs%26aulast%3DKnight%26aufirst%3DZ.%2BA.%26aulast%3DLin%26aufirst%3DH.%26aulast%3DShokat%26aufirst%3DK.%2BM.%26atitle%3DTargeting%2520the%2520cancer%2520kinome%2520through%2520polypharmacology%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2010%26volume%3D10%26spage%3D130%26epage%3D137" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref82"><div class="reference"><strong class="refLabel"><a href="#ref82" class="rightTabRefNumLink">82</a></strong><div class="NLM_citation" id="rightTab-cit82"><span><span class="NLM_contrib-group">Fedorov, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, S.</span><span> </span><span class="NLM_article-title">The (un)target cancer kinome</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">166</span><span class="NLM_x">–</span> <span class="NLM_lpage">169</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=16&amp;doi=10.1021%2Fjm200285z&amp;key=10.1038%2Fnchembio.297" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=8&amp;doi=10.1021%2Fjm200285z&amp;key=20154661" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Fjm200285z&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhvFGntbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2010&pages=166-169&author=O.+Fedorovauthor=S.+M%C3%BCllerauthor=S.+Knapp&title=The+%28un%29target+cancer+kinome"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">The (un)targeted cancer kinome</span></div><div class="casAuthors">Fedorov, Oleg; Mueller, Susanne; Knapp, Stefan</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">166-169</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review and discussion.  The complexity of cancer signaling and the resulting difficulties in target selection have strongly biased kinase drug discovery towards clin. validated targets.  Recently, novel kinase targets that are uncharacterized have emerged from genome sequencing and RNAi studies.  Chem. probes are urgently needed to functionally annotate these kinases and to stimulate new drug discovery efforts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpwcnq0-qjPirVg90H21EOLACvtfcHk0liLlj8xMnKPjw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhvFGntbk%253D&md5=198ae8d39d40247e17aef5e9de0f2a99</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.297&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.297%26sid%3Dliteratum%253Aachs%26aulast%3DFedorov%26aufirst%3DO.%26aulast%3DM%25C3%25BCller%26aufirst%3DS.%26aulast%3DKnapp%26aufirst%3DS.%26atitle%3DThe%2520%2528un%2529target%2520cancer%2520kinome%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2010%26volume%3D6%26spage%3D166%26epage%3D169" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref83"><div class="reference"><strong class="refLabel"><a href="#ref83" class="rightTabRefNumLink">83</a></strong><div class="NLM_citation" id="rightTab-cit83"><span><span class="NLM_contrib-group">Gossage, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eisen, T.</span><span> </span><span class="NLM_article-title">Targeting multiple kinase pathways: a change in paradigm</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">1973</span><span class="NLM_x">–</span> <span class="NLM_lpage">1978</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=16&amp;doi=10.1021%2Fjm200285z&amp;key=10.1158%2F1078-0432.CCR-09-3182" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=8&amp;doi=10.1021%2Fjm200285z&amp;key=20215532" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Fjm200285z&amp;key=1%3ACAS%3A528%3ADC%252BC3cXktFygu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2010&pages=1973-1978&author=L.+Gossageauthor=T.+Eisen&title=Targeting+multiple+kinase+pathways%3A+a+change+in+paradigm"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting Multiple Kinase Pathways: A Change In Paradigm</span></div><div class="casAuthors">Gossage, Lucy; Eisen, Tim</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1973-1978</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A review.  Anticancer drugs that target protein kinases include small mol. inhibitors and monoclonal antibodies.  Feedback loops and cross talk between signaling pathways impact significantly on the efficacy of cancer therapeutics, and resistance to targeted agents is a major barrier to effective treatments.  Increasingly, therapies are being designed to target multiple kinase pathways.  This can be achieved using a single agent that inhibits multiple signaling pathways or a combination of highly selective agents.  In this review we discuss the principles of specifically targeting multiple kinase pathways with particular ref. to angiogenic signaling pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwTqIFjKKuX7Vg90H21EOLACvtfcHk0liLlj8xMnKPjw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXktFygu7w%253D&md5=fc074fb853129324db0b36ec148f2401</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-09-3182&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-09-3182%26sid%3Dliteratum%253Aachs%26aulast%3DGossage%26aufirst%3DL.%26aulast%3DEisen%26aufirst%3DT.%26atitle%3DTargeting%2520multiple%2520kinase%2520pathways%253A%2520a%2520change%2520in%2520paradigm%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2010%26volume%3D16%26spage%3D1973%26epage%3D1978" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref84"><div class="reference"><strong class="refLabel"><a href="#ref84" class="rightTabRefNumLink">84</a></strong><div class="NLM_citation" id="rightTab-cit84"><span><span class="NLM_contrib-group">Agrawal, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jain, D. C.</span><span> </span><span class="NLM_article-title"><sup>13</sup>C NMR spectroscopy of oleanane triterpenoids</span> <span class="citation_source-journal">Prog. NMR Spectrosc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">90</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=16&amp;doi=10.1021%2Fjm200285z&amp;key=10.1016%2F0079-6565%2892%2980011-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=32&amp;doi=10.1021%2Fjm200285z&amp;key=1%3ACAS%3A528%3ADyaK38XitFCks7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=1992&pages=1-90&author=P.+K.+Agrawalauthor=D.+C.+Jain&title=13C+NMR+spectroscopy+of+oleanane+triterpenoids"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit84R"><div class="casContent"><span class="casTitleNuber">84</span><div class="casTitle"><span class="NLM_cas:atitle">Carbon-13 NMR spectroscopy of oleanane triterpenoids</span></div><div class="casAuthors">Agrawal, Pawan K.; Jain, Dharam C.</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Nuclear Magnetic Resonance Spectroscopy</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-90</span>CODEN:
                <span class="NLM_cas:coden">PNMRAT</span>;
        ISSN:<span class="NLM_cas:issn">0079-6565</span>.
    </div><div class="casAbstract">Review with 406 refs. including the assignment of 13C-NMR spectra, chem. shifts and shielding behavior of 456 oleanane triterpenoids.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgg74AL9F5HbVg90H21EOLACvtfcHk0lhxwJNiQ9hgLA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38XitFCks7s%253D&md5=492e1948d29e6f3fee14f2be2836b471</span></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1016%2F0079-6565%2892%2980011-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0079-6565%252892%252980011-4%26sid%3Dliteratum%253Aachs%26aulast%3DAgrawal%26aufirst%3DP.%2BK.%26aulast%3DJain%26aufirst%3DD.%2BC.%26atitle%3D13C%2520NMR%2520spectroscopy%2520of%2520oleanane%2520triterpenoids%26jtitle%3DProg.%2520NMR%2520Spectrosc.%26date%3D1992%26volume%3D24%26spage%3D1%26epage%3D90" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref85"><div class="reference"><strong class="refLabel"><a href="#ref85" class="rightTabRefNumLink">85</a></strong><div class="NLM_citation" id="rightTab-cit85"><span><span class="NLM_contrib-group">Mahato, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kundu, A. P.</span><span> </span><span class="NLM_article-title"><sup>13</sup>C NMR spectra of pentacyclic triterpenoids – a compilation and some salient features</span> <span class="citation_source-journal">Phytochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">1517</span><span class="NLM_x">–</span> <span class="NLM_lpage">1575</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1994&pages=1517-1575&issue=6&author=S.+B.+Mahatoauthor=A.+P.+Kundu&title=13C+NMR+spectra+of+pentacyclic+triterpenoids+%E2%80%93+a+compilation+and+some+salient+features"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMahato%26aufirst%3DS.%2BB.%26aulast%3DKundu%26aufirst%3DA.%2BP.%26atitle%3D13C%2520NMR%2520spectra%2520of%2520pentacyclic%2520triterpenoids%2520%25E2%2580%2593%2520a%2520compilation%2520and%2520some%2520salient%2520features%26jtitle%3DPhytochemistry%26date%3D1994%26volume%3D37%26issue%3D6%26spage%3D1517%26epage%3D1575" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref86"><div class="reference"><strong class="refLabel"><a href="#ref86" class="rightTabRefNumLink">86</a></strong><div class="NLM_citation" id="rightTab-cit86"><span><span class="NLM_contrib-group">Friesner, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Repasky, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frye, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenwood, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halgren, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanschagrin, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mainz, D. T.</span><span> </span><span class="NLM_article-title">Extra precision Glide: Docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">6177</span><span class="NLM_x">–</span> <span class="NLM_lpage">6196</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm051256o" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=32&amp;doi=10.1021%2Fjm200285z&amp;key=1%3ACAS%3A528%3ADC%252BD28XpvVGmurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=6177-6196&author=R.+A.+Friesnerauthor=R.+B.+Murphyauthor=M.+P.+Repaskyauthor=L.+L.+Fryeauthor=J.+R.+Greenwoodauthor=T.+A.+Halgrenauthor=P.+C.+Sanschagrinauthor=D.+T.+Mainz&title=Extra+precision+Glide%3A+Docking+and+scoring+incorporating+a+model+of+hydrophobic+enclosure+for+protein-ligand+complexes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit86R"><div class="casContent"><span class="casTitleNuber">86</span><div class="casTitle"><span class="NLM_cas:atitle">Extra Precision Glide: Docking and Scoring Incorporating a Model of Hydrophobic Enclosure for Protein-Ligand Complexes</span></div><div class="casAuthors">Friesner, Richard A.; Murphy, Robert B.; Repasky, Matthew P.; Frye, Leah L.; Greenwood, Jeremy R.; Halgren, Thomas A.; Sanschagrin, Paul C.; Mainz, Daniel T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6177-6196</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A novel scoring function to est. protein-ligand binding affinities has been developed and implemented as the Glide 4.0 XP scoring function and docking protocol.  In addn. to unique water desolvation energy terms, protein-ligand structural motifs leading to enhanced binding affinity are included:(1) hydrophobic enclosure where groups of lipophilic ligand atoms are enclosed on opposite faces by lipophilic protein atoms, (2) neutral-neutral single or correlated hydrogen bonds in a hydrophobically enclosed environment, and (3) five categories of charged-charged hydrogen bonds.  The XP scoring function and docking protocol have been developed to reproduce exptl. binding affinities for a set of 198 complexes (RMSDs of 2.26 and 1.73 kcal/mol over all and well-docked ligands, resp.) and to yield quality enrichments for a set of fifteen screens of pharmaceutical importance.  Enrichment results demonstrate the importance of the novel XP mol. recognition and water scoring in sepg. active and inactive ligands and avoiding false positives.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGohZiwN12vaY7Vg90H21EOLACvtfcHk0lhxwJNiQ9hgLA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XpvVGmurg%253D&md5=ea428c82ead0d8c27f8c1a7b694a1edf</span></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1021%2Fjm051256o&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm051256o%26sid%3Dliteratum%253Aachs%26aulast%3DFriesner%26aufirst%3DR.%2BA.%26aulast%3DMurphy%26aufirst%3DR.%2BB.%26aulast%3DRepasky%26aufirst%3DM.%2BP.%26aulast%3DFrye%26aufirst%3DL.%2BL.%26aulast%3DGreenwood%26aufirst%3DJ.%2BR.%26aulast%3DHalgren%26aufirst%3DT.%2BA.%26aulast%3DSanschagrin%26aufirst%3DP.%2BC.%26aulast%3DMainz%26aufirst%3DD.%2BT.%26atitle%3DExtra%2520precision%2520Glide%253A%2520Docking%2520and%2520scoring%2520incorporating%2520a%2520model%2520of%2520hydrophobic%2520enclosure%2520for%2520protein-ligand%2520complexes%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D6177%26epage%3D6196" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref87"><div class="reference"><strong class="refLabel"><a href="#ref87" class="rightTabRefNumLink">87</a></strong><div class="NLM_citation" id="rightTab-cit87"><span><span class="NLM_contrib-group">Arrigo, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldberg, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Welch, W. J.</span><span> </span><span class="NLM_article-title">Identity of the 19S ’prosome’ particle with the large multifunctional protease complex of mammalian cells (the proteasome)</span> <span class="citation_source-journal">Nature (London)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1988</span><span class="NLM_x">, </span> <span class="NLM_volume">331</span><span class="NLM_x">, </span> <span class="NLM_fpage">192</span><span class="NLM_x">–</span> <span class="NLM_lpage">194</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=16&amp;doi=10.1021%2Fjm200285z&amp;key=10.1038%2F331192a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=8&amp;doi=10.1021%2Fjm200285z&amp;key=3277060" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=32&amp;doi=10.1021%2Fjm200285z&amp;key=1%3ACAS%3A528%3ADyaL1MXptFSjug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=331&publication_year=1988&pages=192-194&author=A.+P.+Arrigoauthor=K.+Tanakaauthor=A.+L.+Goldbergauthor=W.+J.+Welch&title=Identity+of+the+19S+%E2%80%99prosome%E2%80%99+particle+with+the+large+multifunctional+protease+complex+of+mammalian+cells+%28the+proteasome%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit87R"><div class="casContent"><span class="casTitleNuber">87</span><div class="casTitle"><span class="NLM_cas:atitle">Identity of the 19S 'prosome' particle with the large multifunctional protease complex of mammalian cells (the proteasome)</span></div><div class="casAuthors">Arrigo, Andre Patrick; Tanaka, Keiji; Goldberg, Alfred L.; Welch, William J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">1988</span>),
    <span class="NLM_cas:volume">331</span>
        (<span class="NLM_cas:issue">6152</span>),
    <span class="NLM_cas:pages">192-4</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    </div><div class="casAbstract">Evidence is presented indicating that the previously described eukaryotic 19-20 S particle termed the prosome may actually be a high-mol.-wt. protease complex (designated LAMP for large alk. multi-functional protease).  The prosomes and these protease complexes are very similar or identical with respect to their size, polypeptide compn., immunol. cross-reactivity, appearance in the electron microscope, radial symmetry of subunits, subcellular localization, and proteolytic activities.  Therefore, the prosome probably plays a crit. role in intracellular protein breakdown, and it is proposed that it be renamed proteasome.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGryCVhvvnOZFrVg90H21EOLACvtfcHk0lhxwJNiQ9hgLA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1MXptFSjug%253D%253D&md5=5e60a608bac706e7a9786636251b8cdc</span></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.1038%2F331192a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F331192a0%26sid%3Dliteratum%253Aachs%26aulast%3DArrigo%26aufirst%3DA.%2BP.%26aulast%3DTanaka%26aufirst%3DK.%26aulast%3DGoldberg%26aufirst%3DA.%2BL.%26aulast%3DWelch%26aufirst%3DW.%2BJ.%26atitle%3DIdentity%2520of%2520the%252019S%2520%25E2%2580%2599prosome%25E2%2580%2599%2520particle%2520with%2520the%2520large%2520multifunctional%2520protease%2520complex%2520of%2520mammalian%2520cells%2520%2528the%2520proteasome%2529%26jtitle%3DNature%2520%2528London%2529%26date%3D1988%26volume%3D331%26spage%3D192%26epage%3D194" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref88"><div class="reference"><strong class="refLabel"><a href="#ref88" class="rightTabRefNumLink">88</a></strong><div class="NLM_citation" id="rightTab-cit88"><span><span class="NLM_contrib-group">Sadowski, J.</span><span> </span><span class="NLM_article-title">A hybrid approach for addressing ring flexibility in 3D database searching</span> <span class="citation_source-journal">J. Comput.-Aided Mol. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">53</span><span class="NLM_x">–</span> <span class="NLM_lpage">60</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=1997&pages=53-60&author=J.+Sadowski&title=A+hybrid+approach+for+addressing+ring+flexibility+in+3D+database+searching"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSadowski%26aufirst%3DJ.%26atitle%3DA%2520hybrid%2520approach%2520for%2520addressing%2520ring%2520flexibility%2520in%25203D%2520database%2520searching%26jtitle%3DJ.%2520Comput.-Aided%2520Mol.%2520Des.%26date%3D1997%26volume%3D11%26spage%3D53%26epage%3D60" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref89"><div class="reference"><strong class="refLabel"><a href="#ref89" class="rightTabRefNumLink">89</a></strong><div class="NLM_citation" id="rightTab-cit89"><span><span class="NLM_contrib-group">Moravec, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Brien, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daily, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scurria, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernad, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riss, T. L.</span><span> </span><span class="NLM_article-title">Cell-based bioluminescent assays for all three proteasome activities in a homogeneous format</span> <span class="citation_source-journal">Anal. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">387</span><span class="NLM_x">, </span> <span class="NLM_fpage">294</span><span class="NLM_x">–</span> <span class="NLM_lpage">302</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=387&publication_year=2009&pages=294-302&author=R.+A.+Moravecauthor=M.+A.+O%E2%80%99Brienauthor=W.+J.+Dailyauthor=M.+A.+Scurriaauthor=L.+Bernadauthor=T.+L.+Riss&title=Cell-based+bioluminescent+assays+for+all+three+proteasome+activities+in+a+homogeneous+format"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMoravec%26aufirst%3DR.%2BA.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DM.%2BA.%26aulast%3DDaily%26aufirst%3DW.%2BJ.%26aulast%3DScurria%26aufirst%3DM.%2BA.%26aulast%3DBernad%26aufirst%3DL.%26aulast%3DRiss%26aufirst%3DT.%2BL.%26atitle%3DCell-based%2520bioluminescent%2520assays%2520for%2520all%2520three%2520proteasome%2520activities%2520in%2520a%2520homogeneous%2520format%26jtitle%3DAnal.%2520Biochem.%26date%3D2009%26volume%3D387%26spage%3D294%26epage%3D302" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref90"><div class="reference"><strong class="refLabel"><a href="#ref90" class="rightTabRefNumLink">90</a></strong><div class="NLM_citation" id="rightTab-cit90"><span><span class="NLM_contrib-group">Lamoral-Theys, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pottier, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kerff, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dufrasne, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Proutière, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wauthoz, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neven, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ingrassia, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Antwerpen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lefranc, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gelbcke, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pirotte, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kraus, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nève, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kornienko, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiss, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dubois, J.</span><span> </span><span class="NLM_article-title">Simple di- and trivanillates exhibit cytostatic properties toward cancer cells resistant to pro-apoptotic stimuli</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">3823</span><span class="NLM_x">–</span> <span class="NLM_lpage">3833</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2010&pages=3823-3833&author=D.+Lamoral-Theysauthor=L.+Pottierauthor=F.+Kerffauthor=F.+Dufrasneauthor=F.+Prouti%C3%A8reauthor=N.+Wauthozauthor=P.+Nevenauthor=L.+Ingrassiaauthor=P.+Van+Antwerpenauthor=F.+Lefrancauthor=M.+Gelbckeauthor=B.+Pirotteauthor=J.+L.+Krausauthor=J.+N%C3%A8veauthor=A.+Kornienkoauthor=R.+Kissauthor=J.+Dubois&title=Simple+di-+and+trivanillates+exhibit+cytostatic+properties+toward+cancer+cells+resistant+to+pro-apoptotic+stimuli"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLamoral-Theys%26aufirst%3DD.%26aulast%3DPottier%26aufirst%3DL.%26aulast%3DKerff%26aufirst%3DF.%26aulast%3DDufrasne%26aufirst%3DF.%26aulast%3DProuti%25C3%25A8re%26aufirst%3DF.%26aulast%3DWauthoz%26aufirst%3DN.%26aulast%3DNeven%26aufirst%3DP.%26aulast%3DIngrassia%26aufirst%3DL.%26aulast%3DVan%2BAntwerpen%26aufirst%3DP.%26aulast%3DLefranc%26aufirst%3DF.%26aulast%3DGelbcke%26aufirst%3DM.%26aulast%3DPirotte%26aufirst%3DB.%26aulast%3DKraus%26aufirst%3DJ.%2BL.%26aulast%3DN%25C3%25A8ve%26aufirst%3DJ.%26aulast%3DKornienko%26aufirst%3DA.%26aulast%3DKiss%26aufirst%3DR.%26aulast%3DDubois%26aufirst%3DJ.%26atitle%3DSimple%2520di-%2520and%2520trivanillates%2520exhibit%2520cytostatic%2520properties%2520toward%2520cancer%2520cells%2520resistant%2520to%2520pro-apoptotic%2520stimuli%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2010%26volume%3D18%26spage%3D3823%26epage%3D3833" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3D29" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3D29','PDB','3D29'); return false;">PDB: 3D29</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3NZJ" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3NZJ','PDB','3NZJ'); return false;">PDB: 3NZJ</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3MG8" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3MG8','PDB','3MG8'); return false;">PDB: 3MG8</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3MG4" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3MG4','PDB','3MG4'); return false;">PDB: 3MG4</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3GPJ" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3GPJ','PDB','3GPJ'); return false;">PDB: 3GPJ</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i30"><a href="/doi/suppl/10.1021/jm200285z">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_57505"></div></div></div></div></div><hr /></hr><p class="last">The characterization data for all compounds that have been synthesized and biologically evaluated in this study (HPLC, <sup>1</sup>H NMR, <sup>13</sup>C NMR, mass spectra, etc.) and the detailed biological and biochemical protocols.This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm200285z/suppl_file/jm200285z_si_001.pdf">jm200285z_si_001.pdf (413.0 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm200285z&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2011.54.issue-19%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Barticle%3Aarticle%3A10.1021%2Fjm200285z" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm200285z" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                4MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67991c4caa02d203","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
